"URL","Uniprot ID","PMID","Abstract"
https://pharos.nih.gov/idg/targets/P55263,P55263,28789481,"The results of this study showed that over-expression of the major adenosine removing enzyme ADK in reactive astrocytes and subpopulation of remaining neurons in Rasmussen Encephalitis patients plays an important role in the epileptogensis of Rasmussen Encephalitis."
https://pharos.nih.gov/idg/targets/P55263,P55263,26329539,"ADA and ADK are involved in glioma progression; increased ADA and ADK levels in peritumoral tissues may be associated with epilepsy in glioma patients."
https://pharos.nih.gov/idg/targets/P55263,P55263,26040919,"rs11001109 rare allele homozygosity is associated with increased risk of post-traumatic epilepsy development after brain injury."
https://pharos.nih.gov/idg/targets/P55263,P55263,25575137,"The results of this study suggest that upregulation of ADK is a common pathologic component of FCDIIB."
https://pharos.nih.gov/idg/targets/P55263,P55263,24128682,"These results suggest that upregulation of ADK is a common pathologic hallmark of Rasmussen encephalitis and that ADK might be a target in the treatment of epilepsy associated with Rasmussen encephalitis."
https://pharos.nih.gov/idg/targets/P55263,P55263,22092111,"Data show that we a significantly higher expression of ADK in the peritumoral infiltrated tissue of patients with epilepsy than in patients without epilepsy."
https://pharos.nih.gov/idg/targets/P55263,P55263,21635241,"The results of this study suggested that dysregulation of ADK in astrocytes is a common pathologic hallmark of temporal lobe epilepsy."
https://pharos.nih.gov/idg/targets/P55263,P55263,20881134,"The cytoplasmic isoform of adenosine kinase is sufficient to alter sleep physiology. ADK might orchestrate neurotransmitter pathways involved in the generation of electroencephlogram oscillations and regulation of sleep."
https://pharos.nih.gov/idg/targets/P55263,P55263,20698827,"The catalytic properties, gene expression and protein levels of certain proteins involved in mitochondrial ATP synthesis, such as F1F0-ATPase, ANT and AK, in human skin fibroblasts with trisomic karyotype, compared them with euploid fibroblasts."
https://pharos.nih.gov/idg/targets/P55263,P55263,20392501,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P55263,P55263,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P55263,P55263,19635462,"This study reports for the first time subcellular localization of the enzyme AdK in mammalian cells."
https://pharos.nih.gov/idg/targets/P55263,P55263,18600545,"both deoxycytidine kinase and adenosine kinase are involved in this model of ADA deficiency"
https://pharos.nih.gov/idg/targets/P55263,P55263,18600536,"adenosine kinase gene expression was significantly higher in cancer than in normal-appearing tissue, in line with our previous measurements of adenosine kinase enzyme activities in colorectal tumor samples"
https://pharos.nih.gov/idg/targets/P55263,P55263,18309031,"role for HIF-1alpha in transcriptional repression of AK in hypoxia"
https://pharos.nih.gov/idg/targets/P55263,P55263,16385451,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P55263,P55263,12820662,"Equilibrative nucleoside transporters (hENT1, hENT2) together with adenosine kinase and 5'-nucleotidase play a crucial role in the regulation of CFTR through an adenosine-dependent pathway in human airway epithelia."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,27989622,"esults show that Aichi virus 3A protein activates the lipid kinase activity of PI4KIIIb,which activation is sensitized by the protein ACBD3. The interfaces between PI4KIIIbeta-ACBD3 and ACBD3-3A were mapped with hydrogen-deuterium exchange mass spectrometry."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,27093462,"The results showed that, in contrast to the enteroviruses and the cardioviruses, foot-and-mouth disease virus replication does not require PI4KIII (PI4KIIIalpha and PI4KIIIbeta), and phosphatidylinositol 4-phosphate levels do not increase in foot-and-mouth disease virus-infected cells and phosphatidylinositol 4-phosphate is not seen at replication organelles."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,27009356,"Data show that ACBD3 can recruit PI4KB to model membranes as well as redirect PI4KB to cellular membranes where it is not naturally found. Also, results show that ACBD3 regulates the enzymatic activity of PI4KB kinase through membrane recruitment rather than allostery."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,26756197,"Analysis reveals novel aspects of the PI4KIIIb-Rab11 complex and determines binding and catalytic sites of the kinase."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,25410869,"Although human rhinovirus 3A protein was previously shown to interact with ACBD3, these data suggest that PI4KIIIbeta recruitment occurred independently of both GBF1 and ACBD3."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,24962317,"PI4KIIIbeta likely plays a role in breast oncogenesis and that cooperation between Rab11a and PI4KIIIbeta represents a novel Akt activation pathway."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,24876499,"these data provide a mechanism for how PI4KIIIbeta coordinates Rab11 and its effectors on PI4P-enriched membranes and also provide strategies for the design of specific inhibitors that could potentially target plasmodial PI4KIIIbeta to combat malaria."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,24792752,"Authors found that NS5A and PI4KB competed for association of acyl-coenzyme A binding domain containing protein 3 (ACBD3), which inhibited hepatitis C virus replication."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,24672044,"Host ACBD3, PI4KIIIBETA and Aichi virus proteins complexes enhances phosphatidylinositol 4-phosphate synthesis and is critical for viral replication."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,24527995,"These results suggest that poliovirus proteins modulate PI4KB activity and provide PI4P for recruitment of OSBP to accumulate unesterified cholesterol on virus-induced membrane structure for formation of a virus replication complex."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,23258225,"The lipid kinase PI4KIIIbeta preserves lysosomal identity."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,22359663,"During authentic HCV infection, PI4P plays an integral role in virus replication; the vesicular transport proteins ARF1 and GBF1 colocalized with PI4KIIIbeta and were both required for HCV replication."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,22258260,"The 3A protein of picornaviruses utilizes the golgi adaptor protein ACBD3 to recruit PI4KIIIbeta."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,22253445,"Phosphatidylinositol 4-kinase IIIbeta is required for severe acute respiratory syndrome coronavirus spike-mediated cell entry."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,22124328,"results indicate that a viral protein/ACBD3/PI4KB complex is formed to synthesize PI4P at the AiV RNA replication sites and plays an essential role in viral RNA replication"
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,21851817,"The PI4KIIIbeta likely plays an important role in mammary neoplasia and acinar development."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,21810903,"Our data establish PtdIns(4,5)P(2) as a direct activator of TRPV6 and demonstrate that intracellular ATP regulates the channel indirectly as a substrate for type III PI4Ks"
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,21330372,"Study identify the molecular chaperone Hsp90 as a binding partner of PI4KIIbeta, but not of PI4KIIalpha."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,21218173,"Knockdown of PI4KIIalpha does not inhibit EGF-stimulated Akt phosphorylation."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,19608626,"our library screening completed data on the clathrin-mediated endocytosis-dependant entry route of HCV and identified 2 kinases, PI4KIIIalpha and beta, as relevant potential therapeutic targets."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,19605471,"genetic or pharmacological modulation of PI4KA and PI4KB inhibits multiple genotypes of HCV"
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,19204726,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,18474610,"Work suggests an important role for both eEF1A2 and PI4KIIIbeta in the control of PI(4,5)P(2) signaling and actin remodeling."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,17555516,"PI4KIIalpha or PI4KIIbeta knockdown, but not type III PI4Kbeta knockdown, inhibits Listeria internalization."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,17088255,"there is a physical and functional relationship between eEF1A2 and PI4KIIIbeta"
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,17003043,"PI 4-kinase beta is a key enzyme in the control of spingomyelin synthesis by controlling the flow of ceramide from the ER to the Golgi compartment"
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,15634669,"PI4KIIIbeta (PIK4CB) and PI4KIIalpha (PIK4CA) localize to discrete subcompartments of the Golgi complex in Madin-Darby canine kidney (MDCK) cells."
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,12324459,"determination that the enzyme is primarily cytosolic, and it associates peripherally with plasma membranes, endoplasmic reticulum, and the Golgi"
https://pharos.nih.gov/idg/targets/Q9UBF8,Q9UBF8,11923287,"Characterization of type II phosphatidylinositol 4-kinase isoforms reveals association of the enzymes with endosomal vesicular compartments"
https://pharos.nih.gov/idg/targets/P27987,P27987,27582507,"miR-140-5p regulates this context-specific autophagy through its target, inositol 1,4,5-trisphosphate kinase 2 (IP3k2). Therefore, the results of the present study demonstrated that miR-140-5p mediated drug-resistance in osteosarcoma cells by inducing autophagy."
https://pharos.nih.gov/idg/targets/P27987,P27987,27485122,"The authors confirm downregulation of miR-132 and upregulation of ITPKB in three distinct human Alzheimer's disease patient cohorts."
https://pharos.nih.gov/idg/targets/P27987,P27987,24401760,"ITPKB is increased in Alzheimer's brain three-fold in the cerebral cortex of most patients with Alzheimer's disease compared with control subjects and accumulates in dystrophic neurites associated with amyloid plaques."
https://pharos.nih.gov/idg/targets/P27987,P27987,22446005,"a specific increase in inositol 1,4,5-trisphosphate 3-kinase A and B (ITPKA and ITPKB) was observed upon hESCs spontaneous differentiation."
https://pharos.nih.gov/idg/targets/P27987,P27987,21148483,"IP3KB not only regulates cytoplasmic Ca(2+) signals by phosphorylation of subplasmalemmal and cytoplasmic Ins(1,4,5)P(3) but may also be involved in modulating nuclear Ca(2+) signals generated from these nuclear envelope invaginations."
https://pharos.nih.gov/idg/targets/P27987,P27987,20628086,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27987,P27987,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27987,P27987,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27987,P27987,16740130,"In each of the three isoforms a nuclear export signal has evolved in the catalytic domain either de novo (IP3K-A) or as a substitute for an earlier evolved corresponding N-terminal signal (IP3K-B and IP3K-C)."
https://pharos.nih.gov/idg/targets/P27987,P27987,16354157,"We aim to summarize the existing information about functionally uncoupled IP(3)R and RyR channels, and to discuss the concept that those channels can participate in Ca(2+)-leak pathways."
https://pharos.nih.gov/idg/targets/P27987,P27987,12747803,"results highlight the potential role of the three isoforms of InsP3 3-kinase as direct InsP3 metabolizing enzymes and direct regulators of Ca2+ responses to extracellular signals"
https://pharos.nih.gov/idg/targets/P00558,P00558,28923857,"Data show that LINC00963 (MetaLnc9) interacted with the glycolytic kinase PGK1 and prevented its ubiquitination in non-small cell lung cancer (NSCLC) cells, leading to activation of the oncogenic AKT/mTOR signaling pathway."
https://pharos.nih.gov/idg/targets/P00558,P00558,28457968,"Data suggest that, in breast cancer cells, MYC acts as an upstream regulator leading to PGK1 activation. (MYC, proto-oncogene c-myc; PGK1, phosphoglycerate kinase 1)"
https://pharos.nih.gov/idg/targets/P00558,P00558,28238651,"Acetylated PGK1 binds to and phosphorylates Beclin1 at S30, leading to activation of the VPS34-Beclin1 complex to initiate autophagosomal formation."
https://pharos.nih.gov/idg/targets/P00558,P00558,27375898,"HIV-1 gp160 interacts with PGK1"
https://pharos.nih.gov/idg/targets/P00558,P00558,27342824,"PGK1, a glycolytic enzyme catalyzing the conversion of 3-phosphoglycerate into 2-phosphoglycerate, has increased expression in synovial tissues and blood of rheumatoid arthritis, which may be involved in pro-inflammation and synovial hyperplasia of the disease"
https://pharos.nih.gov/idg/targets/P00558,P00558,26942675,"Mitochindrial PGK1 acts as a protein kinase in coordinating glycolysis and the tricarboxylic acid cycle, which is instrumental in cancer metabolism and tumorigenesis."
https://pharos.nih.gov/idg/targets/P00558,P00558,26510737,"In neuroblastoma cells, CAIX and PGK1 expression is up regulated under hypoxia and correlates with response to targeted anti-proliferative treatment."
https://pharos.nih.gov/idg/targets/P00558,P00558,26396085,"Retinal dystrophy may be one of the clinical manifestations of phosphoglycerate kinase deficiency."
https://pharos.nih.gov/idg/targets/P00558,P00558,26356530,"PI3K/AKT/mTOR pathway regulates HDAC3 S424 phosphorylation, which promotes HDAC3-PGK1 interaction and PGK1 K220 deacetylation"
https://pharos.nih.gov/idg/targets/P00558,P00558,25867275,"Results show that PGK1 mRNA and protein expression were significantly increased in breast cancer tissues and can be considered as a prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer."
https://pharos.nih.gov/idg/targets/P00558,P00558,25175369,"Suppression of PGK1 enhanced the radiosensitivity of U251 xenografts and suggest that PGK1 may serve as a useful target in the treatment of radioresistant glioma."
https://pharos.nih.gov/idg/targets/P00558,P00558,24934115,"Phosphoglycerate kinase deficiency due to a novel mutation (c. 1180A>G) manifesting as chronic hemolytic anemia in a Japanese boy."
https://pharos.nih.gov/idg/targets/P00558,P00558,24838780,"mutations associated with hPGK1 deficiency lead to increased aggregation and proteolysis rates in vitro and inside cells due to protein thermodynamic destabilization"
https://pharos.nih.gov/idg/targets/P00558,P00558,24721582,"different factors contributing to hPGK1 thermodynamic and kinetic stability"
https://pharos.nih.gov/idg/targets/P00558,P00558,24376734,"PGK1 appears to play an important role for neuroblastoma"
https://pharos.nih.gov/idg/targets/P00558,P00558,24284928,"PGK1 could promote radioresistance in U251 human cells."
https://pharos.nih.gov/idg/targets/P00558,P00558,23727790,"increased expression of PGK1 in colon cancer tissue is associated with metastasis."
https://pharos.nih.gov/idg/targets/P00558,P00558,23684636,"Conformational dynamics in the catalytic cycle of phosphoglycerate kinase, molecular details provided by structural analysis. [Review]"
https://pharos.nih.gov/idg/targets/P00558,P00558,23336698,"the low kinetic stability displayed by PGK1 protein mutations is causing human PGK1 deficiency"
https://pharos.nih.gov/idg/targets/P00558,P00558,23166591,"HIV-1 gp160 interacts with PGK1"
https://pharos.nih.gov/idg/targets/P00558,P00558,23130662,"Glycolytic enzymes PGK1 and PKM2 are novel transcriptional targets of PPARgamma in breast cancer."
https://pharos.nih.gov/idg/targets/P00558,P00558,22742733,"Phosphoglycerate kinase 1 was up-regulated significantly in radioresistant astrocytomas and also seems to be correlated with the negative prognosis following radiotherapy."
https://pharos.nih.gov/idg/targets/P00558,P00558,22619369,"carbonic anhydrase I, phosphoglycerate kinase 1 and apolipoprotein A-I appeared to be the most significant variations of proteins in patients with osteopenia and osteoarthritis"
https://pharos.nih.gov/idg/targets/P00558,P00558,22348148,"All findings indicate that the different clinical manifestations associated with PGK1 deficiency chiefly depend on the distinctive type of perturbations caused by mutations in the PGK1 gene"
https://pharos.nih.gov/idg/targets/P00558,P00558,21780947,"two key (hub) PPARgamma direct target genes, PRKCZ and PGK1, were experimentally validated to be repressed upon PPARgamma activation by its natural ligand, 15d-PGJ2 in three prostrate cancer cell lines"
https://pharos.nih.gov/idg/targets/P00558,P00558,21549683,"Molecular dynamics simulations were carried out with four different nucleotides (D-/L-ADP and D-/L-CDP) in complex with PGK and 1,3-bisphospho-d-glycerate. The binding affinities of CDPs were very weak while D- and L-ADP were better substrates."
https://pharos.nih.gov/idg/targets/P00558,P00558,21505655,"enzyme kinetics studies show that the absence of the ribose OH-groups with is better tolerated for the purine than for the pyrimidine containing compounds in phosphoglycerate kinase 1"
https://pharos.nih.gov/idg/targets/P00558,P00558,21349853,"PGK domain movement and catalysis is regulated by a spring-loaded release mechanism"
https://pharos.nih.gov/idg/targets/P00558,P00558,20068185,"PGK1-overexpressing fibroblasts with prostate tumor cells promoted tumor cell growth in vivo. Observations suggest that PGK1 helps support the interactions between cancer and its microenvironment."
https://pharos.nih.gov/idg/targets/P00558,P00558,19854185,"Results suggest that conformational rearrangements in the hinge generated by binding of both substrates provide the main driving force for domain closure overcoming the slightly unfavourable contact interactions between the domains."
https://pharos.nih.gov/idg/targets/P00558,P00558,19778949,"Phosphoglycerate kinase 1 (PGK1) showed a difference between follicular cells from follicles leading to a pregnancy or developmental failure."
https://pharos.nih.gov/idg/targets/P00558,P00558,19688824,"Data show that PGK1 regulates the expression of CXCR4 and beta-catenin at the mRNA and protein levels."
https://pharos.nih.gov/idg/targets/P00558,P00558,19110265,"This protein has been found differentially expressed in the dorsolateral prefrontal cortex from patients with schizophrenia."
https://pharos.nih.gov/idg/targets/P00558,P00558,18603805,"PGK1 was selectively overexpressed in human colon tumor cells by treating with hydrogen peroxide as oxidative stress, while its expression was suppressed by co-treatment with antioxidants."
https://pharos.nih.gov/idg/targets/P00558,P00558,18540639,"transmission path of the nucleotide effect toward the main hinge of phosphoglycerate kinase is described for the first time at the level of interactions existing in the tertiary structure[ 3-phosphoglycerate kinase]"
https://pharos.nih.gov/idg/targets/P00558,P00558,18453750,"overexpression of PGK1 and its signalling targets may be a expression-pathway in diffuse primary gastric carcinomas promoting peritoneal dissemination"
https://pharos.nih.gov/idg/targets/P00558,P00558,18288812,"Although L-ADP is almost as catalytically competent as D-ADP, under our experimental conditions (buffer containing 30% methanol, 4 degrees C) phosphoglycerate kinase binds D- and L-ADP with similar kinetics."
https://pharos.nih.gov/idg/targets/P00558,P00558,18096512,"Aa steady state kinetic and biophysical study of the interaction of the model compound l-MgADP with hPGK, is presented."
https://pharos.nih.gov/idg/targets/P00558,P00558,17661373,"our study indicates that inhibition of the transcription mechanism is the cause of PGK deficiency."
https://pharos.nih.gov/idg/targets/P00558,P00558,17565005,"The impact of hypoxic treatment on the expression of PGK1 and the cytotoxicity of troxacitabine and gemcitabine are reported."
https://pharos.nih.gov/idg/targets/P00558,P00558,16363799,"During domain closure, Lys 215 in 3-phosphoglycerate kinase possibly moves together with the transferring phosphate, and this group is being positioned properly for catalysis."
https://pharos.nih.gov/idg/targets/P00558,P00558,15255553,"phosphoglycerate kinase does not appear to have a role in the development or progression of neoplasms [letter]"
https://pharos.nih.gov/idg/targets/P00558,P00558,15053920,"production and secretion of PGK are regulated separately and oxygen and the protein hydroxylases can control not only gene expression but also protein secretion"
https://pharos.nih.gov/idg/targets/P00558,P00558,14764427,"These results demonstrate that phosphpglycerate kinase regulates uPAR expression at the post-transcriptional level."
https://pharos.nih.gov/idg/targets/P00558,P00558,12869554,"3-phosphoglycerate kinase has a role in the activation of L-nucleoside analogs"
https://pharos.nih.gov/idg/targets/P00558,P00558,12174867,"Overexpression induces a multidrug resistance phenotype."
https://pharos.nih.gov/idg/targets/P00558,P00558,12080078,"Phosphorylates pyrimidine L-deoxynucleoside analog diphosphaates"
https://pharos.nih.gov/idg/targets/P00558,P00558,11745195,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P00558,P00558,11130727,"Phosphoglycerate kinase is a moonlighting protein that functions as both a glycolytic enzyme and a disulfide reductase. "
https://pharos.nih.gov/idg/targets/P00558,P00558,2324090,"Generif: Phosphoglycerate kinase is a moonlighting protein that functions as both a glycolytic enzyme and a primer recognition protein of DNA polymerase alpha. "
https://pharos.nih.gov/idg/targets/P14618,P14618,29277786,"Due to achieved results concerning expression of PKM2 there is a lack of evidence for its diagnostic and prognostic usage in ovarian cancer."
https://pharos.nih.gov/idg/targets/P14618,P14618,29058718,"The CARM1-PKM2 axis serves as a metabolic reprogramming mechanism in tumorigenesis."
https://pharos.nih.gov/idg/targets/P14618,P14618,29032577,"These findings suggested that PKM2 and GLS might play important roles in the proliferation of hypoxic gastric cancer cells"
https://pharos.nih.gov/idg/targets/P14618,P14618,28994148,"demonstrated that lincRNA-p21 blunted the prostate cancer cell proliferation and tumorigenic capacity through down-regulation of PKM2"
https://pharos.nih.gov/idg/targets/P14618,P14618,28802581,"The PKM2 may promote hepatic IR via STAT3 pathway and would provide a new insight into dissecting the molecular pathogenesis of hepatic insulin resistance."
https://pharos.nih.gov/idg/targets/P14618,P14618,28778925,"Data suggest that PKM1 and PKM2, alternative splice variants that interact with each other, are expressed and localized differently in lung carcinoma cell lines; PKM1 or PKM2 knockdown (via RNA interference) differentially affects net pyruvate kinase activity, mitochondrial biogenesis, energy metabolism, ATP level, autophagy, and apoptosis/cell viability."
https://pharos.nih.gov/idg/targets/P14618,P14618,28746922,"The PKM2-shRNA group exhibited reduced PKM2 mRNA and protein expression, whereas p53 and p21 expression was increased compared with the blank and empty plasmid groups."
https://pharos.nih.gov/idg/targets/P14618,P14618,28656802,"our results identified that mammalian sterile 20-like kinase 1 is a novel downstream target of pyruvate kinase M2, and knockdown of pyruvate kinase M2 contributes apoptosis via promoting nuclear translocation of mammalian sterile 20-like kinase 1 by enhancing Caspase-3-dependent cleavage."
https://pharos.nih.gov/idg/targets/P14618,P14618,28641694,"Overexpression of miR-133b inhibited the growth and proliferation of lung cancer stem cells by down regulating PKM2."
https://pharos.nih.gov/idg/targets/P14618,P14618,28630053,"These results suggest that increased expression of PKM2 is not required to support c-MYC-induced tumorigenesis in the liver and that various PKM1/PKM2 ratios and pyruvate kinase activities can sustain glucose catabolism required for this process."
https://pharos.nih.gov/idg/targets/P14618,P14618,28583828,"Blockage of autophagy enhanced Tat-induced HIV-1 transactivation in TZM-bl cells. Moreover, Tat activated the Akt/mTOR and inhibited AMPK signaling pathway that was related to its up-regulation of PKM2 expression."
https://pharos.nih.gov/idg/targets/P14618,P14618,28543190,"These findings indicate that shRNA-mediated silencing of PKM2 gene promotes apoptosis and inhibits aerobic glycolysis, proliferation, migration, and invasion in colorectal cancer cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,28436957,"In the glomeruli of patients with longstanding diabetes with and without diabetic nephropathy, pyruvate kinase M2 (PKM2) expression and activity were upregulated. PKM2 activation may protect against DN by increasing glucose metabolic flux, inhibiting the production of toxic glucose metabolites and inducing mitochondrial biogenesis to restore mitochondrial function."
https://pharos.nih.gov/idg/targets/P14618,P14618,28418088,"It has been found that the adaptor protein receptor for activated PKC kinase (RACK1) formed a complex with FGFR1 and PKM2, and activated the FGFR1/PKM2 signaling. The study shows that RACK1 forms a complex with FGFR1 and PKM2, and stimulates the growth and migration of squamous lung cancer cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,28414323,"Studied interactions of polypyrimidine tract-binding protein (PTBP1), pyruvate kinase M2 (PKM2), and STAT3 (signal transducer and activator of transcription 3) in oncogenesis of anaplastic large cell lymphoma (ALCL). Results show that in ALCL cells, PTBP1 is crucial for PKM2 phosphorylation of STAT3 in the nucleus."
https://pharos.nih.gov/idg/targets/P14618,P14618,28394882,"Authors subsequently investigated whether miR-4417 and TRIM35 regulate HCC cell proliferation and apoptosis through PKM2 Y105 phosphorylation, and the results supported our speculation that miR-4417 targets TRIM35 and regulates the Y105 phosphorylation of PKM2 to promote hepatocarcinogenesis."
https://pharos.nih.gov/idg/targets/P14618,P14618,28393220,"PKM2 downregulation resulted in, metformin inhibited glucose uptake, lactate production and ATP production in osteosarcoma cancer stem cells"
https://pharos.nih.gov/idg/targets/P14618,P14618,28347237,"we revealed a novel mechanism of pyruvate kinase M2 in promoting colorectal cancer progression by recruitment of macrophages through p65 nuclear factor-kappaB-mediated expression of CCL2."
https://pharos.nih.gov/idg/targets/P14618,P14618,28346425,"Study reveals a mechanism that the Warburg effect is regulated by CHIP through its function as an E3 ligase, which mediates the degradation of PKM2 during tumor progression."
https://pharos.nih.gov/idg/targets/P14618,P14618,28281967,"Cell migration and invasion were significantly suppressed by siRNA-PKM2."
https://pharos.nih.gov/idg/targets/P14618,P14618,28259998,"Study shows that the enhanced expression of PKM2 in lung cancer cells is likely associated with the biological properties of cancer stem cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,28235245,"Knockdown of PKM2 in GC cells caused significant decreases in cellular proliferation."
https://pharos.nih.gov/idg/targets/P14618,P14618,28183315,"reverse phase protein microarrays identified the glycolysis promoting PKM2 and IF1 proteins as specific biomarkers of dermatomyositis."
https://pharos.nih.gov/idg/targets/P14618,P14618,28086949,"NEK2 promotes aerobic glycolysis through regulating splicing of PKM and increasing the PKM2/PKM1 ratio in myeloma cells which contributes to its oncogenic activity."
https://pharos.nih.gov/idg/targets/P14618,P14618,28035139,"These findings uncover a novel mechanism through which mitochondrial PKM2 phosphorylates Bcl2 and inhibits apoptosis directly."
https://pharos.nih.gov/idg/targets/P14618,P14618,27989750,"UCP2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreatic cancer cells to glycolysis inhibition."
https://pharos.nih.gov/idg/targets/P14618,P14618,27894667,"Nuclear PKM2 expression as an independent risk factor for early recurrence of hepatocellular carcinoma after curative resection."
https://pharos.nih.gov/idg/targets/P14618,P14618,27821480,"RBM4 is induced and is involved in the PKM splicing switch and neuronal gene expression during hypoxia-induced neuronal differentiation."
https://pharos.nih.gov/idg/targets/P14618,P14618,27810895,"PKM2 interferes with phosphorylation of P53 at serine 15, known to stimulate P53 activity by the ATM serine/threonine kinase."
https://pharos.nih.gov/idg/targets/P14618,P14618,27683215,"PKM2 activity is higher in patients with NSCLC than in healthy subjects. The level of PKM2 activity is associated with advanced stage of cancer."
https://pharos.nih.gov/idg/targets/P14618,P14618,27644251,"PKM2 expression was elevated in the cancerous tissues and it was more abundant than the adjacent normal tissues. the overall survival for patients with high PKM2 expression was significantly lower than those with low PKM2 expression."
https://pharos.nih.gov/idg/targets/P14618,P14618,27573352,"Results show that PKM2 physically associates with TSC22D2 reducing its nuclear localization and contributing to tumor suppressor function of TSC22D2 in colorectal cancer."
https://pharos.nih.gov/idg/targets/P14618,P14618,27467582,"results show that the Aha1-Hsp90-PKM2/HIF-1alpha axis mediates the induction of aromatase in Li-Fraumeni Syndrome."
https://pharos.nih.gov/idg/targets/P14618,P14618,27431728,"High PKM2 expression is associated with clear-cell renal cell carcinoma."
https://pharos.nih.gov/idg/targets/P14618,P14618,27413251,"In CRC, sensitivity of M2PK, iFOBT, and Hb/Hp complex proved to be high. Combined use of M2PK, iFOBT, and FC may be valuable in the detection of large adenomas."
https://pharos.nih.gov/idg/targets/P14618,P14618,27385486,"We further hypothesize that mTOR/PKM2 pathway stimulation serves to sustain the oncogenic activity of mutant p53 through both the enhancement of chemoresistance and of aerobic glycolysis of cancer cells"
https://pharos.nih.gov/idg/targets/P14618,P14618,27249540,"PKM2 is a transcriptional co-activator of HIV-1 long terminal repeat."
https://pharos.nih.gov/idg/targets/P14618,P14618,27199445,"Jmjd8 is upregulated during endothelial differentiation and regulates endothelial sprouting and metabolism by interacting with pyruvate kinase M2."
https://pharos.nih.gov/idg/targets/P14618,P14618,27197174,"Acetylation of PKM2 is associated with breast Cancer."
https://pharos.nih.gov/idg/targets/P14618,P14618,27163637,"These findings suggest that 3,3',5-triiodothyroxine (T3) can inhibit apoptosis and oxidative stress in an oxygen-glucose deprivation/reperfusion model AC16 and HCM-a cells by regulating the PKM2/PKM1 ratio."
https://pharos.nih.gov/idg/targets/P14618,P14618,27040384,"the anticancer activity of tanshinone A was targeted at metabolic regulation of miR-122/PKM2 in human esophagus cancer cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,27014756,"Faecal tumor M2-pyruvate kinase ELISA may have utility as an adjunct to faecal occult blood test in a screening context, but do not support its use in symptomatic patients."
https://pharos.nih.gov/idg/targets/P14618,P14618,27012213,"PKM1 has a role in resistance to anti-cancer drugs"
https://pharos.nih.gov/idg/targets/P14618,P14618,26989901,"Multivariable analysis showed that combined expression of pyruvate kinase type M2 and lactate dehydrogenase A was an independent poor prognostic marker for survival."
https://pharos.nih.gov/idg/targets/P14618,P14618,26981025,"Data indicate that combined use of immunochemical test for hemoglobin (FIT) and fecal M2-type pyruvate kinase (M2-PK) permitted the identification of 18 more neoplasm (25%)."
https://pharos.nih.gov/idg/targets/P14618,P14618,26975375,"Ubiquitylation of PKM2 by parkin does not affect its stability but decreases its enzymatic activity."
https://pharos.nih.gov/idg/targets/P14618,P14618,26959741,"we demonstrated that SHP-1 dephosphorylates PKM2Y105 to inhibit the Warburg effect and nucleus-dependent cell proliferation, and the dephosphorylation of PKM2Y105 by SHP-1 determines the efficacy of targeted drugs for hepatocellular carcinoma treatment"
https://pharos.nih.gov/idg/targets/P14618,P14618,26926996,"PKM2 serves a previously unidentified role as a molecular integrator of metabolic dysfunction, oxidative stress and tissue inflammation and represents a novel therapeutic target in cardiovascular disease."
https://pharos.nih.gov/idg/targets/P14618,P14618,26926077,"PKM2 interacts with Tristetraprolin directly, regulates Tristetraprolin transcriptional modification, destabilizes Tristetraprolin, and then impairs cell proliferation in breast cancer. Collectively, the results offer evidence of a role for PKM2 in Tristetraprolin regulation in cancer cells which may be a potential therapy target in breast cancer."
https://pharos.nih.gov/idg/targets/P14618,P14618,26876154,"Our results provided the first phosphorylome of PKM2 and revealed a constitutive mTORC1 activating mechanism in cancer cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,26874904,"These results define a novel mechanism by which PKM2 regulates glioma cell growth, and also define a novel set of potential therapeutic targets along the PKM2-HuR-p27 pathway"
https://pharos.nih.gov/idg/targets/P14618,P14618,26787900,"demonstrate that PKM2 deacetylation is integral to SIRT6-mediated tumor suppression and inhibition of metastasis. Additionally, reduced SIRT6 levels correlate with elevated nuclear acetylated PKM2 levels in increasing grades of hepatocellular carcinoma"
https://pharos.nih.gov/idg/targets/P14618,P14618,26780311,"Mammalian photoreceptors contain dimeric and tetrameric PKM2 and LDH-A. This is consistent with the ability to switch between energy production and biosynthesis like a proliferating tissue, possibly due to demands of opsin synthesis."
https://pharos.nih.gov/idg/targets/P14618,P14618,26739387,"in hypoxic pancreatic tumors PKM2 interferes both with NF-kappaB/p65 and HIF-1alpha activation that ultimately triggers VEGF-A secretion and subsequent blood vessel formation."
https://pharos.nih.gov/idg/targets/P14618,P14618,26715276,"Increased PKM2 expression is associated with triple-negative breast cancer."
https://pharos.nih.gov/idg/targets/P14618,P14618,26702927,"PKM2/TG2 interplay plays an important role in the regulation of autophagy in particular under cellular stressful conditions such as those displayed by cancer cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,26639784,"GLUT3 and OCT4 expression were correlated suggesting that Human embryonic stem cells self-renewal is regulated by the rate of glucose uptake."
https://pharos.nih.gov/idg/targets/P14618,P14618,26617865,"our studies reveal the prognostic value of PKM2 in colorectal cancer"
https://pharos.nih.gov/idg/targets/P14618,P14618,26607846,"Overexpression of PKM2 is associated with high risks of recurrent metastasis in primary breast carcinoma."
https://pharos.nih.gov/idg/targets/P14618,P14618,26576639,"PKM2 regulates neural invasion of HC cells at least in part via regulation of SDC2."
https://pharos.nih.gov/idg/targets/P14618,P14618,26542452,"The activation of STAT3 by nuclear PKM2 was associated with gefitinib resistance."
https://pharos.nih.gov/idg/targets/P14618,P14618,26506517,"High PKM2 expression is associated with colorectal cancer."
https://pharos.nih.gov/idg/targets/P14618,P14618,26500118,"PKM2 exhibits a tumor-suppressive role through altered Warburg effect in pancreatic ductal adenocarcinoma."
https://pharos.nih.gov/idg/targets/P14618,P14618,26500058,"Data show that pyruvate kinase M2 (PKM2) directly interacted with mutant growth factor receptor (EGFR) and heat-shock protein 90 (HSP90), and thus stabilized EGFR by maintaining its binding with HSP90 and co-chaperones."
https://pharos.nih.gov/idg/targets/P14618,P14618,26493994,"Critical roles of PKM2 in the stemness of breast cancer cells which may elevate the therapeutic effect on breast cancer patients."
https://pharos.nih.gov/idg/targets/P14618,P14618,26493215,"laforin/malin complex is able to interact with and ubiquitinate both PKM1 and PKM2"
https://pharos.nih.gov/idg/targets/P14618,P14618,26464675,"Our results suggest that overexpression of PKM2 and HK1, especially the latter, significantly associates with lymphatic metastasis, advanced clinical staging and unfavorable prognosis in gastric cancer."
https://pharos.nih.gov/idg/targets/P14618,P14618,26453405,"PKM2 expression was positively correlated with cell proliferation and knockdown of PKM2 contributed to the increased cell adhesion rate in multiple myeloma."
https://pharos.nih.gov/idg/targets/P14618,P14618,26410533,"PKM2 interacts with DDB2 and reduces cell survival upon UV irradiation."
https://pharos.nih.gov/idg/targets/P14618,P14618,26405201,"PKM2 sensitizes AhR-mediated detoxification in actively proliferating cells such as cancer and fetal cells. PKM2 and p300 constitute a complex with AhR on chromatin."
https://pharos.nih.gov/idg/targets/P14618,P14618,26404132,"PKM2 was involved in progression of ESCC."
https://pharos.nih.gov/idg/targets/P14618,P14618,26385349,"Loss of PKM2 expression was associated with Pancreatic Ductal Adenocarcinoma."
https://pharos.nih.gov/idg/targets/P14618,P14618,26339369,"PKM2 expression was correlated with VEGF-C expression, and combination of PKM2 and VEGF-C levels had the better prognostic significance in predicting the poor outcome of patients with breast cancer."
https://pharos.nih.gov/idg/targets/P14618,P14618,26300261,"Using [(32)P]-phosphoenolpyruvate (PEP) we examine the direct substrates of PKM2 using recombinant enzyme and in vitro systems where PKM2 is genetically deleted. The findings argue against a role for PKM2 as a protein kinase."
https://pharos.nih.gov/idg/targets/P14618,P14618,26290635,"PKM2 can regulate cell motility through the EGF/EGFR and TGFbeta/TGFR signaling pathways in hepatocellular carcinoma cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,26258887,"The PARP14-JNK1-PKM2 regulatory axis is an important determinant for the Warburg effect in tumour cells and provides a mechanistic link between apoptosis and metabolism."
https://pharos.nih.gov/idg/targets/P14618,P14618,26252736,"These results suggested roles of O-GlcNAcylation in modulating serine phosphorylation, as well as in regulating PKM2 activity and expression."
https://pharos.nih.gov/idg/targets/P14618,P14618,26252254,"Data show that miR-122 has a low expression in Human hepatocellular carcinoma (HCC) tissues, and correlates with poor prognosis. It plays an important role in the invasion and metastasis of HCC by targeting PKM2."
https://pharos.nih.gov/idg/targets/P14618,P14618,26234680,"findings point to PKM2 and PTBP1 as new potential therapeutic targets to improve response of PDAC to chemotherapy"
https://pharos.nih.gov/idg/targets/P14618,P14618,26183399,"pyruvate kinase M2 (PKM2), an established effector of Warburg-like glycolytic behavior, has a role in oxidative phosphorylation metabolism induced by cancer associated fibroblasts"
https://pharos.nih.gov/idg/targets/P14618,P14618,26172294,"Data show that pyruvate kinase muscle isozyme (PKM2 )was positively regulated by NF-kappa B (NF-kappaB)/transcription factor RelA (RelA) at the transcriptional level."
https://pharos.nih.gov/idg/targets/P14618,P14618,26158845,"Data show that the M2 pyruvate kinase (M2-PK)Quick, rapid, point-of-care test is a highly accurate test in the detection of colorectal cancer (CRC)."
https://pharos.nih.gov/idg/targets/P14618,P14618,26140362,"purine biosynthetic pathway enzymes PPAT and PAICS, as well as pyruvate kinase activity are increased in lung cancer"
https://pharos.nih.gov/idg/targets/P14618,P14618,26092770,"findings provide a molecular mechanism for how HIF-1 dysregulation fuels both angiogenesis and tumor metabolism in KS and support further investigations on therapeutic approaches targeting HIF-1 and PKM2 for KS treatment."
https://pharos.nih.gov/idg/targets/P14618,P14618,26082202,"The downregulation of PKM2 induced apoptosis and autophagy in A549 cells and this autophagy protected the cells from apoptotic cell death."
https://pharos.nih.gov/idg/targets/P14618,P14618,26059508,"The maintenance of high glycolysis levels by Pkm2 (and Hk2) overexpression preserves the pluripotency of embryonic stem cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,25970228,"PKM2 is critically involved in OSCC initiation and progression probably by promoting cell proliferation and migration as well as reducing apoptosis."
https://pharos.nih.gov/idg/targets/P14618,P14618,25964202,"Data show that cosilencing of pyruvate kinase M2 and multidrug resistance gene-1 (PKM-2 and MDR-1) improves the efficacy of paclitaxel against multidrug resistance (MDR) ovarian cancer in a murine model."
https://pharos.nih.gov/idg/targets/P14618,P14618,25955657,"oxaliplatin and PKM2 silencing altered cell death gene expression patterns."
https://pharos.nih.gov/idg/targets/P14618,P14618,25936600,"Overexpression of PKM2 contributes to radiation resistance and acts a poor prognosis indicator in patients with locally advanced cervical squamous cell carcinoma."
https://pharos.nih.gov/idg/targets/P14618,P14618,25912843,"Glucose transporter 1 expression exhibits a strong correlation with 18F-FDG uptake in cholangiocellular carcinoma tissue, while pyruvate kinase type M2 expression was not associated with fluoro-2-deoxy-d-glucose uptake."
https://pharos.nih.gov/idg/targets/P14618,P14618,25893434,"Low expression of PKM2 was associated with cervical squamous cell carcinoma."
https://pharos.nih.gov/idg/targets/P14618,P14618,25880801,"Our data shows that overexpression and increased phosphorylation of PKM2 and LHDA is a common finding in thyroid malignancies."
https://pharos.nih.gov/idg/targets/P14618,P14618,25818238,"Suggest that miR-124 acts as a tumor-suppressor and a modulator of energy metabolism through a PTB1/PKM1/PKM2 feedback cascade in human colorectal tumor cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,25808097,"High PKM2 expression significantly correlated with poor response to chemotherapy in Esophageal Squamous Cell Carcinoma."
https://pharos.nih.gov/idg/targets/P14618,P14618,25788265,"PKM2 serves as a promising biomarker for poor prognosis of patients with HCC and its knockdown induces HCC apoptosis by stabilizing Bim."
https://pharos.nih.gov/idg/targets/P14618,P14618,25773278,"The regulation of PKM2 oligomerization may be a general mechanism to modulate PKM2 activity."
https://pharos.nih.gov/idg/targets/P14618,P14618,25768091,"3 SNPs (rs2856929, rs8192381 and rs8192431) of PKM2 could generate an alternative transcript by influencing splicing factor binding."
https://pharos.nih.gov/idg/targets/P14618,P14618,25738776,"isoform switch of PKM1 does indeed occur, but it switches to other isoforms rather than PKM2"
https://pharos.nih.gov/idg/targets/P14618,P14618,25735978,"observed a shift in the enzyme pyruvate kinase from the adult M1 (PKM1) isoform to the fetal M2 (PKM2) isoform, a hallmark of the Warburg Effect, in sunitinib-treated patients developing cardiac failure"
https://pharos.nih.gov/idg/targets/P14618,P14618,25732087,"PKM2 could be secreted from colon cancer cells, and purified PKM2 protein mimicing the secreted PKM2 was able to promote colon cancer cell migration."
https://pharos.nih.gov/idg/targets/P14618,P14618,25708858,"we investigated the inter-action between PKM2 and USP20. Our results suggest a new molecular pathway in cancer metabolism through the regulation of PKM2."
https://pharos.nih.gov/idg/targets/P14618,P14618,25703326,"Disruption of PKM2/NF-kappaB/miR-148a/152 feedback loop can regulate cancer cell growth."
https://pharos.nih.gov/idg/targets/P14618,P14618,25661370,"PKM2 is an active protein kinase, and promotes liver cancer cell proliferation by up-regulating HIF-1alpha and Bcl-xL expression."
https://pharos.nih.gov/idg/targets/P14618,P14618,25649613,"PKM2 knockdown leaded to increased radiosensitivity of radioresistant cell lines.  Significant inhibition in tumor size under regular radiotherapy was found in Balb/c-nude mice bearing radioresistant NSCLC tumors with PKM2 knockdown."
https://pharos.nih.gov/idg/targets/P14618,P14618,25645022,"K422R, a patient-derived mutation of PKM2, favors a stable, inactive T-state tetramer because of strong intermolecular interactions."
https://pharos.nih.gov/idg/targets/P14618,P14618,25644089,"AIC-47, acting through the PPARgamma/beta-catenin pathway, induced down-regulation of c-Myc, leading to the disruption of the bcr-abl/mTOR/hnRNP signaling pathway, and switching of the expression of PKM2 to PKM1 in acute myeloid leukemia."
https://pharos.nih.gov/idg/targets/P14618,P14618,25576919,"Data suggest that pyruvate kinase isoform M2 (PKM2)/tripartite motif-containing 35 (TRIM35) expression could be a biomarker for the prognosis of hepatocellular carcinoma (HCC) and target for cancer therapy."
https://pharos.nih.gov/idg/targets/P14618,P14618,25541689,"Results show that PKM2 over-expression in human hepatocellular carcinoma was associated with down-regulation of its regulator mir-122 resulting in an aggressive clinicopathological features and poor prognosis."
https://pharos.nih.gov/idg/targets/P14618,P14618,25514599,"Data suggest that targeted therapy aimed at pyruvate kinase M2 (PKM2) may represent an effective treatment approach for hepatocellular carcinoma (HCC)."
https://pharos.nih.gov/idg/targets/P14618,P14618,25444918,"High Pyruvate Kinase, M2-Type expression is associated with low radiosensitivity in non-small cell lung cancer."
https://pharos.nih.gov/idg/targets/P14618,P14618,25412762,"PKM2-regulated MLC2 phosphorylation, which is greatly enhanced by EGF stimulation or EGFRvIII, K-Ras G12V and B-Raf V600E mutant expression, plays a pivotal role in cytokinesis, cell proliferation and brain tumour development."
https://pharos.nih.gov/idg/targets/P14618,P14618,25411978,"PKM2 gene regulates the behavior of pancreatic cancer cells via mitogen-activated protein kinase pathways"
https://pharos.nih.gov/idg/targets/P14618,P14618,25344422,"median bile M2-PK levels were significantly elevated in patients with malignant biliary strictures"
https://pharos.nih.gov/idg/targets/P14618,P14618,25313085,"This previously unidentified finding of the molecular interaction of PKM2 in the nucleus sheds light on the significance of PKM2 expression in cancer cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,25263439,"TRIM35 regulates the Warburg effect and tumorigenicity through interaction with PKM2 in hepatocellular carcinoma."
https://pharos.nih.gov/idg/targets/P14618,P14618,25260566,"expression increased in pre-eclamptic placenta at delivery"
https://pharos.nih.gov/idg/targets/P14618,P14618,25233397,"High PKM2 levels were associated with low platinum sensitivity in metastatic non-small-cell lung cancer."
https://pharos.nih.gov/idg/targets/P14618,P14618,25070887,"Only the dimeric PKM2 possess the activity in promoting tumor angiogenesis, which is consistent with the observations that PKM2 in circulation of cancer patients is a dimer form."
https://pharos.nih.gov/idg/targets/P14618,P14618,25041845,"PKM2 depletion could provoke glutamine metabolism by enhancing the beta-catenin signaling pathway and consequently promoting its downstream c-Myc-mediated glutamine metabolism in colon cancer cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,24982407,"PKM2 and PKM1 have no value as predictive markers of NSCLC regardless of the histological type and grade of malignancy."
https://pharos.nih.gov/idg/targets/P14618,P14618,24898807,"overexpression of miR-122 in 5-FU-resistant cells resensitizes 5-FU resistance through the inhibition of PKM2"
https://pharos.nih.gov/idg/targets/P14618,P14618,24884829,"upregulation and specific modification to PKM2 associate with prostate cancer progression."
https://pharos.nih.gov/idg/targets/P14618,P14618,24859886,"Data indicate that zinc finger protein SNAIL modulates ribosomal protein S6 kinase 1 (RPS6KB1)/HIF-1alpha/protein kinase 2 (PKM2) signaling pathway through miR-128."
https://pharos.nih.gov/idg/targets/P14618,P14618,24817408,"Up-regulation of PKM2 might protect intestinal epithelial cells against apoptosis possibly through Bcl-xl in Crohn's disease."
https://pharos.nih.gov/idg/targets/P14618,P14618,24795025,"Findings suggest that the altered metabolism observed in most cancer cells may facilitate a SAICAR-dependent PKM2 functional switch that sustains cell proliferation."
https://pharos.nih.gov/idg/targets/P14618,P14618,24762230,"Overexpression of PKM2 and LDH5 associates with key clinicopathological features and unfavourable prognosis in tongue squamous cell carcinoma."
https://pharos.nih.gov/idg/targets/P14618,P14618,24759699,"The two markers pyruvate kinase isoform M2 and calprotectin did not prove their clinical utility in differential diagnosis of infectious acute diarrhea in those children demanding hospitalization."
https://pharos.nih.gov/idg/targets/P14618,P14618,24747424,"PKM2 regulation and the benefits it confers to cancer cells"
https://pharos.nih.gov/idg/targets/P14618,P14618,24716919,"Nuclear translocation of PKM2 regulated beta-catenin-TCF/LEF-1 transcriptional activity."
https://pharos.nih.gov/idg/targets/P14618,P14618,24699725,"The addition of M2-PK in a biennial bowel screening programme is acceptable to patients, feasible and detects additional adenomas, potentially at an earlier stage."
https://pharos.nih.gov/idg/targets/P14618,P14618,24686087,"The overexpression of PKM2, particularly its dimer form, induces CRC cell migration and cell-matrix adhesion by driving STAT3 transcription, which is required for the PKM2-induced activation of beta1-integrin-FAK signalling, Snail-2 signalling."
https://pharos.nih.gov/idg/targets/P14618,P14618,24658033,"HSP40 interacts with pyruvate kinase M2 and regulates glycolysis and cell proliferation in tumor cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,24649481,"FC reflects pediatric IBD severity and activity better than M2-PK. This difference is particularly pronounced when identifying patients with mild UC and UC in remission."
https://pharos.nih.gov/idg/targets/P14618,P14618,24626155,"increased PKM2 is the culprit of enhanced aerobic glycolysis in cancer cells"
https://pharos.nih.gov/idg/targets/P14618,P14618,24619225,"Data indicate that pyruvate kinase PKM1 regulates miR-124 expression via hepatocyte nuclear factor 4 (HNF4alpha)."
https://pharos.nih.gov/idg/targets/P14618,P14618,24606918,"ligand-induced protein kinase activity from PKM2 is a mechanism that directly couples cell proliferation with intracellular metabolic status"
https://pharos.nih.gov/idg/targets/P14618,P14618,24508027,"this study discusses the current understanding of PKM2 in regulating cancer metabolism."
https://pharos.nih.gov/idg/targets/P14618,P14618,24492614,"This study demonstrates for the first time the possible predisposition of Bloom syndrome patients with impaired PKM2 activity to cancer."
https://pharos.nih.gov/idg/targets/P14618,P14618,24481450,"PKM2-Oct4 interaction controls glioma cell death and differentiation."
https://pharos.nih.gov/idg/targets/P14618,P14618,24471565,"PKM2 acts as a transcriptional coactivator for ERalpha and small-molecule PKM2 activators inhibit ERalpha transcriptional activity and reduce E2-induced cell proliferation."
https://pharos.nih.gov/idg/targets/P14618,P14618,24466275,"High PKM2 expression is associated with hepatocellular carcinoma."
https://pharos.nih.gov/idg/targets/P14618,P14618,24344305,"JMJD5 has a role in regulating PKM2 nuclear translocation and reprogramming HIF-1alpha-mediated glucose metabolism"
https://pharos.nih.gov/idg/targets/P14618,P14618,24316223,"These findings highlight the role of PKM2 as a protein kinase controlling the fidelity of chromosome segregation, cell-cycle progression, and tumorigenesis."
https://pharos.nih.gov/idg/targets/P14618,P14618,24142698,"PIM2 could directly phosphorylate PKM2 on the Thr-454 residue, resulting in an increase of PKM2 protein levels. Compared with wild type, PKM2 with the phosphorylation-defective mutation displayed a reduced effect on glycolysis."
https://pharos.nih.gov/idg/targets/P14618,P14618,24120661,"K433 acetylation links cell proliferation and transformation to the switch of PKM2 from a cytoplasmic metabolite kinase to a nuclear protein kinase"
https://pharos.nih.gov/idg/targets/P14618,P14618,24120138,"These data suggest that regulation of pyruvate kinase M2 isoform activity supports the different metabolic requirements of proliferating and nonproliferating tumor cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,24100037,"PKM2 activity in beta-cells is oscillatory and are consistent with pulsatile PFK1 being the mediator of slow glycolytic oscillations."
https://pharos.nih.gov/idg/targets/P14618,P14618,24077665,"Suggest that isoform switch of PKM1 to PKM2 in cancers is tissue-specific and targeting PKM2 activity in tumors remains a promising approach for clinical intervention of multiple cancer types."
https://pharos.nih.gov/idg/targets/P14618,P14618,23880164,"Esophageal squamous cell carcinoma patients with high PKM2 expression in the nucleus had significantly shorter survival times."
https://pharos.nih.gov/idg/targets/P14618,P14618,23874603,"A stable-isotope labeling by amino acids in cell culture coupled with mass spectrometry-based proteomics identifies upregulation of pyruvate kinase, muscle (PKM) expression by HIV-1 Vpr in Vpr transduced macrophages"
https://pharos.nih.gov/idg/targets/P14618,P14618,23846818,"overexpression of PKM2 provides a selective growth advantage for papillary thyroid cancer cells through activation of glycolysis. Aberrant PKM2 overexpression may serve as a novel biomarker and a potential treatment target for papillary thyroid cancer."
https://pharos.nih.gov/idg/targets/P14618,P14618,23840737,"Cytoplasmic PKM2 expression were correlated with each other."
https://pharos.nih.gov/idg/targets/P14618,P14618,23814019,"NPM-ALK-mediated phosphorylation of PKM2 and metabolic reprogramming has a role in anaplastic large cell lymphoma"
https://pharos.nih.gov/idg/targets/P14618,P14618,23794342,"Serum M2-pyruvate kinase levels may be useful in distinguishing malignant and benign lesions of the colon and may provide insight in terms of survival."
https://pharos.nih.gov/idg/targets/P14618,P14618,23793810,"PKM2 overexpression is a marker of metastasis, invasion and poor prognosis of Gallbladder cancer."
https://pharos.nih.gov/idg/targets/P14618,P14618,23752568,"PKM2 is secreted in metastatic hepatocellular carcinoma cell lines; differences between secretomes of the two metastatic human cell lines are also explored."
https://pharos.nih.gov/idg/targets/P14618,P14618,23640882,"PKM2 is a novel substrate of PTP1B tyrosine phosphorylation."
https://pharos.nih.gov/idg/targets/P14618,P14618,23576436,"the conversion between the pyruvate kinase and protein kinase activities of PKM2 may be an important mechanism mediating the effects of growth signals in promoting cell proliferation."
https://pharos.nih.gov/idg/targets/P14618,P14618,23530218,"X-ray structures and biophysical binding data of M2PYK complexes explain how fluctuations in concentrations of amino acids, thyroid hormone, and glucose metabolites switch M2PYK to provide the cell with nutrient sensing and growth signaling mechanism"
https://pharos.nih.gov/idg/targets/P14618,P14618,23515579,"Findings collectively support the utility of PKM2 as a therapeutic target for high lactate-producing glycolytic hepatocellular carcinoma (HCC)."
https://pharos.nih.gov/idg/targets/P14618,P14618,23451252,"Showed a 3-5 fold further increase in PKM2 RNA and protein expression."
https://pharos.nih.gov/idg/targets/P14618,P14618,23423437,"findings add additional complexity to how PKM2 is regulated in cells and support the notion that modulating PKM2 activity enables cells to adapt their metabolic state to specific physiological contexts."
https://pharos.nih.gov/idg/targets/P14618,P14618,23364796,"A stable-isotope labeling by amino acids in cell culture coupled with mass spectrometry-based proteomics identifies upregulation of pyruvate kinase, muscle (PKM) expression by HIV-1 Vpr in Vpr transduced macrophages"
https://pharos.nih.gov/idg/targets/P14618,P14618,23317289,"pkm2 expression was higher in esophageal squamous cell carcinoma than in normal tissue, and was related to neoplasm differentiation."
https://pharos.nih.gov/idg/targets/P14618,P14618,23267074,"M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth."
https://pharos.nih.gov/idg/targets/P14618,P14618,23212076,"summarizes the biological characteristics of PKM2 and discusses the dual role in cancer metabolism as well as the potential therapeutic applications"
https://pharos.nih.gov/idg/targets/P14618,P14618,23178880,"Findings highlight the importance of nuclear functions of PKM2 in the Warburg effect and tumorigenesis."
https://pharos.nih.gov/idg/targets/P14618,P14618,23166591,"A stable-isotope labeling by amino acids in cell culture coupled with mass spectrometry-based proteomics identifies upregulation of pyruvate kinase, muscle (PKM) expression by HIV-1 Vpr in Vpr transduced macrophages"
https://pharos.nih.gov/idg/targets/P14618,P14618,23155487,"Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides."
https://pharos.nih.gov/idg/targets/P14618,P14618,23130662,"Glycolytic enzymes PGK1 and PKM2 are novel transcriptional targets of PPARgamma in breast cancer."
https://pharos.nih.gov/idg/targets/P14618,P14618,23125841,"A stable-isotope labeling by amino acids in cell culture coupled with mass spectrometry-based proteomics identifies upregulation of pyruvate kinase, muscle (PKM) expression by HIV-1 Vpr in Vpr transduced macrophages"
https://pharos.nih.gov/idg/targets/P14618,P14618,23123196,"Report metabolic cooperation between the EGFR/PKC-epsilon/NF-kappaB pathway in PKM2 upregulation and tumorigenesis."
https://pharos.nih.gov/idg/targets/P14618,P14618,23086999,"Upon glucose starvation, cellular SAICAR concentration increased in an oscillatory manner and stimulated PKM2 activity in cancer cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,23071357,"PKM2 is induced translocation into the nucleus, where it activates transcription of various genes by interacting with and phosphorylating specific nuclear proteins, endowing cancer cells with a survival and growth advantage."
https://pharos.nih.gov/idg/targets/P14618,P14618,23064226,"serine can bind to and activate human PKM2, and that PKM2 activity in cells is reduced in response to serine deprivation"
https://pharos.nih.gov/idg/targets/P14618,P14618,22944692,"A stable-isotope labeling by amino acids in cell culture coupled with mass spectrometry-based proteomics identifies upregulation of pyruvate kinase, muscle (PKM) expression by HIV-1 Vpr in Vpr transduced macrophages"
https://pharos.nih.gov/idg/targets/P14618,P14618,22901803,"These findings highlight the role of PKM2 as a protein kinase in its nonmetabolic functions of histone modification, which is essential for its epigenetic regulation of gene expression and tumorigenesis."
https://pharos.nih.gov/idg/targets/P14618,P14618,22889453,"PKM2 and HSPA5 may play an important role in the progression of endometrioid carcinoma. These two proteins are potential biomarkers to better predict high-risk endometrioid carcinoma and thereby guide clinical therapy."
https://pharos.nih.gov/idg/targets/P14618,P14618,22864959,"Bile M2-PK is a novel tumor marker for biliary tract cancer and correlates with tumor aggressiveness and poor outcome."
https://pharos.nih.gov/idg/targets/P14618,P14618,22824010,"review of role of PKM2 in cancer cells, cell proliferation, and neoplastic cell transformation: PKM2 expression is increased and facilitates lactate production/oxidative stress in cancer cells. [REVIEW]"
https://pharos.nih.gov/idg/targets/P14618,P14618,22807066,"the expression of PKM2 plays a critical role in development of colorectal cancer, and it may provide a growth advantage for colon cancer cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,22736014,"Fecal M2-PK is increased in children with active Crohn's disease."
https://pharos.nih.gov/idg/targets/P14618,P14618,22627140,"PKM2 may function as an upstream molecule that regulates p65 function and thus enhances the growth of tumor cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,22509023,"PKM2-expressing cells can maintain mammalian target of rapamycin complex 1 activity and proliferate in serine-depleted medium, but PKM1-expressing cells cannot."
https://pharos.nih.gov/idg/targets/P14618,P14618,22465421,"In patients with age-related macular degeneration, anti-PKM2 IgG serves as a biomarker for diagnosis and prognosis."
https://pharos.nih.gov/idg/targets/P14618,P14618,22334075,"PPARgamma contributes to PKM2 and HK2 expression in fatty liver"
https://pharos.nih.gov/idg/targets/P14618,P14618,22306293,"PKM2 upregulates mek5 Transcription by promoting stat3 DNA interaction and phosphorylation of stat3."
https://pharos.nih.gov/idg/targets/P14618,P14618,22271574,"Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression."
https://pharos.nih.gov/idg/targets/P14618,P14618,22236875,"PKM2 did not lead to lactate accumulation in breast cancer cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,22231432,"These findings suggest that plasmatic Tu M2-PK levels of more than 20 U/mL may be a predictor of death risk."
https://pharos.nih.gov/idg/targets/P14618,P14618,22190034,"A stable-isotope labeling by amino acids in cell culture coupled with mass spectrometry-based proteomics identifies upregulation of pyruvate kinase, muscle (PKM) expression by HIV-1 Vpr in Vpr transduced macrophages"
https://pharos.nih.gov/idg/targets/P14618,P14618,22140559,"These findings indicate that the MUC1-C subunit regulates glycolysis and that this response is conferred in part by PKM2."
https://pharos.nih.gov/idg/targets/P14618,P14618,22056988,"epidermal growth factor receptor (EGFR) activation induces translocation of PKM2, but not PKM1, into the nucleus, where K433 of PKM2 binds to c-Src-phosphorylated Y333 of beta-catenin"
https://pharos.nih.gov/idg/targets/P14618,P14618,22052977,"findings show, in lung cancer cells, increases in intracellular ROS caused inhibition of PKM2 through oxidation of Cys(358);regulatory properties of PKM2 may confer an additional advantage to cancer cells by allowing them to withstand oxidative stress"
https://pharos.nih.gov/idg/targets/P14618,P14618,22044881,"Exons are the key determinants of PK-M splicing isoform ratios."
https://pharos.nih.gov/idg/targets/P14618,P14618,21725354,"Data show that pyruvate kinase M2 (PKM2) was a binding partner of death-associated protein kinase (DAPk)."
https://pharos.nih.gov/idg/targets/P14618,P14618,21620138,"Interaction of PKM2 with prolyl hydroxylase 3 (PHD3) enhances PKM2 binding to HIF-1alpha and PKM2 coactivator function; PKM2 participates in a positive feedback loop that promotes HIF-1 transactivation and reprograms glucose metabolism in cancer cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,21325052,"Components of the mTOR/HIF1alpha/Myc-hnRNPs/PKM2 glycolysis signaling network could be targeted for the treatment of cancer caused by an aberrant RTK/PI3K/AKT/mTOR signaling pathway"
https://pharos.nih.gov/idg/targets/P14618,P14618,20977946,"A study on the relationship between prothymosin alpha kinase(ProTalphaK) activity and pyruvate kinase isoforms confirmed that the M2 isoform is the enzyme responsible for ProTalphaK activity in proliferating cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,20962042,"inhibition of PKM2 by PRL contributes to the PRL-stimulated cell"
https://pharos.nih.gov/idg/targets/P14618,P14618,20857498,"This review aims to provide an overview of the involvement of human PKM2 in various physiological pathways with possible functional implications."
https://pharos.nih.gov/idg/targets/P14618,P14618,20847263,"histidine-phosphorylated PGAM1 correlated with expression of PKM2 in cancer cell lines; decreased pyruvate kinase activity in PKM2-expressing cells allows PEP-dependent histidine phosphorylation of PGAM1 and may provide an alternate glycolytic pathway"
https://pharos.nih.gov/idg/targets/P14618,P14618,20721957,"Overexpression of PKM2 is associated with recurrences in chordomas."
https://pharos.nih.gov/idg/targets/P14618,P14618,20667897,"human glioblastoma cells with high levels of PKM2 expressed lower levels of miR-326, suggestive of endogenous regulation of PKM2 by miR-326."
https://pharos.nih.gov/idg/targets/P14618,P14618,20602615,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P14618,P14618,20592362,"M2PK has a role in preventing, and pAkt has a role in enhancing progression of breast cancer"
https://pharos.nih.gov/idg/targets/P14618,P14618,20332442,"Increased M2 pyruvate kinase is associated with cervical cancer progression."
https://pharos.nih.gov/idg/targets/P14618,P14618,20304929,"human pyruvate kinase M2 isozyme dominant mutations promote cellular growth and polyploidy"
https://pharos.nih.gov/idg/targets/P14618,P14618,20133837,"splicing repressors hnRNP A1 and A2, as well as the polypyrimidine-tract-binding protein PTB, contribute to control of pyruvate kinase isoform M1 and M2 expression"
https://pharos.nih.gov/idg/targets/P14618,P14618,20082317,"the association of PKM2 and HSPD1, two differentially expressed proteins, with MDR were analyzed, and the results showed that they could contribute considerably to the cisplatin resistance in ovarian cancer cell"
https://pharos.nih.gov/idg/targets/P14618,P14618,20010808,"human gliomas overexpress c-Myc, PTB, hnRNPA1 and hnRNPA2 in a manner that correlates with PKM2 expression"
https://pharos.nih.gov/idg/targets/P14618,P14618,19920251,"Data show that oncogenic forms of fibroblast growth factor receptor type 1 inhibit the pyruvate kinase M2 (PKM2) isoform by direct phosphorylation of PKM2 tyrosine residue 105 (Y(105))."
https://pharos.nih.gov/idg/targets/P14618,P14618,19920249,"Studies suggest that regulation of PKM2 seems to be pivotal for regulating glycolysis in proliferating cells.  regulation of PKM2 seems to be pivotal for regulating glycolysis in proliferating cells."
https://pharos.nih.gov/idg/targets/P14618,P14618,19820423,"Tumor-M2-PK may have a role in diagnosing pancreatic ductal adenocarcinoma."
https://pharos.nih.gov/idg/targets/P14618,P14618,19754967,"Complete lack of M2-PK expression was observed in benign pancreatic ducts, premalignant lesions and cancer."
https://pharos.nih.gov/idg/targets/P14618,P14618,19734428,"Pyruvate kinase M2 and prednisolone resistance in acute lymphoblastic leukemia."
https://pharos.nih.gov/idg/targets/P14618,P14618,19401544,"The gene ratio test with the PKM2 gene for survival of patients with malignant pleural mesothelioma has robust predictive value."
https://pharos.nih.gov/idg/targets/P14618,P14618,19265196,"Differential behavior of missense mutations in the intersubunit contact domain of the human pyruvate kinase M2 isozyme."
https://pharos.nih.gov/idg/targets/P14618,P14618,19097497,"fecal pyruvate kinase M2 is an inferior biological marker of inflammatory bowel disease when compared with fecal calprotectin"
https://pharos.nih.gov/idg/targets/P14618,P14618,18996102,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P14618,P14618,18789002,"Data confirmed the cancer-associated expression of the PKM2 variant with primary colon cancer and colon cancer cell lines, with PKM2 expressed at high levels in colon cancer and in colon cancer cell lines."
https://pharos.nih.gov/idg/targets/P14618,P14618,18519040,"NS5B interacted with M2 type pyruvate kinase but not L type pyruvate kinase."
https://pharos.nih.gov/idg/targets/P14618,P14618,18464261,"aberrant reduction of miR-133a and miR-133b was associated with the dysregulation of M2-type pyruvate kinase (PKM2) in squamous cell carcinoma (SCC) of the tongue."
https://pharos.nih.gov/idg/targets/P14618,P14618,18394773,"expression of pyruvate kinase M2 isoenzyme was found in 53% 0f granulosa cell tumors of the ovary"
https://pharos.nih.gov/idg/targets/P14618,P14618,18337815,"results indicate that expression of this phosphotyrosine-binding form of pyruvate kinase is critical for rapid growth in cancer cells"
https://pharos.nih.gov/idg/targets/P14618,P14618,18298799,"PKM2 exists in either an active tetrameric form which has high affinity for its substrate phosphoenolpyruvate (PEP) or a less active dimeric form which has low affinity for its substrate."
https://pharos.nih.gov/idg/targets/P14618,P14618,17414054,"An elevated level in this enzyme on admission in suspected periampullary cancer is a predictor of adverse prognosis in periampullary cancer."
https://pharos.nih.gov/idg/targets/P14618,P14618,17406361,"A sensitive and specific tumor marker for colorectal cancer, seen in older adults."
https://pharos.nih.gov/idg/targets/P14618,P14618,17011640,"PK can function as an autoimmune target and that this immunoreactivity may be associated with Tourette syndrome, obsessive compulsive disorder, and associated disorders"
https://pharos.nih.gov/idg/targets/P14618,P14618,16132722,"PanK4 interacts with Pkm2 and thereby may modulate the glucose metabolism through regulating the activity of Pkm2."
https://pharos.nih.gov/idg/targets/P14618,P14618,15996096,"The X-ray structure of tumor specific PKM2 complexed with Mg2+, K+, inhibitor oxalate, and allosteric activator fructose 1,6-bisphosphate has been determined, and its unique structural characteristics relative to other known isoforms have been analyzed."
https://pharos.nih.gov/idg/targets/P14618,P14618,12820337,"phosphorylated at tyrosine residues in breast cancer patients; did not find any evidence that this phosphorylation is initiated by the oncoprotein HER-2/neu"
https://pharos.nih.gov/idg/targets/P14618,P14618,12820320,"With the fuzzy logic method and a tumor marker panel (including the new marker Tumor M2-PK), a useful diagnostic tool for the detection of progression in lung cancer patients is available"
https://pharos.nih.gov/idg/targets/P14618,P14618,12820312,"measurement of fecal Tumor M2-PK concentrations might provide an interesting screening tool for colorectal cancer"
https://pharos.nih.gov/idg/targets/P23677,P23677,27234602,"ITPKA is a potential oncogene that it is overexpressed in most tumors, and its overexpression promotes tumorigenesis; ITPKA gene body methylation regulates its expression and serves as a novel and potential biomarker for early cancer detection"
https://pharos.nih.gov/idg/targets/P23677,P23677,26249031,"Our data indicated that ITPKA expression was significantly up-regulated in hepatocellular carcinoma and could serve as a potential novel prognostic biomarker"
https://pharos.nih.gov/idg/targets/P23677,P23677,25101901,"describe the crystal structure of the complex between human Ca2+/CaM and the CaM-binding region of human IP3-3K isoform A (residues 158-183)"
https://pharos.nih.gov/idg/targets/P23677,P23677,21792881,"we conclude that the observed expression of ITPKA early in tumor development increases the metastatic potential of lung adenocarcinoma cells."
https://pharos.nih.gov/idg/targets/P23677,P23677,20022963,"Inositol 1,4,5-trisphosphate 3-kinase-A is a new cell motility-promoting protein that increases the metastatic potential of tumor cells by two functional activities."
https://pharos.nih.gov/idg/targets/P23677,P23677,18498254,"the morphological changes induced by IP3K-A are mediated by non-enzymatic activities of the protein."
https://pharos.nih.gov/idg/targets/P23677,P23677,18187620,"Knockdown of inositol-trisphosphate 3-kinase A (ITPKA) by siRNA inhibits HIV-1 replication in HeLa-derived TZM-bl cells"
https://pharos.nih.gov/idg/targets/P23677,P23677,16525636,"Data suggest that ITPKA may be related to carcinogenesis by the modulation of inositol polyphosphates and Ca2+ homeostasis and that ITPKA may be a potential novel molecular target and biomarker."
https://pharos.nih.gov/idg/targets/P23677,P23677,15350214,"We report the structure of an IPK, the human Ins(1,4,5)P3 3-kinase-A, both free and in complexes with substrates and products."
https://pharos.nih.gov/idg/targets/P23677,P23677,12747803,"results highlight the potential role of the three isoforms of InsP3 3-kinase as direct InsP3 metabolizing enzymes and direct regulators of Ca2+ responses to extracellular signals"
https://pharos.nih.gov/idg/targets/O00443,O00443,28910396,"Results present evidence that PI3K-C2alpha is critical in the proper maturation of endosomes, and for coordinating the use of endosomes as an additional membrane source during autophagy."
https://pharos.nih.gov/idg/targets/O00443,O00443,28195573,"PIK3C2A was associated with bipolar disorder."
https://pharos.nih.gov/idg/targets/O00443,O00443,27412598,"Therefore, PI3K-C2A is a factor important for human cytomegalovirus replication and has a role in the production of human cytomegalovirus virions."
https://pharos.nih.gov/idg/targets/O00443,O00443,27270320,"These results elucidated that PIK3C2A mRNA acts as a miR-124 decoy to regulate CD151 and to affect hepatocellular carcinoma malignant phenotypes."
https://pharos.nih.gov/idg/targets/O00443,O00443,26950487,"miR-518a-5p was downregulated in imatinib-resistant gastrointestinal stromal tumors (GISTs), and the expression of miR-518a-5p was confirmed with good concordance between real-time PCR and miRNA microarray results. Luciferase reporter assays indicated that miR-518a-5p bound to the PIK3C2A 3'UTR."
https://pharos.nih.gov/idg/targets/O00443,O00443,26387957,"PI3KC2a knockdown results in rerouting of insulin signaling and pancreatic beta cell proliferation."
https://pharos.nih.gov/idg/targets/O00443,O00443,26175229,"MiR-206 regulates endothelial progenitor cell activities by targeting PIK3C2alpha expression.The role of PIK3C2alpha in endothelial progenitor cell function in coronary artery disease"
https://pharos.nih.gov/idg/targets/O00443,O00443,25779105,"PI3KC2alpha has a role in regulating shear-dependent platelet adhesion via regulation of membrane structure, rather than acute signalling"
https://pharos.nih.gov/idg/targets/O00443,O00443,25667265,"a model of S. flexneri dissemination is proposed in which the formation of vacuole-like protrusions is mediated by the PIK3C2A-dependent production of the signaling lipid phosphatidylinositol 3-phosphate in the protrusion membrane"
https://pharos.nih.gov/idg/targets/O00443,O00443,25614622,"These observations indicate that PI3K-C2alpha plays the pivotal role in TGFbeta receptor endocytosis and thereby Smad2/3 signaling, participating in angiogenic actions of TGFbeta."
https://pharos.nih.gov/idg/targets/O00443,O00443,25233418,"Data (including data from knockout mice) suggest that PI3KC2a participates in tumor angiogenesis. [REVIEW]"
https://pharos.nih.gov/idg/targets/O00443,O00443,24073214,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,23320105,"Class II enzyme PI3K-C2beta and the class IB isozyme p110gamma mainly regulate the S1P- and high density lipoprotein (HDL)-dependent endothelial cell (EC) migration and PI3K-C2alpha primarily controls EC survival"
https://pharos.nih.gov/idg/targets/O00443,O00443,23301033,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,23251686,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,23215766,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,23192342,"PI3K-C2alpha plays the crucial role in S1P(1) internalization into the intracellular vesicular compartment, Rac1 activation on endosomes, and thereby migration through regulating vesicular trafficking in ECs"
https://pharos.nih.gov/idg/targets/O00443,O00443,21081650,"These data suggest a general role for PI3KC2alpha in regulating physiologically relevant dynamin-independent internalization pathways."
https://pharos.nih.gov/idg/targets/O00443,O00443,21029719,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,20818790,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,20453000,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00443,O00443,20416519,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00443,O00443,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00443,O00443,20197460,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00443,O00443,20019835,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,19591801,"Taken together, these data suggest for the first time that in addition to class I PI3Ks in cancer, class II PIK3C2alpha can modulate hepatocellular carcinoma cell growth."
https://pharos.nih.gov/idg/targets/O00443,O00443,19261849,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00443,O00443,18854243,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,18453587,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,18403640,"Lowering the levels of PI3K-C2alpha in a number of cancer cell lines reduces their proliferation and cell viability."
https://pharos.nih.gov/idg/targets/O00443,O00443,17644513,"phosphoinositide 3-kinase C2alpha has a role in insulin signaling"
https://pharos.nih.gov/idg/targets/O00443,O00443,17632570,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,17157319,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,17110375,"molecular linkage between PI3K-C2alpha and the microtubule motor machinery, with implications for membrane trafficking in intact cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,17038310,"analysis of the PI specificities of PX domains and the mechanism by which the PI3K-C2alpha PX domain interacts with PtdIns(4,5)P(2)-containing membranes"
https://pharos.nih.gov/idg/targets/O00443,O00443,16524887,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,16215232,"demonstrated that the isolated clathrin binding domain of Phosphoinositide 3-kinase C2alpha can drive clathrin lattice assembly and can independently modulate clathrin distribution and function when expressed in cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,16081599,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,15689238,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,15183893,"VEGFR1 and VEGFR2 initiate a clonogenic response in myeloid leukemia cells that is PI3-kinase dependent."
https://pharos.nih.gov/idg/targets/O00443,O00443,14729612,"Nickel compounds induce HIF-1 transactivation and Cap43 protein expression through a PI-3K/Akt-dependent and p70(S6k)- independent pathway."
https://pharos.nih.gov/idg/targets/O00443,O00443,14602571,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,12960231,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,12584329,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,12551992,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,12526811,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,12237112,"Phosphoinositide 3-kinase C2alpha was found to be differentially regulated by alpha(v)beta(3) and alpha(v)beta(5) integrin, and may represent a new regulatory pathway of cell migration downstream of integrin engagement."
https://pharos.nih.gov/idg/targets/O00443,O00443,12077252,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,11994280,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,11289809,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,11156964,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,11154208,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,10985305,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,10641798,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,10208934,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,9808187,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,9708406,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,9446795,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,9394803,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,9341793,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,9247029,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,8798481,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00443,O00443,8636073,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00142,O00142,28729369,"We confirm the pathogenicity of the rare mitochondrial m.8340G>A variant the basis of single-fibre segregation studies and its association with an expanded clinical phenotype. Our case expands the phenotypic spectrum of diseases associated with mitochondrial tRNA point mutations, highlighting the importance of considering a mitochondrial diagnosis."
https://pharos.nih.gov/idg/targets/O00142,O00142,25948719,"Severe deficiency of thymidine kinase 2 was associated with patients with mild forms of myopathy."
https://pharos.nih.gov/idg/targets/O00142,O00142,25215937,"Data indicate that the thymidine kinase 2 enzyme kinetics of thymidine (dT) phosphorylation exhibits negative cooperativity, but deoxycytidine (dC) phosphorylation follows hyperbolic Michaelis-Menten kinetics."
https://pharos.nih.gov/idg/targets/O00142,O00142,24940680,"thymidine kinase 2 but not deoxyguanosine kinase is up-regulated during the stationary growth phase of cultured cells"
https://pharos.nih.gov/idg/targets/O00142,O00142,24455740,"We suggest that a chip including DPYD, TYMS, TYMP, TK1, and TK2 genes is a potential tool to predict response in LARC following fluoropyrimidine-based CCRT."
https://pharos.nih.gov/idg/targets/O00142,O00142,24198295,"Thymidine kinase-2 mutations causing mtDNA deletions are linked to a case of late-onset respiratory failure."
https://pharos.nih.gov/idg/targets/O00142,O00142,23932787,"Clinically, hypotonia and proximal muscle weakness are the major phenotypes present in all subjects. In summary, our study expands the molecular and clinical spectrum associated with TK2 deficiency."
https://pharos.nih.gov/idg/targets/O00142,O00142,22661713,"Results strongly suggest that oxidative damage-induced S-glutathionylation and degradation of TK2 have significant impact on mitochondrial DNA precursor synthesis."
https://pharos.nih.gov/idg/targets/O00142,O00142,21937588,"R225W and T230A mutation of TK2 leads to a significant reduction activity in autosomal recessive progressive external ophthalmoplegia patients."
https://pharos.nih.gov/idg/targets/O00142,O00142,21382338,"TK2-deficient cells showed severe mtDNA depletion."
https://pharos.nih.gov/idg/targets/O00142,O00142,20877624,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00142,O00142,20237496,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00142,O00142,19736010,"Sequence analysis of the TK2 gene revealed two novel heterozygous mutations: the frame shift mutation, c.255_c.258delAGAA, and the heterozygous missense mutation, c.515G>A, (p.R172Q)."
https://pharos.nih.gov/idg/targets/O00142,O00142,19265691,"Gene mutations in TK2 resulting in MDS syndrome was studied."
https://pharos.nih.gov/idg/targets/O00142,O00142,19154348,"Normal fibroblasts apparently contain more TK2 than needed to maintain dTTP during quiescence, which would explain why TK2-mutated fibroblasts do not manifest mtDNA depletion despite their reduced TK2 activity."
https://pharos.nih.gov/idg/targets/O00142,O00142,18508266,"Novel mutations(p.Q87X and p.N100S) in the TK2 gene associated with fatal mitochondrial DNA depletion myopathy."
https://pharos.nih.gov/idg/targets/O00142,O00142,18446447,"Mutations in TK2, necessary for mtDNA biogenesis, increased risk for defective mtDNA replication, leading to LV hypertrophy."
https://pharos.nih.gov/idg/targets/O00142,O00142,18265975,"FMAU is preferably phosphorylated by TK2 and can track TK2 activity and mitochondrial mass in cellular stress. FMAU may provide an early marker of treatment effects."
https://pharos.nih.gov/idg/targets/O00142,O00142,18021809,"A 12-year-old patient with mitochondrial DNA (mtDNA) depletion syndrome due to TK2 gene mutations has been evaluated serially over the last 10 years. We observed progressive muscle atrophy with selective loss of type 2 muscle fibers."
https://pharos.nih.gov/idg/targets/O00142,O00142,17913703,"activity of TK2 is curbed by thymidine phosphorylase, which degrades thymidine in the cytoplasm, thus limiting the availability of thymidine for phosphorylation by TK2 in mitochondria"
https://pharos.nih.gov/idg/targets/O00142,O00142,17468435,"Using (124)I-FIAU, (18)F-FIAU, or (18)F-FEAU, it should be possible to image DeltahTK2 reporter gene expression with PET in preclinical and clinical studies."
https://pharos.nih.gov/idg/targets/O00142,O00142,17065084,"import of cytosolic dNTPs in mitochondria of proliferating cells can compensate a TK2 induced imbalance of the mitochondrial dNTP pool"
https://pharos.nih.gov/idg/targets/O00142,O00142,16969512,"an increase in activity of dCK, TK1 and 2 might be involved in an adaptive response of cultured human squamous lung carcinoma cells to radiation by facilitation of DNA repair"
https://pharos.nih.gov/idg/targets/O00142,O00142,14659972,"Long-term treatment of H9 human lymphoid cells in the presence of dideoxycytidine down-regulated TK2 gene expression and reduced the expression and activity of TK in resistant cells."
https://pharos.nih.gov/idg/targets/O00142,O00142,12873860,"exon 5 is a \"hot spot\" for TK2 mutations in patients with myopathic mitochondrial DNA depletion syndrome"
https://pharos.nih.gov/idg/targets/O00142,O00142,12682338,"TK2 deficiency associated with myopathy and apparent reversion of mtDNA depletion noted in a 14-year-old patient in whom pathogenic mutations were identified in the TK2 gene"
https://pharos.nih.gov/idg/targets/O00142,O00142,12493767,"human thymidine kinase 2 has a role in mitochondrial DNA depletion myopathy as demonstrated by kinetic analysis"
https://pharos.nih.gov/idg/targets/O00142,O00142,12391347,"TK2 mutations have been identified in four patients from two families with myopathic mitochondrial DNA depletion and spinal muscular atrophy."
https://pharos.nih.gov/idg/targets/P35790,P35790,28566381,"hCKalpha functions as an indispensable regulator that bridges PI4KIIIalpha and hepatitis C virus NS5A and potentiates NS5A-stimulated PI4KIIIalpha activity, which then facilitates the targeting of the ternary complex to the endoplasmic reticulum for viral replication."
https://pharos.nih.gov/idg/targets/P35790,P35790,28065789,"We found levels of CHKA to be increased in human HCCs compared to nontumor tissues, and increased expression to be associated with tumor aggressiveness. Overexpression of CHKA in HCC cell lines increased their invasiveness, resistance to EGFR inhibitors, and ability to form metastatic tumors in mice by promoting interaction of EGFR with mechanistic target of rapamycin complex 2."
https://pharos.nih.gov/idg/targets/P35790,P35790,27489281,"These findings demonstrate that hCKalpha forms a complex with hepatitis C virus NS5A and that hCKalpha activity enhances the targeting of the complex to the endoplasmic reticulum, where hCKalpha protein, not activity, mediates NS5A binding to NS5B, thereby promoting functional membranous viral replication complex assembly and viral RNA replication."
https://pharos.nih.gov/idg/targets/P35790,P35790,26769123,"Study shows increased CHKA expression in pancreatic ductal adenocarcinoma tumors and may be a predictive marker of response to chemotherapy."
https://pharos.nih.gov/idg/targets/P35790,P35790,26657335,"CHKA can act as an AR chaperone, providing, to our knowledge, the first evidence for kinases as molecular chaperones, making CHKA both a marker of tumor progression and a potential therapeutic target for PCa."
https://pharos.nih.gov/idg/targets/P35790,P35790,26503172,"These data also support the approach of antitumor strategies that destabilize Chk-alpha protein or downregulate PtdCho in breast cancer treatment."
https://pharos.nih.gov/idg/targets/P35790,P35790,26496360,"Downregulation of choline kinase-alpha enhances autophagy in tamoxifen-resistant breast cancer cells."
https://pharos.nih.gov/idg/targets/P35790,P35790,26041862,"Increased expression of CHKA is seen in malignant lesions of prostate cancer"
https://pharos.nih.gov/idg/targets/P35790,P35790,25796169,"Identify choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinoma."
https://pharos.nih.gov/idg/targets/P35790,P35790,25768400,"Chokalpha possessed oncogenic activity and could be a potential therapeutic target in T-cell lymphoma , as well as other hematological malignancies with interrupted Ras signaling pathways"
https://pharos.nih.gov/idg/targets/P35790,P35790,25522435,"there is a role for the ChoKalpha protein in promoting cancer cell survival that is independent of its catalytic activity."
https://pharos.nih.gov/idg/targets/P35790,P35790,25267063,"The significance of CHKA overexpression on a TMA."
https://pharos.nih.gov/idg/targets/P35790,P35790,25028471,"choline kinase alpha is inhibited by a near-infrared fluorescent carbocyanine"
https://pharos.nih.gov/idg/targets/P35790,P35790,24583375,"Our data suggest that choline kinase and its product phosphocholine are required for the normal growth and mineralization of MG-63 cells."
https://pharos.nih.gov/idg/targets/P35790,P35790,24556997,"Downregulation of Chk-alpha with siRNA increased PLD1 expression, and downregulation of PLD1 increased Chk-alpha expression."
https://pharos.nih.gov/idg/targets/P35790,P35790,24287694,"pharmacological inhibition of ChoKalpha induces cancer cell death through a mechanism that involves the activation of exaggerated and persistent ER stress supported by CHOP overproduction."
https://pharos.nih.gov/idg/targets/P35790,P35790,24281000,"In EOC that CHKA downregulation significantly decreased the aggressive EOC cell."
https://pharos.nih.gov/idg/targets/P35790,P35790,23775813,"Chk-alpha expression and the effect of its downregulation in human umbilical vein endothelial cells, is reported."
https://pharos.nih.gov/idg/targets/P35790,P35790,23762272,"High choline kinase A expression is associated with colorectal cancer."
https://pharos.nih.gov/idg/targets/P35790,P35790,23416529,"A combination of initial velocity and product inhibition studies, together with the kinetic and structural characterisation of a novel ChoKalpha inhibitor is used to support a mechanism of action for human ChoKalpha."
https://pharos.nih.gov/idg/targets/P35790,P35790,23071593,"HK2 and CKA expression may have biologic and prognostic significance in hepatocellular carcinoma, with tumor HK2 expression being a potential independent predictor of survival."
https://pharos.nih.gov/idg/targets/P35790,P35790,22972156,"CHKA SNPs (rs3794186 and rs11481) are not associated with HCC development; however, rs3794186 may correlate with serum AFP levels in HCC."
https://pharos.nih.gov/idg/targets/P35790,P35790,22515519,"ASAH1 inhibition synergistically sensitizes lung cancer cells resistant to the antiproliferative effect of choline kinase alpha inhibitors."
https://pharos.nih.gov/idg/targets/P35790,P35790,22038995,"Data show choline kinase alpha (CHKalpha) expressed in both cytoplasm and nucleus in malignant lesions."
https://pharos.nih.gov/idg/targets/P35790,P35790,21822308,"these results strongly implicate a new c-Src-dependent link between CHKA and EGFR, which contributes to the regulation of cell proliferation and tumorigenesis."
https://pharos.nih.gov/idg/targets/P35790,P35790,21048031,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35790,P35790,20662904,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35790,P35790,20299452,"kinetic studies revealed that HC-3 is a much more potent inhibitor for ChoKalpha isoforms (alpha1 and alpha2) compared with ChoKbeta."
https://pharos.nih.gov/idg/targets/P35790,P35790,20042122,"From our data, we proposed that Choline kinase plays a key role in regulating Akt(ser473) phosphorylation, thereby promoting cell survival and proliferation"
https://pharos.nih.gov/idg/targets/P35790,P35790,19915674,"ChoKalpha and ChoKbeta isoforms have different physiological roles and implications in human carcinogenesis"
https://pharos.nih.gov/idg/targets/P35790,P35790,19855431,"Data show that RNA silencing of choline kinase in HeLa cells completely abrogates the high concentration of phosphocholine, which in turn decreases phosphatidylcholine, phosphatidic acid and signaling through the MAPK and PI3K/AKT pathways."
https://pharos.nih.gov/idg/targets/P35790,P35790,19737740,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35790,P35790,19448670,"ChoKalpha plays a role in the aggressiveness of bladder tumors and constitutes a new approach for bladder cancer treatment."
https://pharos.nih.gov/idg/targets/P35790,P35790,19156696,"The rates of choline kinase reaction in cell lysates of MDA-MB-231 breast, PC-3 prostate and HeLa cervical cancer cells and in solutions of purified human ChoK, was measured."
https://pharos.nih.gov/idg/targets/P35790,P35790,18296102,"The molecular basis to understand the connection between phospholipids metabolism and cell cycle regulation through choline kinase is reported."
https://pharos.nih.gov/idg/targets/P35790,P35790,18172309,"These data suggest that HIF-1 activation of HREs within the putative chk-a promoter region can increase Chk-A expression within hypoxic environments, consequently increasing cellular PC and tCho levels within these environments."
https://pharos.nih.gov/idg/targets/P35790,P35790,17184542,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35790,P35790,17184542,"Analyses showed genotype effects of CHKA genes on spina bifida risk, but did not show evidence of gene-nutrient."
https://pharos.nih.gov/idg/targets/P35790,P35790,16820874,"ChoK may have a role in carcinogenesis"
https://pharos.nih.gov/idg/targets/P35790,P35790,12176020,"upregulation of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal cancers"
https://pharos.nih.gov/idg/targets/P35790,P35790,12082619,"ChoK overexpression was found in 17% of the samples. ChoK may be related to the development of human breast cancer, suggesting that this finding may suggest a novel antitumoral strategy."
https://pharos.nih.gov/idg/targets/P35790,P35790,11840339,"activity regulated by Ras proteins through Ral-GDS and PI-3-kinase; has role in malignant transformation"
https://pharos.nih.gov/idg/targets/P04183,P04183,28651488,"though TK1 expression was an independent prognostic factor for relapse, but not for survival, TK1 is a more informative expression than Ki-67 for LI, relapse and overall survival rates. Thus, when TK1 is combined with MDACC grading, pTNM staging and lymph node metastasis, IHC determination of TK1 expression may improve the overall prediction of prognosis in patients with ovarian cancer."
https://pharos.nih.gov/idg/targets/P04183,P04183,28093273,"The results have implications for the mechanism by which Fhit regulates TK1 mRNA, and more broadly, for its modulation of multiple functions as tumor suppressor/genome caretaker."
https://pharos.nih.gov/idg/targets/P04183,P04183,27625087,"Results suggest that positive expression of CK19 mRNA and TK1 protein is closely correlated with poor prognosis in advanced gastrointestinal cancer."
https://pharos.nih.gov/idg/targets/P04183,P04183,27114546,"HIV-1 Vpr upregulates TK1 in HeLa cells within 12 hours of exposure"
https://pharos.nih.gov/idg/targets/P04183,P04183,27079872,"Data show that the median thymidine kinase (TK1) levels found in sera from breast cancer patients with T1 to T4 stage disease were 0.31, 0.46, 0.47, and 0.55 ng/ml, and these levels significantly differed from healthy controls."
https://pharos.nih.gov/idg/targets/P04183,P04183,27069161,"Serum Thymidine Kinase 1 Activity Following Nephrectomy for Renal Cell Carcinoma and Radiofrequency Ablation of Metastases to Lung and Liver"
https://pharos.nih.gov/idg/targets/P04183,P04183,27002755,"STK1 is a reliable biomarker for discovering people with malignant tumors in cancer screening."
https://pharos.nih.gov/idg/targets/P04183,P04183,26231311,"TK1 expression is significantly different in invasive urothelial carcinoma and benign urothelium, which underlines its potential as a diagnostic marker"
https://pharos.nih.gov/idg/targets/P04183,P04183,25964590,"A regression analysis showed that only TK1 levels were significant (relative risk (RR)=1.03 for each unit, confidence interval (CI)=1-1.05; p=0.015) for diagnosing a true transformation"
https://pharos.nih.gov/idg/targets/P04183,P04183,25921119,"High Thymidine Kinase expression is associated with adenocarcinoma in Non-small Cell Lung Cancer."
https://pharos.nih.gov/idg/targets/P04183,P04183,25881026,"These results demonstrate that there are differences in the specific activities and the subunit compositions of STK1 in hematological malignancies compared with breast and prostate cancer."
https://pharos.nih.gov/idg/targets/P04183,P04183,25769404,"Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours--A prognostic test after surgical resection."
https://pharos.nih.gov/idg/targets/P04183,P04183,24455740,"We suggest that a chip including DPYD, TYMS, TYMP, TK1, and TK2 genes is a potential tool to predict response in LARC following fluoropyrimidine-based CCRT."
https://pharos.nih.gov/idg/targets/P04183,P04183,23693054,"Nuclear TK1 expression in early grade cervical intraepithelial neoplasia predicts risk for progression to malignancy"
https://pharos.nih.gov/idg/targets/P04183,P04183,23229746,"3'-deoxy-3'-[18F]-fluorothymidine (18F-FLT) kinetics correlates with thymidine kinase-1 expression and cell proliferation in newly diagnosed gliomas"
https://pharos.nih.gov/idg/targets/P04183,P04183,23179401,"Increased serum level of thymidine kinase 1 correlates with metastatic site in patients with malignant melanoma."
https://pharos.nih.gov/idg/targets/P04183,P04183,23116493,"The magnitude of maximum fluorodeoxyglucose uptake in primary tumors and the serum TK1 level in patients with metastatic NSCLC were found to be independent prognostic predictors of overall survival."
https://pharos.nih.gov/idg/targets/P04183,P04183,22741536,"results suggest that the serum TK1 protein differs from cellular or recombinant forms, is more active in high molecular weight complexes, and is sensitive to reducing agents"
https://pharos.nih.gov/idg/targets/P04183,P04183,22385435,"The crystal structure of the T163S-mutated HuTK1 reveals a less ordered conformation of the ligand thymidine triphosphate compared with the wild-type structure"
https://pharos.nih.gov/idg/targets/P04183,P04183,22263569,"Data suggest that serum thymidine kinase 1 (TK1) levels may help to refine risk assessment in the modern immunotherapy era."
https://pharos.nih.gov/idg/targets/P04183,P04183,22143937,"TK1 may be involved in poor survival in patients with pT1 of lung adenocarcinoma"
https://pharos.nih.gov/idg/targets/P04183,P04183,22027876,"frequencies of polymorphic mutations in HIV-1 (subtype B) were compared between patients detected with the 69 insertion (n = 17), Q151M (n = 29), >/=2 thymidine analogue mutations (TAM) 1 (n = 400) or >/=2 TAM 2 (n = 249)."
https://pharos.nih.gov/idg/targets/P04183,P04183,21764789,"(18)F-FLT uptake and retention within cells may be complicated by a variety of still undetermined factors in addition to TK1 enzymatic activity"
https://pharos.nih.gov/idg/targets/P04183,P04183,21545220,"Elevated serum thymidine kinase 1 is associated with pre/early cancerous progression."
https://pharos.nih.gov/idg/targets/P04183,P04183,21505426,"data demonstrate that the Flt3L/TK gene therapeutic approach can induce systemic immunological memory capable of recognizing a brain tumor neoantigen in a model of recurrent GBM"
https://pharos.nih.gov/idg/targets/P04183,P04183,20849417,"direct involvement of the G-quadruplex motif in transcription of TK1"
https://pharos.nih.gov/idg/targets/P04183,P04183,20628086,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P04183,P04183,20592392,"thymidine kinase has a role in progression of lung cancer"
https://pharos.nih.gov/idg/targets/P04183,P04183,20560637,"nucleoside recognition mechanisms for TK1 and TK2 are very different. nonpolar nucleosides are likely to be active in the nucleotide salvage pathway in human cells."
https://pharos.nih.gov/idg/targets/P04183,P04183,20554529,"more dTTP synthesis via TK1 take place after genotoxic insults in tumor cells, improving DNA repair during G(2) arrest."
https://pharos.nih.gov/idg/targets/P04183,P04183,20544519,"The expression of TK1 in tumor tissues correlated to pathological stages and clinical grades of carcinomas (ca) of esophagus, lung and in premalignancy of breast ductal ca. STK1p could monitor the out-come of tumor therapy."
https://pharos.nih.gov/idg/targets/P04183,P04183,20544518,"Results suggest that higher thymidine levels in the TK- cells caused by defect thymidine salvage to dTTP protects against UV irradiation."
https://pharos.nih.gov/idg/targets/P04183,P04183,20479645,"Serological thymidine kinase 1 is a useful marker for prognosis in patients with esophageal, cardial and lung carcinomas."
https://pharos.nih.gov/idg/targets/P04183,P04183,20450760,"High levels of HER2 and Ki-67 or TK1 expression correlate with the increase of tumor grades and tumor recurrence in meningiomas."
https://pharos.nih.gov/idg/targets/P04183,P04183,20372850,"Thymidine kinase-1 and thymidylate synthase expression was markedly different between cancer types, suggesting that response to TAS-102 may differ."
https://pharos.nih.gov/idg/targets/P04183,P04183,20354751,"Serum TK1 correlates to clinical stages and clinical reactions and monitors the effect of tumor therapies, not only in controlled clinical trials, but also in routine clinical settings."
https://pharos.nih.gov/idg/targets/P04183,P04183,20140744,"TK1 in serum may possess a reference value in the evaluation of treatment and prognosis of non-Hodgkin's lymphoma following chemotherapy."
https://pharos.nih.gov/idg/targets/P04183,P04183,20003201,"The TK1 model presented supports both K and k positive cooperativity. Three-parameter mass action models can and should replace the 3-parameter Hill model."
https://pharos.nih.gov/idg/targets/P04183,P04183,19957115,"cell cycle regulation of TK1 in normal tubule cells differ from that in other type of normal and malignant renal cells."
https://pharos.nih.gov/idg/targets/P04183,P04183,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P04183,P04183,19654105,"the relationship between the expression of TK1 and TP as they relate to proliferation (Ki-67 labeling index) and angiogenesis (Chalkley count of CD31-stained blood vessels) in a series of 110 non-small-cell lung cancer (NSCLC) tumors"
https://pharos.nih.gov/idg/targets/P04183,P04183,19396699,"study indicates that the tumour proliferation marker thymidine kinase 1 has a potential as a serum marker in breast cancer"
https://pharos.nih.gov/idg/targets/P04183,P04183,19282758,"Increased TK1 is associated with renal cell carcinoma."
https://pharos.nih.gov/idg/targets/P04183,P04183,19123476,"Mice with reduced thymidine Kinase treated neonatally with acrylamide or glycidamide is associated with DNA adduct formation and induction of micronuclei and mutations."
https://pharos.nih.gov/idg/targets/P04183,P04183,19087190,"TK1 concentration was found to have a pivotal effect on catalytic efficiency"
https://pharos.nih.gov/idg/targets/P04183,P04183,18615770,"Clinical-grade preparation of regulatory T-cells encoding the TK1 suicide gene as a safety gene is reported."
https://pharos.nih.gov/idg/targets/P04183,P04183,17407781,"The structures of hTK1 and of the Thermotoga maritima thymidine kinase (TmTK) in complex with the bisubstrate inhibitor TP4A, is reported."
https://pharos.nih.gov/idg/targets/P04183,P04183,17227951,"thymidine is not only a substrate of TK1 but also acts as its expression regulator by modulating its proteolytic control during mitotic exit, conferring a feed-forward regulation of dTTP formation"
https://pharos.nih.gov/idg/targets/P04183,P04183,17065087,"analysis of the role of C-terminal 20, 40, and 44 amino acids of TK1 in in vitro stability, oligomerization, and enzyme kinetics"
https://pharos.nih.gov/idg/targets/P04183,P04183,16969512,"an increase in activity of dCK, TK1 and 2 might be involved in an adaptive response of cultured human squamous lung carcinoma cells to radiation by facilitation of DNA repair"
https://pharos.nih.gov/idg/targets/P04183,P04183,15978330,"an increased expression of mRNA, specific for TK1, deoxycytidine kinase, and thymidine phosphorylase, may be involved in carcinogenic processes in the human thyroid"
https://pharos.nih.gov/idg/targets/P04183,P04183,15809747,"TK1 expression is apparently a reliable marker in patients with non-small cell lung cancer."
https://pharos.nih.gov/idg/targets/P04183,P04183,15733844,"crystal structure of thymidine kinase 1"
https://pharos.nih.gov/idg/targets/P04183,P04183,15611477,"analysis and comparison of human and mycoplasmic thymidine kinase 1"
https://pharos.nih.gov/idg/targets/P04183,P04183,15353126,"activation of TK1 may be critical to modulate the radiation-induced cell death and cell cycle progression in irradiated K562 cells."
https://pharos.nih.gov/idg/targets/P04183,P04183,15153115,"The importance of valine 106 for the structure and function of TK1."
https://pharos.nih.gov/idg/targets/P04183,P04183,14719072,"Activity of thymidine kinase, thymidine phosphorylase and thymidilate synthase in human cancer xenografts to investigate the contribution of these enzymes to the sensitivity of TAS-102."
https://pharos.nih.gov/idg/targets/P04183,P04183,14701726,"activation of the APC/C-Cdh1 complex during mitotic exit controls timing of TK1 destruction"
https://pharos.nih.gov/idg/targets/P04183,P04183,14697231,"the enzymatic function at the G2/M phase of TK1 depends on its quaternary structure"
https://pharos.nih.gov/idg/targets/P04183,P04183,14659972,"Long-term treatment of H9 human lymphoid cells in the presence of dideoxycytidine down-regulated TK1 gene expression and reduced the expression and activity of TK in resistant cells."
https://pharos.nih.gov/idg/targets/P04183,P04183,12699056,"Mutation analysis in the coding sequence of thymidine kinase 1 in breast and colorectal cancer"
https://pharos.nih.gov/idg/targets/P04183,P04183,11992400,"TK1 gene expression together with TS, TP and DPD gene expression may play important roles in influencing the malignant behavior of epithelial ovarian cancer."
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,25164007,"our findings identify a functional role for Cerk in breast cancer recurrence and suggest the clinical utility of agents targeted against this prosurvival pathway."
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,22579669,"Data suggest that inhibition of ceramide kinase (CerK) [by specific gene silencing or pharmacological inhibition] drastically reduced cell proliferation in a neuroblastoma cell line."
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,22230689,"TNF-alpha exposure of human SH-SY5Y neuroblastoma caused a profound increase in CERK activity."
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,21621503,"Expression of hCERK enhanced ceramide-1-phosphate formation and release of arachidonic acid in Ca(2+) ionophore-stimulated cells."
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,21255156,"We have identified a differential role for ceramide kinase in mast-cell activation"
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,20877624,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,19778898,"JNK and ceramide kinase govern the biogenesis of lipid droplets through activation of group IVA phospholipase A2"
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,19501188,"The Pleckstrin Homology (PH) domain of CERK, which is required for Golgi complex localization, can substitute for the N-terminal region of CERKL and allow for wild-type CERKL localization, which is typified by nucleolar accumulation."
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,19125296,"ceramide kinase, was associated with poor pathohistological grading in breast cancer"
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,18662741,"identification of a cluster of cysteines, C(347)XXXC(351)XXC(354), essential for CerK function"
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,18156590,"higher Ca2+ signal observed in hCERK transfected cells as well as the fact that CERK colocalized with EIgG during phagocytosis support hypothesis that Ca2+ signaling is an important factor for increasing phagocytosis and is regulated by CERK"
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,17957442,"HL-60 cells are useful for studying CerK functions in leukocyte differentiation, and they also suggest that CerK might have an important role in such differentiation."
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,17392267,"Results demonstrate that CERK localizes to areas of eicosanoid synthesis and uses a ceramide \"pool\" transported in an active manner via CERT."
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,17274985,"These results suggest that ceramide kinase determines the balance between pro-apoptotic ceramide and anti-apoptotic C1P to regulate cell fate, reminiscent of its function in plants."
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,16488390,"CERK-pleckstrin homology domain plays a crucial role in plasma membrane targeting through its binding to phosphatidylinositol 4,5-bisphosphate and subsequent induction of ceramide-1-phosphate production in the vicinity of the membrane."
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,16269826,"Recombinant CERK was analyzed with regard to dependence on divalent cations, to substrate delivery, specificity, and stereoselectivity. CERK associated with the plasma membrane in CHO cells, which is mediated by the N-terminal putative pleckstrin domain."
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,16170208,"sphingoid chain was also required for substrate recognition by CERK"
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,16081073,"Pleckstrin homology domain of CERK is not only indispensable for its activity but also act as a regulator of CERK activity."
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,15899891,"CERK translocates during activation from the cytosol to a lipid raft fraction"
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,12855693,"ceramide kinase and its product, C-1-P, have roles in arachidonic acid release and production of eicosanoids"
https://pharos.nih.gov/idg/targets/Q8TCT0,Q8TCT0,11956206,"Molecular cloning and functional characterization"
https://pharos.nih.gov/idg/targets/O60825,O60825,27802586,"Crystal structure of human and cattle heart PFKFB2 and the inhibitory influence of citrate on substrate binding has been described."
https://pharos.nih.gov/idg/targets/O60825,O60825,25662186,"Variation in PFKFB2 appears to reduce PFKFB2 expression in adipose and kidney tissues, and thereby increase risk for adiposity and diabetic nephropathy."
https://pharos.nih.gov/idg/targets/O60825,O60825,24634222,"bifunctionality of PFK-2/FBPase-2 complements the metabolic zonation of the liver by ensuring coherent switching in response to insulin and glucagon."
https://pharos.nih.gov/idg/targets/O60825,O60825,24568531,"Highly expressed PFKFB2 protein is associated with hepatocellular carcinoma."
https://pharos.nih.gov/idg/targets/O60825,O60825,23457334,"amino acids stimulate Fru-2,6-P2 synthesis by Akt-dependent PFKFB2 phosphorylation and activation and show how signaling and metabolism are inextricably linked."
https://pharos.nih.gov/idg/targets/O60825,O60825,22241065,"A persistent increase in 6-phosphofructo-2-kinase produced by a change in PFK-2/FBPase-2 isoform expression that may play an important role in the regulation of muscle glycolysis."
https://pharos.nih.gov/idg/targets/O60825,O60825,21092265,"Suggest that PFKFB2 is not an essential upstream regulator of the anti-leukemic effects of glucocorticoids."
https://pharos.nih.gov/idg/targets/O60825,O60825,20958264,"induction of de novo lipid synthesis by androgen requires transcriptional up-regulation of HK2 and PFKFB2, and phosphorylation of PFKFB2 generated by the PI3K/Akt signal pathway to supply the source for lipogenesis from glucose in prostate cancer cells."
https://pharos.nih.gov/idg/targets/O60825,O60825,20438785,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O60825,O60825,20406964,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O60825,O60825,19423540,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O60825,O60825,18039179,"Human islets expressed the PFKFB2 and PFKFB3 isoforms. PFK-2/FBPase-2 protein rather than its product fructose 2,6-P(2) is the over-riding determinant of glucose-induced insulin secretion through regulation of glucokinase activity"
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,29145490,"results were consistent across all of the four serotypes of DENV infection, which supports the pro-apoptotic role of SPHK2 in DENV-infected liver cells"
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,28807595,"sphingosine kinase-2 plays an important role in kidney fibrogenesis by modulating transforming growth factor-beta signaling"
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,28108260,"SphKs/Sphingosine-1-phosphate signaling is critical for the growth and survival of estrogen receptor positive MCF-7 human breast cancer cells."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,27223438,"miR-613 functions as a tumor suppressor in papillary thyroid carcinoma and its suppressive effect is mediated by repressing SphK2 expression"
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,27021309,"The analysis suggests that the catalytic function and regulation of SPHK1 and SPHK2 might be dependent on their conformational mobility. (Review)"
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,26886371,"increased SK and SPL mRNA expression along with reduced sphingosine 1-phosphate levels were more commonly observed in hepatocellular carcinoma tissues."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,26822263,"data suggest that in vitro inhibition of SK-2, can compromise the integrity of the EC monolayer"
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,26733171,"the pathogenesis of CRC maybe mediated by SphK2, and SphK2 could represent a selective target for the molecularly targeted treatments of CRC"
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,26628299,"In this study, we describe the findings that overexpression of SphK2 promotes chemoresistance in non-small cell lung cancer (NSCLC) cells. Inhibition of SphK2 might be considered as a strategy in NSCLC treatment with gefitinib"
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,26494858,"ABC294640 may reduce the proliferative capacity of castration-resistant prostate cancer cells through inhibition of both sphingosine kinase 2 and dihydroceramide desaturase."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,26337959,"Targeting of SphK2 by ABC294640 potently inhibits colorectal cancer cell growth both in vitro and in vivo."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,26209696,"results define new mechanistic insights for EGF-mediated invasion and novel actions of SK2"
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,25808826,"Because of the unique relationship observed after serum depletion, we examined effects of siRNA for SPHK2, and found the role of SPHK2 as a growth or survival factor but not a cell proliferation inhibitor in FCS(-) culture"
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,25455157,"Down-regulation of SphK2 increased the effects of all-trans-retinoic acid on colon cancer cells."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,25010828,"These data illuminate a novel survival mechanism and potential therapeutic target for KSHV-infected endothelial cells: SphK2-associated maintenance of viral latency"
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,24903384,"Data show that sphingosine kinase SphK1 and sphingosine-1-phosphate (S1P) receptors S1P1, S1P2, S1P3, and S1P5 were expressed from primary, up to recurrent and secondary glioblastomas, with sphingosine kinase SphK2 levels were highest in primary tumors."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,24709100,"SPHK2 regulates apoptosis in colon cancer cells."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,24686171,"Results demonstrated that SK2 regulates MYC, which has a pivotal role in hematologic malignancies."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,24486401,"SK2 prevents the nuclear translocation of Y416 phosphorylated c-Src and this appears to be independent of S1P4 and might involve an intracellular S1P-dependent mechanism, which is resistant to exogenously added S1P."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,24422628,"IGF1R mediates insulin-stimulated phosphorylation of both SphK1 and SphK2."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,24385109,"Silencing of sphingosine kinase 2 (SphK-2) also blocked HDL-induced COX-2/PGI-2 activation."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,24140934,"these results implicate interrelated mechanisms and SPHK2 inhibition in the induction of PEL cell death by ABC294640 and rationalize evaluation of ABC294640 in clinical trials for the treatment of KSHV-associated lymphoma."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,23918304,"the expression of SphK2 parallels the progression of NSCLC. The expression of SphK2 might represent a novel and potentially independent biomarker for the prognosis of patients with NSCLC."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,23881266,"SphK2 plays a controversial role in arthritis."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,23359503,"The function of SphK1 and SphK2 can be interchangeable in mast cells and is species and cell type determined."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,23314175,"Sphingosine kinase 2 might function simply to dynamically regulate sphingosine-S1P cycling."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,21620961,"SK2 functions as a pro-survival protein and is involved in promoting actin rearrangement into membrane ruffles/lamellipodia in response to sphingosine 1-phosphate in MCF-7 breast cancer cells."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,21307639,"pharmacological inhibition of Sphk2 with the orally bioavailable selective inhibitor, ABC294640, has therapeutic potential in the treatment of chemo- and endocrine therapy- resistant breast cancer."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,20237496,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,20197547,"Cleavage of sphingosine kinase 2 by caspase-1 provokes its release from apoptotic cells."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,19490468,"SPHK2 may regulate the autonomous proliferation of synovial fibroblasts as one of the predisposing genes to rheumatoid arthritis"
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,19240026,"Results indicate that SPHK1 and 2 isoforms and neutral sphingomyelinase contribute to the regulation of chemosensitivity by controlling ceramide formation and the downstream Akt pathway in human colon cancer cells."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,19168031,"A lipid binding domain in Sphk2 that is important for the enzyme's sub-cellular localisation was identified."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,18263879,"a novel mechanism of regulation of both SK1 and SK2 that is mediated by their interaction with eEF1A."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,18178871,"These data suggest that differential formation of sphingosine-1-phosphate by SphK1 and SphK2 has distinct and important actions in human mast cells."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,17895250,"Sphingosine kinase 2, but not sphingosine kinase 1, acted in concert with SPP-1 to regulate recycling of sphingosine into ceramide."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,17635916,"PKD is a physiologically relevant enzyme for SPHK2 phosphorylation, which leads to its nuclear export for subsequent cellular signaling."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,17311928,"hSphK2 is phosphorylated on Ser-351 and Thr-578 by ERK1 and phosphorylation of these residues is important for EGF-stimulated migration of MDA-MB-453 cells"
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,16103110,"the N-terminal-extended form of sphingosine kinase 2 has a role in serum-dependent regulation of cell proliferation and apoptosis"
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,15951439,"Sphingosine kinase 2 plays an important role in migration of MDA-MB-453 cells toward EGF."
https://pharos.nih.gov/idg/targets/Q9NRA0,Q9NRA0,14596938,"although both sphingosine kinase type 1 (SphK1) and type 2 (SphK2) can phosphorylate FTY720 with low efficiency, SphK2 is much more effective than SphK1"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,28846113,"Vps34 stimulates tumor development mainly through PKC-delta- activation of p62."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,28844862,"p300-dependent VPS34 acetylation/deacetylation is the physiological key to VPS34 activation, which controls the initiation of canonical autophagy and of non-canonical autophagy in which the upstream kinases of VPS34 can be bypassed."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,28157699,"Low VPS34 expression is associated with cancer."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,28059666,"This study reveals NRBF2 as a critical molecular switch of PtdIns3K and autophagy activation, and its on/off state is precisely controlled by MTORC1 through phosphorylation."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,28038917,"High expression of VPS34 promoted GRP78 transcription by modulating ATF6. VPS34 could enhance GRP78 protein stability."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,27821547,"These results establish Vps34 as an essential determinant of both short-term and long-term canonical GPCR signaling."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,27793976,"Vps34 has a previously unknown role in regulating Rab7 activity and late endosomal trafficking."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,27630019,"Atg38 and its human ortholog NRBF2, accessory components of complex I consisting of Vps15-Vps34-Vps30/Atg6-Atg14 (yeast) and PIK3R4/VPS15-PIK3C3/VPS34-BECN1/Beclin 1-ATG14 (human), were characterized."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,27385829,"Here we show that a putative fifth subunit, nuclear receptor binding factor 2 (NRBF2), is a tightly bound component of the class III phosphatidylinositol 3-kinase complex I that profoundly affects its activity and architecture.  NRBF2 is a homodimer and drives the dimerization of the larger PI3KC3-C1 complex, with implications for the higher-order organization of the preautophagosomal structure."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,26687681,"Study identifies a key role of Cul3-KLHL20 in autophagy termination by controlling autophagy-dependent turnover of ULK1 and VPS34 complex subunits and reveals the pathophysiological functions of this autophagy termination mechanism."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,26686095,"Arf tumor suppressor as a new transcriptional target of nuclear EGFR and highlight Vps34 as an important regulator of the nuclear EGFR/Arf survival pathway."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,26139536,"tubulation requires mTOR activity, and we identified two direct mTOR phosphorylation sites on UVRAG (S550 and S571) that activate VPS34."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,25840748,"High expression of PI3K core complex genes is associated with poor prognosis in chronic lymphocytic leukemia."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,25714112,"cis-unsaturated fatty acids require neither BECN1 nor PIK3C3 to stimulate the autophagic flux"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,25593308,"DNA damage regulates Vps34 complexes and its downstream mechanisms, including autophagy and receptor endocytosis, through SCF (Skp1-Cul1-F-box)-mediated ubiquitination and degradation"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,25402320,"Data indicte that Compound 31 constitutes an optimized class III phosphoinositide 3-kinase Vps34 inhibitor that could be used to investigate cancer biology."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,25395352,"VPS34-IN1 will provide a useful tool to decipher the kinase-dependent functions of Vps34, with acute changes in SGK3 phosphorylation and subcellular localization being new biomarkers of Vps34 activity."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,25046113,"reveal a novel function of GABP in the regulation of autophagy via transcriptional activation of the BECN1-PIK3C3 complex"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,24785657,"NRBF2 regulates macroautophagy as a component of Vps34 Complex I."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,24582588,"Insulin can spatially regulate VPS34 activity through Src-mediated tyrosine phosphorylation."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,24466196,"Ric-8A co-localized with Vps34 at the midbody."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,24073214,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,24013218,"A mechanistic link between amino acid starvation and autophagy induction via the direct activation of the autophagy-specific PIK3C3 kinase."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,23301033,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,23215766,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,22719072,"Via direct interaction with the class III PI-3-kinase (PI3KC3)/Beclin1, DEDD activated autophagy and induced the degradation of Snail and Twist, two master regulators of EMT"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,22493499,"conclude that Slamf1 recruits a subset of Vps34-associated proteins, which is involved in membrane fusion and NOX2 regulation"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,22095288,"Results describe PKD as a novel Vps34 kinase that functions as an effecter of autophagy under oxidative stress."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,22024166,"Class III PI-3-kinase activates phospholipase D in an amino acid-sensing mTORC1 pathway"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,22021616,"Though dispensable for autophagy induction, transgenic Vps34 is a critical regulator of naive T cell homeostasis, modulating interleukin (IL)-7 receptor alpha trafficking, signaling, and recycling."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,21835792,"Coimmunoprecipitation assay indicated that hepatitis C virus NS4B formed a complex with human Rab5 and Vps34, supporting the notion that Rab5 and Vps34 are involved in NS4B-induced autophagy."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,21702994,"Activation of mTOR by leucine or insulin upregulated hVps34."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,21062745,"a critical role of the Rubicon RUN domain in PI3KC3 and autophagy regulation"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,21029719,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,20955765,"Pik3c3 is essential for central nervous system neuronal homeostasis and Pik3c3 deletion; CaMKII-Cre transgenic mouse is a useful model for studying pathological changes in progressive forebrain neurodegeneration."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,20885446,"14-3-3zeta proteins are shown as a negative regulator of autophagy through regulation of a key component of early stages of the autophagy pathway, such as hVps34."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,20818790,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,20671926,"A PIK3C3 promoter variant (rs3813065/-442 C/T) in an independent multiancestral cohort of 478 systemic lupus erythematosus cases and 522 controls, was examined."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,20671926,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,20643123,"A specific sub-complex containing VPS15, VPS34, Beclin 1, UVRAG and BIF-1 regulates both receptor degradation and cytokinesis, whereas ATG14L, a PI3K-III subunit involved in autophagy, is not required."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,20602615,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,20529838,"Data show that knockdown of Vps34 reduces gossypol-induced autophagy in both MCF-7 human breast adenocarcinoma and HeLa cell lines."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,20453000,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,20019835,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,19887755,"was expressed in cancer tissues at 11 times the level of that found in normal tissue; findings suggest that activation of the PI3K-AKT signal pathway is associated with oral carcinogenesis"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,19359265,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,18996102,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,18957027,"hVps34 activity is regulated through its interactions with hVps15, but is independent of Ca2+/CaM."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,18854243,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,18774718,"A phylogenetic study revealing co-evolution of myotubularins phosphoinositides phosphatases with PI 3-kinase class III complex"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,18755982,"Class III PI3K Vps34 is responsible for the synthesis of PtdIns(3)P on phagosomes containing either S aureus or E coli. PtdIns(3)P binding to p40(phox) is important for CD18-dependent activation oxidase activation in response to S aureus and E coli"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,18725540,"SopB mediates PI(3)P production on the SCV indirectly through recruitment of Rab5 and its effector Vps34."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,18649358,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,18453587,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,18420347,"our results do support PIK3C3 play a significant role in the etiology of schizophrenia"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,18420347,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,18077426,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,18048384,"the lipid kinase activity of Vps34 has a role in resveratrol-induced apoptosis and in the formation of autophagolysosomes"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,17632570,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,17319803,"study indicates that hVps34 and its product PI(3)P are involved in endosome to Golgi transport of ricin, and that SNX2 and SNX4 are likely to be effectors in this pathway"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,17157319,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,16874027,"There is a connection between Beclin 1-associated Class III PI3K/Vps34-dependent autophagy, but not VPS, function and the mechanism of Beclin 1 tumor suppressor action in human breast cancer cells."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,16524887,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,16390869,"Results argue against a role for Beclin 1 as an essential chaperone or adaptor for hVps34 in normal vesicular trafficking, and they support the hypothesis that Beclin 1 functions mainly to engage hVps34 in the autophagic pathway."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,16176982,"Amino acids mediate mTOR activation by signaling through class 3 PI3K, hVps34."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,16081599,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,16049009,"hVps34 is a nutrient-regulated lipid kinase that integrates amino acid and glucose inputs to mTOR and S6K1"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,15689238,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,15121481,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,15121481,"A promoter mutation in a PI regulator affecting the binding of a POU-type transcription factor may be involved in BD and SZ in a subset of patients."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,14617358,"Data identify rab7 as an important regulator of late endosomal VPS34 function and link rab7 to the regulation of phosphatidylinositol 3'-kinase cycling between early and late endosomes."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,14602571,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,12960231,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,12925680,"Results describe how Mycobacterium tuberculosis toxin lipoarabinomannan causes phagosome maturation arrest, interfering with a calcium/calmodulin phosphatidylinositol (PI)3 kinase hVPS34 cascade."
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,12584329,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,12551992,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,12526811,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,12077252,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,11994280,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,11289809,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,11156964,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,11154208,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,10985305,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,10208934,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,9808187,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,9708406,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,9446795,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,9394803,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,9341793,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,9247029,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,8798481,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8NEB9,Q8NEB9,8636073,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,28982849,"Sphingosine kinase 1 is involved in papillary thyroid carcinoma development and progression and can serve as a potential biomarker predictive of lymph node metastasis."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,28733250,"SK1 activation is renoprotective via induction of autophagy in the fibrotic process"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,28729416,"High SPHK1 expression is associated with ovarian Cancer."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,28405684,"our data suggest that SphK1 modulates the expression of EMT-related markers and cell migration by regulating the expression of p-FAK in CRC cells. Thus, SphK1 may play a functional role in mediating the EMT process in CRC."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,28351953,"Data indicate that the mitotic kinase Polo-like kinase 1 (PLK1) was an important effector of S1P-S1P5 signaling, and a new function of the SphK1-S1P pathway specifically in the control of mitosis in HeLa cells."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,28206952,"High SPHK1 expression is associated with hepatocellular carcinoma."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,28178265,"By simulating therapeutic strategies that target multiple nodes of the pathway such as Raf and SphK1, we conclude that combination therapy should be much more effective in blocking VEGF signaling to EKR1/2. The model has important implications for interventions that target signaling pathways in angiogenesis relevant to cancer, vascular diseases, and wound healing."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,28108260,"SphKs/Sphingosine-1-phosphate signaling is critical for the growth and survival of estrogen receptor positive MCF-7 human breast cancer cells."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,28049734,"These results highlight the importance of sphingosine and its conversion to sphingosine-1-phosphate by SphK1 in endocytic membrane trafficking."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,27956387,"Inhibition of SPHK1 in human acute myeloid leukemia cells induces MCL1 degradation and caspase-dependent cell death."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,27942860,"demonstrated the roles played by miR-144-3p and FN1 in mediating the oncogenic function of SphK1, which enhanced the understanding of the etiology of PTC"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,27801960,"Melatonin-treated cells also exhibited an inhibition of the SphK1/S1P axis. Antifibrogenic effect of SphK1 inhibition was confirmed by treatment of LX2 cells with PF543. Abrogation of the lipid signaling pathway by the indole reveals novel molecular pathways that may account for the protective effect of melatonin in liver fibrogenesis."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,27621003,"high expression associated with higher levels of sphingosine-1-phosphate, which in turn is associated with lymphatic metastasis in breast cancer"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,27467777,"SPHK1 mediated autophagy is different in neurons and neuroblastoma cells"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,27099350,"SphK1 is regulated by PDGF-BB in pulmonary artery smooth muscle cells via the transcription factor Egr-1, promoting cell proliferation."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,27065335,"we identified sphingosine kinase 1 (SPHK1) as a novel target of miR-506, the expression of which inhibited the SPHK1/Akt/NF-kappaB signaling pathway, which is activated in pancreatic cancer. High SPHK1 expression was significantly associated with poor survival in a large cohort of pancreatic cancer specimens."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,27021309,"The analysis suggests that the catalytic function and regulation of SPHK1 and SPHK2 might be dependent on their conformational mobility. (Review)"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,26937138,"SPHK1 mRNA is up-regulation in colorectal cancer."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,26912347,"In conclusion, these data suggested that HuR bound to SphK1 mRNA and played a crucial role in TGF-beta1-induced hepatic stellate cell activation."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,26886371,"increased SK and SPL mRNA expression along with reduced sphingosine 1-phosphate levels were more commonly observed in hepatocellular carcinoma tissues."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,26877098,"Found that upregulation of SphK1 expression in the stiff substrate is dominant in metastatic cancer cells but not in primary cancer cells. These results suggest that alterations in the mechanical environment of the extracellular matrix surrounding the tumor cells actively regulate cellular properties such as secretion, which in turn, may contribute to cancer progression."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,26855418,"low oxLDL concentration triggers sprouting angiogenesis that involves ROS-induced activation of the neutral sphingomyelinase-2/sphingosine kinase-1 pathway, and is effectively inhibited by GW4869."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,26842184,"Sphk1 plays an important role in the malignant transformation of breast epithelial cells and modulates breast cancer metastasis through the regulation of Ecadherin expression."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,26716409,"High SPHK1 expression is associated with ovarian cancer."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,26673009,"SphK1 expression is functionally associated to cellular proliferation, apoptosis, invasion and mitotane sensitivity of adrenocortical carcinoma."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,26662312,"SphK1 is associated with the proliferation and invasiveness of CRC cells and the SphK1 gene may contribute to a novel therapeutic approach against CRC."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,26590717,"Results reveal an lncRNA- and E2F1-driven regulatory loop in which E2F1-dependent induction of antisense RNA leads to changes in chromatin structure, facilitating E2F1-dependent expression of SPHK1 and restriction of E2F1-induced apoptosis."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,26549227,"MiR-506 suppresses the angiogenesis of liver cancer by inhibiting SPHK1."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,26540633,"Data show that long non-coding RNA HULC promotes tumor angiogenesis in liver cancer through microRNA miR-107/E2F1 transcription factor (E2F1)/sphingosine kinase 1 (SPHK1) signaling."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,26493335,"High SPHK1 protein correlated with resistance to cisplatin (IC50) in an independent gastric cancer cell line panel and with survival of patients treated with chemotherapy prior to surgery but not in patients treated with surgery alone."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,26376826,"In summary, this study demonstrates a link between SphK1/sphingosine-1-phosphate and TGF-beta-induced miR-21 in renal tubular epithelial cells."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,26311741,"SPHK1 is involved in tumor development and progression of cervical cancer"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,26264277,"The silencing of SphK1 potentiated the apoptotic effects of the green tea polyphenol epigallocatechin-3-O-gallate."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,26073327,"Hepatitis B virus X protein is able to elevate the expression of SPHK1 in hepatoma cells by upregulating transcription factor AP2 alpha."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,26071354,"results indicate that miR-101 exerts its anti-CRC activities probably through down-regulating SphK1"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,26045781,"Resveratrol-induced proliferation inhibition of K562 cells might be mediated through its modulation activity of SphK1 pathway by regulating S1P and ceramide levels, which then affected the proliferation and apoptosis process of leukemia cells."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,25892494,"A novel chimeric aequorin fused with caveolin-1 reveals a sphingosine kinase 1-regulated Ca(2) microdomain in the caveolar compartment."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,25805832,"SK1 is overexpressed in 786-0 renal carcinoma cells lacking functional VHL, with concomitant high sphingosine 1-phosphate levels that appear to be HIF-2alpha mediated."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,25786072,"In contrast to the SK activity, S1PP activity was homogeneous across the peripheral blood NK cells, suggesting a bias in the SK pathway towards proliferation and migration, activities supported by S1P."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,25778867,"results suggest for the first time that SPHK1 is involved in the development and progression of NPC, which can be used as a useful prognostic marker for NPC patients and may be an effective target for treating NPC"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,25671829,"SPHK1 might represent a novel and useful prognostic marker of hepatocellular carcinoma progression in patients with portal vein tumor thrombus."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,25587035,"the A2B adenosine receptor (ADORA2B) is essential for adenosine-induced SphK1 activity in human and mouse normal and sickle erythrocytes in vitro"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,25481644,"Our findings demonstrate that leptin-induced STAT3 is partially cross activated through SK1-mediated IL6 secretion and gp130 activation. Positive correlations in human tissues suggest the potential significance of this pathway in ER-negative breast cancer"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,25417698,"induced pluripotent stem cell derived human Niemann-Pick type C disease neurons are generated and the abnormalities caused by VEGF/SphK inactivity in these cells are corrected by replenishment of VEGF."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,25411162,"E2F7 directly increases the transcription and activity of the Sphk1/S1P axis resulting in activation of AKT and subsequent drug resistance."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,25404266,"Data suggest that sphingosine kinase 1 (SPHK1) is involved in the regulation of small cell lung cancer multi-drug resistance, and a target gene to evaluate the chemosensitivity and clinical prognostic for small cell lung cancer (SCLC)."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,25319495,"This establishes that sphingosine kinase, in addition to producing sphingosine-1-phosphate as a signaling molecule, also consumes dihydrosphingosine to regulate ceramide synthesis."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,25310737,"these data indicated that Sphk1 inhibition plays an important role in caspase-dependent apoptotic neuronal death in an experimental Parkinson's disease model"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,25260803,"Sacral chordoma patients with high expression of SPHK1 possessed shorter continuous disease-free survival time."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,25176316,"oxLDL induced angiogenesis requires SPHK1/S1P signalling both in vitro in a HMEC-1 tube formation model and in vivo in the murine Matrigel plug model"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,25109605,"SphK1 confers resistance to apoptosis in gastric cancer cells via the Akt/FoxO3a/Bim pathway."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,24903384,"Data show that sphingosine kinase SphK1 and sphingosine-1-phosphate (S1P) receptors S1P1, S1P2, S1P3, and S1P5 were expressed from primary, up to recurrent and secondary glioblastomas, with sphingosine kinase SphK2 levels were highest in primary tumors."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,24816639,"Knockdown of SPHK1 expression inhibits the PI3K/AKT activation, MMP-2 and MMP-9 expression, and human RA-FLS migration and invasion in vitro. Potentially, SPHK1 may be a novel therapeutic target for rheumatoid arthritis."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,24503067,"Sphingosine kinase 1 regulates measles virus replication."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,24473437,"this study delineates a novel role for sphingosine kinase 1 (SK1) in metabolic disorders associated with obesity"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,24468113,"The results highlight the importance of S1P in AD suggesting the existence of a global deregulation of S1P signaling in this disease from its synthesis by SphK1 and degradation by SPL to its signaling by the S1P1 receptor."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,24452756,"Endogenously liberated amyloid Beta peptides significantly decreases expression and activity of SPK1."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,24422628,"IGF1R mediates insulin-stimulated phosphorylation of both SphK1 and SphK2."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,24337110,"suggest that combined inhibition of epidermal growth factor receptor and sphingosine kinase-1 has potential as an anticancer therapy in triple-negative breast cancer in which insulin-like growth factor-binding protein-3 expression is high."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,24276247,"these findings suggest that TFR1 has an important role in sphingosine kinase 1-mediated oncogenesis."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,24162774,"HIV-1 gp120 upregulates the expression of sphingosine kinase 1 (SPHK1) in human B cells"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,24137500,"SK is a key pro-viral factor regulating multiple cellular signal pathways triggered by influenza virus infection"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,24092575,"increased expression of SPHK1 may be involved in the pathogenesis and progression of bladder cancer"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,23955546,"SphK1 may be a predictive factor for treatment outcome after neoadjuvant treatment in luminal type breast cancers."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,23939980,"We propose that the reduction in SphK1 activity late in DENV-2-infected cells is a consequence of DENV-2 out-competing SphK1 for eEF1A binding and hijacking cellular eEF1A for its own replication strategy."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,23928990,"High sphingosine kinase 1 is associated with breast cancer."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,23893239,"SPHK1 expression was increased in cancer versus non-cancer tissue in patients with cutaneous melanoma and this corroborates previous reports showing that the levels of SPHK1 mRNA and protein are higher in malignant tumors than in healthy tissues."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,23861887,"the SPHK rheostat does not play a major role in tumor cell viability, and that SPHKs might not be attractive targets for pharmacological intervention in the area of oncology."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,23839903,"Demonstrate that HPPCn attenuated oxidative injury and fibrosis induced by ethanol feeding and that the SphK1/S1P/S1PRs signalling pathway contributes to this protective effect."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,23658376,"In carotid artery plaque, expression of SPHK1 was observed at smooth muscle cell-rich sites and was co-localized with intraplaque FX/FXa content."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,23651497,"The H2O2-induced src/PDGFRbeta/SK1 signaling cascade was impaired in nSMase2-deficient fro/fro cells and was rescued by exogenous C2Cer that activated src/PDGFRbeta/SK1."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,23602659,"SphK1 recognizes the lipid substrate and catalyzes ATP-dependent phosphorylation."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,23576579,"SPHK1 overexpression modulates intestinal cell proliferation through increased c-Myc translation."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,23466305,"key role of Sphk1, S1PR1 and S1PR3 in angiogenesis underlying the liver fibrosis process"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,23462226,"We are herein provide the first evidence of increased SPHK-1 expression in post-labor amnions, and that sphingosine-1-phosphate increases the PTGS-2 expression in amnion cells"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,23426175,"SPHK1 contributes toward the regulation of CD44 protein expression through the ERK signaling pathway through sphingosine-1-phosphate in human colon cancer cells."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,23359503,"The function of SphK1 and SphK2 can be interchangeable in mast cells and is species and cell type determined."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,23314175,"Sphingosine kinase 1 functions to increase the stability of c-Myc and suppresses Ap3A formation, which might maintain the Warburg effect and cell survival."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,23232649,"SphK1 regulates tumor cell proliferation, apoptosis and invasion, which ultimately contributes to tumor progression and malignancy phenotype in colon cancer. FAK pathway, ICAM-1 and VCAM-1 may play critical roles in this SphK1mediated effect."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,23166225,"a correlation between SphK1 expression and cetuximab response was found in colorectal cancer patients."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,22961081,"Data have identified that the enzyme SphK1 is an important regulator of lipid partitioning and insulin action in skeletal muscle under conditions of increased lipid supply."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,22833671,"Oncogenic K-Ras regulates bioactive sphingolipids in a sphingosine kinase 1-dependent manner"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,22781898,"Overexpression of SphK1 and NF-kappaB may be involved in the pathogenesis and progression of colon carcinoma."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,22733311,"findings identify a novel role for the nuclear localization of sphingosine kinase 1 combined with either ERK-1/2 or SFK or LYN or AKT or NF-kappaB, which significantly shortens disease-specific survival and/or recurrence in estrogen receptor positive breast cancer"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,22684547,"SphK1 promoting the secretion of MMP-2/9 and uPA via activation of ERK1/2 and suppression of p38 MAPK pathways maybe the molecular mechanisms for its regulation of the malignant behavior of colon cancer cell."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,22460268,"findings highlight an important role for S1P(4) and SK1 in ER(-) breast cancer progression."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,22450659,"miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,22422617,"Data suggest that sphingosine 1-phosphate receptor 1 transactivation is dependent on SPHK1, is upstream of MAP kinase signaling system, and is required for LDL-regulated expression of connective tissue growth factor in mesangial cells."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,22331716,"Results that antineoplastic agents induce apoptosis in MCF-7 cells by downregulating the antiapoptotic SK-1 and GCS genes that may result in accumulation of apoptotic ceramides."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,22322303,"These findings demonstrate a key role for sphingosine kinase-1 in histamine-induced rapid P-selectin up-regulation and associated leukocyte rolling, and suggest that endothelial SK-1 is an important contributor to allergic inflammation"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,22322056,"The expression of SPHK1 in gastric cancer is significantly associated with lymph node metastasis, distant metastasis and a poor prognosis."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,22315056,"data suggest that decrease in circulating Sphingosine-1-phosphate during prostate cancer progression may stem from a significant downregulation of erythrocyte sphingosine kinase-1 activity which may be a potential mechanism of cancer-induced anaemia."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,22227192,"These data suggest that SPK1 acetylation plays a key role in cell growth, cell size, and cell-cycle control."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,22155656,"SphK1 activity is important for insulin synthesis and secretion"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,22016563,"activation of phospholipase C and protein kinase C-beta 2 by the IGF-II/mannose-6-phosphate receptor are required for the activation of sphingosine kinase 1."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,21940753,"Study has identified SphK1 as a proproliferative oncogenic kinase, an Akt/glycogen synthase kinase-3beta/beta-catenin activator, and probably a biomarker for thyroid cancer as well."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,21936950,"SPHK1 is implicated in the metastasis of esophageal cancer."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,21769916,"results showed that in TGW cells, GDNF increased SPHK1 transcription, leading to the production and secretion of S1P"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,21756066,"Data show that nilotinib induces apoptosis through upregulating ceramide synthase genes and downregulating SK-1 in CML cells in addition to inhibition of BCR/ABL."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,21696364,"[review] SK and the sphingolipid rheostat are important for both islet function and beta cell survival as a common therapeutic target that protects the beta cell from diabetogenic insults and ultimately improves pancreatic islet function."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,21672077,"over-expression of sphingosine kinase-1 in human endothelial cells promotes, in part, their de-differentiation to a progenitor cell phenotype"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,21625639,"Increased SPHK1 expression is associated with glioma."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,21575515,"SphK1 potently enhances the prolieration, migration and invasion of colon cancer HT-29 cells, and suppresses cell apoptosis."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,21464128,"Comparisons with the SK1 inhibitor, SKi or siRNA knockdown of SK1 indicated that (S)-FTY720 vinylphosphonate and FTY720 behave as typical SK1 inhibitors in preventing sphingosine 1-phosphate-stimulated rearrangement of actin in MCF-7 cells."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,21418911,"SphK1 plays an important role in regulating the MUC5AC expression in airway epithelial cells under the induction of TNF-alpha."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,21392092,"Melatonin inhibited the stability of HIF-1alpha in a time- and concentration- dependent manners. Also, melatonin decreased SPHK1 activity in PC-3 cells during hypoxia."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,21304987,"S1P(ext) mediated endothelial cell motility is dependent on intracellular S1P production, which is regulated, in part, by SphK1 and S1P lyase."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,21209394,"SphK1/S1P signaling may play important roles in head and neck squamous cell carcinoma carcinogenesis"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,21075214,"The PP2A-B'alpha holoenzyme appears to function as an important endogenous regulator of SK1."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,21075134,"Data suggest that whereas sphingosine kinase localization does not affect downstream metabolism of sphingosine-1-phosphate, localization has an important effect on the pools of substrate to which this key signaling enzyme has access."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,20926375,"the ubiquitin-proteasomal degradation of SK1 is an important mechanism controlling cell survival"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,20889557,"These results support a model in which the interaction between sphingosine kinase 1, sphingosine 1-phosphate receptors 1 and/or 3, and ERK-1/2 might drive breast cancer progression"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,20846391,"Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,20838377,"study defines the mechanism regulating eEF1A-mediated SK1 activation, and also establishes SK1 as being integral for PTI-1-induced oncogenesis"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,20661259,"TLR4-mediated SphK1 activation was found to be critical for the redox-dependent activation of HIF-1alpha and ASK1, and the prevention of lipopolysaccharide-induced activation of caspase 3 and the expression interleukin-6."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,20634980,"Data implicate Sphk-1 in HBD-2 regulation in oral keratinocytes which also involves the activation of PI3K, AKT, GSK-3beta and ERK 1/2."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,20606403,"results demonstrate that SPHK1 is upregulated in head and neck squamous cell carcinoma and provide clues of the role SPHK1 might play in tumor progression"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,20520628,"conversion of sphingosine to sphingosine-1-phosphate (S1P) protects keratinocytes from UVB-induced cell death"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,20519401,"Overexpression of sphingosine 1-phosphate-producing sphingosine kinase 1 heightened the cells' susceptibility to influenza virus infection."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,20404323,"Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,20386061,"Data suggest that the localization of sphingosine kinase 1 influences the substrate pools that it has access to and that S1P can rapidly translocate from the site where it is synthesized to other intracellular sites."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,20237496,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,20104488,"CXCL4 induces SphK1 enzyme activity as well as its translocation to the cell membrane. SphK1 as a central regulator of acute and delayed monocyte activation"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,20053797,"The effect of isoflurane on caveolae formation in proximal tubule cells via transforming growth factor beta-1 release is reported."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,19956567,"Sphingosine kinase-1 is central to androgen-regulated prostate cancer growth and survival"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,19914200,"evidence indicates that the COOH-terminal region of SphK1 encompasses a structural element that is necessary for the increase in catalytic activity in response to PMA treatment and that its deletion renders SphK1 active with respect to PMA treatment"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,19854831,"CIB1 interacts with SK1 in a Ca(2+)-dependent manner at the previously identified \"calmodulin-binding site\" of SK1."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,19830907,"SphK1 is an important effector of Gq-coupled receptors, linking them via cross-activation of S1P receptors to G(i) and G12/13 signalling pathways."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,19815712,"Data show that under basal conditions, sphingosine kinase-1, integrin alpha(v)beta(3), and CD31 exist as a heterotrimeric complex which is required in SK-1-mediated endothelial cell survival."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,19782042,"Direct evidence shows that the plasma membrane lipid raft microdomain is the major site of action for SphK1 to overcome serum-deprived cell growth inhibition."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,19706837,"Inhibition of SphK1 activity restored the antiproliferative and proapoptotic effects of tamoxifen in TamR cells."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,19657322,"Transforming growth factor-beta2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-beta2 by impeding CTGF expression."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,19633297,"IGFBP-3 in MCF-10A cells requires SphK1 activity and S1P1/S1P3, suggesting that S1P, the product of SphK activity and ligand for S1P1 and S1P3"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,19240026,"Results indicate that SPHK1 and 2 isoforms and neutral sphingomyelinase contribute to the regulation of chemosensitivity by controlling ceramide formation and the downstream Akt pathway in human colon cancer cells."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,19238330,"The sphingosine kinase 1 signaling pathway is activated in Rheumatoid Arthritis, suggesting that manipulation of sphingosine kinase 1 activity in diseases of aberrant inflammation and angiogenesis may be beneficial."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,19162217,"SPHK1 inhibition is a novel way to block PAR-1 mediated signalling."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,19116345,"Evidence suggesting that SPHK enhances migration of ML-1 cells by an autocrine mechanism and that the S1P-evoked migration is dependent on protein kinase C alpha, ERK1/2, and SPHK."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,19074142,"SphK1 expression is transcriptionally regulated by IL-1 in glioblastoma cells, and this pathway may be important in regulating survival and invasiveness of glioblastoma cells."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,19017993,"Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,18980995,"SPHK1 in astrocytoma cell lines was elevated at both mRNA and protein levels, and the SPHK1 mRNA and protein were significantly up-regulated by up to 6.8- and 40-fold, respectively, in primary astrocytomas"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,18922940,"Sphingosine kinase 1 is a new modulator of hypoxia inducible factor 1alpha during hypoxia in human cancer cells."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,18852266,"PP2A appears to function as an endogenous regulator of SK1 phosphorylation"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,18849324,"the crucial role of activation of the SPHK1S1PS1P1 signaling pathway in response to inflammatory mediators in endothelial cells in regulating endothelial barrier homeostasis."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,18824518,"SphK1/sphingosine-1-phosphate pathway contributes to colon carcinogenesis"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,18718048,"Chronic myelogenous leukemia cells express SphK-1 and different S1P receptor, and P210(bcr/abl) fusion protein in CML cells can activate SphK-1."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,18644866,"Datas suggest that filamin A links sphingosine kinase 1 and sphingosine-1-phosphate receptor 1 to locally influence the dynamics of actin cytoskeletal structures at lamellipodia to promote cell movement."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,18426913,"Sphingosine kinases and sphingosine-1-phosphate are critical for transforming growth factor beta-induced ERK1 and ERK2 activation and promotion of migration and invasion of esophageal cancer cells"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,18401414,"SphK1 is inolved in regulating imatinib-induced apoptosis and SphK1 is a downstream effector of the Bcr-Abl/Ras/ERK pathway inhibited by imatinib but upstream regulator of Bcl-2 family members"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,18362204,"apoptotic cells may up-regulate SphK1 to produce and secrete sphingosine-1-phosphate that serves as a \"come-and-get-me\" signal for scavenger cells to engulf them in order to prevent necrosis"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,18263879,"a novel mechanism of regulation of both SK1 and SK2 that is mediated by their interaction with eEF1A."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,18261991,"The hypoxia-stimulated SK-1 upregulation was functionally coupled to increased migration since the selective depletion of SK-1, but not of SK-2, by siRNAs abolished the migratory response."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,18199826,"Ang-1-induced inhibition of leakiness is mediated through activation of SK-1, defining a new signaling pathway in the Ang-1 regulation of permeability."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,18192241,"Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferation and angiogenesis by epoxyeicosatrienoic acids."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,18178871,"These data suggest that differential formation of sphingosine-1-phosphate by SphK1 and SphK2 has distinct and important actions in human mast cells."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,18058224,"High expression of sphingosine kinase 1 is associated with estrogen receptor negative breast breast cancer."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,17822721,"the SKase pathway, through the generation of S1P, is critically involved in mediating globular adiponectin-induced endothelial cell activation"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,17641298,"These data suggested that SPHK1 activation by TGF-beta1 leads to Rho-associated myofibroblasts differentiation mediated by transactivated S1P receptors in the lung fibrogenic process."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,17599053,"BCR/ABL induces SPK1 expression and increases its cellular activity, leading to upregulation of Mcl-1 in CML cells."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,17519232,"the localization and activity of SK1 are coordinately regulated with actin dynamics during macrophage activation"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,17482291,"the PI3K/AKT/mTOR signaling pathway is involved in regulation of SphK1, with AKT2 playing a key role in PDGF-induced SphK1 expression"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,17388800,"IGFBP-3 induces angiogenesis through IGF-I- and SphK1-dependent mechanisms"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,17114809,"SphK-dependent Akt activation plays a significant role in TNF-alpha-induced cyclin D expression and cell proliferation"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,17064696,"SK1 is cleaved by cathepsin B in a sequential manner after basic amino acids, and the initial cleavages at the two identified sites, histidine 122 and arginine 199, occur independently of each other."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,16623665,"results suggest that export of Sphk-1a isoform occurs under physiological conditions and may contribute to the establishment of the vascular S1P gradient."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,16571380,"Data show that protein kinase C-alpha activation in endothelial cells leads to upregulation of sphingosine kinase-1 expression and activity, which is critically involved in the mechanism of endothelial cell migration."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,16529909,"These findings uncover a new functional role for Sphingosine kinase 1 (SK1), which can control survival/death balance by targeting sphingolipid de novo biosynthesis."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,16516161,"These findings strongly suggest that high expression and up-regulation of SPHK1 and S1P receptors protect PC3 cells from the apoptosis induced by CPT."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,16507765,"For the first time endogenous SK1 is implicated as an important survival enzyme in MCF-7 cells. The biological consequences of knocking down the enzyme are linked to its biochemical role as a regulator of sphingolipid metabolism."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,16243846,"the specific plasma membrane localization and activation of SK1 is mediated largely by specific lipid-protein interactions"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,16194537,"results suggest that SphK1 may be critical for growth, metastasis and chemoresistance of human breast cancers"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,16038795,"Findings demonstrate a role of SPHK1 activation in proinflammatory signalling and of SPHK1 basal activity in survival of A549 lung carcinoma cells."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,15855330,"IL-1beta and TNF-alpha induced an early and sustained increase in SPHK activity in INS-1 cells and isolated islets."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,15749892,"model in which M.tuberc. inhibits both the activation and phagosomal translocation of sphingosine kinase 1 to block the localized Ca2+ transients required for phagosome maturation"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,15710602,"SK1 down-regulation by TNF is dependent on the lysosomal pathway of apoptosis and specifically on cathepsin B, which functions as an SK1 protease in cells"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,15693752,"SK1 has marked effects on cell function, with plasma membrane-associated SK having a potent inhibitory effect on the G1-S phase transition [SK1]"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,15632208,"role for SK in the regulation of vascular phenomena that occur under conditions of stress"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,15585953,"Comparison of base sequence of SPHK1/Sphk1 in human, mouse, and rat."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,15302883,"SPHK plays an important role in the immune-inflammatory pathologies triggered by anaphylatoxins in human neutrophils"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,15265705,"PI3K and ERK/MAPK mediated the activation of sphingosine kinase and would be involved in the HGF-induced migration of endothelial cells."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,15191888,"SphK1 mediates TNF-alpha-induced MCP-1 gene expression through a p38 MAPK-dependent pathway and may participate in oscillatory flow-mediated proinflammatory signaling pathway in the vasculature."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,15052627,"hereditary neuralgic amyotrophy is not caused by point mutations of sphingosine kinase 1"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,14988393,"SK1 is down-regulated by genotoxic stress, and basal SK1 function may be necessary for the maintenance of tumor cell growth"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,14742298,"Data show that respiratory syncytial virus stimulates sphingosine kinase activity in lung epithelial cells, leading to activation of antiapoptotic sphingosine 1-phosphate and subsequently activation of Akt and extracellular signal-related kinase."
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,14575709,"results provide the first evidence of the active nuclear export of SPHK1 and suggest it is mediated by a CRM1-dependent pathway"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,14532121,"Activation of this enzyme in mediated by ERK1/2 phoshporylation"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,12847068,"Resting tone and myogenic responses of isolated hamster resistance arteries increased with forced expression of human Sphk1 in smooth muscle cells"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,12444147,"role for sphingosine kinase in the regulation of neutrophil priming"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,12393916,"characterization of the nucleotide-binding site of human sphingosine kinase 1 through a combination of site-directed mutagenesis and affinity labeling with the ATP analogue, FSBA"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,12124383,"activation and translocation to cell membrane dependent on protein kinase C"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,12080051,"results indicate that SPHK1-interacting protein(SKIP) is a novel protein likely to play a regulatory role in the modulation of SPHK1 activity"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,11915350,"synthesize sphingosine 1-phosphate,a lipid mediator in intracellular signaling system"
https://pharos.nih.gov/idg/targets/Q9NYA1,Q9NYA1,11777919,"These findings show a role for SphK in the signal transduction by TRAF2 specifically leading to activation of NF-kappa B and antiapoptosis."
https://pharos.nih.gov/idg/targets/P27707,P27707,27879648,"Phosphorylated and activated DCK can inhibit radiation-induced cell death including apoptosis and mitotic catastrophe, and promote radiation-induced autophagy through PI3K/Akt/mTOR pathway."
https://pharos.nih.gov/idg/targets/P27707,P27707,26962792,"expression and A9846G AA genotype significantly associated with reduced mortality in pancreatic ductal adenocarcinoma"
https://pharos.nih.gov/idg/targets/P27707,P27707,26485161,"recently described a human deoxycytidine kinase mutant (G12) that sensitizes cancer cell lines to treatment with gemcitabine. Here, starting from the G12 variant, we identified a mutant that triggers even greater sensitisation to gemcitabine than G12."
https://pharos.nih.gov/idg/targets/P27707,P27707,26362587,"Low deoxycytidine kinase expression is associated with periampullary adenocarcinoma."
https://pharos.nih.gov/idg/targets/P27707,P27707,26196746,"results strongly suggest that (1) the E197K alteration in DCK causes inactivation of DCK, and that (2) loss of the normal E197 allele is the crucial mechanism in acquisition of gemcitabine resistance in the RMKN28 tumor cell line"
https://pharos.nih.gov/idg/targets/P27707,P27707,26090398,"n the multivariate Cox regression analysis, we found that age at diagnosis, wild-type genotype of the CDA A79C polymorphism, and wild-type genotype of the dCK C360G polymorphism were the most significant prognostic factors for predicting the risk of death"
https://pharos.nih.gov/idg/targets/P27707,P27707,26083014,"RNA expression of deoxycytidine kinase (DCK), human equilibrative nucleoside transporter-1 (ENT1) and ribonucleotide reductase M1 (RRM1) were significantly higher and cytidine deaminase (CDA) was significantly lower in ex vivo Ara-C sensitive samples."
https://pharos.nih.gov/idg/targets/P27707,P27707,25557962,"DCK rs12648166 and DCK rs4694362 SNPs were associated with hematologic toxicity (OR = 2.63, CI 95% = 1.37-5.04, P = 0.0036 and OR = 2.53, CI 95% = 1.34-4.80, P = 0.0044, respectively)."
https://pharos.nih.gov/idg/targets/P27707,P27707,25533931,"These findings indicate that the decitabine metabolic pathway affects its therapeutic effects, lower hENT1 expression may induce primary resistance and down-regulated DCK expression may be related to secondary resistance."
https://pharos.nih.gov/idg/targets/P27707,P27707,25358054,"induction after hypoxia plays a role in the progression of pulmonary fibrosis by contributing to alveolar epithelial cell proliferation"
https://pharos.nih.gov/idg/targets/P27707,P27707,24618665,"DCK expression levels are prognostic and had predictive value for sensitivity to 5-FU in pancreatic cancer."
https://pharos.nih.gov/idg/targets/P27707,P27707,24462681,"PP2A constitutively dephosphorylates dCK in cells and negatively regulates its activity."
https://pharos.nih.gov/idg/targets/P27707,P27707,24294360,"DCK could regulate the migration and invasion of fibroblast-like synoviocytes through AKT pathway in rheumatoid arthritis patients."
https://pharos.nih.gov/idg/targets/P27707,P27707,23230131,"Report genetic variation in deoxycytidine kinase and subsequent gemcitabine metabolism."
https://pharos.nih.gov/idg/targets/P27707,P27707,23035362,"Hematologic toxicity such as neutropenia, thrombocytopenia, and anemia were not associated with three tagged single-nucleotide polymorphisms of deoxycytidine kinase or haplotypes. Genetic variations did not affect survival of the patients."
https://pharos.nih.gov/idg/targets/P27707,P27707,22884143,"It is evident that the DCK and CDA polymorphisms might be the important markers for the AML patients' therapy outcomes in a Chinese population."
https://pharos.nih.gov/idg/targets/P27707,P27707,22705007,"High levels of dCK in pancreatic ductal adenocarcinoma predict longer survival times in patients treated with adjuvant gemcitabine."
https://pharos.nih.gov/idg/targets/P27707,P27707,22490663,"These results indicate that the inactivation of DCK is one of the crucial mechanisms in acquisition of gemcitabine resistance."
https://pharos.nih.gov/idg/targets/P27707,P27707,21858090,"Data show that the CDA/DCK ratio was 3 fold higher in non-responders than responders (P<.05), suggesting that this could be a mechanism of primary resistance."
https://pharos.nih.gov/idg/targets/P27707,P27707,21832002,"Although dFdU increased the net intracellular radioactivity of [5-(3)H]dFdC at 24 h in control cells, this increase was abolished in the absence of dCK activity."
https://pharos.nih.gov/idg/targets/P27707,P27707,21351740,"Data show that dCK must make the transition between the open and closed states during the catalytic cycle."
https://pharos.nih.gov/idg/targets/P27707,P27707,21336182,"High deoxycytidine kinase is associated with response to pemetrexed-gemcitabine combination in patients with advanced non-small cell lung cancer."
https://pharos.nih.gov/idg/targets/P27707,P27707,21245102,"We show that ABCG2 influence on clofarabine cytotoxicity was markedly influenced by dCK activity"
https://pharos.nih.gov/idg/targets/P27707,P27707,21225236,"Overexpressed dCK and knocked down p8 is associated with enhancement of gemcitabine sensitivity in pancreatic cancer."
https://pharos.nih.gov/idg/targets/P27707,P27707,21030078,"Data indicate that variant C28624T showed a lower risk of lymphopenia (P=0.04), but a higher risk of neutropenia."
https://pharos.nih.gov/idg/targets/P27707,P27707,21030078,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27707,P27707,20890066,"Data show that dCK-360G allele was found to increase the risk of mucositis after exposure to low-dose cytarabine in childhood ALL therapy."
https://pharos.nih.gov/idg/targets/P27707,P27707,20890066,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27707,P27707,20665488,"Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27707,P27707,20637175,"Site-directed mutagenesis demonstrated that only Ser-74 phosphorylation was involved in dCK activation by casein kinase 1 delta, strengthening the key role of this residue in the control of dCK activity."
https://pharos.nih.gov/idg/targets/P27707,P27707,20614893,"it is residue Asp133 of dCK that is most responsible for discriminating against the thymine base"
https://pharos.nih.gov/idg/targets/P27707,P27707,20608756,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27707,P27707,20544528,"Data show that methylation was detected in one of the SP1 binding sites of the dCK promoter, in most tested cancer cell lines and in patient samples from brain tumors and leukemia. Methylation might therefore regulate transcription of dCK."
https://pharos.nih.gov/idg/targets/P27707,P27707,20544527,"Data show that phosphorylation of the three other sites, located in the N-terminal extremity of the protein, does not significantly modify dCK activity, but phosphorylation of Thr-3 could promote dCK stability."
https://pharos.nih.gov/idg/targets/P27707,P27707,20137114,"dCK expression level in fludarabine-sensitive patients was much higher than in Flud-resistant patients."
https://pharos.nih.gov/idg/targets/P27707,P27707,20043109,"Sensitivity of two pancreatic cancer cell lines transduced with deoxycytidine kinase to gemcitabine elevated dramatically in comparison with control cells."
https://pharos.nih.gov/idg/targets/P27707,P27707,20028759,"Clinical trial of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27707,P27707,19568409,"thymidylate synthase/ribonucleotide reductase gene silencing and deoxycytidine kinase::uridine monophosphate kinase fusion gene gene overexpression markedly improved gemcitabine's therapeutic activity"
https://pharos.nih.gov/idg/targets/P27707,P27707,19428333,"The DCK/cN-II ratio was again proportional to ara-CTP production and to ara-C sensitivity."
https://pharos.nih.gov/idg/targets/P27707,P27707,19287976,"dCK can regulate the in vitro cellular response to Ara-C in acute myeloid leukemia cells"
https://pharos.nih.gov/idg/targets/P27707,P27707,19159229,"Several hydrophobic residues at position 104 endow dCK with thymidine kinase activity."
https://pharos.nih.gov/idg/targets/P27707,P27707,18974616,"29 variations including 20 novel ones were identified in DCK from 256 Japanese cancer patients administered gemcitabine."
https://pharos.nih.gov/idg/targets/P27707,P27707,18974616,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27707,P27707,18775979,"In leukoblasts from 82 patients with acute myeloid leukemia, various extent and frequency of differential allelic expression in the CDA, DCK, NT5C2, NT5C3, and TP53 genes was observed."
https://pharos.nih.gov/idg/targets/P27707,P27707,18600545,"both deoxycytidine kinase and adenosine kinase are involved in this model of ADA deficiency"
https://pharos.nih.gov/idg/targets/P27707,P27707,18600530,"dCK and dGK were downregulated by approximately 70% in CEM cells and tested against six nucleoside"
https://pharos.nih.gov/idg/targets/P27707,P27707,18361501,"illuminate the key contributions of these two amino acid positions to enzyme function by demonstrating their ability to moderate substrate specificity"
https://pharos.nih.gov/idg/targets/P27707,P27707,18258203,"Phosphorylation may represent a mechanism to enhance the catalytic activity of the relatively slow dCK enzyme."
https://pharos.nih.gov/idg/targets/P27707,P27707,17855478,"study identified novel coding, promoter, intronic, and 3'-UTR genetic variants at the DCK locus in two major ethnic groups; results suggest that genetic variation in DCK influences its activity and expression"
https://pharos.nih.gov/idg/targets/P27707,P27707,17602053,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27707,P27707,17065091,"deoxycytidine kinase, deoxyguanosine kinase, and cytosolic 5'-nucleotidase I are regulated in a cell cycle-dependent manner in MOLT-4 cells"
https://pharos.nih.gov/idg/targets/P27707,P27707,17065085,"deoxycytidine kinase activity is enhanced after pulsed low dose rate and single dose gamma irradiation"
https://pharos.nih.gov/idg/targets/P27707,P27707,17065080,"analysis of deoxycytidine kinase reversible phosphorylation in normal human lymphocytes"
https://pharos.nih.gov/idg/targets/P27707,P27707,17065079,"analysis of phosphorylation sites on human deoxycytidine kinase"
https://pharos.nih.gov/idg/targets/P27707,P27707,17065053,"deoxycytidine kinase has a role in lymphoma cell sensitivity to cladribine"
https://pharos.nih.gov/idg/targets/P27707,P27707,16969512,"an increase in activity of dCK, TK1 and 2 might be involved in an adaptive response of cultured human squamous lung carcinoma cells to radiation by facilitation of DNA repair"
https://pharos.nih.gov/idg/targets/P27707,P27707,16799820,"Observational study of genotype prevalence. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27707,P27707,16401075,"Crystal structures of a deoxycytidine kinase variant lacking a flexible insert (residues 65-79) reveal major changes in the donor base binding loop (residues 240-247) between UDP-bound and ADP-bound forms, involving significant main-chain rearrangement."
https://pharos.nih.gov/idg/targets/P27707,P27707,16361699,"dCK activity can be controlled by phosphorylation in intact cells, and Ser-74 is required for activity"
https://pharos.nih.gov/idg/targets/P27707,P27707,15978330,"an increased expression of mRNA, specific for thymidine kinase 1, dCK and thymidine phosphorylase, may be involved in carcinogenic processes in the human thyroid"
https://pharos.nih.gov/idg/targets/P27707,P27707,15571259,"deoxycytidine kinase activity is regulated by reversible phosphorylation"
https://pharos.nih.gov/idg/targets/P27707,P27707,15571258,"deoxycytidine kinase activity is stimulated by 2-chlorodeoxyadenosine and aphidicolin in the cellular context"
https://pharos.nih.gov/idg/targets/P27707,P27707,15571257,"dCK expression varies between individual samples and between different types of malignancies and may play a role in resistance to ara-C in particular tumor types"
https://pharos.nih.gov/idg/targets/P27707,P27707,15571255,"analysis of antitumor drug binding to deoxycytidine kinase"
https://pharos.nih.gov/idg/targets/P27707,P27707,15564883,"Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27707,P27707,15561147,"dCK can act as a phosphorylase, similar to the nucleoside phosphorylase family of enzymes"
https://pharos.nih.gov/idg/targets/P27707,P27707,14514691,"human deoxycytidine kinase promoter activity is regulated by USF and Sp1"
https://pharos.nih.gov/idg/targets/P27707,P27707,12535661,"Data show that inorganic tripolyphosphate (PPP(i)) is a good donor for human ceoxycytidine kinase and deoxyguanosine kinase."
https://pharos.nih.gov/idg/targets/P27707,P27707,11952160,"Molecular basis of 2',3'-dideoxycytidine-induced drug resistance in human cells."
https://pharos.nih.gov/idg/targets/P27707,P27707,11830489,"alternatively spliced dCK forms found in acute myeloid leukemia cells play an important role in cytarabine resistance"
https://pharos.nih.gov/idg/targets/P50053,P50053,28954733,"Data indicate metabolic enzymes NAD kinase and ketohexokinase as candidate metabolic gene targets, and the chromatin remodeling protein INO80C as a tumor suppressor in KRAS(MUT) colorectal tumor xenograft."
https://pharos.nih.gov/idg/targets/P50053,P50053,27322374,"Angelica archangelica, Garcinia mangostana, Petroselinum crispum, and Scutellaria baicalensis were the top four botanical candidiates identified with inhibitory activity against ketohexokinase-C."
https://pharos.nih.gov/idg/targets/P50053,P50053,27088854,"compared with normal hepatocytes, hepatocellular carcinoma (HCC) cells markedly reduce the rate of fructose metabolism and the level of reactive oxygen species, as a result of a c-Myc-dependent and heterogeneous nuclear ribonucleoprotein (hnRNP) H1- and H2-mediated switch from expression of the high-activity fructokinase (KHK)-C to the low-activity KHK-A isoform."
https://pharos.nih.gov/idg/targets/P50053,P50053,26083752,"myocardial hypoxia actuates fructose metabolism in human and mouse models of pathological cardiac hypertrophy through hypoxia-inducible factor 1alpha (HIF1alpha) activation of SF3B1 and SF3B1-mediated splice switching of KHK-A to KHK-C"
https://pharos.nih.gov/idg/targets/P50053,P50053,24876114,"These studies identify fructokinase as a novel mediator of diabetic nephropathy and document a novel role for endogenous fructose production, or fructoneogenesis, in driving renal disease."
https://pharos.nih.gov/idg/targets/P50053,P50053,23341889,"This study determined if single nucleotide polymorphisms in genes involved in fructose transport,SLC2A2 and SLC2A5 and metabolism, etohexokinase affect inter-individual variability in metabolic phenotypes."
https://pharos.nih.gov/idg/targets/P50053,P50053,23112875,"In human hepatocytes uric acid up-regulates KHK expression thus leading to the amplification of the lipogenic effects of fructose."
https://pharos.nih.gov/idg/targets/P50053,P50053,20628086,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P50053,P50053,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P50053,P50053,19237742,"The structure of the KHK-A ternary complex revealed an active site with fructose & the ATP analogue in positions ready for phosphorylation. The effects of the pathogenic mutations Gly40Arg & Ala43Thr have been modelled in the context of the KHK structure."
https://pharos.nih.gov/idg/targets/P50053,P50053,19158351,"Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells."
https://pharos.nih.gov/idg/targets/P50053,P50053,16372272,"The expression of ketohexokinase is diminished in human clear cell type of renal cell carcinoma"
https://pharos.nih.gov/idg/targets/P50053,P50053,12941785,"ketohexokinase-A serves an unknown physiologic function that remains intact in essential fructosuria."
https://pharos.nih.gov/idg/targets/P27986,P27986,28676499,"Data suggest that Lys-776 (in the P-loop of PIK3CA) is critical for autophosphorylation in PIK3CA/PIK3R1 heterodimer; both His-936 and His-917 (in the activation and catalytic loops of PIK3CA) are important catalytically, but appear to have different functions; bisubstrate kinetic analysis of PIK3CA/PIK3R1 heterodimer indicates an ordered sequential mechanism."
https://pharos.nih.gov/idg/targets/P27986,P27986,28632845,"A dominant-negative mutation in the p85alpha regulatory subunit of PI3K affects development of the iris, and contributes to changes consistent with anterior segment dysgenesis in both humans and mice."
https://pharos.nih.gov/idg/targets/P27986,P27986,28394344,"these results reveal that p85alpha expression in stromal fibroblasts haves a crucial role in regulating breast cancer tumourigenesis and progression by modifying stromal-epithelial crosstalk and remodelling the tumour microenvironment."
https://pharos.nih.gov/idg/targets/P27986,P27986,28381646,"Data, including data from hydrogen/deuterium exchange mass spectrometry studies using full-length constructs for both catalytic/p110alpha and regulatory/p85alpha subunits of phosphoinositide 3-kinase isoform, suggest that the catalytic subunit exhibits binding sites for four inhibitor compounds studied, including a low-affinity binding site for CAL-101."
https://pharos.nih.gov/idg/targets/P27986,P27986,28351303,"This review will summarize the biological roles of phosphatidylinositol 3-kinase regulatory subunit 1 and phosphatase and tensin homolog in breast cancer, with an emphasis on recent findings and the potential of phosphatidylinositol 3-kinase regulatory subunit 1 and phosphatase and tensin homolog as a therapeutic target for breast cancer therapy."
https://pharos.nih.gov/idg/targets/P27986,P27986,28124643,"this study shows that rapamycin inhibits TGF beta 1 induced myofibroblast differentiation in nasal polyp-derived fibroblasts through the PI3K/mTOR signal pathways"
https://pharos.nih.gov/idg/targets/P27986,P27986,28104464,"The B-cell compartment in PI3K-delta syndrome patients is affected by the mutations in PIK3CD and PIK3R1. There is reduced differentiation beyond the transitional stage, increased AKT phosphorylation and increased apoptosis."
https://pharos.nih.gov/idg/targets/P27986,P27986,27927989,"Following phosphorylation of the tyrosine, the proteins growth factor receptor-bound protein 2 (Grb2), Grb2-related adaptor downstream of Shc (Gads), and p85 subunit of phosphoinositide 3-kinase may bind to pYMNM (where pY is phosphotyrosine) via their Src homology 2 (SH2) domains, leading to downstream signaling to distinct immune pathways. These three adaptor proteins bind to the same site on CD28 with variable affinity"
https://pharos.nih.gov/idg/targets/P27986,P27986,27819673,"results definitively show that LMP1 promotes IRF4 tyrosine phosphorylation and markedly stimulates its transcriptional activity through recruiting Src via P85"
https://pharos.nih.gov/idg/targets/P27986,P27986,27701424,"In conclusion, we identified four novel loci (TGFA, PIK3R1, FGFR3 and TREH) and confirmed two loci known to be associated with cartilage thickness.The identified associations were not caused by rare exonic variants. This is the first report linking TGFA to human Osteoarthritis, which may serve as a new target for future therapies."
https://pharos.nih.gov/idg/targets/P27986,P27986,27693481,"Gain-of-function mutation in PIK3R1 in a patient with hypogammaglobulinemia and a narrow clinical phenotype of respiratory infections"
https://pharos.nih.gov/idg/targets/P27986,P27986,27515006,"Expression of miR-26a and miR-29a was significantly down regulated in leukoplakia and cancer tissues but up regulated in lichen planus tissues. Expression of target genes such as, ADAMTS7, ATP1B1, COL4A2, CPEB3, CDK6, DNMT3a and PI3KR1 was significantly down regulated in at least two of three disease types with respect to normal tissues."
https://pharos.nih.gov/idg/targets/P27986,P27986,27157990,"suggest that small-bowel resection reduces p85alpha and TP53, which increases survivin and intestinal epithelial cell expansion during therapeutic adaptation in patients with short bowel syndrome"
https://pharos.nih.gov/idg/targets/P27986,P27986,27076228,"this study shows that dominant splice site mutations in PIK3R1 cause Hyper IgM syndrome, lymphadenopathy and short stature"
https://pharos.nih.gov/idg/targets/P27986,P27986,27070751,"Our data do not support an up-regulation of p85alpha subunit of PI3K expression as a mechanism of growth hormone-induced insulin resistance in subcutaneous adipose tissue of acromegalic patients."
https://pharos.nih.gov/idg/targets/P27986,P27986,27068087,"The results identify several host proteins that mediate invasin-induced effects on the actin cytoskeleton and indicate that a subset of PI3K pathway components promote internalization of both Y. enterocolitica and L. monocytogenes."
https://pharos.nih.gov/idg/targets/P27986,P27986,27025927,"Data indicate that the most prominent proteins associating with Gab2 are PTPN11, PIK3R1 and ARID3B."
https://pharos.nih.gov/idg/targets/P27986,P27986,26988918,"CASP8: rs1045494 (C > T), PIK3R1: rs3756668 (A > G) and CASP7: rs4353229 (T > C), were associated with longer overall survival in limited disease-small cell lung cancer patients after chemoradiotherapy"
https://pharos.nih.gov/idg/targets/P27986,P27986,26972586,"Findings indicate that 3' utranslated regions (3'UTR) of PIK3R1, which encodes class I PI3K regulatory subunit 1 (alpha), contained the microRNA miR-634 seed sites sequences."
https://pharos.nih.gov/idg/targets/P27986,P27986,26867574,"RAC1/RAC2 and SFK are proximal and essential for phosphatidylinositol 3-kinase (PI3K) activation in NK cell-mediated direct cytotoxicity against Cryptococcus neoformans."
https://pharos.nih.gov/idg/targets/P27986,P27986,26827886,"PI3KR1 plays a crucial role in the development of germinal center follicular helper T cells and is not involved in the generation of normal follicular regulatory T cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,26676464,"PIK3R1 knockdown abrogated antimiR21-induced effect on breast cancer cells."
https://pharos.nih.gov/idg/targets/P27986,P27986,26565021,"A Cytosolic Multiprotein Complex Containing p85alpha Is Required for beta-Catenin Activation in Colitis and Colitis-associated Cancer."
https://pharos.nih.gov/idg/targets/P27986,P27986,26475863,"study provides new insight into the structure and assembly of the p85alpha homodimer and suggests that this protein is a highly dynamic molecule whose conformational flexibility allows it to transiently associate with multiple binding proteins."
https://pharos.nih.gov/idg/targets/P27986,P27986,26284543,"NOS stimulation via PI3K, calpain proteases, and SIRT1-dependent deacetylation downstream from VEGFR2 activation contributes to these vasodilator responses."
https://pharos.nih.gov/idg/targets/P27986,P27986,26222500,"As a consequence, homodimeric but not monomeric p85alpha suppresses the phosphatidylinositol 3-kinase pathway by protecting PTEN from E3 ligase WWP2-mediated proteasomal degradation."
https://pharos.nih.gov/idg/targets/P27986,P27986,26125867,"Three of these, PIK3R1, VEGFA, and ITGB1, are known to be associated with preeclampsia or preeclampsia-related biological processes"
https://pharos.nih.gov/idg/targets/P27986,P27986,26122737,"Analysis of interdomain interactions of wild-type and mutants at the p110alpha-p85alpha interface with molecular dynamics simulations suggest that tumor-associated mutations weaken interactions between p110alpha and p85alpha by disrupting key stabilizing interactions."
https://pharos.nih.gov/idg/targets/P27986,P27986,25979433,"The synaptic recruitment of lipid rafts is dependent on CD19-PI3K module and cytoskeleton remodeling molecules."
https://pharos.nih.gov/idg/targets/P27986,P27986,25962360,"we conclude that miR-128-3p, which is frequently downregulated in HCC, inhibits hepatocellular carcinoma (HCC).  progression by regulating PIK3R1 and PI3K/AKT activation, and is a prognostic marker for HCC patients."
https://pharos.nih.gov/idg/targets/P27986,P27986,25939554,"Heterozygous splice site mutations in PIK3R1 are associated with an immunological phenotype resembling hyper-IgM syndrome, and altered germinal center reaction with abnormal B cell peripheral maturation."
https://pharos.nih.gov/idg/targets/P27986,P27986,25846727,"expression determinant of gemcitabine sensitivity in pancreatic ductal adenocarcinoma"
https://pharos.nih.gov/idg/targets/P27986,P27986,25757764,"PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3beta/CTNNB1 signaling pathway"
https://pharos.nih.gov/idg/targets/P27986,P27986,25754093,"Defective podocyte insulin signaling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy."
https://pharos.nih.gov/idg/targets/P27986,P27986,25746038,"genetic association studies in populations in Ireland and Belgium: Data suggest that frequencies of mutations in PIK3R1, MET (MET proto-oncogene receptor tyrosine kinase), and BRAF (B-Raf proto-oncogene) vary by demographic location."
https://pharos.nih.gov/idg/targets/P27986,P27986,25488983,"Patients who harbor a recently reported heterozygous splice site mutation in PIK3R1 suffer from recurrent sinopulmonary infections and lymphoproliferation."
https://pharos.nih.gov/idg/targets/P27986,P27986,25475121,"Data conclude that miR-486-5p, which is frequently downregulated in HCC, inhibits HCC progression by targeting PIK3R1 and phosphatidylinositol 3-kinase-AKT activation."
https://pharos.nih.gov/idg/targets/P27986,P27986,25387834,"these data demonstrate that Pyk2 is a critical regulator of PI3K function downstream of the TCR."
https://pharos.nih.gov/idg/targets/P27986,P27986,25314071,"describe two neomorphic PIK3R1 mutants prevalent in endometrial and colon cancer that induce transformation via activation of PI3K-independent pathways"
https://pharos.nih.gov/idg/targets/P27986,P27986,25243493,"This study identified that CGPs was found to significantly correlate with the differential expression and methylation of genes encoding phosphoinositide-3-kinase, regulatory subunit 1."
https://pharos.nih.gov/idg/targets/P27986,P27986,25236949,"Data show that miR-221 and miR-222 repress respectively the levels of PIK3R1 and ETS1 to regulate angiogenic features in endothelial progenitor cells and endothelial cells."
https://pharos.nih.gov/idg/targets/P27986,P27986,25133428,"PI3K activity is tightly regulated in T and B lymphocytes and that various defects in the PI3K-triggered pathway can cause primary immunodeficiencies."
https://pharos.nih.gov/idg/targets/P27986,P27986,25114970,"This study highlights the p85alpha (PI3K)S83 role as a key regulator of cell proliferation and motility induced by insulin in MCF-7 cells breast cancer model."
https://pharos.nih.gov/idg/targets/P27986,P27986,25104021,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,25098276,"In trastuzumab-treated HER2-positive breast cancer patients, positive p85 protein expression appears to be a prognostic factor of poor survival and, if validated, might have important implications in the treatment of such patients."
https://pharos.nih.gov/idg/targets/P27986,P27986,24886349,"we report PIK3R1 as the gene implicated in SHORT syndrome in two patients."
https://pharos.nih.gov/idg/targets/P27986,P27986,24819169,"SchA-FAK-p85 complex subsequently selectively recruited and activated Akt2, not Akt1"
https://pharos.nih.gov/idg/targets/P27986,P27986,24657164,"BRD7-mediated translocation of a subfraction (but not all) of the p85 protein to the nucleus could enhance PI3K signaling."
https://pharos.nih.gov/idg/targets/P27986,P27986,24550137,"High PI3K p85 expression is associated with non-small cell lung cancer."
https://pharos.nih.gov/idg/targets/P27986,P27986,24503895,"MPP3 and Dlg, membrane-associated guanylate kinase homologs (MAGuK) proteins, connect CADM1 with p85 of PI3K by forming a multi-protein complex at the periphery of cells."
https://pharos.nih.gov/idg/targets/P27986,P27986,24367658,"mutant forms of p85alpha may play an oncogenic role in bladder cancer"
https://pharos.nih.gov/idg/targets/P27986,P27986,24316008,"These data, plus the fact that Sam68 is known to be a signaling adaptor protein, indicated that Sam68 is a signal molecule with a functional role in the PI3K/Akt signal pathway during enterovirus 71 infection."
https://pharos.nih.gov/idg/targets/P27986,P27986,24244431,"Knockdown of RPS7 resulted in increased expression of P85alpha, P110alpha, and AKT2."
https://pharos.nih.gov/idg/targets/P27986,P27986,24229420,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,24229379,"PIK3CA mutations and PIK3R1 underexpression show opposite effects on patient outcome and could become useful prognostic and predictive factors in breast cancer."
https://pharos.nih.gov/idg/targets/P27986,P27986,24223153,"HSP20 directly associates with PI3K subunits and suppresses its activity in hepatocellular carcinoma, resulting in the inhibition of the AKT pathway, and subsequently decreasing the growth of hepatocellular carcinoma."
https://pharos.nih.gov/idg/targets/P27986,P27986,24073214,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,23980586,"PIK3R1 de novo missense mutation (c.1945C>T; p.Arg649Trp) cause SHORT syndrome."
https://pharos.nih.gov/idg/targets/P27986,P27986,23980150,"miR-486 directly targets components of insulin growth factor (IGF) signaling including IGF1, IGF1 receptor, and phosphoinositide-3-kinase, regulatory subunit 1alpha (PIK3R1, or p85a) and functions as a potent tumor suppressor of lung cancer."
https://pharos.nih.gov/idg/targets/P27986,P27986,23810382,"PIK3R1 mutations are the major cause of SHORT syndrome."
https://pharos.nih.gov/idg/targets/P27986,P27986,23810379,"A heterozygous PIK3R1 mutation is observed in two unrelated families affected by partial lipodystrophy, low body mass index, short stature, progeroid face, and Rieger anomaly (SHORT syndrome)."
https://pharos.nih.gov/idg/targets/P27986,P27986,23810378,"Individuals with PIK3R1 mutations showed severe insulin resistance for both proximal and distal PI3K-dependent signaling."
https://pharos.nih.gov/idg/targets/P27986,P27986,23603894,"It is a key player in cell-growth signaling in a number of lymphoid malignancies."
https://pharos.nih.gov/idg/targets/P27986,P27986,23583404,"Data indicate PI3K p85 mediates the interaction of beta-catenin with NF-kappaB (p65)."
https://pharos.nih.gov/idg/targets/P27986,P27986,23569237,"Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells."
https://pharos.nih.gov/idg/targets/P27986,P27986,23562842,"PI3K behaves as an upstream regulator of PKCdelta and p38 MAPK in WISH cells."
https://pharos.nih.gov/idg/targets/P27986,P27986,23301033,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,23251686,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,23221569,"Both alpha and beta isomers of the PI3K regulatory subunit p85 and full-length rotavirus NSP1 are important for this interaction, which results in efficient activation of the PI3K/Akt pathway during rotavirus infection."
https://pharos.nih.gov/idg/targets/P27986,P27986,23215766,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,23166678,"Introduction of a subset of the mutations identified in human glioblastoma, in the nSH2 and iSH2 domains, increases signaling through the PI3K pathway and promotes tumorigenesis of primary normal human astrocytes."
https://pharos.nih.gov/idg/targets/P27986,P27986,22752602,"Data indicate that erufosine caused dose-dependent decreases in the phosphorylation of PI3K (p85), Akt (PKB) at Thr 308 and cRaf in both MCF-7 and MDA-MB 231 cell lines."
https://pharos.nih.gov/idg/targets/P27986,P27986,22728334,"Insulin stimulation promoted an interaction between the IRS1/p85 complex and PPP1R12A; however, p85 and PPP1R12A did not interact independent of IRS1."
https://pharos.nih.gov/idg/targets/P27986,P27986,22684007,"miR-376a may contribute to the development of hepatocellular carcinoma by targeting p85alpha"
https://pharos.nih.gov/idg/targets/P27986,P27986,22355357,"High p85alpha is associated with non-small cell lung cancer."
https://pharos.nih.gov/idg/targets/P27986,P27986,22271581,"Cyclin G1 overexpression enhanced Akt activation through interaction with p85 (regulatory subunit of phosphoinositide 3-kinase)"
https://pharos.nih.gov/idg/targets/P27986,P27986,22120714,"a global conformational change in p110alpha consistent with allosteric regulation of the kinase domain by the P85 N-terminal SH2 domain"
https://pharos.nih.gov/idg/targets/P27986,P27986,22064833,"PIK3R1, like PIK3CA, is a potential therapeutic target in Glioblastoma multiforme and that it also influences tumor cell growth and motility"
https://pharos.nih.gov/idg/targets/P27986,P27986,21984976,"Multiple PIK3R1 and PIK3R2 mutations demonstrate gain of function, including disruption of a novel mechanism of pathway regulation wherein p85alpha dimers bind and stabilize PTEN."
https://pharos.nih.gov/idg/targets/P27986,P27986,21765914,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,21743495,"Data show that mutation of serine 83 to alanine on p85 inhibited 14-3-3zeta binding to the p85 subunit of PI3K."
https://pharos.nih.gov/idg/targets/P27986,P27986,21533174,"presence of TSC2 mutations, in addition to TSC1 mutations, underlines the involvement of mTOR signaling in urothelial carcinoma"
https://pharos.nih.gov/idg/targets/P27986,P27986,21487925,"We did not find any mutation in the GNAQ, AKT3, and PIK3R1 genes in various types of thyroid cancer."
https://pharos.nih.gov/idg/targets/P27986,P27986,21478295,"found that PIK3R1 was somatically mutated in 43% of endometrial cancers and 12% of nonendometrioid endometrial cancers"
https://pharos.nih.gov/idg/targets/P27986,P27986,21430300,"Single nucleotide polymorphisms in PIK3R1 is associated with prostate cancer."
https://pharos.nih.gov/idg/targets/P27986,P27986,21362552,"lipid kinase p110beta/p85beta elucidates an unusual SH2-domain-mediated inhibitory mechanism"
https://pharos.nih.gov/idg/targets/P27986,P27986,21241768,"SIRT1 interacts in an insulin-independent manner with the PI3K adapter subunit p85"
https://pharos.nih.gov/idg/targets/P27986,P27986,21113646,"rs3756668 located in 3'-UTR of the PIK3R1 gene is associated with insulin resistant phenotype"
https://pharos.nih.gov/idg/targets/P27986,P27986,21077741,"Leukemia cells can regulate the expression of p85alpha by posttranscriptional regulation."
https://pharos.nih.gov/idg/targets/P27986,P27986,21057544,"In the current study, we have shown that p85alpha, the regulatory subunit of phosphatidylinositol-3-kinase, has a critical role in mediating p53 acetylation and promoter-specific transactivation in the ultraviolet B (UVB) response."
https://pharos.nih.gov/idg/targets/P27986,P27986,21029719,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,20846792,"PIK3R1 might play a role in the pathogenesis of hypersplenism due to portal hypertension, and inhibition of PIK3R1 expression might be a novel therapeutic strategy for it."
https://pharos.nih.gov/idg/targets/P27986,P27986,20818790,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,20800603,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,20714879,"PI-3K p85 in gestational diabetes mellitus patients may be involved in the insulin signaling pathway, resulting in insulin resistance."
https://pharos.nih.gov/idg/targets/P27986,P27986,20713702,"Data show that the mutations weaken an inhibitory interaction between p85alpha and p110alpha."
https://pharos.nih.gov/idg/targets/P27986,P27986,20702582,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,20628086,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,20602615,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,20530665,"Results substantiate the concept that the p85 subunit of PI3K has a tumor-suppressive role in the liver and possibly other tissues."
https://pharos.nih.gov/idg/targets/P27986,P27986,20501401,"PI3Kp85alpha gene silencing can significantly promote 5-fluorouracil-induced apoptosis of colorectal LoVo cells."
https://pharos.nih.gov/idg/targets/P27986,P27986,20407443,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,20237496,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,20212113,"p85alpha regulatory protein binds directly to and enhances PTEN lipid phosphatase activity"
https://pharos.nih.gov/idg/targets/P27986,P27986,20056178,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,20019835,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,19962665,"findings show presence of frequent mutations in p85alpha in colon cancer, a majority of which occurs in the inter-Src homology-2 domain; these mutations uncouple & retain p85alpha's p110-stabilizing activity, while abrogating its p110-inhibitory activity"
https://pharos.nih.gov/idg/targets/P27986,P27986,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,19885597,"PI3K p85alpha depletion induces cell cycle arrest and apoptosis in colorectal cancer cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,19747165,"Data show that mesothelin is a potential target in reducing resistance to cytotoxic drugs, and mesothelin-treated cells revealed rapid tyrosine phosphorylation of the p85 subunit of PI3K."
https://pharos.nih.gov/idg/targets/P27986,P27986,19640849,"Findings indicate a novel mechanism by which hypoxia induces CD36 expression via activation of HIF-1 and the phosphatidylinositol 3-kinase pathway."
https://pharos.nih.gov/idg/targets/P27986,P27986,19639178,"Our results demonstrated that shRNA targeting COX-2, Akt1 and PIK3R1 downregulates their expression significantly in a sequence-specific manner, exerting proliferation and invasion inhibition effects on SGC7901 and U251 cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,19635806,"PTEN-p85 association involves the unphosphorylated form of PTEN engaged within the PTEN-associated complex and also includes the p110beta isoform of PI3K."
https://pharos.nih.gov/idg/targets/P27986,P27986,19634059,"the PIK3R1 mutation is rare in human cancers"
https://pharos.nih.gov/idg/targets/P27986,P27986,19634059,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,19578796,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,19482007,"CoA synthase is involved in signaling events in the cell and forms a functional complex with p85alphaPI3K in vivo."
https://pharos.nih.gov/idg/targets/P27986,P27986,19454690,"an interaction between the regulatory subunit of PI3K, p85, and the adaptor protein CrkL is required for efficient NKG2D-mediated cellular cytotoxicity"
https://pharos.nih.gov/idg/targets/P27986,P27986,19351817,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,19336760,"p85alpha and p85beta may recruit proteins in the endocytic machinery on Epo stimulation; mutated EpoRs from primary familial and congenital polycythemia patients lacking the 3 important tyrosines do not bind p85 or internalize on stimulation"
https://pharos.nih.gov/idg/targets/P27986,P27986,19304514,"Abnormal PI3K p85alpha expression occurs in the progression of colorectal cancer in close relation to the clinical stage."
https://pharos.nih.gov/idg/targets/P27986,P27986,19286672,"FGFR3 and p85 proteins interact in myeloma cells which express p85alpha and p85beta."
https://pharos.nih.gov/idg/targets/P27986,P27986,19218574,"The PI3-kinase gene Met326Ile polymorphism may not be a major determinant for the development of polycystic ovary syndrome (PCOS), but it may modulate the concentrations of serum 17-OHP or free testosterone in PCOS patients."
https://pharos.nih.gov/idg/targets/P27986,P27986,19218574,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,18996102,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,18990689,"ARF1 regulates epidermal growth factor-dependent breast cancer cell growth and invasion during cancer progression by controlling the activation of the phosphatidylinositol 3-kinase pathway"
https://pharos.nih.gov/idg/targets/P27986,P27986,18974049,"caspase 8 has a role as a modulator of p85alpha Rab5-GAP activity and endosomal trafficking"
https://pharos.nih.gov/idg/targets/P27986,P27986,18854243,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,18660489,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,18534979,"the influenza A virus NS1 protein interacts with the p85beta, but not the p85alpha, subunit of phosphatidylinositol 3-kinase"
https://pharos.nih.gov/idg/targets/P27986,P27986,18453587,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,18418043,"structure of the complex between the catalytic subunit of PI3Kalpha, p110alpha, & a portion of its regulatory subunit, p85alpha reveals the majority of the oncogenic mutations occur at the interfaces between p110 domains & between p110 & p85 domains"
https://pharos.nih.gov/idg/targets/P27986,P27986,18372911,"p85alpha and p110beta are essential for androgen-stimulated AR transactivation, and their aberrant expression or activation might play an important role in prostate cancer progression"
https://pharos.nih.gov/idg/targets/P27986,P27986,18335044,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,18328427,"Binding of CD95 Ligand to CD95 on glioblastoma cells recruit Yes and the p85 subunit of phosphatidylinositol 3-kinase to CD95, which signal invasion via the glycogen synthase kinase 3-beta pathway and subsequent expression of matrix metalloproteinases."
https://pharos.nih.gov/idg/targets/P27986,P27986,18249389,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,18245521,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,18227218,"PI3K is activated by toll-like receptor stimulation in primary human plasmacytoid predendritic cells (pDCs), and it is required for type I IFN production by pDCs, both at the transcriptional and protein levels"
https://pharos.nih.gov/idg/targets/P27986,P27986,18079394,"study reports a 3.0 angstrom resolution structure of a complex between p110alpha and a polypeptide containing the p110alpha-binding domains of p85alpha; results suggest specific mechanisms for the effect of oncogenic mutations in p110alpha and p85alpha"
https://pharos.nih.gov/idg/targets/P27986,P27986,17890432,"Endothelial cell PI 3-kinase activity and F-actin remodeling are required during lymphocyte diapedesis and identify a PI 3-kinase-dependent step following initial separation of the VE-cadherin barrier."
https://pharos.nih.gov/idg/targets/P27986,P27986,17827393,"IGF-1 activates the IGF receptor/IRS/PI3K/PKB pathway, and that PI3Kalpha is essential for the potentiatory effect of IGF-1 on platelet responses"
https://pharos.nih.gov/idg/targets/P27986,P27986,17632570,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,17570359,"RhoG protects cells from apoptosis caused by the loss of anchorage through a PI3K-dependent mechanism, independent of its activation of Rac1"
https://pharos.nih.gov/idg/targets/P27986,P27986,17486587,"PKC alpha may be associated with regulation of cell proliferation/migration/invasion in human poorly differentiated hepatocellular carcinoma cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,17442886,"These results support a model in which phagosomal PI3K generates PI(3,4,5)P(3) necessary for later stages of phagocytosis, PTEN determines whether those late stages can occur, and SHIP-1 regulates when and where they occur."
https://pharos.nih.gov/idg/targets/P27986,P27986,17404186,"These results indicate that the phosphatidylinositol 3-kinase/Akt/FoxO1 pathway participates in Ang II suppression of hSR-BI/CLA-1 expression and suggests that the endothelial receptor for hSR-BI/CLA-1 is downregulated by the renin-angiotensin system."
https://pharos.nih.gov/idg/targets/P27986,P27986,17302605,"PI3K is not overexpressed in melanocytic lesions."
https://pharos.nih.gov/idg/targets/P27986,P27986,17242406,"the recruitment of PI3K to the E-cadherin/beta-catenin/p120-catenin complex via beta-catenin at the plasma membrane is required for calcium-induced phospholipase C-gamma1 activation and, ultimately, keratinocyte differentiation"
https://pharos.nih.gov/idg/targets/P27986,P27986,17242350,"the WASp/SNX9/p85/CD28 complex enables a unique interface of endocytic, actin polymerizing, and signal transduction pathways required for CD28-mediated T cell costimulation"
https://pharos.nih.gov/idg/targets/P27986,P27986,17214991,"hypothesized that variants in the SHP-2 gene PTPN11 and PI3K p85alpha subunit gene PIK3R1 may influence fasting levels of plasma apoB and/or LDL cholesterol"
https://pharos.nih.gov/idg/targets/P27986,P27986,17157319,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,17038539,"constitutively active Stat5 mutant forms a complex with the p85 subunit of phosphatidylinositol 3-kinase and the scaffolding adapter Gab2 in leukemic bone marrow cells, resulting in the activation of Akt/PKB, a crucial downstream target of PI3-K"
https://pharos.nih.gov/idg/targets/P27986,P27986,17016694,"Association of single nucleotide polymorphisms with serum leptin and body fat may reflect a diminished ability of this enzyme to signal in ersponse to leptin."
https://pharos.nih.gov/idg/targets/P27986,P27986,17013094,"autotaxin induces uPA expression via the Gi-PI3K-Akt-NF-kappaB signaling pathway that might be critical for autotaxin-induced tumor cell invasion and metastasis"
https://pharos.nih.gov/idg/targets/P27986,P27986,17006756,"It has recently been shown that Akt activation is associated with a worse outcome among endocrine treated breast cancer patients and that it also inhibits the progesterone receptor (PR) expression via the PI3K/Akt pathway in breast cancer cells."
https://pharos.nih.gov/idg/targets/P27986,P27986,16921024,"direct interactions between native Syk and PI3K proteins are differentially regulated during FcgammaR phagocytosis and endocytosis."
https://pharos.nih.gov/idg/targets/P27986,P27986,16844778,"Hsp90 inhibition transiently activates Src kinase and promotes Src-dependent p85 PI3K and Akt and Erk activation"
https://pharos.nih.gov/idg/targets/P27986,P27986,16787925,"Gab1 thus appears as a primary actor in coupling VEGFR-2 to PI3K/Akt, recruited through an amplification loop involving PtdIns(3,4,5)P3 and its PH domain"
https://pharos.nih.gov/idg/targets/P27986,P27986,16644730,"MyD88 bridges TLR5 engagement to PI3K activation in response to flagellin"
https://pharos.nih.gov/idg/targets/P27986,P27986,16524887,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,16491394,"increased expression of p85alpha may be one of the earliest molecular alterations in the mechanism of the insulin resistance associated with overfeeding"
https://pharos.nih.gov/idg/targets/P27986,P27986,16412560,"the PI3-K pathway negatively regulates TGF-beta/Smad signaling in neuroblastoma cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,16306077,"SHP-2 recruitment to p85 is required for IGF-I-stimulated association of the p85/p110 complex with insulin receptor substrate-1 and for the subsequent activation of the PI-3 kinase pathway leading to increased cell migration"
https://pharos.nih.gov/idg/targets/P27986,P27986,16289966,"CD21 activation triggered Cbl tyrosine phosphorylation, which interacts with SH2 domains of p85 subunit, SH2 domains of Crk-L and with tyrosine phosphorylated Syk kinase.  CD21 activation triggers dissociation of Cbl-Vav complex."
https://pharos.nih.gov/idg/targets/P27986,P27986,16228294,"the signals induced by integrin alpha6beta1 modulate at the level of PI3K and Cdc42 activity to allow platelets to actively form filopodia"
https://pharos.nih.gov/idg/targets/P27986,P27986,16168140,"Inhibitors may provide an alternative route to effective PI3K pathway inhibition for breast cancer treatment."
https://pharos.nih.gov/idg/targets/P27986,P27986,16081599,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,15932879,"the nSH2 domain of the p85 regulatory subumit is responsible for p110 regulatory contacts, and its disruption leads to constitutive p110 activity"
https://pharos.nih.gov/idg/targets/P27986,P27986,15910625,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,15872086,"calcium activates PLC-gamma1 via increased PIP3 formation mediated by c-src- and fyn-activated PI3K"
https://pharos.nih.gov/idg/targets/P27986,P27986,15826941,"WAVE3-mediated migration in MDA-MB-231 cells via lamellipodia formation is activated downstream of PI3K and induced by PDGF"
https://pharos.nih.gov/idg/targets/P27986,P27986,15809724,"PI3K regulates cell cycle progression and cell proliferation in human gastric tumor cells via Rb-mediated pathway; effect mediated through direct association with Rb via N-terminal end of its p55 kDa regulatory subunits and modulating Rb-E2F interactions"
https://pharos.nih.gov/idg/targets/P27986,P27986,15741161,"p110gamma and p85alpha class Ia phosphoinositide 3-kinase (PI3K) subunits play roles in generating the antiapoptotic and chemoresistant phenotype associated with accelerated local tumor recurrence"
https://pharos.nih.gov/idg/targets/P27986,P27986,15689238,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,15638726,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,15490304,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,15388330,"Data suggest that SLP-76 may play a role in signaling pathways by interacting with the p85 subunit of phosphoinositide 3-kinase (PI3K)."
https://pharos.nih.gov/idg/targets/P27986,P27986,15351743,"coupling of Gab1 to PI3K is important for biological responses in RET-expressing cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,15127203,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,14965316,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,14769856,"These findings reveal key events of the phosphatidylinositol 3-kinase pathway that play distinct roles to maintain tissue polarity and that when disrupted are instrumental in the malignant breast tumor phenotype."
https://pharos.nih.gov/idg/targets/P27986,P27986,14602571,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,14597629,"PI3K has a novel role as a bikunin target gene on uPA up-regulation and invasion"
https://pharos.nih.gov/idg/targets/P27986,P27986,14551916,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,12960231,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,12734410,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,12714585,"the role of p85-ALPHA in the survival of cancer cells that express wild-type PTEN"
https://pharos.nih.gov/idg/targets/P27986,P27986,12644569,"protein whose expression is deregulated in the epidermis of the elderly."
https://pharos.nih.gov/idg/targets/P27986,P27986,12588990,"p55gamma binds to Rb and modification of this association can lead to cell cycle arrest"
https://pharos.nih.gov/idg/targets/P27986,P27986,12584329,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,12582030,"The isoleucine variant of codon 326 of the p85alpha subunit of PI3-K might be associated with decreased risk of Prostate Cancer."
https://pharos.nih.gov/idg/targets/P27986,P27986,12551992,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,12526811,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,12397383,"Gene expression of full-length p85alpha is increased in skeletal muscle from type 2 diabetics, this is not reflected by increased protein. Defects in PI 3-kinase activity are likely due to impaired activation of the enzyme."
https://pharos.nih.gov/idg/targets/P27986,P27986,12393736,"The p85 subunit of PI 3-kinase mediates GPIb-related activation signals and activates Src independently of the enzymatic activity of PI 3- kinase."
https://pharos.nih.gov/idg/targets/P27986,P27986,12185156,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P27986,P27986,12077252,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,12009866,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,11994280,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,11986952,"Expression of a mutated in a Hodgkin's lymphoma-derived cell line; the first detection in human hematopoietic cells further underlining a potential role of PI3-kinase/Akt signaling in human leukemogenesis"
https://pharos.nih.gov/idg/targets/P27986,P27986,11842213,"Thus, the Met-326Ile variant of p85alpha is functional for intracellular signaling and adipocyte differentiation but has small alterations in protein expression and activity that could play a role in modifying insulin action."
https://pharos.nih.gov/idg/targets/P27986,P27986,11689886,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,11289809,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,11156964,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,11154208,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,10985305,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,10422873,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,10358157,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,10208934,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,9808187,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,9708406,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,9446795,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,9394803,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,9341793,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,9247029,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,9123823,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,8798481,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,8636073,"HIV-1 Nef synergizes with KSHV oncoprotein K1 to activate PI3K/AKT/mTOR signaling pathway, and induces cell proliferation and microtubule formation in endothelial cells"
https://pharos.nih.gov/idg/targets/P27986,P27986,2174051,"This paper reports the first purification of a phosphoinositide 3-kinase and shows that the protein is a heterodimer of an 85 kd regulatory subunit that mediates binding to phosphorylated proteins and a 110 kd catalytic subunit."
https://pharos.nih.gov/idg/targets/P35557,P35557,29166588,"GCK-dependent glycolysis regulates Treg cell migration."
https://pharos.nih.gov/idg/targets/P35557,P35557,29056535,"Mutations in the GCK gene were identified in 79 out of 177."
https://pharos.nih.gov/idg/targets/P35557,P35557,28783164,"GCK GCK GCK GCK"
https://pharos.nih.gov/idg/targets/P35557,P35557,27634015,"Glucokinase mutations are associated with Maturity-Onset Diabetes of the Young."
https://pharos.nih.gov/idg/targets/P35557,P35557,27520373,"GCK expression is regulated by nutrient-sensing O-linked beta-N-acetylglucosaminylation cycling in liver."
https://pharos.nih.gov/idg/targets/P35557,P35557,27289208,"The number of mutations in GCK/MODY2 or even other MODY-related genes is undoubtedly underestimated, as accepted criteria for performing genetic tests include family history of the pathology."
https://pharos.nih.gov/idg/targets/P35557,P35557,27269892,"GCK mutations are associated with MODY2."
https://pharos.nih.gov/idg/targets/P35557,P35557,27256595,"GCK gene mutations (pathogenic or likely pathogenic variants) and a novel intronic variant of uncertain significance (c.208 + 3A>T) were identified in 13/54 probands (24%)."
https://pharos.nih.gov/idg/targets/P35557,P35557,27185633,"The results show that p.Leu77Arg but not p.Val101Met GCK mutation is considered a pathogenic mutation associated with maturity onset diabetes of the young."
https://pharos.nih.gov/idg/targets/P35557,P35557,27146014,"Data suggest that hepatic glucokinase activity is regulated by reversible binding to specific inhibitor protein glucokinase regulatory protein (GKRP) and by binding to activator proteins such as 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase (PFK2/FBP2); changes in glucokinase expression and activity are associated with poorly controlled type 2 diabetes and nonalcoholic fatty liver disease. [REVIEW]"
https://pharos.nih.gov/idg/targets/P35557,P35557,27016322,"glucokinase mutation is associated with Maturity-Onset Diabetes of the Young, Type 2."
https://pharos.nih.gov/idg/targets/P35557,P35557,26669242,"GCK mutations are associated with Maturity onset diabetes of youth."
https://pharos.nih.gov/idg/targets/P35557,P35557,26620281,"Given that acetylated GKRP may affiliate with type-2 diabetes mellitus (T2DM), understanding the mechanism of GKRP acetylation in the liver could reveal novel targets within the GK-GKRP pathway, for treating T2DM and other metabolic pathologies."
https://pharos.nih.gov/idg/targets/P35557,P35557,26283387,"analysis of allosteric activation mechanisms in monomeric human glucokinase"
https://pharos.nih.gov/idg/targets/P35557,P35557,26240958,"DR of any degree was not present in our GCK-MODY group, while in spite of young age almost every fourth subject with HNF1A-MODY showed signs of this complication."
https://pharos.nih.gov/idg/targets/P35557,P35557,26226118,"The results of this study showed that mutations in the GCK gene are the leading cause of maturity-onset diabetes of the young in our population"
https://pharos.nih.gov/idg/targets/P35557,P35557,26208450,"Thus, a glucokinase activator drug therapy may help MODY2 patients not in general, but seems to be a useful strategy for carriers of the L315H glucokinase mutation."
https://pharos.nih.gov/idg/targets/P35557,P35557,25987348,"Plasma ghrelin is higher in glucokinase-maturity onset diabetes of the young than in the common polygenic forms of diabetes."
https://pharos.nih.gov/idg/targets/P35557,P35557,25935773,"Patients had higher fasting and postprandial glycemic excursions in the first trimester of GCK mutation MODY pregnancies than HNF-1alpha mutation MODY pregnancies despite insulin treatment. There was an increased percentage of miscarriages in GCK pregnancies."
https://pharos.nih.gov/idg/targets/P35557,P35557,25892191,"Aberrant methylation of the GCK gene body was significantly associated with the risk of essential hypertension."
https://pharos.nih.gov/idg/targets/P35557,P35557,25850297,"Two novel GCK splicing mutations in Maturity Onset Diabetes of Young 2 have been characterized."
https://pharos.nih.gov/idg/targets/P35557,P35557,25633883,"The meta-analysis showed that GCK-30G > A polymorphism was associated with GDM in Caucasian and Asian."
https://pharos.nih.gov/idg/targets/P35557,P35557,25336239,"High levels of HbA1c were associated with an increased risk of recurrence of atrial tachyarrhythmia in patients with T2DM and PAF undergoing catheter ablation."
https://pharos.nih.gov/idg/targets/P35557,P35557,25200293,"Data suggest that brain glucokinase (especially in glial cells and neurons) plays key role in glucose sensing, feedback to pancreatic islets, and metabolic homeostasis. [REVIEW]"
https://pharos.nih.gov/idg/targets/P35557,P35557,25174781,"GCK mutations were found in 8 families, all patients with mild asymptomatic hyperglycaemia; 3 of them are novel: p.Asp365Asn, p.Gly81Asp and p.Val253Leu."
https://pharos.nih.gov/idg/targets/P35557,P35557,25074928,"Atf3-silencing reversed ethanol-mediated Gck down-regulation and beta-cell dysfunction, followed by the amelioration of impaired glucose tolerance and insulin resistance."
https://pharos.nih.gov/idg/targets/P35557,P35557,25015100,"Phenotypic severity of homozygous GCK mutations causing neonatal or childhood-onset diabetes is primarily mediated through effects on protein stability."
https://pharos.nih.gov/idg/targets/P35557,P35557,24992032,"Elevated GCK CpG4 methylation was observed in male T2D patients."
https://pharos.nih.gov/idg/targets/P35557,P35557,24890200,"A heterozygous activating mutation, p.Val389Leu, was found in the proband and four other family members with familial adult onset hyperinsulinism."
https://pharos.nih.gov/idg/targets/P35557,P35557,24804978,"genetic association study in population in Japan: In study of 55 probands diagnosed at 0-14 years and 23 adult family members, 35 different mutations in GCK were identified as associated with MODY2 (glucokinase maturity-onset diabetes of the young)."
https://pharos.nih.gov/idg/targets/P35557,P35557,24728127,"Common variation in GCK influences the rate of carbohydrate oxidation, 24 h energy expenditure and diabetes risk in Pima Indians."
https://pharos.nih.gov/idg/targets/P35557,P35557,24723372,"Results suggest a model in which the primary structure of connecting loop I affects cooperativity by influencing conformational dynamics, without altering the equilibrium distribution of GCK conformations."
https://pharos.nih.gov/idg/targets/P35557,P35557,24720358,"structural variations in in exons 10 and 11 due to mutations could be one of the strongest reasons for the hyperglycemic levels in these type 2 diabetic patients"
https://pharos.nih.gov/idg/targets/P35557,P35557,24696842,"The hypomethylation of GCK gene-body was significantly associated with the risk of coronary heart disease."
https://pharos.nih.gov/idg/targets/P35557,P35557,24637025,"Studies indicate differential regulation of glucokinase in pancreatic beta cells and the liver."
https://pharos.nih.gov/idg/targets/P35557,P35557,24578721,"MODY 2-associated deleterious missense mutations in the GCK gene were found to alter the stability, flexibility, and solvent-accessible surface area of the protein."
https://pharos.nih.gov/idg/targets/P35557,P35557,24568320,"Data suggest that GK (glucokinase) and GKRP (glucokinase regulatory protein) form stabile complex with co-operative interaction and allosteric regulation of both activities; studies involved isolated recombinant proteins/site-directed mutagenesis."
https://pharos.nih.gov/idg/targets/P35557,P35557,24520939,"meta-analysis indicated that the risk allele of the GCK -30G>A polymorphism may increase gestational diabetes mellitus and type 2 diabetes mellitus risk in whites, whereas additional studies are needed to confirm the effect of this polymorphism on both diseases in Asians and Africans"
https://pharos.nih.gov/idg/targets/P35557,P35557,24495862,"This is the first report that presents a significant association of polymorphism rs2268574 in Glucokinase gene with gestational Diabetes mellitus patients."
https://pharos.nih.gov/idg/targets/P35557,P35557,24447338,"The amplified luminescent proximity homogeneous assay (AlphaScreen) identifies the interaction of HIV-1 Gag with GCK"
https://pharos.nih.gov/idg/targets/P35557,P35557,24430320,"Despite a median duration of 48.6 years of hyperglycemia, patients with a GCK mutation had low prevalence of microvascular and macrovascular complications"
https://pharos.nih.gov/idg/targets/P35557,P35557,24405491,"This is the first study of MODY 2 mutations from India and confirms the importance of considering GCK gene mutation screening in patients with mild early-onset hyperglycemia who are negative for beta-cell antibodies."
https://pharos.nih.gov/idg/targets/P35557,P35557,24323243,"Mutations in GCK, HNF1A or HNF4A genes were detected in 58 of 150 individuals. Parents of 28 probands were unavailable for further analysis, and in 19 probands the mutation was inherited from an asymptomatic parent."
https://pharos.nih.gov/idg/targets/P35557,P35557,24146201,"GK and GKRP immunoreactivities are changed in pyramidal neurons and newly expressed in astrocytes in the ischemic CA1 after transient cerebral ischemia"
https://pharos.nih.gov/idg/targets/P35557,P35557,24001579,"On mutation of glucokinase, a hydrogen bond between the R275 side-chain and the carbonyl oxygen of D267 is broken, destabilizing the F260-L271 loop structure and the protein."
https://pharos.nih.gov/idg/targets/P35557,P35557,23957911,"we report the crystal structure of the mammalian GCK-GKRP complex in the presence of fructose 6-phosphate at a resolution of 3.50 A."
https://pharos.nih.gov/idg/targets/P35557,P35557,23878349,"Heterozygous mutations in the GCK and HNF1A/ HNF4A genes account for up to 80% of all Maturity onset diabetes of the young cases. (Review)"
https://pharos.nih.gov/idg/targets/P35557,P35557,23843579,"Complete sequencing of the GCK gene, carried out in the patient, identified a novel mutation c.1268T>A (p.Phe423Tyr) in exon 10 of the gene GCK in heterozygosity. Further studies revealed the same mutation in her mother and maternal grandfather"
https://pharos.nih.gov/idg/targets/P35557,P35557,23840762,"GCKR rs780094 variant confers high cross-ethnicity risk for the development of T2DM, while significant associations between GCK, MTNR1B and G6PC2 variants and T2DM risk are limited to Caucasians."
https://pharos.nih.gov/idg/targets/P35557,P35557,23733961,"We find that GKRP acts as an allosteric switch for GK in blood glucose control by the liver."
https://pharos.nih.gov/idg/targets/P35557,P35557,23586928,"Data suggest that single nucleotide mutations in 3'-untranslated region of GSK can lead to false positives in genetic text for deletions in GSK exon 10. [CASE REPORT; 2 unrelated patients]"
https://pharos.nih.gov/idg/targets/P35557,P35557,23441155,"This meta-analysis demonstrated that the -30G>A polymorphism of GCK is a risk factor associated with increased T2D susceptibility, but these associations vary in different ethnic populations."
https://pharos.nih.gov/idg/targets/P35557,P35557,23433541,"the deletion 96_98delAAG (p.Lys32del) - a novel mutation in patients with mild familial hyperglycaemia"
https://pharos.nih.gov/idg/targets/P35557,P35557,23271955,"GCK cooperativity is explained in terms of large-scale, glucose-mediated disorder-order transitions."
https://pharos.nih.gov/idg/targets/P35557,P35557,23155715,"report of a family with MODY2 caused by a novel NM_000162.3:c.878T>C mutation in exon 8 of the GCK gene"
https://pharos.nih.gov/idg/targets/P35557,P35557,23139355,"The results show that mutations in glucokinase resulting in maturity-onset diabetes of the young 2 yield a metabolically normal condition, which may contribute to the lack of late complications and the nonprogressive nature of the disease."
https://pharos.nih.gov/idg/targets/P35557,P35557,23085272,"study identified new GCK gene mutations in a Brazilian family of Italian descendance, with one due to a premature stop codon located in the second exon of the gene"
https://pharos.nih.gov/idg/targets/P35557,P35557,23029263,"Sequences downstream of the liver-specific mRNA start site have important roles in the regulation of liver-specific glucokinase gene expression."
https://pharos.nih.gov/idg/targets/P35557,P35557,23009393,"Carriers of both GCK and HNF1A mutations manifested a typical maturity-onset diabetes of the young 3 phenotype and showed that the presence of a second mutation in the GCK gene apparently did not modify the clinical outcome."
https://pharos.nih.gov/idg/targets/P35557,P35557,22820548,"similar properties may represent the molecular mechanisms for additional unexplained GCK-MODY mutations, and may also contribute to the disease mechanism in other previously characterized GCK-MODY inactivating mutations"
https://pharos.nih.gov/idg/targets/P35557,P35557,22761713,"Glucokinase mutations are associated with Type 2 Maturity Onset Diabetes of the Young."
https://pharos.nih.gov/idg/targets/P35557,P35557,22653590,"Data conclude that mutations in GCK introns and in non-translatable regions of the GCK gene do not affect glycemic control and are not correlated with gestational diabetes mellitus."
https://pharos.nih.gov/idg/targets/P35557,P35557,22611063,"R43H-GCK appeared to have similar basic kinetic characteristics to WT-GCK, there was in vitro evidence of protein instability, indicating that this variant is pathogenic. For G68D-GCK, there was no evidence of protein instability"
https://pharos.nih.gov/idg/targets/P35557,P35557,22540858,"We found coincidence between the GCK-diabetes and type 2 diabetes in the members of a single Roma (Gypsy) family."
https://pharos.nih.gov/idg/targets/P35557,P35557,22517333,"Essential roles of the polymorphisms of the APOA5, GCK and GCKR in the lipid or glucose metabolism disorders."
https://pharos.nih.gov/idg/targets/P35557,P35557,22493702,"22 glucokinase mutations causing maturity-onset diabetes of the young in Slovakia have been identified."
https://pharos.nih.gov/idg/targets/P35557,P35557,22432108,"In the type 1 diabetic group, two HNF1A mutations were found (0.8% prevalence). In type 2 diabetic subjects, 10 HNF1A, two HNF4A, and one GCK mutation were identified."
https://pharos.nih.gov/idg/targets/P35557,P35557,22341299,"Structural modeling and clinical correlation suggests that the GCK variant causes monogenic diabetes while the variant in HNF1A is unlikely to be pathogenic."
https://pharos.nih.gov/idg/targets/P35557,P35557,22335469,"mutations in the glucokinase (GCK) gene have not been described previously and were shown to be associated with maturity onset diabetes of the young ."
https://pharos.nih.gov/idg/targets/P35557,P35557,22332836,"The large proportion of families carrying three ancestral mutations in GCK indicates that the previously assumed rarity of the founder effect with regard to GCK-maturity onset diabetes of the young (MODY) should be reconsidered."
https://pharos.nih.gov/idg/targets/P35557,P35557,22298776,"analysis of respective crystal structures of the catalytic complex of GK and of a GK-glucose complex in a wide open conformation"
https://pharos.nih.gov/idg/targets/P35557,P35557,22291974,"The Ala449Thr mutation alters the equilibrium between the conformational states of glucokinase and highlights the importance of the fine-tuning of GK and its role in glucose sensing."
https://pharos.nih.gov/idg/targets/P35557,P35557,22177951,"the compensatory down-regulation of UCP2 is involved in preserving the insulin secretory capacity of glucokinase mutant mice and might also be implicated in limiting disease progression in MODY2 patients."
https://pharos.nih.gov/idg/targets/P35557,P35557,22096510,"Six SNP(rs7754840 in CDKAL1, rs391300 in SRR, rs2383208 in CDKN2A/2B, rs4402960 in IGF2BP2, rs10830963 in MTNR1B, rs4607517 in GCK)risk alleles of type 2 diabetes were associated with GDM in pregnant Chinese women."
https://pharos.nih.gov/idg/targets/P35557,P35557,22060211,"In Japanese patients with pediatric-onset MODY-type diabetes, mutations in known genes were identified at a much higher frequency than previously reported for adult Asians."
https://pharos.nih.gov/idg/targets/P35557,P35557,22043488,"MODY type 2 in Greig cephalopolysyndactyly syndrome (GCPS) as part of a contiguous GCK gene deletion syndrome"
https://pharos.nih.gov/idg/targets/P35557,P35557,22038520,"Data suggest that glucokinase regulatory protein (GCKR) P446L variant (an SNP [rs1260326] associated with type 2 diabetes risk) alters ability of GCKR to sequester glucokinase in nucleus of hepatocytes."
https://pharos.nih.gov/idg/targets/P35557,P35557,21978167,"The high incidence of the mutant allele in GCK-MODY patients of Jewish-Ashkenazi descent suggests a founder effect."
https://pharos.nih.gov/idg/targets/P35557,P35557,21720051,"Results suggest that GCK gene defects exist in non-obese children who are diagnosed with asymptomatic diabetes by school medical examinations."
https://pharos.nih.gov/idg/targets/P35557,P35557,21604084,"Data show that T342P GCK missense variant is not a pathogenic mutation causing MODY."
https://pharos.nih.gov/idg/targets/P35557,P35557,21544516,"Data ound mutations in KCNJ11, INS and ABCC8 and GCK genes in permanent diabetes mellitus with onset in the first 12 months of age."
https://pharos.nih.gov/idg/targets/P35557,P35557,21518409,"We report four novel cases of permanent neonatal diabetes mellitus caused by homozygous GCK mutations, including a non-sense mutation in exon 3 (Q98X) and a missense mutation in exon 7 (G261R)"
https://pharos.nih.gov/idg/targets/P35557,P35557,21454584,"Glucagon-like peptide 1 stimulates post-translational activation of glucokinase in pancreatic beta cells"
https://pharos.nih.gov/idg/targets/P35557,P35557,21437567,"Heterozygous mutations of the GCK gene may result in neonatal diabetes similar to type 1 diabetes, the cause of such phenotype variety is still unknown."
https://pharos.nih.gov/idg/targets/P35557,P35557,21420961,"findings provide structural basis for the reduced activity of E339K GK mutant."
https://pharos.nih.gov/idg/targets/P35557,P35557,21348868,"Novel mutations within the GCK gene are associated with monogenic diabetes."
https://pharos.nih.gov/idg/targets/P35557,P35557,21104275,"a novel missense mutation (Glu339 to Lys339) in the glucokinase gene from a Chinese family with hyperglycemia decreased glucokinase kinetics and severely impaired glucokinase stability."
https://pharos.nih.gov/idg/targets/P35557,P35557,21036910,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,20979768,"glucokinase gene E339K mutation promotes the development of maturity-onset diabetes of the young-2"
https://pharos.nih.gov/idg/targets/P35557,P35557,20889853,"Observational study of gene-disease association, gene-gene interaction, and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,20878480,"Mutations in pancreatic ss-cell Glucokinase as a cause of hyperinsulinaemic hypoglycaemia and neonatal diabetes mellitus."
https://pharos.nih.gov/idg/targets/P35557,P35557,20858683,"Observational study, meta-analysis, and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,20845477,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,20828143,"Global fit analysis of glucose binding curves reveals a minimal model for kinetic cooperativity in human glucokinase."
https://pharos.nih.gov/idg/targets/P35557,P35557,20682688,"Maternal GCK variants are associated with glucose levels carry an increased risk of adverse pregnancy outcome in women without overt diabetes."
https://pharos.nih.gov/idg/targets/P35557,P35557,20682688,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,20682687,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,20668700,"Study showed that SNPs from GCK, G6PC2 and MTNR1B modulated the fasting glucose levels in the normoglycaemic population while SNPs from G6PC2 and GCKR was associated with type 2 diabetes."
https://pharos.nih.gov/idg/targets/P35557,P35557,20668700,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,20628598,"Common variants of MTNR1B, G6PC2 and GCK are associated with elevated FPG and impaired insulin secretion, both individually and jointly, suggesting that these risk alleles may precipitate or perpetuate hyperglycemia in predisposed individuals."
https://pharos.nih.gov/idg/targets/P35557,P35557,20628598,"Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,20628086,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,20587714,"two new mutations in GCK in MODY2 disease"
https://pharos.nih.gov/idg/targets/P35557,P35557,20536962,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,20490451,"Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,20458967,"Our data indicated that the previously studied mutations in Italian and Caucasian patients in the GCK gene are not common in MODY Jordanian population, suggesting a racial difference can be found in the frequency of the GCK polymorphism."
https://pharos.nih.gov/idg/targets/P35557,P35557,20458967,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,20337973,"The study shows a relatively high proportion of GCK mutations among individuals with GCK-like phenotype. We report several prevalent GCK mutations with a likely founder effect in the Czech population."
https://pharos.nih.gov/idg/targets/P35557,P35557,20337973,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,20227404,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,20185807,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,20164212,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,20144192,"Variant rs730947 in the GCK1 gene is associated with end-stage renal disease in type 2 diabetes."
https://pharos.nih.gov/idg/targets/P35557,P35557,20144192,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,20132997,"three novel mutations causing MODY (Maturity Onset Diabetes of the Young) -two missense mutations in HNF1A [F268L (c.802T>C) and P291S (c.871C>T)] and one frame shift mutation in GCK V244fsdelG (c.729delG"
https://pharos.nih.gov/idg/targets/P35557,P35557,20081858,"Meta-analysis and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,20015564,"We report a case of type 2 diabetes caused by a novel GCK mutation and demonstrate differential glycemic/C-peptide responses to treatment with insulin, no medication, and an oral sulfonylurea."
https://pharos.nih.gov/idg/targets/P35557,P35557,19948975,"Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and genetic testing. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19937311,"Fasting glucose association at GCK is replicable across ethnic groups, although ethnic diversity in the pattern and strength of linkage disequilibrium exists."
https://pharos.nih.gov/idg/targets/P35557,P35557,19937311,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19934346,"findings link defects in hormone-regulated GCK S-nitrosylation to hyperglycemia and support a role for posttranslational regulation of GCK S-nitrosylation as a vital regulatory mechanism for glucose-stimulated insulin secretion"
https://pharos.nih.gov/idg/targets/P35557,P35557,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19884385,"Data identified a novel activating GCK mutation that although being associated with severe neonatal hypoglycemia is characterized by the mildest activation of the glucokinase enzyme of all previously reported."
https://pharos.nih.gov/idg/targets/P35557,P35557,19790256,"mutations in glucokinase which cause maturity-onset diabetes of the young, permanent neonatal diabetes & hyperinsulinemic hypoglycemia [review]"
https://pharos.nih.gov/idg/targets/P35557,P35557,19741166,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19741163,"Data suggest that variation in GCK and G6PC2 have additive effects on both fasting glucose and insulin secretion."
https://pharos.nih.gov/idg/targets/P35557,P35557,19741163,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19651812,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19643913,"Data show that assays matched for GKRP activity demonstrated no difference in dose-dependent inhibition of GCK activity or F1P-mediated regulation."
https://pharos.nih.gov/idg/targets/P35557,P35557,19617908,"elucidates atomic information of the catalytic site in GK for glucose phosphorylation. A 10-ns MD simulation of the GMAG complex revealed that Lys169 plays a dominant role in glucose phosphorylation"
https://pharos.nih.gov/idg/targets/P35557,P35557,19578796,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19564454,"GCK mutations are the prevailing cause of MODY (63.4%) when the index case is recruited in Italian children with incidental hyperglycemia."
https://pharos.nih.gov/idg/targets/P35557,P35557,19564454,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19551638,"Data did not find any association of mutations in the GCK gene in Jordanian suspected MODY2 patients or in healthy controls."
https://pharos.nih.gov/idg/targets/P35557,P35557,19551638,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19533084,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19515026,"Genetic testing showed combination MODY2 (c.1019+18G >A) and MODY4 (c.226G>A) gene mutations"
https://pharos.nih.gov/idg/targets/P35557,P35557,19473033,"The alpha13 C-terminal helix of glucokinase plays an essential role in facilitating cooperativity. Findings establish a link between the alpha13 amino acid sequence and the functional dynamics of the glucokinase scaffold that are required for allostery."
https://pharos.nih.gov/idg/targets/P35557,P35557,19459610,"The glucose dependence of the major kinetic phase supported the preexistence of at least two slowly interconverting glucokinase conformers."
https://pharos.nih.gov/idg/targets/P35557,P35557,19411616,"To ensure correct diagnosis of potential type 2 diabetes, analysis of the beta-cell GCK promoter should be included."
https://pharos.nih.gov/idg/targets/P35557,P35557,19410318,"Non-frameshift deletion may implicate the affinity of GCK mutations in maturity onset diabetes of the young."
https://pharos.nih.gov/idg/targets/P35557,P35557,19368707,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19358091,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19336674,"Responsiveness to diazoxide varies with genotype in glucokinase hyperinsulinism mutations, resulting in hypoglycemia, which can be more difficult to control than previously believed."
https://pharos.nih.gov/idg/targets/P35557,P35557,19282865,"These results suggest that SORBS1 and GCK are susceptibility loci for hypertension in Japanese women and that WISP1 is such a locus in men."
https://pharos.nih.gov/idg/targets/P35557,P35557,19282865,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19241058,"GCK rs1799884 A allele is significantly associated with decreased beta-cell function, but not with type 2 diabetes in Han Chinese individuals."
https://pharos.nih.gov/idg/targets/P35557,P35557,19241058,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19228875,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19187021,"MODY2 glucokinase variants V62M and G72R showed reduced enzymatic activities, kinetics and glucose binding affinities."
https://pharos.nih.gov/idg/targets/P35557,P35557,19169489,"Heterozygous variants in GCK and HNF1alpha genes were observed respectively in one (7.7%), and six (46.2%) families but it could not be ascertained whether the GCK Gly117Ser variant found in one family is a causal mutation."
https://pharos.nih.gov/idg/targets/P35557,P35557,19150152,"Missense mutation and insertional mutagenesis are observed in Italian families with type 2 diabetes."
https://pharos.nih.gov/idg/targets/P35557,P35557,19146401,"Eleven new activating mutations in the glucokinase gene have been discovered that are associated with persistent hyperinsulinemic hypoglycemia of infancy (PHHI). The stimulatory mutations described represent surreptitious genetic determinants of PHHI."
https://pharos.nih.gov/idg/targets/P35557,P35557,19125755,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19096518,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19073768,"This protein and glucokinase regulatory protein increase fasting blood glucose and risk of diabetics who have other risk factors."
https://pharos.nih.gov/idg/targets/P35557,P35557,19073768,"Observational study and meta-analysis of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19060907,"Meta-analysis and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19018513,"Effects of established gene variation on lipid and glucose traits do not tend to alter with age during adulthood or over time."
https://pharos.nih.gov/idg/targets/P35557,P35557,19018513,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,19002431,"prevalence of GCK mutations in individuals screened for fasting hyperglycaemia who were thought to be at increased risk of developing type 2 diabetes."
https://pharos.nih.gov/idg/targets/P35557,P35557,19002431,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,18828733,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,18811724,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,18809676,"Prototypical activator of Glucokinase (GK) of the amino-heteroaryl-amide type bound to GK in a glucose-dependent manner and impaired the association of GK with GK regulatory protein"
https://pharos.nih.gov/idg/targets/P35557,P35557,18805788,"HNF-4 and Foxo1 are required for reciprocal transcriptional regulation of glucokinase and glucose-6-phosphatase genes in response to fasting and feeding"
https://pharos.nih.gov/idg/targets/P35557,P35557,18672310,"results suggested that mutations in MODY2 and MODY3 genes do not explain the majority of maturity-onset diabetes of the young (MODY) cases in Brazilian population"
https://pharos.nih.gov/idg/targets/P35557,P35557,18651836,"[Review] Increase in blood-glucose concentration in the portal vein activates glucokinase, first enzyme in the molecular pathway, causing an increase in concentration of glucose 6-phosphate, which modulates the phosphorylation state of downstream enzymes."
https://pharos.nih.gov/idg/targets/P35557,P35557,18571549,"analysis of a neonatal diabetes mellitus patient with a novel homozygous (T168A) glucokinase (GCK) mutation [case report]"
https://pharos.nih.gov/idg/targets/P35557,P35557,18556336,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,18498634,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,18483479,"In a population from southern Spain, carriers of the A allele of the -30G>A polymorphism in the promoter of the glucokinase gene had a lower risk for obesity and the likelihood of losing weight was greater in obese persons who had the A allele (GA or AA)."
https://pharos.nih.gov/idg/targets/P35557,P35557,18483479,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,18450771,"In the largest study performed to date on GCK in children with congenital hyperinsulinism, GCK mutations were found only in medically responsive children who were negative for ABCC8 and KCNJ11 mutations."
https://pharos.nih.gov/idg/targets/P35557,P35557,18450771,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,18411240,"Glucose tolerance can remain stable over many years in subjects with type 2 diabetes due to relative stability of the glucokinase mutations."
https://pharos.nih.gov/idg/targets/P35557,P35557,18399931,"study found 2 novel (S76Y & N231S) & 13 previously reported (V62A, G72R, L146R, R191W, A208T, M210K, Y215X, M235T, R275C, E339G, R377C, S453L & IVS5+1G>C) GCK mutations in 23 maturity-onset diabetes of the young, type 2 probands & their 33 family members"
https://pharos.nih.gov/idg/targets/P35557,P35557,18397317,"Results identify residue contacts in human glucokinase involved in the initial binding of alpha-d-glucose and conformational transitions."
https://pharos.nih.gov/idg/targets/P35557,P35557,18382660,"analysis of structural and genotype-phenotype analyses for glucokinase in MODY children from South Italy"
https://pharos.nih.gov/idg/targets/P35557,P35557,18370929,"analysis of glucokinase by kinetic measurement and tryptophan fluorescence"
https://pharos.nih.gov/idg/targets/P35557,P35557,18332101,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,18325809,"Overexpression of glucokinase is unlikely to be a common cause of hypoglycaemia of infancy in humans."
https://pharos.nih.gov/idg/targets/P35557,P35557,18322640,"In a study of six missense mutations, mutation severity correlated with the importance of the glucokinase structural changes introduced by the mutations."
https://pharos.nih.gov/idg/targets/P35557,P35557,18298419,"Viallelic GCK loss should be considered as a potential cause permanent neonatal diabetes in children born to consanguineous parents."
https://pharos.nih.gov/idg/targets/P35557,P35557,18271687,"no difference in the frequencies of GCK polymorphisms between Czech diabetic (diabetes type 2, gestational diabetes) and non-diabetic populations"
https://pharos.nih.gov/idg/targets/P35557,P35557,18271687,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,18248649,"This study showed that, although the presence of haploinsufficiency of GCK is not a common cause of diabetes type 2 in children, gene dose analysis should be performed when no mutation is found."
https://pharos.nih.gov/idg/targets/P35557,P35557,18208578,"The activating GCK(glucokinase)mutation was dominantly inherited, Hypoglycaemia unawareness seems to be a prominent feature, but hypoglycaemic attacks occur after slimming, especially postprandially."
https://pharos.nih.gov/idg/targets/P35557,P35557,18196929,"The polymorphism at -258 of the fetal hepatic glucokinase promoter is most probably not of a major relevance in the pathophysiology of low birth weight in preterm neonates."
https://pharos.nih.gov/idg/targets/P35557,P35557,18196929,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,18187620,"Knockdown of glucokinase (hexokinase 4) (GCK) by siRNA inhibits HIV-1 replication in HeLa-derived TZM-bl cells"
https://pharos.nih.gov/idg/targets/P35557,P35557,18184897,"Insulin, directly or indirectly, plays a role in placental growth, especially as a mutation in the GCK gene, which is known to only alter fetal insulin secretion."
https://pharos.nih.gov/idg/targets/P35557,P35557,18184897,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,18159847,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,18159847,"Our study suggests that c.1253+8 C-->T polymorphism in intron 9 of glucokinase gene could have a role in predisposition to type 2 diabetes in women with gestational diabetes."
https://pharos.nih.gov/idg/targets/P35557,P35557,18039179,"PFK-2/FBPase-2 protein rather than its product fructose 2,6-P(2) is the over-riding determinant of glucose-induced insulin secretion through regulation of glucokinase activity or subcellular targeting."
https://pharos.nih.gov/idg/targets/P35557,P35557,18008060,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,17994217,"adipocyte-derived Wnt signalling molecules regulate insulin secretion, glucokinase gene transcription and beta cell proliferation"
https://pharos.nih.gov/idg/targets/P35557,P35557,17976205,"study of a pedigree with 8 affected persistent hyperinsulinaemic hypoglycaemia of infancy individuals; the novel GCK mutation G68V is associated with variable phenotypic severity"
https://pharos.nih.gov/idg/targets/P35557,P35557,17937063,"Four missense mutations were found in the GCK gene. All mutations in the GCK gene co-segregated with diabetes mellitus."
https://pharos.nih.gov/idg/targets/P35557,P35557,17584736,"GCK is required for JNK and, unexpectedly, p38 activation by three bacterial PAMPs, lipopolysaccharide, peptidoglycan, and flagellin"
https://pharos.nih.gov/idg/targets/P35557,P35557,17573900,"Almost 90% of the MODY cases in the group studied are explained by mutations in the major genes GCK (MODY2) and HNF-1alpha(MODY3), although differences in the relative prevalence of each form could be partly due to patient referral bias."
https://pharos.nih.gov/idg/targets/P35557,P35557,17561510,"human glucokinase is allosterically activated by free polyubiquitin chains and its ubiquitin-dependent cotranslational proteasomal degradation"
https://pharos.nih.gov/idg/targets/P35557,P35557,17389332,"results suggest that cellular loss of GK catalytic activity rather than impaired translation or enhanced protein degradation may account for the hyperglycemia in subjects with V62M and G72R mutations"
https://pharos.nih.gov/idg/targets/P35557,P35557,17327436,"A study evaluating the extent to which common variation in the six known maturity-onset diabetes of the young (MODY) genes, which cause a monogenic form of type 2 diabetes, is associated with type 2 diabetes is presented."
https://pharos.nih.gov/idg/targets/P35557,P35557,17260972,"data support control of GK activity and Km through the ratio of distinct conformers (super-open, open, and closed) through either substrate or other ligand binding and/or dissociation"
https://pharos.nih.gov/idg/targets/P35557,P35557,17216282,"Lack of genetic predisposition in offspring to progressive beta cell dysfunction in glucokinase mutation of mmothrs."
https://pharos.nih.gov/idg/targets/P35557,P35557,17186458,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,17186458,"GCK is associated with fetal growth and birth weight"
https://pharos.nih.gov/idg/targets/P35557,P35557,17186219,"Different type 2 doabetes mutations impair glucokinase function through different mechanisms such as enzymatic activity, protein stability and increased interaction with the flucokinase receptor"
https://pharos.nih.gov/idg/targets/P35557,P35557,17082186,"The alteration in glucokinase (GK) activity caused by polymorphic activating mutations may have a more profound biological impact than the alleviation of inhibition caused by interaction with GKRP."
https://pharos.nih.gov/idg/targets/P35557,P35557,17070428,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,16963153,"The prevalence of mutations in the GSK gene was studied in Polish women with gestational diabetes."
https://pharos.nih.gov/idg/targets/P35557,P35557,16936201,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,16752173,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,16752173,"The -30G-->A polymorphism of the beta-cell-specific promoter of GCK and the I27L polymorphism of HNF1A seem to increase the risk of GDM in Scandinavian women."
https://pharos.nih.gov/idg/targets/P35557,P35557,16632067,"Observational study of genotype prevalence. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,16444761,"Families of young children with fasting hyperglycemia with family histories of diabetes showed mutations in glucokinase."
https://pharos.nih.gov/idg/targets/P35557,P35557,16378108,"Observational study of genotype prevalence and gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,16331569,"The prevalence of structural mutations in glucokinase gene responsible for early-onset diabetes appears to be rare among Chinese patients."
https://pharos.nih.gov/idg/targets/P35557,P35557,16331569,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,16186409,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,16186409,"glucokinase -30G>A polymorphism associates with elevated fasting and post-oral glucose tolerance test glycemia in the middle-aged whites as well as with impaired glucose regulation and WHO-defined metabolic syndrome"
https://pharos.nih.gov/idg/targets/P35557,P35557,16173921,"identification and functional characterization of missense mutations in the GCK gene in diabetic families that result in protein mutations Leu165-->Phe, Glu265-->Lys and Thr206-->Met."
https://pharos.nih.gov/idg/targets/P35557,P35557,15987895,"Two new activating mutations of human glucokinase increase the affinity of the enzyme for glucose."
https://pharos.nih.gov/idg/targets/P35557,P35557,15928245,"relative prevalence of 3% of MODY1 (two different mutations in two families), 10% of MODY2 (seven in eight), and 36% of MODY3 (21 in 28) among Danish kindred clinically diagnosed as MODY"
https://pharos.nih.gov/idg/targets/P35557,P35557,15918042,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,15841481,"5 novel mutations within the GCK gene, associated with Maturity-onset diabetes of the young, are discussed."
https://pharos.nih.gov/idg/targets/P35557,P35557,15677518,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,15677518,"COmmon genetic variation, in addition to rare mutations and environmental factors, can affect both fastinsg blood glucose and birth weight."
https://pharos.nih.gov/idg/targets/P35557,P35557,15677479,"Data describe the glucokinase V62M mutation identified in two families and co-segregating with hyperglycemia to understand how this mutation resulted in reduced function."
https://pharos.nih.gov/idg/targets/P35557,P35557,15305805,"a mutation of the GCK gene was found in families and patients with maturity-onset diabetes of the young"
https://pharos.nih.gov/idg/targets/P35557,P35557,15277402,"Range of the clinical phenotype caused by GCK mutations varies from complete insulin deficiency to extreme hyperinsulinemia."
https://pharos.nih.gov/idg/targets/P35557,P35557,15173029,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,15173029,"A G(-30)A polymorphism in the beta-cell-specific promoter of glucokinase (GK-30PM)increases the risk of CAD in individuals with and without type 2 diabetes mellitus."
https://pharos.nih.gov/idg/targets/P35557,P35557,15009676,"We have found GLUT-2 and glucokinase mRNAs in several brain regions, including the ventromedial and arcuate nuclei of the hypothalamus"
https://pharos.nih.gov/idg/targets/P35557,P35557,14747279,"high-fat feeding impairs both insulin- and exercise-stimulated muscle glucose uptake, but only exercise-stimulated MGU was corrected by HK II overexpression"
https://pharos.nih.gov/idg/targets/P35557,P35557,14617577,"fructose-2,6-diphosphate can stimulate hepatic glucokinase gene expression in an insulin-independent manner"
https://pharos.nih.gov/idg/targets/P35557,P35557,14578306,"Autosomal recessive inheritance and GLK deficiency are features typical for an inborn error of metabolism, which occurred in the glucose-insulin signaling pathway in these subjects."
https://pharos.nih.gov/idg/targets/P35557,P35557,14517946,"summary of glucokinase mutations in glucose metabolism disorders."
https://pharos.nih.gov/idg/targets/P35557,P35557,12941786,"two novel spontaneous GCK-activating mutations whose clinical phenotype clearly differs from mutations in ATP-sensitive K(+) channel genes"
https://pharos.nih.gov/idg/targets/P35557,P35557,12627330,"Twenty different mutations in the HNF-4alpha, GCK and HNF-1alpha in 29 families. Three of 3, 10 of 11 and 1 of 6 of the mutations identified in HNF-4alpha, GCK and HNF-1alpha respectively, were new."
https://pharos.nih.gov/idg/targets/P35557,P35557,12515438,"Observational study of genotype prevalence. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,12442280,"Four novel GCK mutations, namely IVS2-7G>A, G72R, T206R and S263P, were identified in Canadian MODY patients."
https://pharos.nih.gov/idg/targets/P35557,P35557,12101177,"insulin regulates both the association of GK with secretory granules and the activity of the enzyme within the pancreatic beta-cell."
https://pharos.nih.gov/idg/targets/P35557,P35557,12050210,"mutations in maturity-onset diabetes of the young (MODY) candidate genes in 22 Spanish families."
https://pharos.nih.gov/idg/targets/P35557,P35557,11914755,"Mutations are not a common cause of permanent neonatal diabetes in France."
https://pharos.nih.gov/idg/targets/P35557,P35557,11772903,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,11756407,"These results are consistent with GKRP having one single binding site for phosphate esters. They also show that a missense mutation of GKRP can lead to a gain of function"
https://pharos.nih.gov/idg/targets/P35557,P35557,11440371,"Uncategorized study of genetic testing. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,11112984,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P35557,P35557,11112984,"G-to-A polymorphism in the hepatic GCK promoter is associated with hepatic insulin resistance in normotensive Asian Indians with normal glucose tolerance."
https://pharos.nih.gov/idg/targets/P35557,P35557,11106831,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9H999,Q9H999,27555321,"Biochemical analyses showed that the transition between the inactive and active conformations, as assessed by the binding of either ATP.Mg(2+) or acyl-CoA to PANK3, is highly cooperative indicating that both protomers move in concert."
https://pharos.nih.gov/idg/targets/Q9H999,Q9H999,18976975,"Knockdown of pantothenate kinase 3 (PANK3) by siRNA inhibits HIV-1 replication in HeLa P4/R5 cells"
https://pharos.nih.gov/idg/targets/Q9H999,Q9H999,17631502,"analysis of the homodimeric structures of the catalytic cores of PanK1alpha and PanK3 in complex with acetyl-CoA and the the structural effects of the PanK2 mutations that have been implicated in neurodegeneration"
https://pharos.nih.gov/idg/targets/O00329,O00329,28515318,"Data suggest HRas activates both p110alpha and p110delta isoforms; membrane-resident HRas, not soluble HRas, increases membrane recruitment of both p110alpha and p110delta. (HRas = v-Ha-ras Harvey rat sarcoma viral oncogene homolog; p110alpha = class IA phosphoinositide 3-kinases, subunit p110alpha; p110delta = class IA phosphoinositide 3-kinases, subunit p110delta)"
https://pharos.nih.gov/idg/targets/O00329,O00329,28373165,"The findings, specifically frequent mutations of STAT5B, PIK3CD, and the histone methyltransferase SETD2, may help guide translational efforts to target hepatosplenic T-cell lymphoma"
https://pharos.nih.gov/idg/targets/O00329,O00329,28339079,"A combination of CAL-101, a p110delta-specific inhibitor, with bortezomib treatment of HT/EBV cells synergistically suppressed proliferation, reduced levels of drug resistance-related proteins, activated caspase cleavage and recovered expression of p110a/p110b."
https://pharos.nih.gov/idg/targets/O00329,O00329,28280276,"miR-26b inhibited the PI3K/AKT pathway by directly targeting PIK3CD, the gene encoding PI3Kdelta, in human T-ALL cell lines"
https://pharos.nih.gov/idg/targets/O00329,O00329,28199309,"PI3Kdelta or Bruton's tyrosine kinase inhibitors increase genomic instability in normal and neoplastic B cells by an AID-dependent mechanism; this effect should be carefully considered, as such inhibitors can be administered to patients for years"
https://pharos.nih.gov/idg/targets/O00329,O00329,28190771,"biased CD4(+) T cell differentiation was independent of any crosstalk between CD4(+) T cells and dendritic cells and was mediated via direct exposure of CD4(+) T cells to palmitate, leading to increased activation of a PI3K p110delta-Akt-dependent pathway upon priming."
https://pharos.nih.gov/idg/targets/O00329,O00329,28122867,"Our work defines SETD2 as a tumor suppressor gene in Hepatosplenic T-cell lymphoma (HSTL)and implicates genes including INO80 and PIK3CD in the disease"
https://pharos.nih.gov/idg/targets/O00329,O00329,28122310,"miR-125b suppressed anaplastic thyroid cancer cell migration and invasion by targeting PIK3CD expression."
https://pharos.nih.gov/idg/targets/O00329,O00329,28104464,"The B-cell compartment in PI3K-delta syndrome patients is affected by the mutations in PIK3CD and PIK3R1. There is reduced differentiation beyond the transitional stage, increased AKT phosphorylation and increased apoptosis."
https://pharos.nih.gov/idg/targets/O00329,O00329,27716212,"Targeting PI3Kdelta or JAK may prove effective in reducing T-cell activation and the resulting cytokine production in asthma."
https://pharos.nih.gov/idg/targets/O00329,O00329,27448819,"Data show that phosphoinositide-3-kinase, catalytic, delta polypeptide (PIK3CD) can promote proliferation and prevent apoptosis in diffuse large B cell lymphoma (DLBCL) cells in vitro through upregulation of c-myc protein."
https://pharos.nih.gov/idg/targets/O00329,O00329,27176780,"PI3K isoforms p110a, p110b and p110g were selectively inhibited and effects on proliferation and migration assessed. Inhibition increased transcription of cancer stem cell genes in both models, suggesting de-differentiation in response to blockade of the PI3K/AKT/mTOR signalling axis."
https://pharos.nih.gov/idg/targets/O00329,O00329,27174919,"PI3Kdelta and PI3Kgamma inhibition with IPI-145 has anti-proliferative activity in primary AML cells by inhibiting the activity of AKT and MAPK"
https://pharos.nih.gov/idg/targets/O00329,O00329,27154356,"PI3K, independently of protein kinase B, has a role in parasite-induced netosis. One of the main isoforms involved is PI3Kdelta, which works in a reactive-oxygen-species-independent way."
https://pharos.nih.gov/idg/targets/O00329,O00329,26961147,"Strong synergism was observed with pimasertib combined with the PI3K inhibitor idelalisib and the BTK inhibitor ibrutinib in cell lines derived from diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma. The data were confirmed in an in vivo experiment treating DLBCL xenografts with pimasertib and ibrutinib."
https://pharos.nih.gov/idg/targets/O00329,O00329,26770665,"Impaired signaling and protein synthesis through the PI3K catalytic subunit p110delta is an underlying molecular defect and potential treatment target in select autism spectrum disorders."
https://pharos.nih.gov/idg/targets/O00329,O00329,26540567,"Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kdelta or PKCbeta signaling pathways."
https://pharos.nih.gov/idg/targets/O00329,O00329,26437962,"study concludes that activating mutations in PIK3CD may cause immunodeficiency in patients with a complex phenotype combining defective B and T cell responses, but are less likely to be discovered in patients where only the humoral arm of the immune response is affected and naive T cell numbers are normal"
https://pharos.nih.gov/idg/targets/O00329,O00329,26286043,"Studies indicate that phosphatidylinositol-45-bisphosphate 3-kinase 110 kDa catalytic subunit (PIK3CD p110delta) have been described (N334K, C416R, E525K and E1021K with the majority of cases carrying E1021K) as a cause for primary immunodeficiency."
https://pharos.nih.gov/idg/targets/O00329,O00329,26270987,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,26265781,"Combined PI3K/Akt and Hsp90 targeting synergistically suppresses essential functions of alloreactive T cells and increases Tregs."
https://pharos.nih.gov/idg/targets/O00329,O00329,26251180,"work identifies FAK as a target of p110delta PI3K that links RhoA with PTEN and establishes for the first time that PTEN is a substrate of FAK-mediated Tyr phosphorylation"
https://pharos.nih.gov/idg/targets/O00329,O00329,26075907,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,25632006,"Expression of functional S1PR1 is reduced by B cell receptor signaling and increased by inhibition of PIK3CD but not SYK or BTK in chronic lymphocytic leukemia cells."
https://pharos.nih.gov/idg/targets/O00329,O00329,25469863,"Data indicate a series of quinolinylpurines as potent and selective PI3Kdelta kinase inhibitors with in vivo efficacy as measured by two rodent disease models of inflammation and autoimmune disease."
https://pharos.nih.gov/idg/targets/O00329,O00329,25352054,"We describe a family of two adults and three children with a gain of function mutation in PIK3CD, all with recurrent sinopulmonary infections and varied infectious and non-infectious complications. Sequencing of PIK3CD confirmed a known heterozygous mutation c3061G>A, p.E1021K in all affected family members. The two adults have primary sclerosing cholangitis without C. parvum infection."
https://pharos.nih.gov/idg/targets/O00329,O00329,25104021,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,24716596,"These results collectively indicate that inducible PI3Kdelta plays a crucial role in persistent activation of PI3K-Akt in fibroblast-like synoviocytes, and in the formation of a hypertrophic synovial lining."
https://pharos.nih.gov/idg/targets/O00329,O00329,24698326,"Patients with activated phosphoinositide 3-kinase delta syndrome (mutation in PIK3CD) develop B-cell lymphomas."
https://pharos.nih.gov/idg/targets/O00329,O00329,24648465,"The p110delta PI3K-selective compound CAL-101 (Idelalisib) did not inhibit markers of PI3K activity in cancer or stromal cells."
https://pharos.nih.gov/idg/targets/O00329,O00329,24610295,"Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility."
https://pharos.nih.gov/idg/targets/O00329,O00329,24553178,"PI3K p110delta uniquely promotes gain-of-function Shp2-induced GM-CSF hypersensitivity in a model of juvenile myelomonocytic leukemia."
https://pharos.nih.gov/idg/targets/O00329,O00329,24549598,"Gestational diabetes mellitus is accompanied by leukocyte PIK3CD overexpression associated with reduced plasma LDL-C and TC levels, as well as with hyperglycaemia and elevated leukocyte SIRT1 mRNA."
https://pharos.nih.gov/idg/targets/O00329,O00329,24523440,"PIK3CD was inversely correlated with miR-663 in glioblastoma specimens and predicted poor prognosis of patients with glioblastoma"
https://pharos.nih.gov/idg/targets/O00329,O00329,24517182,"PIK3CD is a target gene of miR-125b in Ewing's sarcoma cells. RT-PCR and western blot assays identify over-expression of miR-125b that suppresses the expression of PIK3CD mRNA and protein."
https://pharos.nih.gov/idg/targets/O00329,O00329,24470496,"PI3Kdelta contributes to multiple aspects of the pathogenic FLS behavior in RA. These observations, together with previous findings that PI3Kdelta regulates FLS growth and survival"
https://pharos.nih.gov/idg/targets/O00329,O00329,24293274,"Study reveals functional and mechanistic links between miRNA-30b and oncogene KRAS, PIK3CD and BCL2 in the pathogenesis of colorectal carcinoma."
https://pharos.nih.gov/idg/targets/O00329,O00329,24165795,"Data indicate that patients with combined immunodeficiency disease who share gain-of-function mutations in PIK3CD (p110delta), resulting in hyperactivation of mTOR signaling and skewed the differentiation of CD8+ T cells."
https://pharos.nih.gov/idg/targets/O00329,O00329,24136356,"this study found E1021K in 17 patients with activated PI3K-delta syndrome (APDS), from seven unrelated families with, but not among 3346 healthy subjects."
https://pharos.nih.gov/idg/targets/O00329,O00329,24073214,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,23660190,"These results suggest that PI3Kdelta mediates dsRNA-induced upregulation of B7-H1 without affecting the activation of NF-kappaB."
https://pharos.nih.gov/idg/targets/O00329,O00329,23486085,"The expression of PIK3CD is inversely correlated with miR-30a levels in metastatic colorectal carcinoma tissues."
https://pharos.nih.gov/idg/targets/O00329,O00329,23341541,"High PIK3CA/PIK3CD ratio identified a subset of primary mantle cell lymphomas resistant to GS-1101 and this ratio increased significantly with relapse."
https://pharos.nih.gov/idg/targets/O00329,O00329,23301033,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,23251686,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,23215766,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,23077641,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,22711705,"Studies indicate that the research with phosphoinositide 3-kinase p110-delta (p110delta) in chronic lymphocytic leukemia (CLL) have led to a more fundamental understanding of CLL signaling defects."
https://pharos.nih.gov/idg/targets/O00329,O00329,22689948,"PIK3CD shows evidence of association with schizophrenia, and is a previously undescribed therapeutic target for the treatment of psychiatric disorders."
https://pharos.nih.gov/idg/targets/O00329,O00329,22433439,"PI3 kinase delta is a key regulator of synoviocyte function in rheumatoid arthritis."
https://pharos.nih.gov/idg/targets/O00329,O00329,22375552,"present a detailed biochemical and bioinformatic characterization of p110delta gene regulation, demonstrating that PIK3CD has distinct promoters, some of which can be dynamically activated by pro-inflammatory mediators"
https://pharos.nih.gov/idg/targets/O00329,O00329,22210877,"Findings suggest that excessive PI3Kdelta activity is characteristic in Hodgkin lymphoma (HL) and support clinical evaluation of GS-1101, alone and in combination, as targeted therapy for HL."
https://pharos.nih.gov/idg/targets/O00329,O00329,22084313,"p110delta-dependent translocation of exogenous CSF-1 to the nucleus-associated CSF-1Rs, correlating with a prominent role of p110delta in activation of the Rab5 GTPase, a key regulator of endocytic trafficking"
https://pharos.nih.gov/idg/targets/O00329,O00329,22079609,"Isoform specific targeting of PI3Kdelta may be beneficial in the treatment of glioblastoma multiforme by specifically inhibiting tumour cell migration capacity."
https://pharos.nih.gov/idg/targets/O00329,O00329,22020336,"p37delta appears to be a new tumor-specific isoform of p110delta with growth-promoting properties"
https://pharos.nih.gov/idg/targets/O00329,O00329,22015454,"PI3K p110delta is important for TGFB1 induced production of the contractile proteins calponin and alpha-SMA and the proinflammatory cytokine IL-6"
https://pharos.nih.gov/idg/targets/O00329,O00329,21810603,"These observations suggest that PI3Kdelta contributes to induction of enhanced systemic lupus erythematosus memory T cell survival"
https://pharos.nih.gov/idg/targets/O00329,O00329,21765914,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,21029719,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,20837746,"IFN-beta triggers an atypical MEK2/PI3Kdelta signaling cascade to regulate sIL-1Ra expression in monocytes."
https://pharos.nih.gov/idg/targets/O00329,O00329,20818790,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,20702582,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,20628086,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00329,O00329,20602615,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00329,O00329,20381852,"PI3Kdelta expression and signaling is increased in the lungs of patients with COPD."
https://pharos.nih.gov/idg/targets/O00329,O00329,20197460,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00329,O00329,20103642,"Data show that similar responses were seen in cancer cells with wild-type or activated mutant PI3K genes treated with p110alpha/delta or p110alpha/beta/delta inhibitors in cell viability assays."
https://pharos.nih.gov/idg/targets/O00329,O00329,20081091,"These studies establish that previously activated memory T cells are at least as sensitive to p110delta inhibition as naive T cells and show that mouse models accurately predict p110delta function in human T cells."
https://pharos.nih.gov/idg/targets/O00329,O00329,20056178,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00329,O00329,20041213,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,20019835,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00329,O00329,19638627,"RUNX1 may play a critical role in chemotherapy response in acute megakaryocytic leukemia by regulating the PI3-kinase/Akt pathway."
https://pharos.nih.gov/idg/targets/O00329,O00329,19357769,"Results identify a conserved phosphoinositide 3-kinase p11delta promoter region that may account for the predominant leukocyte expression of p110delta."
https://pharos.nih.gov/idg/targets/O00329,O00329,18996102,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00329,O00329,18854243,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,18471882,"In contrast with PI3Kalpha, beta and gamma, PI3Kdelta accounts for most of the PI3K-dependent signaling ruling the production of IL-1beta, IL-6, TNF and sIL-1Ra in monocytes."
https://pharos.nih.gov/idg/targets/O00329,O00329,18453587,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,18348712,"These results demonstrate that CD148 may interact with and dephosphorylate p85 when it is phosphorylated and modulate the magnitude of phosphoinositide 3-kinase activity."
https://pharos.nih.gov/idg/targets/O00329,O00329,18281552,"novel function of the class I(A) PI3K isoform p110delta in neuroblastoma growth and survival."
https://pharos.nih.gov/idg/targets/O00329,O00329,17632570,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,17581634,"identifies the RhoA/ROCK pathway as a major target of p110delta-mediated PI3K signalling"
https://pharos.nih.gov/idg/targets/O00329,O00329,17290298,"This review describes the second-messenger PI3K delta signalling pathways that are involved in immune responses relevant to the pathogenesis of rheumatoid arthritis and other inflammatory diseases."
https://pharos.nih.gov/idg/targets/O00329,O00329,17157319,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,17015696,"p110delta contributes significantly to Th cell expansion and differentiation in vitro and in vivo, also in the context of CD28 costimulation."
https://pharos.nih.gov/idg/targets/O00329,O00329,16984281,"These findings could shed light on further understanding the polymorphisms of p110delta in B-cell immunodeficiency and different populations."
https://pharos.nih.gov/idg/targets/O00329,O00329,16524887,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,16432180,"p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase have roles in oncogenic transformation"
https://pharos.nih.gov/idg/targets/O00329,O00329,16081599,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,15878979,"Stimulation of TNF-alpha-primed human neutrophils with fMLP results in biphasic activation of PI3K; the first phase is largely dependent on PI3Kgamma; the second phase is largely dependent on PI3Kdelta and regulates parallel activation of ROS production"
https://pharos.nih.gov/idg/targets/O00329,O00329,15840695,"p110delta isoform of PI3K is consistently expressed at a high level in blast cells from AML, in contrast to the other class I isoforms"
https://pharos.nih.gov/idg/targets/O00329,O00329,15689238,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,14602571,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,12960231,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,12594293,"PI3K delta can play a selective role in the amplification of phosphatidylinositol (3,4,5) trisphosphate (PIP3) levels that lead to neutrophil polarization and regulate directional migration, but not random locomotion."
https://pharos.nih.gov/idg/targets/O00329,O00329,12584329,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,12551992,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,12526811,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,12077252,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,11994280,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,11289809,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,11156964,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,11154208,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,10985305,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,10208934,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,9808187,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,9708406,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,9446795,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,9394803,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,9341793,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,9247029,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,8798481,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/O00329,O00329,8636073,"HIV-1 Vpr induced upregulation of IL6 involves PI3K/Akt mediated activation of NFKB1 (NF-kappa-B) in astrocytes"
https://pharos.nih.gov/idg/targets/P48736,P48736,28885323,"A positive correlation may exist between PIK3CG single nucleotide polymorphisms and patients with poor responsiveness to clopidogrel."
https://pharos.nih.gov/idg/targets/P48736,P48736,28581524,"we propose that the PKA-Smurf1-PIPKIgamma pathway has an important role in pulmonary tumorigenesis and imposes substantial clinical impact on development of novel diagnostic markers and therapeutic targets for lung cancer treatment."
https://pharos.nih.gov/idg/targets/P48736,P48736,27174919,"PI3Kdelta and PI3Kgamma inhibition with IPI-145 has anti-proliferative activity in primary AML cells by inhibiting the activity of AKT and MAPK"
https://pharos.nih.gov/idg/targets/P48736,P48736,27154356,"PI3K, independently of protein kinase B, has a role in parasite-induced netosis. One of the main isoforms involved is PI3Kgamma which works in a reactive-oxygen-species-dependent way."
https://pharos.nih.gov/idg/targets/P48736,P48736,27076174,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,26839042,"Diminished expression of p110gamma in pulmonary vascular endothelial cells of patients with acute respiratory distress syndrome suggests that impaired p110gamma-FoxM1 vascular repair signaling is a critical factor in persistent leaky lung microvessels in ARDS."
https://pharos.nih.gov/idg/targets/P48736,P48736,26658747,"Findings suggest the pathophysiological role of phosphoinositide 3-kinase gamma (PI3Kgamma) in atherogenesis."
https://pharos.nih.gov/idg/targets/P48736,P48736,26270987,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,26173259,"data argue for differential regulatory functions of the non-catalytic subunits and a specific Gbetagamma-dependent regulation of p101 in PI3Kgamma activation."
https://pharos.nih.gov/idg/targets/P48736,P48736,26163264,"findings suggest that miR-502 functions as a tumor suppressor in HCC via inhibition of PI3KCG, supporting its utility as a promising therapeutic gene target for this tumor type"
https://pharos.nih.gov/idg/targets/P48736,P48736,26075907,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,25808869,"Mfng is an oncogene acting through Notch-mediated induction of Pik3cg."
https://pharos.nih.gov/idg/targets/P48736,P48736,25753393,"Our findings suggest that p84 binding to p110gamma may represent a novel negative feedback signal that terminates PI3Kgamma activity."
https://pharos.nih.gov/idg/targets/P48736,P48736,25751541,"increased susceptibility of individuals with COPD to influenza likely results from impaired antiviral responses, which are mediated by increased PI3K-p110alpha activity."
https://pharos.nih.gov/idg/targets/P48736,P48736,25644171,"The interaction between PI3Kgamma and CNGA1 does not appear to play a role in regulation of CNG channel activity, but PI3Kgamma uses CNGA1 as an anchoring module to achieve close proximity to its substrate to generate D3-phosphoinositides"
https://pharos.nih.gov/idg/targets/P48736,P48736,25290554,"PI3Kgamma-induced VEGF expression was reduced when the human tocopherol-associated protein 1 (hTAP1/SEC14L2) was overexpressed suggesting formation of an inactive PI3Kgamma/hTAP1 heterodimer."
https://pharos.nih.gov/idg/targets/P48736,P48736,25288806,"phosphatidylinositol 3-kinase gamma has a role in insulin secretion induced by glucose-dependent insulinotropic polypeptide"
https://pharos.nih.gov/idg/targets/P48736,P48736,25104021,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,24754609,"Data indicate class of benzothiazoles as inhibitors of phosphoinositide 3-kinase gamma."
https://pharos.nih.gov/idg/targets/P48736,P48736,24654606,"The data indicate that PI3Kgamma has a critical role in cAMP-mediated inflammatory hypernociception and analgesic signalling via mu-opioid receptors and PI3K/Akt in neuronal cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,24425731,"Binding of the HSV-1 envelope initiates the epidermal growth factor receptor EGFR-PI3K signaling pathway, which leads to virus-induced early cofilin phosphorylation and F-actin polymerization."
https://pharos.nih.gov/idg/targets/P48736,P48736,24333185,"PI3Kgamma plays an important role in the development of eosinophilic inflammation a"
https://pharos.nih.gov/idg/targets/P48736,P48736,24190998,"Ablating the interaction of PI3Kgamma with Gbetagamma heterodimers attenuates signaling, chemotaxis, and transformation driven by a GPCR agonist in cell lines."
https://pharos.nih.gov/idg/targets/P48736,P48736,24073214,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,23500535,"Upregulated phosphoinositide 3-kinase gamma is a target to suppress breast cancer cell migration and invasion."
https://pharos.nih.gov/idg/targets/P48736,P48736,23439433,"Assessed the expression of class I PI3K p110 isoforms in idiopathic pulmonary fibrosis lung tissue as well as in tissue-derived fibroblast cell lines."
https://pharos.nih.gov/idg/targets/P48736,P48736,23354687,"kinase-independent function of PI3Kgamma could directly inhibit GSK-3 function by preventing the PP2A-PPMT-1 interaction and that this inhibition of GSK-3 was independent of Akt."
https://pharos.nih.gov/idg/targets/P48736,P48736,23320105,"Class II enzyme PI3K-C2beta and class IB isozyme p110gamma mainly regulate the S1P- and high density lipoprotein (HDL)-dependent endothelial cell (EC) migration and PI3K-C2alpha primarily controls EC survival"
https://pharos.nih.gov/idg/targets/P48736,P48736,23301033,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,23251686,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,23215766,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,23107319,"PI3K/AKT/mTOR signalling components appear to be differentially implicated in urothelial tumorigenesis and, with the exception of p85aPI3K, are unrelated to the PIK3CA or AKT1 mutational status."
https://pharos.nih.gov/idg/targets/P48736,P48736,23077641,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,22825625,"PI3Kgamma plays a key role in ipopolysaccharide-induced ROS generation in alveolar epithelial cells, thereby activating NF-kappaB"
https://pharos.nih.gov/idg/targets/P48736,P48736,22573891,"a novel mechanism that links PI3Kgamma activity with chemotaxis and superoxide production in G-protein coupled receptor signaling."
https://pharos.nih.gov/idg/targets/P48736,P48736,22568210,"Culturing spermatogonia in vitro at 37 degrees C could inhibit the expression of PI3K and c-kit, and lead to the mutation of the c-kit gene."
https://pharos.nih.gov/idg/targets/P48736,P48736,22449554,"findings suggest that PIK3CG function impacts the severity of the intraparenchymal bleed in patients with intracerebral hemorrhage"
https://pharos.nih.gov/idg/targets/P48736,P48736,22325219,"The expression levels of PI3K protein and mRNA in esophageal squamous cell carcinoma tissues are significantly increased and PI3K plays a role in the carcinogenesis and development of ESCC."
https://pharos.nih.gov/idg/targets/P48736,P48736,22054284,"A novel regulatory role of p101 in the activation of PI3Kgamma."
https://pharos.nih.gov/idg/targets/P48736,P48736,21949398,"protection from insulin resistance, metabolic inflammation, and fatty liver in mice lacking functional PI3Kgamma is largely consequent to their leaner phenotype"
https://pharos.nih.gov/idg/targets/P48736,P48736,21930962,"Ras-p110gamma interaction is necessary for efficient beta-selection-promoted proliferation but is dispensable for the survival or differentiation of thymocytes."
https://pharos.nih.gov/idg/targets/P48736,P48736,21856935,"our study reveals a novel link between NF-kappaB and PI3K/Akt and establishes c-FLIP as an important regulator of FasL-mediated cell death."
https://pharos.nih.gov/idg/targets/P48736,P48736,21796621,"role of p110gamma as a promoter of HCC proliferation and unveil an important cell cycle regulation function of this molecule."
https://pharos.nih.gov/idg/targets/P48736,P48736,21765914,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,21707707,"Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder."
https://pharos.nih.gov/idg/targets/P48736,P48736,21665152,"PI3Kgamma, a PI3K isoform exhibiting restricted tissue distribution, is strictly required for signaling from the KSHV-encoded vGPCR oncogene to Akt/mTOR."
https://pharos.nih.gov/idg/targets/P48736,P48736,21665146,"Once activated, p110gamma promotes inside-out activation of a single integrin, alpha4beta1, causing myeloid cell invasion into tumors."
https://pharos.nih.gov/idg/targets/P48736,P48736,21474070,"p110gamma anchors protein kinase A (PKA) through a site in its N-terminal region. Anchored PKA activates PDE3B to enhance cAMP degradation and phosphorylates p110gamma to inhibit PIP(3) production"
https://pharos.nih.gov/idg/targets/P48736,P48736,21435395,"Data demonstrate that AG/UAG attenuation of ISO-induced lipolysis involves PI3Kgamma/AKT and PDE3B."
https://pharos.nih.gov/idg/targets/P48736,P48736,21185806,"This indicates that not only MAPK activation, but PI3Kgamma protein kinase activity in general is localized in the cytosol."
https://pharos.nih.gov/idg/targets/P48736,P48736,21173233,"PI3K-PDK1 signaling is essential for viability, MALT1 protease activity, and NF-kappaB activation in activated B-cell-like diffuse large B-cell lymphoma cells that carry mutations in the BCR proximal signaling adaptor CD79B."
https://pharos.nih.gov/idg/targets/P48736,P48736,21045158,"Findings show that oncogenic factors activating the phosphoinositide 3-kinase/Akt pathway can regulate alternative splicing of Casp9 via a coordinated mechanism involving the phosphorylation of SRp30a."
https://pharos.nih.gov/idg/targets/P48736,P48736,21029719,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,20935218,"Data show an in vitro link between phosphoinositide 3-kinase-mediated HOXA9/HOXA10 expression, and a drug-resistant, progenitor cell phenotype in MGMT-independent pediatric glioblastoma."
https://pharos.nih.gov/idg/targets/P48736,P48736,20870746,"Data demonstrate an important role for the PI3-kinase-Akt pathway in intracellular transport of surfactant protein A receptor P63."
https://pharos.nih.gov/idg/targets/P48736,P48736,20863633,"C. jejuni activates a PI3K/Akt-dependent anti-inflammatory pathway in human intestinal epithelial cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,20855526,"These results show that PI 3-kinase regulation of mRNA stability, predominantly mediated by BRF1, plays a major role in regulating gene expression."
https://pharos.nih.gov/idg/targets/P48736,P48736,20852838,"Platelet migration was stimulated by SDF-1 through PI3 kinase dependent mechanism."
https://pharos.nih.gov/idg/targets/P48736,P48736,20852826,"Studies indicate that molecular mechanisms underlying phyagocyytossis are starting to point to the interplay between two families of crucial proteins: the PI3K lipid kinases and the Rac GTPases."
https://pharos.nih.gov/idg/targets/P48736,P48736,20818790,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,20811632,"levated PI3K pathway activity in acute myelogenous leukemia"
https://pharos.nih.gov/idg/targets/P48736,P48736,20810749,"An inhibitor of PI3K (LY294002) blocked HSV-1 entry and the blockage was cell-type- and viral glycoprotein gD receptor-independent."
https://pharos.nih.gov/idg/targets/P48736,P48736,20809254,"These findings demonstrated that PI3K-mediated actin rearrangements are required for Cronobacter sakazakii invasion of human brain microvascular endothelial cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,20805333,"VEGFR1 contributes to E. coli K1 invasion of human brain microvascular endothelial cells through the phosphatidylinositol 3-kinase/Akt signaling pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,20800603,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P48736,P48736,20702582,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,20685403,"Phosphoinositide-3-kinase gamma plays a major role in the induction of chemotaxis in platelet-activating factor-stimulated human eosinophils."
https://pharos.nih.gov/idg/targets/P48736,P48736,20675006,"Bile salt-induced hepatocyte apoptosis is partly mediated via a PI3K p110gamma dependent signaling pathway, potentially involving JNK."
https://pharos.nih.gov/idg/targets/P48736,P48736,20672329,"demonstrate that alphaVbeta3 ligation results in sustained increases of PI3 kinase/Akt-dependent binding of transcription factor NF-kappaB to DNA."
https://pharos.nih.gov/idg/targets/P48736,P48736,20671123,"FOXO3a is in a constant inactive state due to its cytoplasmic localization, and that neither PI3K/Akt nor extra-signal-regulated kinase-specific inhibition resulted in its nuclear translocation."
https://pharos.nih.gov/idg/targets/P48736,P48736,20661648,"The results above collectively show that C/EBPepsilon participates in all-trans retinoic acid induction of PI3Kgamma."
https://pharos.nih.gov/idg/targets/P48736,P48736,20657188,"Data indicate that stathmin is a target of the PI3K/Akt pathway in cervical cancer cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,20627085,"Our study suggests that the type III PI3 kinase integrates diverse signals to regulate cellular levels of autophagy, and that autophagy and cell proliferation may represent two alternative cell fates that are regulated in a mutually exclusive manner."
https://pharos.nih.gov/idg/targets/P48736,P48736,20622047,"Studies indicate that targeting the deregulated PI3K/PTEN-Akt signaling axis has currently emerged as one of the major tenets in anticancer drug development."
https://pharos.nih.gov/idg/targets/P48736,P48736,20620179,"Collectively, these data suggested that, in oral epithelial cells, the herpes simplex virus 1-induced PI3K/Akt activation was involved in the regulation of apoptosis blockage and viral gene expression."
https://pharos.nih.gov/idg/targets/P48736,P48736,20606682,"The bFGF-FGFR1-PI3K-Rac1 pathway in the bone microenvironment may have a significant role in the invasion and metastasis of Ewing sarcoma."
https://pharos.nih.gov/idg/targets/P48736,P48736,20602615,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P48736,P48736,20578837,"The activated PI3K/Akt/COX-2 signal transduction pathway was found to be the main cause for decline in radiosensitivity in HeLa cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,20560677,"PDCD4 regulates TRAIL sensitivity in gastric cancer cells by inhibiting the PI3K/Akt signaling pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,20530239,"Role of germ line genetic variations in the PI3K-AKT-mTOR pathway genes as predictors of bladder cancer metastasis and invasiveness."
https://pharos.nih.gov/idg/targets/P48736,P48736,20526338,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P48736,P48736,20513426,"The phosphorylation of Thr159 in Vps34 is a key regulatory mechanism that controls the class III PtdIns3 kinase activity in cell-cycle progression, development, and human diseases including neurodegeneration and cancers."
https://pharos.nih.gov/idg/targets/P48736,P48736,20512574,"Data suggest that the induction of apoptosis by tanshinone I in leukemia cells is mainly related to the disruption of Deltapsim, inactivation of PI3k/Akt signaling pathway, upregulation of Bax expression, and the activation of caspase-3."
https://pharos.nih.gov/idg/targets/P48736,P48736,20508983,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P48736,P48736,20506537,"Data demonstrate that PI3K/Akt pathway regulates the expression of DNMT3B at transcriptional and post-transcriptional levels, which is particularly important to understand the effects of PI3K/Akt and DNMT3B on hepatocarcinogenesis."
https://pharos.nih.gov/idg/targets/P48736,P48736,20505158,"Increased PI3K is associated with multiple myeloma."
https://pharos.nih.gov/idg/targets/P48736,P48736,20488790,"PI3K-PKB-mTOR signaling plays a crucial role in the development of functional CD34-derived myeloid Dendritic cells"
https://pharos.nih.gov/idg/targets/P48736,P48736,20465946,"PI3K might play a role in silica-induced DNA double strand break repair by regulating the expression levels of Ku70 and Ku80 in lung fibroblasts."
https://pharos.nih.gov/idg/targets/P48736,P48736,20458733,"These findings suggest that angiotensin II plays a role in the growth of angiotensin II type I receptor-positive breast cancer cells through PI3-kinase/Akt pathway activation."
https://pharos.nih.gov/idg/targets/P48736,P48736,20453000,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P48736,P48736,20432929,"Angiotensin II increased Akt phosphorylation and PI3K activity in cultured hypertrophic scar fibroblasts in a dose- and time-dependent manner."
https://pharos.nih.gov/idg/targets/P48736,P48736,20412587,"prostate cancer cell lines differentially express phosphoinositide-3 kinase (PI3K) catalytic subunit isoforms and dedicator of cytokinesis 2"
https://pharos.nih.gov/idg/targets/P48736,P48736,20375364,"These results suggest that deregulation of the PI3K pathway in the bronchial airway epithelium of smokers is an early, measurable, and reversible event in the development of lung cancer."
https://pharos.nih.gov/idg/targets/P48736,P48736,20368287,"Data identify DEAF1 as an interactor and in vitro substrate of GSK3A and GSK3B that interacts with the phosphatidylinositol 3-kinase-mammalian target of rapamycin pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,20361045,"PDK1 with AKT1 is sufficient for pathway activation independent of membrane localization and phosphatidylinositol 3 kinase"
https://pharos.nih.gov/idg/targets/P48736,P48736,20354121,"AR mediates EGF- and bFGF-induced colon cancer cell proliferation by activating or expressing G(1)-S phase proteins such as E2F-1, cdks, and cyclins through the reactive oxygen species/phosphoinositide 3-kinase/AKT pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,20331378,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P48736,P48736,20237496,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P48736,P48736,20226014,"Data show that the coexpression of HSP90 with PI3K-p110alpha or expression of HSP90 along with PTEN loss has a potential as a molecular prognostic marker to predict early relapse in patients with invasive breast cancers."
https://pharos.nih.gov/idg/targets/P48736,P48736,20224967,"Data show that significant expression of PI3Kgamma in neuroblastoma patient biopsies and tumor cell lines was detected."
https://pharos.nih.gov/idg/targets/P48736,P48736,20204404,"PI3K/Akt prevents the malignant phenotype of HCT-116 colorectal cancer cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,20195717,"Data show that each of the five domains of phosphoinositide 3-kinase gamma is capable of binding anionic phospholipids to varying degrees, depending on the charge of the anionic substrate."
https://pharos.nih.gov/idg/targets/P48736,P48736,20166697,"Data indicate that compound 26 (PKI-587) has shown excellent activity as highly efficacious PI3K/mTOR inhibitor."
https://pharos.nih.gov/idg/targets/P48736,P48736,20164468,"Activation through CD160 leads to PI3K-dependent chronic lymphocytic leukemia protection from spontaneous in vitro apoptosis, as well as cellular activation with cell cycle progression and cytokine production."
https://pharos.nih.gov/idg/targets/P48736,P48736,20157769,"PI3-kinase exerts a major morphogenetic impact in simple cultured epithelia through preservation of cell height."
https://pharos.nih.gov/idg/targets/P48736,P48736,20157617,"The activation of the PI-3K/mTOR/translational pathway is important for IFNgamma-mediated VEGF expression in retinal pigmented epithelial cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,20150971,"These results suggested that although hypercholesterolemic serum could not change the expression of ZO-1, it could change the distribution and increase the permeability in endothelial cells through PI3K signaling pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,20145951,"molecular cross-talk between the MKP-1, p38 MAPK and PI3K pathways promotes resistance to PI3K inhibitors in hilar cholangiocarcinoma cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,20124452,"phosphoinositide 3-kinase and RAS-RAF pathways drive the activity of RAF265, a novel RAF/VEGFR2 inhibitor, and RAD001 (Everolimus) in combination"
https://pharos.nih.gov/idg/targets/P48736,P48736,20107185,"Data show that the expression of tenascin-C is induced in immune myeloid cells, and its synthesis is transcriptionally regulated and requires the specific activation of AKT/PI3K and NF-kappaB signaling pathways."
https://pharos.nih.gov/idg/targets/P48736,P48736,20089844,"Data report that activation of P2Y(2) receptors by extracellular UTP inhibits the IGF-I-induced p110alpha-PI3K activation."
https://pharos.nih.gov/idg/targets/P48736,P48736,20089415,"These results indicate that human nasal airway fibroblasts strongly induce BLyS-expression and production by poly(I:C) through PI3-K signaling during airway immune responses."
https://pharos.nih.gov/idg/targets/P48736,P48736,20088406,"The PI3K/Akt pathway may play an inhibitory role in inflammatory mediators-induced human vascular smooth muscle cell calcification through regulating alkaline phosphatase expression."
https://pharos.nih.gov/idg/targets/P48736,P48736,20086095,"Data show that PI3K activation and PIP3 production lead to recruitment of the PKB/beta-arrestin/PDE4 complex to the membrane via the PKB PH domain, resulting in degradation of the TCR-induced cAMP pool and allowing full T-cell activation to proceed."
https://pharos.nih.gov/idg/targets/P48736,P48736,20062086,"genomic alterations in the Ras-PI3K pathway are widespread in endometrial carcinomas, regardless of the type of genomic instability"
https://pharos.nih.gov/idg/targets/P48736,P48736,20056178,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P48736,P48736,20041213,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,20030877,"Studies indicate that the PI3K/Akt/mTOR pathway plays a critical role in breast cancer development and resistance to traditional anti-tumor strategy."
https://pharos.nih.gov/idg/targets/P48736,P48736,20019835,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,20018937,"Heat shock protein 70 (Hsc70) plays a significant role in vascular endothelial cells via the phosphatidylinositol 3-kinase/Akt pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,20018188,"Data show that c-mip interacts with the p85 subunit of PI3 kinase and inactivates Lck, which results in Erk1/2 and p38 MAPK activation."
https://pharos.nih.gov/idg/targets/P48736,P48736,20011604,"These data elucidate the role of PLCgamma1 in FGF-2 signalling in human umbilical vein endothelial cells demonstrating its key role in FGF-2-dependent tubulogenesis."
https://pharos.nih.gov/idg/targets/P48736,P48736,20009532,"Genetic and biochemical analysis of these \"hot-spot\" mutations in human p110alpha, is reported."
https://pharos.nih.gov/idg/targets/P48736,P48736,20003467,"Increased expression of Lewis y antigen plays an important role in promoting cell proliferation through activating PI3K/Akt signaling pathway in ovarian carcinoma-derived RMG-I cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,19966853,"Data show that suppression of PUMA through the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/p53 axis in the intestinal stem cells as a novel molecular mechanism of growth factor-mediated intestinal radioprotection."
https://pharos.nih.gov/idg/targets/P48736,P48736,19926313,"Data show 5-HT can induce activation of two interrelated signaling pathways, Erk1/2 and PI3K/Akt to induce proliferation, migration, and differentiation."
https://pharos.nih.gov/idg/targets/P48736,P48736,19924283,"Hepcidin mRNA expression in vitro is highly sensitive to the presence of serum factors and PI3 kinase inhibition and parallels TfR2 expression"
https://pharos.nih.gov/idg/targets/P48736,P48736,19917135,"Elevated expression of p53-R175H mutant may exert gain-of-function activity to activate the EGFR/PI3K/AKT pathway and thus may contribute to the invasive phenotype in endometrial cancer."
https://pharos.nih.gov/idg/targets/P48736,P48736,19903888,"Data show that DAB2IP is a potent growth inhibitor by inducing G(0)/G(1) cell cycle arrest and is proapoptotic in response to stress, and that DAB2IP can suppress the PI3K-Akt pathway and enhance ASK1 activation leading to cell apoptosis."
https://pharos.nih.gov/idg/targets/P48736,P48736,19897009,"The key signaling molecules in the PI3K signaling cascade, the abnormalities known to occur in thyroid cancer, and the potential for therapeutic targeting of PI3K pathway members are discussed."
https://pharos.nih.gov/idg/targets/P48736,P48736,19889638,"Oscillatory shear stress induces osteoblast-like cell proliferation through activation of alpha(v)beta(3) and beta(1) integrins and synergistic interactions of FAK and Shc with PI3K, leading to the modulation of ERK and Akt/mTOR/p70S6K pathways."
https://pharos.nih.gov/idg/targets/P48736,P48736,19855431,"Data show that RNA silencing of choline kinase in HeLa cells completely abrogates the high concentration of phosphocholine, which in turn decreases phosphatidylcholine, phosphatidic acid and signaling through the MAPK and PI3K/AKT pathways."
https://pharos.nih.gov/idg/targets/P48736,P48736,19835871,"BMP-2 promotes motility and invasion of gastric cancer cells by activating the PI-3 kinase/Akt signal pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,19815050,"Data suggest that investigation of the mechanisms of abnormal RAS and phosphoinositide-3 kinase pathway activation in erythroblasts may contribute to the understanding of the molecular pathogenesis of PV."
https://pharos.nih.gov/idg/targets/P48736,P48736,19801684,"Data show that stimulation of HIF-1alpha transcription by the ND6 mutation was mediated by overproduction of reactive oxygen species (ROS) and subsequent activation of phosphatidylinositol 3-kinase (PI3K)-Akt and protein kinase C (PKC) signaling pathways."
https://pharos.nih.gov/idg/targets/P48736,P48736,19801633,"Data show that B[a]PDE increases cyclin D1 expression, and activate the PI3-kinase/Akt/MAPK- and p70s6k pathway in Beas-2B bronchial epithelial cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,19801192,"Studies provide models for Ras in association with Raf kinase, RalGDS and PI3Kalpha and PI3Kgamma."
https://pharos.nih.gov/idg/targets/P48736,P48736,19787273,"AP-1 activity in prostate cancer cells mediates EGF-R and PI3K signalling, is essential for their proliferation, and confers protection against radiation-induced cell death"
https://pharos.nih.gov/idg/targets/P48736,P48736,19786618,"These findings identify TAPP2 as a novel link between PI3K signaling and the cytoskeleton with potential relevance for leukemia progression"
https://pharos.nih.gov/idg/targets/P48736,P48736,19734303,"These data indicate PI3Kgamma is an important regulator of fibroblast-mediated joint destruction in rheumatoid arthritis."
https://pharos.nih.gov/idg/targets/P48736,P48736,19726747,"These results identify nNOS as a target gene of a novel RA/PI3K/Akt/DAX1-dependent pathway in human neuroblastoma cells"
https://pharos.nih.gov/idg/targets/P48736,P48736,19723646,"The gene copy number of PIK3CA is frequent genetic alteration that contributes to MCL progression. PIK3CA is a promising therapeutic target in MCL."
https://pharos.nih.gov/idg/targets/P48736,P48736,19711039,"Results suggest that bFGF increases the Mg(2+)](i) from the intracellular Mg(2+) stores through the tyrosine kinase/PI3K/PLCgamma-dependent signaling pathways."
https://pharos.nih.gov/idg/targets/P48736,P48736,19660434,"PI3Kgamma regulates tumor cell adhesion through activation of CXCL12."
https://pharos.nih.gov/idg/targets/P48736,P48736,19636556,"Data show that with SF1126 treatment, caspase 3 and PARP proteins were cleaved, survivin was down-regulated, and inhibition of PI3-kinase was confirmed by reduced phosphorylation of Akt."
https://pharos.nih.gov/idg/targets/P48736,P48736,19621391,"Data suggest an interaction between COX-2 enzymatic activity and PI3Kinase/AKT signaling pathway in EOC."
https://pharos.nih.gov/idg/targets/P48736,P48736,19615795,"Results show interaction between CCR7 and its ligand CCL19 induces phosphorylation of mTOR and its target p70s6k. This phosphorylation is abolished by inhibition of CCR7 and PI3K/Akt, indicating that mTOR is involved in the CCR7-PI3K cascade."
https://pharos.nih.gov/idg/targets/P48736,P48736,19609946,"Data show that aberrant expression of ErbB2, ErbB3 and ErbB4 in the two resistant cell lines, suggesting the existence of an autocrine loop leading to constitutive activation of MAPK and PI3K/Akt survival pathways."
https://pharos.nih.gov/idg/targets/P48736,P48736,19588500,"Data show that IGFBP-3 is regulated by the PI3-kinase/AKT and MAPK/ERK1/2 pathways."
https://pharos.nih.gov/idg/targets/P48736,P48736,19574958,"Mal specifically connects TLR2/6 to PI3K activation, PIP(3) generation and macrophage polarization."
https://pharos.nih.gov/idg/targets/P48736,P48736,19572978,"over-expression of DIXDC1 might target p21 and cyclin D1 to promote colon cancer cell proliferation and tumorigenesis at least partially through activation of the PI3K/Akt pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,19570915,"Data elucidate a novel signaling network that leads to increased IL-8 production through p38 mitogen-activated protein kinase-dependent phosphatidylinositol 3-kinase activation in response to proteasome inactivation."
https://pharos.nih.gov/idg/targets/P48736,P48736,19567590,"Data provide a basis for rational combination of MEK and PI3K inhibitors in basal-like cancers with both intact and deleted PTEN."
https://pharos.nih.gov/idg/targets/P48736,P48736,19567200,"Results demonstrated that the inhibition of spontaneous B cell apoptosis by CpG DNA was correlated to up-regulation of Bcl-xL, IAP and down-regulation of p53 and caspase 3 mediated through PI3K/AKT signaling."
https://pharos.nih.gov/idg/targets/P48736,P48736,19553815,"Studies indicate inhibition of the PI3K/AKT/mTOR pathway is not only a potential first-line therapeutic strategy in ovarian cancer but also could be used in recurrent disease as a means of reversing acquired chemotherapy resistance."
https://pharos.nih.gov/idg/targets/P48736,P48736,19553005,"Data show that inhibition of NF-kappaB or PI3K potently enhanced cisplatin cytotoxicity in cells with endogenous or genetically induced low MKP1 levels."
https://pharos.nih.gov/idg/targets/P48736,P48736,19549714,"p110gamma activity plays an important role in maintaining a membrane-docked, readily releasable pool of secretory granules in insulinoma and human beta-cells"
https://pharos.nih.gov/idg/targets/P48736,P48736,19541408,"Results provide evidence for the potential application of roscovitine/wormannin combination in clinical cancer treatment by repressing PI3K/Akt pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,19533041,"Data indicate that PI3K inhibitor, LY294002, almost completely blocked Lf(Fe(3+))-induced Akt activation, and prevented the cytoplasmic localization of p27(kip1)."
https://pharos.nih.gov/idg/targets/P48736,P48736,19531027,"Data show that IL-4 receptors are functionally competent in pancreatic beta-cells and that they signal via PI3K and JAK/STAT pathways."
https://pharos.nih.gov/idg/targets/P48736,P48736,19525225,"Asef and APC function downstream of HGF and PI3-kinase, and play critical roles in growth factor-mediated regulation of cell morphology and migration"
https://pharos.nih.gov/idg/targets/P48736,P48736,19492417,"The EGF/PI3K/STAT3 signaling is identified as an essential pathway regulating VEGF and leptin expression in EGF-responsive colon cancer cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,19492075,"Targeting NRAS alone or both BRAF and CRAF in combination or both BRAF and PIK3CA together showed delay in tumor growth."
https://pharos.nih.gov/idg/targets/P48736,P48736,19473971,"Results show that this unique and specific bacterial entry process is dependent on the cooperation and activation of Rho family GTPase Cdc42, PI3K, and Akt."
https://pharos.nih.gov/idg/targets/P48736,P48736,19473116,"The constitutive activation of the PI3K-Akt pathway in Fanconi anaemia cells upregulates the expression of IL-1beta."
https://pharos.nih.gov/idg/targets/P48736,P48736,19472218,"inhibition of phosphatidylinositol-3 kinase (PI3K) reversed phospholipid transfer protein -induced increase in levels of GSK3 beta phosphorylated at serine 9"
https://pharos.nih.gov/idg/targets/P48736,P48736,19471547,"Loss of PTEN function in breast cancer can occur either by mutation or reduction of PTEN expression in almost half of sporadic breast tumors."
https://pharos.nih.gov/idg/targets/P48736,P48736,19460752,"Knockdown of phosphoinositide-3-kinase, catalytic, gamma polypeptide (PIK3CG) by shRNA library screening inhibits HIV-1 replication in cultured Jurkat T-cells"
https://pharos.nih.gov/idg/targets/P48736,P48736,19457236,"PI-3 kinase activity is necessary for ERK1/2-induced disruption of mammary epithelial architecture"
https://pharos.nih.gov/idg/targets/P48736,P48736,19454653,"Similar to its function in T cells, CEACAM1 may act as an inhibitory B cell coreceptor, most likely through recruitment of SHP-1 and inhibition of a PI3K-promoted activation pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,19445727,"Increased expression of PI3K is associated with gallbladder adenocarcinoma."
https://pharos.nih.gov/idg/targets/P48736,P48736,19437103,"PTEN modulated VEGF-mediated signaling and affected tumor angiogenesis through PI3K/Akt/VEGF/eNOS pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,19428048,"dysregulation of the phosphoinositide 3-kinase/Akt/PTEN pathway is relevant to the prognosis in node-negative breast carcinoma"
https://pharos.nih.gov/idg/targets/P48736,P48736,19427341,"The authors find that the induction of NF-kappaB and phosphatidylinositol 3-kinase activities following HCMV infection was required for the initiation of monocyte-to-macrophage differentiation."
https://pharos.nih.gov/idg/targets/P48736,P48736,19427038,"the formation of LAT-mediated complexes do not appear to depend on PI3K activity, whereas the optimal downstream function of these complexes requires the catalytic function of PI3K"
https://pharos.nih.gov/idg/targets/P48736,P48736,19421146,"Results show that targeted disruption of the cell surface Cripto/GRP78 complex precludes Cripto activation of MAPK/PI3K and Smad2/3 pathways."
https://pharos.nih.gov/idg/targets/P48736,P48736,19415692,"PRL up-regulated CHIT-1 expression via PTK, PI3-K, MAPK, and signaling transduction components."
https://pharos.nih.gov/idg/targets/P48736,P48736,19376889,"IL-6 functions in a cytoprotective manner, in part, by suppressing Bax translocation and dimerization through PI3K/Akt-mediated Bax phosphorylation."
https://pharos.nih.gov/idg/targets/P48736,P48736,19339247,"TNFalpha facilitates the reduction of FLIP(L) protein, which is dependent on the phosphatidylinositol 3-kinase/Akt signaling."
https://pharos.nih.gov/idg/targets/P48736,P48736,19323811,"Data showed that tumor-associated matrices induced PI3K and beta1-integrin dependent Akt/PKB activity in MDA-MB-231 cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,19303157,"Impaired PI3K signaling might account for the variability in the responses to ischemic preconditioning of human grafts from deceased donors."
https://pharos.nih.gov/idg/targets/P48736,P48736,19269083,"Snail upregulation by HRG-beta1 is mediated via the PI3K/Akt signaling pathway and Snail plays a key role in HRG-beta1 induced breast cancer cell metastasis through induction of EMT"
https://pharos.nih.gov/idg/targets/P48736,P48736,19261616,"bortezomib overcame TRAIL resistance at clinically achievable concentrations in hepatocellular carcinoma cells, and this effect is mediated at least partly via inhibition of the PI3K/Akt pathway"
https://pharos.nih.gov/idg/targets/P48736,P48736,19229860,"These results suggest that one mechanism of the apoptotic activity of magnolol involves its effect on epidermal growth factor receptor-mediated EGFR/PI3K/Akt signaling transduction pathways."
https://pharos.nih.gov/idg/targets/P48736,P48736,19224914,"Results demonstrate that Ron plays an essential role in maintaining malignant phenotypes of colon cancer cells through regulating mutant PI3K activity."
https://pharos.nih.gov/idg/targets/P48736,P48736,19211763,"PI3K signaling, therefore, plays a critical role in regulating protein production during VV infection, at least in part by controlling the abundance and activity of 4E-BP1."
https://pharos.nih.gov/idg/targets/P48736,P48736,19211028,"Data suggest that beta-hydroxy-beta-methylbutyrate (HMB) acts via ERK1/2 and PI3K, as blocking of the PI3K/Akt pathway revealed its requirement in mediating the promotive effects of HMB on muscle cell differentiation and fusion."
https://pharos.nih.gov/idg/targets/P48736,P48736,19192227,"TGF-beta may facilitate airway remodelling by promoting VEGF release through the PI3K pathway, rather than via ASM cell proliferation."
https://pharos.nih.gov/idg/targets/P48736,P48736,19179443,"Endometrial stathmin is linked to HIF-1alpha protein accumulation and VEGF expression through the PI3K/Akt signaling pathway and may be involved in regeneration of the endometrium during the menstrual cycle in human uterine cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,19152965,"Pim-1, but not PI3K, plays a major role in IL-5-mediated antiapoptotic signaling in eosinophils."
https://pharos.nih.gov/idg/targets/P48736,P48736,19103290,"Results suggest that inhibition of PI(3)K is a novel mechanism which contributes to 8-prenylnaringenin activity to inhibit cancer cell survival and epidermal growth factor induced proliferation."
https://pharos.nih.gov/idg/targets/P48736,P48736,19086053,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P48736,P48736,19079138,"mtDNA depletion prevents detachment-induced apoptosis (anoikis) and promotes migratory capabilities onto basement membrane proteins through upregulation of p85 and p110 phosphatidylinositol 3-kinase (PI3K) subunits, which results in Akt2 activation"
https://pharos.nih.gov/idg/targets/P48736,P48736,19078992,"inhibition of the PI3K-AKT-mTOR pathway potently increases sensitivity of melanoma cells to chemotherapy"
https://pharos.nih.gov/idg/targets/P48736,P48736,19062713,"PI3K/Akt/mdm2 signalling pathway can be activated by doxorubicin and suppress apoptosis by promoting phosphorylation of mdm2 in a gastric cancer cell line."
https://pharos.nih.gov/idg/targets/P48736,P48736,19059380,"These data demonstrated that cell adhesion-mediated PI3K/Akt activation could be one of the important mechanisms of resistance to genotoxin-induced cell death in differentiated epithelial cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,19058789,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P48736,P48736,19017490,"NGF induces Mac-2BP expression via the PI3K/Akt/NF-kappaB pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,19011679,"Altered insulin activation of the PI3K/Akt but not the MAPK pathway precedes and may contribute to development of whole-body insulin resistance and type 2 diabetes in men with low birth weight."
https://pharos.nih.gov/idg/targets/P48736,P48736,18996102,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P48736,P48736,18983267,"The direct interaction of PI3Kgamma with PKCalpha forms a discrete regulatory module of N-formylmethionyl-leucyl-phenylalanine-dependent reactive oxygen species production in neutrophils."
https://pharos.nih.gov/idg/targets/P48736,P48736,18973553,"PDGF-mediated protection also involved the inhibition of gp120-induced release of mitochondrial cytochrome C. Our findings thus underscore the roles of both PI3K/Akt and Bcl family pathways in PDGF-mediated neuroprotection."
https://pharos.nih.gov/idg/targets/P48736,P48736,18945831,"IFN-gamma exerted a delayed suppressive effect on K(+) channels by enhancing iNOS expression and an acute stimulatory effect, which was independent of either NO pathways or phosphorylation mediated by PKA, PKG, and PI3K in renal proximal tubule cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,18854243,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,18844239,"These data demonstrate that integrin/EGFR cross-talk is required for expression of Egr-1 through a novel regulatory cascade involving the activation of the PI3K/Akt/Forkhead pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,18824170,"HuR is a direct transcription target of NF-kappaB; its activation in gastric cancer cell lines depends on phosphatidylinositol 3-kinase/AKT signaling. HuR activation by this pathway has proliferative and antiapoptotic effects on gastric cancer cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,18810319,"These data show that, in addition to inactivation of 4E-BP1 via hyperphosphorylation, signaling through the PI3K pathway silences 4E-BP1 gene transcription."
https://pharos.nih.gov/idg/targets/P48736,P48736,18771702,"Glycine-extended gastrin induced signalling involves a JAK2/PI3-kinase/Akt/NF-kappaB sequence leading to COX-2 transcription."
https://pharos.nih.gov/idg/targets/P48736,P48736,18769058,"These findings demonstrate that HAPO induces endothelial cell proliferation through the PI-3K/Akt pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,18766172,"The onset of terminal differentiation, while regulated by PI3-kinase and caspases, is not a classical apoptotic process."
https://pharos.nih.gov/idg/targets/P48736,P48736,18728784,"Gate control for cell polarization can explain how Rac can be employed for both PI3K-dependent and -independent signaling pathways coexisting in the same cell."
https://pharos.nih.gov/idg/targets/P48736,P48736,18725974,"A selective allosteric inhibitor of Akt kinase was used to interrogate a panel of breast cancer cell lines characterized for genetic lesions that activate PI3K/Akt signaling PI3K mutations."
https://pharos.nih.gov/idg/targets/P48736,P48736,18722093,"Endothelin signaling axis activates osteopontin expression through PI3 kinase pathway in A375 melanoma cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,18720410,"These results suggest that the BMP-2 acts through PI3K/Akt, which in turn activates IKKalpha/beta and NF-kappaB, resulting in the activations of beta1 integrin and contributing the migration of human chondrosarcoma cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,18711316,"DIDS-sensitive Cl- channels play a key role in the Low-density lipoprotein-induced cell proliferation of human aortic smooth muscle cells via the activation of Erk1/2 and PI3K/Akt and the upregulation of Egr-1."
https://pharos.nih.gov/idg/targets/P48736,P48736,18678286,"The role of PI3K/Akt activity and DNA-PKcs on XRCC1 expression/stabilization, was studied."
https://pharos.nih.gov/idg/targets/P48736,P48736,18675921,"Data show that IGF2 activates PI3K and TGFbeta signal pathways during proliferation and differentiation of chondrocytes."
https://pharos.nih.gov/idg/targets/P48736,P48736,18652687,"PI3K inhibition by Ly294002 alters gene expression in two breast cancer cell lines."
https://pharos.nih.gov/idg/targets/P48736,P48736,18632611,"PIK3IP1 is an important regulator of PI3K in vivo, and its dysregulation can contribute to liver carcinogenesis"
https://pharos.nih.gov/idg/targets/P48736,P48736,18625725,"Datas show that transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab."
https://pharos.nih.gov/idg/targets/P48736,P48736,18615538,"None of the components in the IGF-1 pathway including IGFBP3, PI3k, and PTEN influence the relation between IRS-1 genotype and prostate cancer risk. Ther is no association between carriage of the variant IRS-1 gene and prostate cancer risk."
https://pharos.nih.gov/idg/targets/P48736,P48736,18603327,"Data show that M. bovis BCG-induced human beta-defensin mRNA expression in A549 cells is regulated at least in part through activation of signaling proteins of PKC, JNK and PI3K."
https://pharos.nih.gov/idg/targets/P48736,P48736,18593948,"Phosphoinositide 3-kinase/AKT signaling can promote AIB1 stability independently of GSK3 phosphorylation."
https://pharos.nih.gov/idg/targets/P48736,P48736,18587247,"Activation of the PI3K pathway is significantly associated with adverse clinical outcome in renal cell carcinoma."
https://pharos.nih.gov/idg/targets/P48736,P48736,18558630,"required for sphingosine-1-phosphate -induced endothelial cell migration through activation of Rac1"
https://pharos.nih.gov/idg/targets/P48736,P48736,18552129,"MCL-1 expression is activated by Triiodothyronine, which increases its promoter activity by a non-genomic mechanism using the PI3-K signal transduction pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,18546844,"mediates intracellular signals to regulate a variety of cellular responses and its genomic mutations and alterations underlie cancer, viral and/or bacterial infections.[review]"
https://pharos.nih.gov/idg/targets/P48736,P48736,18535744,"Our results also indicated that the integrin alphaVbeta3 antibody (LM609) could block the Angptl3-induced protein kinase B phosphorylation."
https://pharos.nih.gov/idg/targets/P48736,P48736,18520805,"The p-EGFR:p-AKT ratio deserves further investigation as a predictive parameter for clinical response to erlotinib in NSCLC tumors expressing wild-type EGFR gene."
https://pharos.nih.gov/idg/targets/P48736,P48736,18515365,"Interleukin (IL) 1beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IkappaB kinase alpha pathway targeting activator protein-1"
https://pharos.nih.gov/idg/targets/P48736,P48736,18511807,"Activation of the PI3K pathway mediated cytoplasmic retention of the Wilms tumor (WTI) protein, which strongly suppressed the hTERT promoter."
https://pharos.nih.gov/idg/targets/P48736,P48736,18502332,"The role of PI3K pathway activation in thyroid cancer is discussed, with a focus on recent advances."
https://pharos.nih.gov/idg/targets/P48736,P48736,18499442,"GILZ is a mediator of glucocorticoid killing, and is regulated by PI3-kinase/AKT."
https://pharos.nih.gov/idg/targets/P48736,P48736,18495460,"7-ketocholesterol-induced apoptosis has a role in phospholipidosis and down-regulation of the PI3-K/PDK-1/Akt signalling pathway"
https://pharos.nih.gov/idg/targets/P48736,P48736,18479604,"High expression of PI3K and Akt are involved in proliferation, malignant transformation, invasion and metastasis of cervical carcinoma."
https://pharos.nih.gov/idg/targets/P48736,P48736,18469852,"High NG2/MPG expression correlated with multidrug resistance mediated by increased activation of alpha3beta1 integrin/PI3K signaling and their downstream targets, promoting cell survival"
https://pharos.nih.gov/idg/targets/P48736,P48736,18467332,"tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases are regulated by phosphorylation"
https://pharos.nih.gov/idg/targets/P48736,P48736,18458059,"The interplay between cancer cell-derived clusterin and IGF-1 may dictate the outcome of cell growth and dormancy during tumorigenic progression."
https://pharos.nih.gov/idg/targets/P48736,P48736,18453587,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,18451140,"Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,18451027,"This study provides a direct link between the growth factor signaling pathways regulated by PI3 kinase/Akt and MAP kinases with Myc-mediated transcription."
https://pharos.nih.gov/idg/targets/P48736,P48736,18434090,"Cav-1 increases the basal and TGF-beta1-induced expression of type I procollagen by regulating two opposite signaling pathways: inhibiting TGF-beta1/smad signaling and activating a PI-3 kinase/Akt/mTOR-dependent pathway in human dermal fibroblasts."
https://pharos.nih.gov/idg/targets/P48736,P48736,18395956,"The PI3K/Akt/mTOR signaling pathway is implicated in the development of cervical cancer."
https://pharos.nih.gov/idg/targets/P48736,P48736,18374639,"Results identify a molecular mechanism by which activated FGFR2 recruits Cbl in raft micro-domains to trigger PI3K ubiquitination and proteasome degradation, and reveal a role for PI3K/Akt in the control of osteoblast survival by FGFR2 signaling."
https://pharos.nih.gov/idg/targets/P48736,P48736,18338817,"Data show that in airway smooth muscle cells from asthmatics, the presence of a strong proliferative stimulus (10% FBS) reduces ERK activation resulting in a shift to the PI 3-kinase pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,18299320,"These data show that Hsp27 antagonizes Bax-mediated mitochondrial injury and apoptosis by promoting Akt activation via a PI3-kinase-dependent mechanism."
https://pharos.nih.gov/idg/targets/P48736,P48736,18273051,"TNF-alpha overrides the G2/M checkpoint in keratinocytes and allows for some cells containing unrepaired cyclobutane pyrimidine dimers to enter the cell cycle. TNF-alpha seems to be dependent on PI3K-Akt activation."
https://pharos.nih.gov/idg/targets/P48736,P48736,18245521,"Association of a functional missense polymorphismwith colon cancer risk in a population-based case-control study. [review]"
https://pharos.nih.gov/idg/targets/P48736,P48736,18201823,"These results suggest that caffeine has a cytoprotective effect due to the activation of the PI3K/Akt pathways in SH-SY5Y cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,18194602,"PI-3K/Akt signaling pathway participates in P2Y receptor-stimulated prostate cancer invasion by enhancing cell motility, rather than up-regulating MMP-2 and MMP-9 activities."
https://pharos.nih.gov/idg/targets/P48736,P48736,18187452,"although PI3K can enhance early responses to the bacterial chemoattractant fMLP, it is not required for migration towards this chemoattractant"
https://pharos.nih.gov/idg/targets/P48736,P48736,18079201,"Signal transduction pathways underlying the enhanced cell migration reveal that the IGF-I-IGFBP-VN complex stimulates a transient activation of the ERK/MAPK signaling pathway and a sustained activation of the phosphatidylinositide 3-kinase/AKT pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,18060476,"These data suggest that the PI3K/Akt and mTOR/p70S6K signaling pathways are essential for adipogenesis of human mesenchymal stem cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,18025271,"Cyclin G2 expression is modulated by HER2 signaling through multiple pathways including phosphoinositide 3-kinase, c-jun NH(2)-terminal kinase, and mTOR signaling."
https://pharos.nih.gov/idg/targets/P48736,P48736,17998459,"human betaARs undergo a process of intracellular sequestration that is dynamically reversed after LVAD support. Importantly, mechanical unloading leads to complete reversal in PI3Kgamma and betaARK1-associated PI3K activation."
https://pharos.nih.gov/idg/targets/P48736,P48736,17971428,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P48736,P48736,17942603,"IFNalpha-induced apoptosis requires activation of ERK1/2, PKCdelta, and JNK downstream of PI3K and mTOR, and it can occur in a nucleus-independent manner, thus demonstrating that IFNalpha induces apoptosis in the absence of de novo transcription."
https://pharos.nih.gov/idg/targets/P48736,P48736,17901375,"VEGF regulates angiopoietin-Tie2 signaling by inducing proteolytic cleavage and shedding of Tie2 via a novel PI3K/Akt-dependent pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,17900864,"Migratory response of freshly isolated T cells is dependent on PI3K signals provided predominantly by PI3Kgamma.t he role of PI3K in cell migration is context-dependent and diminishes during ex vivo maintenance."
https://pharos.nih.gov/idg/targets/P48736,P48736,17878755,"phosphoinositide 3-kinase/Akt/eNOS, but not mitogen-activated protein kinase/ERK, signal transduction pathway may be involved in SDF-1alpha mediated migration of endothelial progenitor cells"
https://pharos.nih.gov/idg/targets/P48736,P48736,17868340,"Phosphatidylinositol 3-kinase inhibition by LY294002 also enhanced TRAIL-induced apoptosis."
https://pharos.nih.gov/idg/targets/P48736,P48736,17855501,"These data identify a novel, PI-3K-dependent pathway by which CSF-1 directs delayed caspase activation in monocytes and thereby modulates DC differentiation."
https://pharos.nih.gov/idg/targets/P48736,P48736,17724079,"mTOR inhibition increases eIF4E phosphorylation through a PI3K-dependent and Mnk-mediated mechanism."
https://pharos.nih.gov/idg/targets/P48736,P48736,17716861,"These results suggested that PKB enhanced DNMT1 stability and maintained DNA methylation and chromatin structure, which might contribute to cancer cell growth."
https://pharos.nih.gov/idg/targets/P48736,P48736,17681345,"In macrophages, uPA was found to activate MAP-kinase through PI3 kinase (PI3K)"
https://pharos.nih.gov/idg/targets/P48736,P48736,17658464,"These results suggest that PLEK2 is involved in actin rearrangement in a PI 3-kinase dependent manner."
https://pharos.nih.gov/idg/targets/P48736,P48736,17646933,"Ep-CAM cross signaling with N-cadherin involves Pi3K, resulting in the abrogation of the cadherin adhesion complexes in epithelial cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,17632570,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,17551921,"Results suggest that aberrant activation of PI3K-Akt pathway may contribute to increased cell invasiveness and facilitate prostate cancer progression."
https://pharos.nih.gov/idg/targets/P48736,P48736,17515959,"Phosphorylated PIK3 was documented in 15/17 cytokeratin-positive breast cancer samples."
https://pharos.nih.gov/idg/targets/P48736,P48736,17497700,"Evidence is presented that PI3K is involved in basic fibroblast growth factor-stimulated fibroblast-collagen matrix contraction."
https://pharos.nih.gov/idg/targets/P48736,P48736,17459875,"phosphatidylinositol 3-kinase/Akt signaling and induces apoptosis is inhibited by energy depletion via AMP-activated protein kinase-dependent phosphorylation of IRS-1 at Ser-794"
https://pharos.nih.gov/idg/targets/P48736,P48736,17410437,"SCF-enhanced proliferation and invasion of KIT-positive colorectal cancer cells is achieved mainly through the PI3K/Akt pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,17375124,"Elevated and highly expressed levels in both laarge B-cell lymphoma and Hodgkin lymphoma."
https://pharos.nih.gov/idg/targets/P48736,P48736,17303701,"PAR1 couples to G(i/o) in human platelets and activates phosphoinositide-3 kinase (PI3K)."
https://pharos.nih.gov/idg/targets/P48736,P48736,17302605,"PI3K is not overexpressed in melanocytic lesions."
https://pharos.nih.gov/idg/targets/P48736,P48736,17290298,"This review describes the second-messenger PI3K gamma signalling pathways that are involved in immune responses relevant to the pathogenesis of rheumatoid arthritis and other inflammatory diseases."
https://pharos.nih.gov/idg/targets/P48736,P48736,17286201,"PI 3-K signaling pathway suppresses phorbol 12-myristate 13-acetate-induced expression of p21WAF1/Cip1 in human leukemia cells, and that this effect is partly mediated by PKC zeta."
https://pharos.nih.gov/idg/targets/P48736,P48736,17235455,"These data indicate that the aberrant expression of PTEN contributes to the activation of the PI3kinase/Akt pathway and its transcription factor mediators in glioma."
https://pharos.nih.gov/idg/targets/P48736,P48736,17173040,"We propose that PI(3)Kgamma regulates some aspects of neutrophil polarization that are relevant to movement, such as integrin-based adhesion and the accumulation of polymerized (F)-actin at the leading-edge."
https://pharos.nih.gov/idg/targets/P48736,P48736,17158252,"PI3K and its product, PIP(3), facilitate bile acid-induced [Ca(2+)](i) responses in pancreatic acinar cells through inhibition of SERCA-dependent Ca(2+) reloading into the ER and that bile acid-induced trypsinogen activation is mediated by PI3K."
https://pharos.nih.gov/idg/targets/P48736,P48736,17157319,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,17126402,"PI3 kinase effectors PKB and PKC(zeta) are also activated by PI3 kinase in a CD14 dependent manner in lipopolysaccharides stimulated human peripheral blood mononuclear cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,17045571,"These results demonstrate that estradiol positively regulates essential proteins of the IGF signalling pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,17008323,"vascular endothelial growth factor expression is induced through the glucocorticoid receptor-related phosphatidylinositol 3-kinase/Akt and beta-catenin/T-cell factor-dependent pathway in human endothelial cells"
https://pharos.nih.gov/idg/targets/P48736,P48736,17001038,"The acid-unfolded state of the SH3 domain adopts a partly folded conformation through nonnative long-range contacts between the dynamically restricted residues at the amyloid-forming condition."
https://pharos.nih.gov/idg/targets/P48736,P48736,16943418,"These studies have revealed a novel mechanism of Trichostatin A action through derecruitment of a repressor from the Luteinizing hormone receptor gene promoter in a PI3K/PKCzeta-induced Sp1 phosphorylation-dependent manner."
https://pharos.nih.gov/idg/targets/P48736,P48736,16772787,"The phosphatidylinositol 3-kinase (PI3K) pathway promotes cancer cell proliferation and survival."
https://pharos.nih.gov/idg/targets/P48736,P48736,16533525,"It is concluded that PI3-kinase induces or modulates the activity of recombinant TRPV2 channels; in contrast to the previously proposed mechanism, activation of TRPV2 channels by PI3-kinase is not due to channel translocation to the plasma membrane."
https://pharos.nih.gov/idg/targets/P48736,P48736,16524887,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,16507111,"Cellular responsiveness to Notch signals depends on the activity of the PI3K-Akt pathway in cells as diverse as CHO cells, primary T-cells and hippocampal neurons."
https://pharos.nih.gov/idg/targets/P48736,P48736,16432180,"p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase have roles in oncogenic transformation"
https://pharos.nih.gov/idg/targets/P48736,P48736,16430866,"analysis of a nuclear matrix attachment region like sequence in the last intron of PI3Kgamma"
https://pharos.nih.gov/idg/targets/P48736,P48736,16328013,"Results showed that inhibition of PI-3 kinase with wortmannin was accompanied by a considerably reduced expression of beta-catenin."
https://pharos.nih.gov/idg/targets/P48736,P48736,16325767,"These results suggest that the cytoprotective effect of deprenyl is, in part, dependent on Nrf2-mediated induction of antioxidative proteins, suggesting that activation of the PI3K-Nrf2 system may be a useful therapeutic strategy for PD."
https://pharos.nih.gov/idg/targets/P48736,P48736,16291747,"this specific PI 3-kinase isoform is involved in both proliferation and the apoptosis resistance associated with chronic myeloid leukemia"
https://pharos.nih.gov/idg/targets/P48736,P48736,16286246,"as tumorigenesis progresses the addiction of cancers to their initiating oncogene is reduced to, at least in the case of Ras, the PI3K/AKT pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,16219695,"The TGFbeta(1)-induced destabilisation of E-cadherin-mediated cell-cell adhesion involves phosphorylation of beta-catenin, which is regulated by E-cadherin adhesion complex-associated PI3-kinase and PTEN."
https://pharos.nih.gov/idg/targets/P48736,P48736,16204373,"In human islets, activation of PPAR-gamma inhibits h-IAPP-induced islet cell apoptosis, and this action is at least in part mediated through activation of the phosphatidylinositol 3'-kinase-Akt cascade."
https://pharos.nih.gov/idg/targets/P48736,P48736,16094730,"The protein phosphorylation activity of PIK3 plays an essential role in beta-adrenergic receptor internalization and identify non-muscle tropomyosin as a cellular substrate."
https://pharos.nih.gov/idg/targets/P48736,P48736,16081599,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,15993382,"In conclusion, erythropoietin may attenuate high glucose-induced endothelial cell apoptosis via PI-3 kinase pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,15932879,"the nSH2 domain of the p85 regulatory subumit is responsible for p110 regulatory contacts, and its disruption leads to constitutive p110 activity"
https://pharos.nih.gov/idg/targets/P48736,P48736,15901830,"the PI3-kinase/p38(MAPK)/CREB pathway contributes to the EGF activation of NF-IL6beta gene expression"
https://pharos.nih.gov/idg/targets/P48736,P48736,15878979,"Stimulation of TNF-alpha-primed human neutrophils with fMLP results in biphasic activation of PI3K; the first phase is largely dependent on PI3Kgamma; the second phase is largely dependent on PI3Kdelta and regulates parallel activation of ROS production"
https://pharos.nih.gov/idg/targets/P48736,P48736,15845472,"Acanthamoeba castellani-mediated brain microvascular endothelial cell death is dependent on phosphatidylinositol 3-kinase"
https://pharos.nih.gov/idg/targets/P48736,P48736,15741161,"p110gamma and p85alpha class Ia phosphoinositide 3-kinase (PI3K) subunits play roles in generating the antiapoptotic and chemoresistant phenotype associated with accelerated local tumor recurrence"
https://pharos.nih.gov/idg/targets/P48736,P48736,15733066,"PI3-K promotes the expression of TFF3 and MUC2 and that the PI3-K pathway may play a pivotal role in intestinal goblet cell differentiation."
https://pharos.nih.gov/idg/targets/P48736,P48736,15689238,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,15678501,"IL-4 > PI3K/Akt > NF-(kappa)B signaling pathways, which activate androgen receptor signaling, play an important role during the development of androgen independent prostate cancer cells."
https://pharos.nih.gov/idg/targets/P48736,P48736,15668028,"activation of the PI3K/Akt pathway identified as an anti-inflammatory signal that may contribute to the establishment of Salmonella typhimurium in the intestine."
https://pharos.nih.gov/idg/targets/P48736,P48736,15611065,"there is a previously unknown, p101-related regulatory subunit for PI3Kgamma"
https://pharos.nih.gov/idg/targets/P48736,P48736,15582274,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P48736,P48736,15558024,"Amiloride enhances TRAIL-induced cytotoxicity by inhibiting phosphorylation of the PI 3-Kinase-Akt pathway-associated kinases and phosphatases."
https://pharos.nih.gov/idg/targets/P48736,P48736,15543611,"PI 3-kinase-initiated signaling pathway is one of the most frequently altered in head and neck squamous cell carcinoma."
https://pharos.nih.gov/idg/targets/P48736,P48736,15496972,"stromal cell-mediated apoptotic protection in B-lineage ALL is mediated by PI3K/mTOR and MEK via a synergistic mechanism"
https://pharos.nih.gov/idg/targets/P48736,P48736,15326564,"In Goto-Kakizaki rat soleus muscle, chronic administration of antioxidant alpha -lipoic-acid partly ameliorated the diabetes-related deficit in glucose metabolism including the enzymes Akt/PKB and PI-3 kinase."
https://pharos.nih.gov/idg/targets/P48736,P48736,15046613,"PI3Kgamma appears to negatively control cardiac contractility through different signalling mechanisms [review]"
https://pharos.nih.gov/idg/targets/P48736,P48736,15044087,"Thus, our results identified a functional region in the IL-1R AcP required for the recruitment and activation of PI 3-kinase."
https://pharos.nih.gov/idg/targets/P48736,P48736,15001544,"Activation of hexosamine pathway affects glucose-induced phosphorylation of IRS-1. Impairs coupling of IRS-1 and PI 3-kinase and activativates Akt/mammalian target of rapamycin/phosphorylated heat- and acid-stable protein-1/p70S6 kinase pathway."
https://pharos.nih.gov/idg/targets/P48736,P48736,14622970,"Vanadyl sulfate treatment also prolonged the insulin-stimulated activation of phosphatidylinositol 3-kinase (PI3-K)."
https://pharos.nih.gov/idg/targets/P48736,P48736,14605879,"1) the PI3K-Akt pathway plays an important role in preventing Fas-mediated apoptosis; and 2) a PI3 K inhibitor, such as LY294002, might be a useful anti-tumoral agent for gastric carcinoma"
https://pharos.nih.gov/idg/targets/P48736,P48736,14602571,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,13130092,"migrating glioma cells activate the PI3-K survival pathway, protecting migrating cells from apoptosis"
https://pharos.nih.gov/idg/targets/P48736,P48736,12960231,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,12606772,"PI3-K activation is signaled by rapid feedback amplification that involves P2Y(12) receptor-mediated activation of Syk."
https://pharos.nih.gov/idg/targets/P48736,P48736,12584329,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,12551992,"regulates human immunodeficiency virus type 1 replication following viral entry in primary CD4+ T lymphocytes and macrophages"
https://pharos.nih.gov/idg/targets/P48736,P48736,12551992,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,12545160,"These results indicate that PI3k/Akt pathway is involved in the signaling cascade of glioma cells required to induce cell migration."
https://pharos.nih.gov/idg/targets/P48736,P48736,12529294,"higher protein levels of the PI3K subunit p110 in neutrophils from MDS patients"
https://pharos.nih.gov/idg/targets/P48736,P48736,12526811,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,12473596,"Down-regulation of PIK3CG by CpG hypermethylation is associated with progression of colorectal cancer"
https://pharos.nih.gov/idg/targets/P48736,P48736,12464013,"Bordetella pertussis infection of human monocytes resulted in a marked recruitment of cellular PI3-K to the sites of B. pertussis contact"
https://pharos.nih.gov/idg/targets/P48736,P48736,12435806,"CB(1)-induced ERK activation was mediated by PI3K(IB) and this effect may have important consequences in the control of cell death/survival decision."
https://pharos.nih.gov/idg/targets/P48736,P48736,12242282,"data indicated that the v-Crk-induced activation of PI3K/AKT pathway was cooperatively achieved by two distinct interactions"
https://pharos.nih.gov/idg/targets/P48736,P48736,12077252,"PI3K inhibits HIV-1 transcription by targeting the viral protein Tat activation complex."
https://pharos.nih.gov/idg/targets/P48736,P48736,12077252,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,11994280,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,11861293,"activates phosphatidylinositol 3 (PI3) kinase and requires PI3 kinase to regulate the cell cycle [TEL/platelet-derived growth factor receptor beta]"
https://pharos.nih.gov/idg/targets/P48736,P48736,11756422,"PI3K promotes assembly of adherens junctions, which, in turn, control p38 MAPK activation and enterocyte differentiation."
https://pharos.nih.gov/idg/targets/P48736,P48736,11289809,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,11156964,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,11154208,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,10985305,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,10208934,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,9808187,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,9708406,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,9446795,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,9394803,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,9341793,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,9247029,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,8798481,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P48736,P48736,8636073,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/Q16875,Q16875,28857200,"Study provides evidence that PFKFB3 overexpression occupied a dominant position in sorafenib resistance of hepatocellular carcinoma cells."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,28161638,"Taken together, our study identifies PFKFB3 as a key TGFbeta1 effector protein that mediates TGFbeta1's effect on Snail expression, invasion, and glycolysis."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,28152500,"This work has uncovered a novel function of the enzymes PFKFB3 and PFKFB4 in ovarian cancer cells during mitotic arrest"
https://pharos.nih.gov/idg/targets/Q16875,Q16875,28082200,"PFKFB3 was a novel downstream substrate of mTOR signaling pathway as PFKFB3 level was augmented after knocking down TSC2 in THP1 and OCI-AML3 acute myeloid leukemia cells."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,27983531,"Knockdown of PFKFB3 by siRNAs significantly inhibited the proliferation and migration abilities of gastric cancer cells. Our data suggest that PFKFB3 might be a potential biomarker for gastric cancer and anti-neoplastic targeting gene."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,27799347,"PFK-2 seems to be a strategic element that links NADPH oxidase activation and glycolysis modulation, and, as such, is proposed as a potential therapeutic target in inflammatory diseases."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,27491149,"The expression of PFKFB3, PFKFB4, NAMPT, and TSPAN13 is strongly up-regulated in pediatric glioma."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,27491040,"we investigate the crosstalk between PFKFB3 and TIGAR (TP53-Induced Glycolysis and Apoptosis Regulator), a protein known to protect cells from oxidative stress. Our results show consistent TIGAR induction in HeLa cells in response to PFKFB3 knockdown"
https://pharos.nih.gov/idg/targets/Q16875,Q16875,27373212,"The targeting of MCT1 and PFKFB3 regulated cell proliferation."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,27262815,"the novel role of PFKFB3 in induction of paclitaxel resistance by raising lactate production and activating TLR4 signaling, was characterized."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,27146014,"Data suggest that hepatic glucokinase activity is regulated by reversible binding to specific inhibitor protein glucokinase regulatory protein (GKRP) and by binding to activator proteins such as 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase (PFK2/FBP2); changes in glucokinase expression and activity are associated with poorly controlled type 2 diabetes and nonalcoholic fatty liver disease. [REVIEW]"
https://pharos.nih.gov/idg/targets/Q16875,Q16875,26827442,"Insulin resistance in obese boys leads to up-regulation of INSIG2 gene expression as well as to down-regulation of PFKFB1, PFKFB3, and HK2 genes in the blood cells as compared to obese patients with normal insulin sensitivity."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,26718307,"a novel role of PFKFB3 in glycolytic metabolism and ER stress of OA cartilage explants and chondrocytes"
https://pharos.nih.gov/idg/targets/Q16875,Q16875,26681033,"MicroRNA-26b inhibits osteosarcoma cell migration and invasion by down-regulating PFKFB3 expression"
https://pharos.nih.gov/idg/targets/Q16875,Q16875,26530697,"Our data suggest that chronic inflammation promotes the development of CRC by stimulating aerobic glycolysis and IL-6 is functioning, at least partly, through regulating PFKFB3 at early stage of colorectal cancer (CRC)."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,26337471,"Data indicate that 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase3 (PFKFB3) and phosphofructokinase (PFK1) expression allows discrimination between induced pluripotent stem cells (iPS) and cancer stem cells (CSCs)."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,26322680,"Data show that inhibition of AMP-Activated kinase (AMPK) or 6-phosphofructo-2-kinase-fructose-2,6-biphosphatase 3 (PFKFB3) results in enhanced cell death in mitosis."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,26171876,"Shh regulates PFKFB3 activation in breast cancer cells."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,26093295,"study demonstrated that miR-206 regulated PFKFB3 expression in breast cancer cells, thereby stunting glycolysis, cell proliferation and migration"
https://pharos.nih.gov/idg/targets/Q16875,Q16875,25672572,"A binding site for miR-26b was predicted in the 3'UTR of PFKFB3. miR-26b overexpression repressed PFKFB3 mRNA and protein levels."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,25359860,"Shear stress-mediated repression of endothelial cell metabolism via KLF2 and PFKFB3 controls endothelial cell phenotype."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,25032860,"PFKFB3 promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,24700124,"PFKFB3 is a promising target for the reduction of endothelial glycolysis and its related pathological angiogenesis"
https://pharos.nih.gov/idg/targets/Q16875,Q16875,24633012,"Reduced methylation of PFKFB3 shifted glucose utilization from glycolysis toward the pentose phosphate pathway."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,24515104,"estrogen receptor directly promotes PFKFB3 mRNA transcription"
https://pharos.nih.gov/idg/targets/Q16875,Q16875,24332967,"blockade of PFKFB3 by the small molecule 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO) reduced vessel sprouting."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,24295899,"PFKFB3 regulates oxidative stress homeostasis via its S-glutathionylation in cancer."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,24204309,"Because deregulation of endometrial SRC-2 expression has been associated with common gynecological disorders of reproductive-age women, this signaling pathway, involving SRC-2 and PFKFB3"
https://pharos.nih.gov/idg/targets/Q16875,Q16875,24043759,"Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,23911327,"Study showed that endothelial cells (ECs)relied on glycolysis rather than on oxidative phosphorylation for ATP production and that loss of the glycolytic activator PFKFB3 in ECs impaired vessel formation."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,23548149,"Stress stimuli affect PFKFB3 transcriptional regulation and kinase activation by protein phosphorylation and glycolysis in cancer cells."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,22275052,"Low bisphosphatase activity of PFKFB3 is solely due to the presence of a serine at residue 302."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,22106309,"The breakdown of PFKFB3 during S phase occurs specifically via a distinct residue (S(273)) within the conserved recognition site for SCF-beta-TrCP."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,21987444,"The allelic deletion of PFKFB3 resulted in a decrease of PFKFB3 mRNA level accompanied by a lower PFKFB3 protein level."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,21860432,"inducible PFKFB3 is required for increased growth, metabolic activity and is regulated through active JAK2 and STAT5."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,21402913,"Data demonstrate that PFKFB3 is essential for cell division and that it is regulated by APC/C-Cdh1 and SKP1-CUL1-F (SCF)-beta-TrCP."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,20453422,"Interleukin 6 enhances glycolysis through expression of the glycolytic enzymes hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,20080744,"Glycolysis-promoting enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, isoform 3 (PFKFB3), is degraded by the E3 ubiquitin ligase APC/C-Cdh1."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,19490427,"Our results demonstrate that the splice variant UBI2K4 impedes the tumour cell growth and might serve as a tumour suppressor in astrocytic tumours."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,19473963,"ectopic expression of PFKFB3 increased the expression of several key cell cycle proteins, including cyclin-dependent kinase (Cdk)-1, Cdc25C, and cyclin D3 and decreased the expression of the cell cycle inhibitor p27"
https://pharos.nih.gov/idg/targets/Q16875,Q16875,18039179,"PFK-2/FBPase-2 protein rather than its product fructose 2,6-P(2) is the over-riding determinant of glucose-induced insulin secretion through regulation of glucokinase activity or subcellular targeting."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,17499765,"Results show a direct substrate-substrate interaction in the kinase domain of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3)."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,17143338,"PFKFB-4 and PFKFB-3 genes are expressed in gastric and pancreatic cancer cells, they strongly respond to hypoxia via a HIF-1alpha dependent mechanism and possibly have a significant role in the Warburg effect which is found in malignant cells"
https://pharos.nih.gov/idg/targets/Q16875,Q16875,16698023,"The results obtained highlight the importance of uPFK-2 on the regulation of glycolysis, on cell viability and proliferation and also on anchorage-independent growth."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,16385451,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q16875,Q16875,16311927,"Our results clearly demonstrated the existence of splice isoform of PFKFB-4 mRNA in the DB-1 melanoma cells and its overexpression under hypoxic conditions."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,16306349,"Insulin induces the phosphorylation of PFKFB3 protein, expanding the role of these structurally unique iPFK-2/PFKFB3 isoforms in the metabolic regulation of adipocytes."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,16115917,"Findings support a potential role for the phosphorylation of PFKFB3 protein in the progression of cancer and angiogenesis."
https://pharos.nih.gov/idg/targets/Q16875,Q16875,15896703,"kinase activity of human brain 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase is regulated via inhibition by phosphoenolpyruvate"
https://pharos.nih.gov/idg/targets/Q16875,Q16875,15466858,"pfkfb3 is a hypoxia-inducible gene that is stimulated through HIF interaction with the consensus HRE site in its promoter region"
https://pharos.nih.gov/idg/targets/Q16875,Q16875,12963966,"PFKFB3 cloning and characterization"
https://pharos.nih.gov/idg/targets/Q16875,Q16875,12935880,"The results show the expression of the pfkfb3 gene in and its downregulation during myogenic cell differentiation, the decrease of uPFK-2 isozyme levels, product of pfkfb3 gene, is due to its degradation through the ubiquitin-proteasome pathway"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,28095071,"Mevalonate kinase deficiency (MKD) can be associated with retinitis pigmentosa (RP) and early onset cataract. Most MKD patients developing RP carry the (p.Ala334Thr) mutation."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,27716295,"These findings suggest that rs11066782 in KCTD10, rs11613718 in KCTD10 and rs11067233 in MMAB may contribute to the susceptibility of coronary heart disease by altering plasma HDL-C levels in Han Chinese."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,27213830,"In a cohort of mevalonate kinase deficiency patients, ninety-six (84%) of the patients harbored at least 1 p.V377I mutation, 14 (12%) of which were homozygous. The second most frequent mutation was p.I268T, occurring in 29 (25%) of the patients. None of them were p.I268T homozygous. A p.C152Y mutation was found in 1 patient."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,26794421,"this study extends the mutation spectrum of MVK; MVK protein stability and correct folding might be the molecular mechanism causing disseminated superficial actinic porokeratosis"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,26420133,"predictive analysis of mutations in MVK to predict disease severity"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,25982894,"Wild-type MK and the variant V261A, which is associated with HIDS, were recombinantly expressed in Escherichia coli. Enzyme activity was determined by formation of MVAP over time"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,25059119,"study reports a novel mutation of the MVK gene in Chinese patients with disseminated superficial actinic porokeratosis (DSAP); result confirms the involvement of MVK gene in DSAP"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,25053464,"results from this 4 generation family imply a causal relationship between MVK and perokeratosis."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,24781643,"mutations are responsible for porokeratosis of Mibelli development in Chinese families"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,24708999,"The testing for the Hyper IgD Syndrome was positive for the pV377I/c.1129 G>A heterozygosity in a patient with periodic fever."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,24551296,"Report a novel missense mutation in mevalonate kinase responsible for disseminated superficial actinic porokeratosis."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,24411001,"Results suggest that the effects of MVK mutations in Behcet's disease could be an additional genetic susceptibility factor for the patients with neurological involvement."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,24084495,"In the current article, we add another phenotype to the spectrum of diverging disorders associated with mutations in MVK."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,24064360,"These results suggest that hCG-induced down-regulation of LHR mRNA expression is mediated by activation of cAMP/PKA/ERK pathways to increase miR-122 expression, which then increases LRBP expression through the activation of SREBPs."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,24008101,"study reportstwo novel mutations of the MVK gene in Chinese patients with disseminated superficial actinic porokeratosis"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,23834120,"Results identify a novel frameshift mutation in this gene implicated in disseminated superficial actinic porokeratosis in 4 Chinese families"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,23333304,"HIV-1 Vif upregulates the expression of mevalonate kinase (MVK) in Vif-expression T cells"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,22983302,"MVK has a role in regulating calcium-induced keratinocyte differentiation and could protect keratinocytes from apoptosis induced by type A ultraviolet radiation."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,22271696,"This atypical presentation of MA suggests that it should be included in the differential diagnosis of unclassified patients with psychomotor retardation, failure to thrive or ataxia, even in the absence of febrile episodes."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,22159817,"Novel mutations of MVK gene in Japanese family members affected with hyperimmunoglobulinemia D and periodic fever syndrome. This is the first case in which exon skipping mutation of the MVK gene has been certainly identified at the genomic DNA level."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,22038276,"hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) patients carried 11 different MVK mutations mostly in compound heterozygosity; the most frequent mutation was p.Val377Ile; in Germany, the incidence of HIDS is very low"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,21548022,"Significant liver disease in a patient with Y116H mutation in the MVK gene."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,21430599,"The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,21147848,"data show that LH-regulated ERK1/2 signaling is required for the LRBP-mediated down-regulation of LHR mRNA"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,21124859,"Results support that deleterious copy number alterations in MVK, NLRP3 and TNFRSF1A are rare or absent from the mutational spectrum of hereditary recurrent fevers."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,20972250,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,20814828,"Report mevalonate kinase deficiency compromized fiberoblast geranylgeranylation of RhoA and Rac1."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,20714348,"Meta-analysis and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,20677014,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,20430392,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,20194276,"A novel missense mutation in mevalonate kinase (Tyr116His) is associated with mevalonate kinase deficiency and dyserythropoietic anemia."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,20160193,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,20159775,"These data suggest MMAB is the most likely gene influencing high-density lipoprotein-cholesterol levels at MMAB-MVK locus."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,19605566,"For the SNPs KCTD10_i5642G-->C and MVK_S52NG-->A, homozygotes for the major alleles (G) had lower HDL-cholesterol concentrations than did carriers of the minor alleles (P = 0.005 and P = 0.019, respectively)."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,19605566,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,19487539,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,19148283,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,18941711,"homozygosity for the mutation of the MVK gene has been reported in an Asian patient, and indicated a need for differentiation."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,18660489,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,18512793,"Observational study of gene-disease association and genetic testing. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,18494797,"an intact active site of MVK is required for its binding to rat LHR mRNA and for its translational suppressor function"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,18302342,"Several hydrophobic amino acid side chains are positioned near the polyisoprenoid chain of FSP & their functional significance has been evaluated in mutagenesis experiments with human MK, which exhibits highest reported sensitivity to feedback inhibition."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,18193043,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,17213252,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,16234278,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,15188372,"Mutations in the coding region of the MVK gene were detected in 6 hyperimmunoglobulinemia D patients, and the most common mutation was V377I."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,15037710,"Mevalonic aciduria, with psychomotor retardation, cerebellar ataxia, recurrent fever, and death in early childhood, and hyper-immunoglobulin D syndrome, with recurrent fever attacks without neurologic symptoms, are caused by mevalonate kinase deficiency"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,14749336,"LH receptor mRNA-binding protein (LRBP) is a a novel trans-factor for luteinizing hormone receptor mRNA from ovary."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,14730012,"The subcellular localisation of human mevalonate kinase (MK) use a variety of biochemical and microscopical techniques."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,12634869,"Observational study of genotype prevalence. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q03426,Q03426,12634869,"Carrier frequency of 1:65 overestimates disease frequency, probably due to a reduced penetrance of V377I homozygosity."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,12477733,"Isoprenoid and cholesterol biosynthesis still occurs in cells from mevalonate kinase-deficient patients."
https://pharos.nih.gov/idg/targets/Q03426,Q03426,12444096,"Mutations of MVK found in hyper-IgD and periodic fever syndrome patients affect the stability and/or maturation of MVK in vitro in a temperature-sensitive manner and may explain the chain of events leading to episodic inflammation and fever."
https://pharos.nih.gov/idg/targets/O60331,O60331,27780861,"These data suggest that S6K1-mediated PIPKIgamma90 phosphorylation regulates cell migration and invasion by controlling PIPKIgamma90 degradation."
https://pharos.nih.gov/idg/targets/O60331,O60331,27557663,"PIPKIgammai5, NEDD4-1, and Mig6 form a novel molecular nexus that controls EGFR activation and downstream signaling."
https://pharos.nih.gov/idg/targets/O60331,O60331,27043085,"FAK sustained the active integrin conformation by maintaining talin association with Rab11 endosomes in a type I phosphatidylinositol phosphate kinase (PIPKIgamma)-dependent manner."
https://pharos.nih.gov/idg/targets/O60331,O60331,26916822,"PIPKIgamma and INPP5E localize to the centrosome and coordinate the initiation of ciliogenesis."
https://pharos.nih.gov/idg/targets/O60331,O60331,26149501,"results suggested that Akt-mediated PIP5Kgamma90 S555 phosphorylation is a novel regulatory point for talin binding to control PIP2 level at the FAs, thereby modulating FA dynamics and cell motility."
https://pharos.nih.gov/idg/targets/O60331,O60331,26070568,"Loss of PIPKIgamma or its focal adhesion-targeting variant, PIPKIgammai2, impaired PI3K/Akt activation upon stimulation with growth factors or extracellular matrix proteins in different tumor cells."
https://pharos.nih.gov/idg/targets/O60331,O60331,24434581,"PIPKIgamma binds to the cryptic polo-box domain of PLK4 and reduces the kinase activity of PLK4."
https://pharos.nih.gov/idg/targets/O60331,O60331,24151076,"This study uncovers a novel mechanism where a phosphoinositide-synthesizing enzyme, PIPKIgammai2, functions with the proto-oncogene Src, to regulate oncogenic signaling"
https://pharos.nih.gov/idg/targets/O60331,O60331,22049025,"PIPKIgamma and phosphatidyl inositol phosphate pools at nascent E-cadherin contacts cue Exo70 targeting and orient the tethering of exocyst-associated E-cadherin"
https://pharos.nih.gov/idg/targets/O60331,O60331,21931851,"PIPKIgamma positively regulates focal adhesion dynamics and cancer invasion, most probably through PIP-mediated vinculin activation."
https://pharos.nih.gov/idg/targets/O60331,O60331,21303971,"A novel mechanism in which PIPKIgamma expression and catalytic activity enhance beta-catenin nuclear translocation and expression of its target genes to promote tumorigenic phenotypes."
https://pharos.nih.gov/idg/targets/O60331,O60331,21216957,"EZH2 regulates neuronal differentiation of mesenchymal stem cells through PIP5K1C-dependent calcium signaling."
https://pharos.nih.gov/idg/targets/O60331,O60331,20668706,"SIRT1 deacetylated two specific lysine residues (K265/K268) in PIP5Kgamma and enhanced PIP5Kgamma enzyme activity."
https://pharos.nih.gov/idg/targets/O60331,O60331,20435073,"Data show that glycation end products (AGE) increase PIP2 production, arachidonic acid release and reactive oxygen species via cytosolic phospholipase A2 activation, and inhibit Na+ K+ ATPase surface expression via PIP5Kgamma."
https://pharos.nih.gov/idg/targets/O60331,O60331,20074374,"Type I gamma phosphatidylinositol phosphate kinase modulates invasion and proliferation and its expression correlates with poor prognosis in breast cancer."
https://pharos.nih.gov/idg/targets/O60331,O60331,19903820,"multiple interactions between PIPKI gamma-p90 and AP-2 lead to spatiotemporally controlled PI(4,5)P(2) synthesis during clathrin-mediated synaptic vesicle endocytosis"
https://pharos.nih.gov/idg/targets/O60331,O60331,19548880,"Data have identified two novel C-terminal splice variants of PIPKIgamma that are expressed in multiple tissue types, display PIPK activity in vitro abd have distinct subcellular targeting."
https://pharos.nih.gov/idg/targets/O60331,O60331,18187620,"Knockdown of phosphatidylinositol-4-phosphate 5-kinase, type I, gamma (PIP5K1C) by siRNA inhibits HIV-1 replication in HeLa-derived TZM-bl cells"
https://pharos.nih.gov/idg/targets/O60331,O60331,18073347,"Type I phosphatidylinositol-4-phosphate-5-kinase (PI5KI) alpha and gamma isoforms were identified as the enzymes responsible for PIP2 synthesis in natural killer cells."
https://pharos.nih.gov/idg/targets/O60331,O60331,17928408,"identify a previously unknown function for PIPKIgamma661 as a novel component of the backness signal that regulates rear retraction during chemotaxis"
https://pharos.nih.gov/idg/targets/O60331,O60331,17701898,"A single homozygous substitution of aspartic acid with asparagine at amino acid 253 in PIP5K1C causes lethal contractural syndrome type 3>"
https://pharos.nih.gov/idg/targets/O60331,O60331,17635937,"PIP5K1C is required for EGF-stimulated diectional cell migration."
https://pharos.nih.gov/idg/targets/O60331,O60331,17261850,"results reveal a novel mechanism where PIPKIgamma serves as a scaffold, linking E-cadherin to adaptor complexes and the trafficking machinery, and a regulator of trafficking events via the spatial generation of phosphatidylinositol-4,5-bisphosphate"
https://pharos.nih.gov/idg/targets/O60331,O60331,17229424,"Localization of ezrin in adherens junctions is regulated by Rac in a manner involving PIPK."
https://pharos.nih.gov/idg/targets/O60331,O60331,16880396,"a positive feedback loop consisting of endocytic cargo proteins, AP-2mu, and PIPK type I which may provide a specific pool of PI(4,5)P(2) dedicated to clathrin/AP-2-dependent receptor internalization"
https://pharos.nih.gov/idg/targets/O60331,O60331,16707488,"PIPKIgamma661 enzyme is involved in the AP2-mediated endocytosis of transferrin."
https://pharos.nih.gov/idg/targets/O60331,O60331,15611330,"The short splice variant of type I phosphatidylinositol 4-phosphate 5-kinase gamma (PIP5KIgamma87) as the major contributor of the PIP(2) pool that supports G protein-coupled receptor (GPCR)-mediated IP(3) generation."
https://pharos.nih.gov/idg/targets/O60331,O60331,12422220,"we show that the type I phosphatidylinositol phosphate kinase isoform-gamma 661 (PIPKI gamma 661), an enzyme that makes PtdIns(4,5)P(2), is targeted to focal adhesions by an association with talin"
https://pharos.nih.gov/idg/targets/O60331,O60331,12422219,"we show that the predominant brain splice variant of PtdInsPKI gamma (PtdInsPKI gamma-90) binds, by means of a short carboxy-terminal peptide, to the FERM domain of talin, and is strongly activated by this interaction"
https://pharos.nih.gov/idg/targets/O60331,O60331,9628581,"This publication discusses the initial identification of human phosphatidylinositol-4-phosphate 5-kinase type-1 gamma (AB011161, KIAA0589)."
https://pharos.nih.gov/idg/targets/O60331,O60331,9535851,"This publication discusses cloning of mouse phosphatidylinositol-4-phosphate 5-kinase type-1 gamma."
https://pharos.nih.gov/idg/targets/P19367,P19367,29054762,"HK1 protein levels was decreased after luteolin treatment and partly restored when co-treated with luteolin and miR-34a inhibitor."
https://pharos.nih.gov/idg/targets/P19367,P19367,27282571,"The pathogenic nature of the identified missense mutations was confirmed by biochemical and 3-dimensional structural analysis. The effects of the novel splice site mutation c.873-2A>G were studied at the level of pre-mRNA processing, and confirmed at the protein level. Four of the 6 mutations studied were new."
https://pharos.nih.gov/idg/targets/P19367,P19367,27012210,"4-hydroxytamoxifen resistance in breast cancer cells is suppressed by curcumin, which targets the SLUG/Hexokinase 2 pathway"
https://pharos.nih.gov/idg/targets/P19367,P19367,26889748,"STAT3 expression is upregulated in both HBV- and HCV-related hepatocellular carcinoma (HCC), while hexokinase II (HK-II) is predominantly upregulated and correlated to STAT3 in HBV-related HCC"
https://pharos.nih.gov/idg/targets/P19367,P19367,26855992,"HK1 and HK2 expression alterations were detected, that could be explained by common deregulation mechanisms of these genes in colorectal tumors. The HK3 expression level was significantly increased in 60% of samples."
https://pharos.nih.gov/idg/targets/P19367,P19367,26822750,"Russe type hereditary motor and sensory neuropathy belongs to the most frequent types of hereditary neuropathy in the Czech Republic, which affects Roma and is caused by a HK1 mutation."
https://pharos.nih.gov/idg/targets/P19367,P19367,26476538,"Data suggest that overexpression of hexokinase 1 (HK1) may act as a significant biomarker of poor prognosis for patients with colorectal cancer (CRC)."
https://pharos.nih.gov/idg/targets/P19367,P19367,26464675,"Our results suggest that overexpression of PKM2 and HK1, especially the latter, significantly associates with lymphatic metastasis, advanced clinical staging and unfavorable prognosis in gastric cancer."
https://pharos.nih.gov/idg/targets/P19367,P19367,26427411,"Data indicate a missense mutation in hexokinase 1 (HK1) c.2539G > A, p.Glu847Lys, tracking with disease in all affected family members."
https://pharos.nih.gov/idg/targets/P19367,P19367,25904018,"HK1 expression is highly enriched in neurons compared to astrocytes in the cerebral cortex."
https://pharos.nih.gov/idg/targets/P19367,P19367,25766729,"The transport of glucose across the cell membrane by glucose transporters (GLUTs) and intracellular phosphorylation by hexokinases (HKs) are the initial steps of the glycolytic pathway."
https://pharos.nih.gov/idg/targets/P19367,P19367,25602755,"HK-1 plays a non-metabolic role in HIV-1 infected macrophages by binding to mitochondria thereby maintaining mitochondrial integrity."
https://pharos.nih.gov/idg/targets/P19367,P19367,25602755,"HIV-1 modulates subcellular localization of HK1 favoring increased association of HK1 with mitochondria, and HIV-1 protein Vpr induces accumulation of HK1 from the cytoplasm to the mitochondria"
https://pharos.nih.gov/idg/targets/P19367,P19367,25501281,"The present study was designed to evaluate the involvement of hexokinase and CPT-1 in the cell growth and proliferation of human prostate cancer cell lines, PC3, and LNCaP-FGC-10."
https://pharos.nih.gov/idg/targets/P19367,P19367,25316723,"Here, we identified HK1 as a novel causative gene for adRP. This is the first report that associates the glucose metabolic pathway with human retinal degenerative disease, suggesting a potential new disease mechanism."
https://pharos.nih.gov/idg/targets/P19367,P19367,25190649,"HK1 is expressed in retina, with two abundant isoforms expressed at similar levels. The Glu847Lys mutation is located at a highly conserved position in the protein, outside the catalytic domains."
https://pharos.nih.gov/idg/targets/P19367,P19367,24560881,"An increased ratio of HK1 protein in the extrasynaptic membrane/mitochondrial fraction of prefronal cortex was found in subjects with schizophrenia, suggesting that HK1 protein is abnormally partitioned in this illness"
https://pharos.nih.gov/idg/targets/P19367,P19367,24018046,"Hexokinase 1 (HK1) is a mitochondrial protein that controls the tramsmembrane potential and blocks apoptotic signals at the mitochondria."
https://pharos.nih.gov/idg/targets/P19367,P19367,23996628,"We detected mutation in the NDRG1 gene in two families and mutation in the HK1 gene in the other two families. These mutations cause Charcot-Marie-Tooth Disease, Type 4D and Charcot-Marie-Tooth disease, type 4g, respectively."
https://pharos.nih.gov/idg/targets/P19367,P19367,23874603,"HIV-1 modulates subcellular localization of HK1 favoring increased association of HK1 with mitochondria, and HIV-1 protein Vpr induces accumulation of HK1 from the cytoplasm to the mitochondria"
https://pharos.nih.gov/idg/targets/P19367,P19367,23859901,"Dominant, diazoxide-responsive HI in this family maps to a novel locus on Chr10q21-22. Disease-associated variants were found in non-coding regions of HK1"
https://pharos.nih.gov/idg/targets/P19367,P19367,23427181,"A genetic association of myelomeningocele in Chile found polymorphisms for HK1."
https://pharos.nih.gov/idg/targets/P19367,P19367,23164509,"A key K8/K18 regulation of glucose metabolism in normal and cancerous hepatic cells through differential modulations of mitochondrial hexokinase status and insulin-mediated signaling."
https://pharos.nih.gov/idg/targets/P19367,P19367,23068103,"The screening for novel Parkin substrate(s) identified mitochondrial hexokinase I (HKI) as a candidate."
https://pharos.nih.gov/idg/targets/P19367,P19367,22978647,"Data indicate that the most frequent form is SH3TC2 gene (CMT4C; 57.14%), followed by HK1 gene causative of CMT4G (CMT4G/HMSN-Russe 25%) and NDRG1 p.R148X in CMT type 4D (CMT4D/HMSN-Lom; 17.86%)."
https://pharos.nih.gov/idg/targets/P19367,P19367,22018957,"This study proposed that HK1 mitochondrial detachment could be linked to these disorders through impaired energy metabolism, increased vulnerability to oxidative stress, and impaired brain growth and development."
https://pharos.nih.gov/idg/targets/P19367,P19367,21781351,"An association is noted between the rs7072268 T-allele in HK1 and an increased blood glucose in non-diabetic individuals and a nominal association with type 2 diabetes prior to Bonferroni correction."
https://pharos.nih.gov/idg/targets/P19367,P19367,21179577,"Abeta-induced cellular redistribution and inactivation of neuronal HKI play important roles in oxidative stress and neurodegeneration in Alzheimer's disease"
https://pharos.nih.gov/idg/targets/P19367,P19367,20877624,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P19367,P19367,20858683,"Observational study, meta-analysis, and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P19367,P19367,20732627,"Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P19367,P19367,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P19367,P19367,20347420,"FimA strengthens the VDAC1-hexokinase(I and II) interaction and prevents dissociation of hexokinase from VDAC1 triggered by apoptotic stimuli."
https://pharos.nih.gov/idg/targets/P19367,P19367,19651813,"HK1 may influence A1C levels through its anemic effect or its effect on glucose metabolism in erythrocytes, which may have implications for type 2 diabetes diagnosis and care."
https://pharos.nih.gov/idg/targets/P19367,P19367,19651813,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P19367,P19367,19608687,"reduced erythroid transcription of HK1 together with aberrant splicing of both hexokinase-1 and red cell specific-hexokinase results in hexokinase deficiency and mild chronic hemolysis."
https://pharos.nih.gov/idg/targets/P19367,P19367,19554504,"The expression pattern of HK1 is reported in newly diagnosed esophageal adenocarcinoma by means of immunohistochemistry."
https://pharos.nih.gov/idg/targets/P19367,P19367,19536174,"The comprehensive sequencing analysis and fine mapping approximately 26 kb of fully characterised sequence spanning the upstream exons of Hexokinase 1 (HK1), is reported."
https://pharos.nih.gov/idg/targets/P19367,P19367,19165527,"Using shotgun mass spectrometry, we found this protein differentially expressed in the dorsolateral prefrontal cortex from patients with schizophrenia."
https://pharos.nih.gov/idg/targets/P19367,P19367,19096518,"Glycated hemoglobin levels are associated with genetic variation of HK1."
https://pharos.nih.gov/idg/targets/P19367,P19367,19096518,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P19367,P19367,19049977,"results point to HK-I and HK-II as promoting tumor cell survival through binding to VDAC1, thereby inhibiting cytochrome c release and apoptotic cell death."
https://pharos.nih.gov/idg/targets/P19367,P19367,19034380,"This protein has been found differentially expressed in the temporal lobe from patients with schizophrenia."
https://pharos.nih.gov/idg/targets/P19367,P19367,18308720,"interference with the binding of Hexokinase-I to mitochondria by VDAC1-derived peptides may offer a novel strategy by which to potentiate the efficacy of conventional chemotherapeutic agents"
https://pharos.nih.gov/idg/targets/P19367,P19367,18212354,"single nucleotide polymorphisms on gene involved with glucose metabolism and obesity may be associated with increased susceptibility to spina bifida"
https://pharos.nih.gov/idg/targets/P19367,P19367,17494625,"Neither human hexokinase-1 nor human inorganic pyrophosphatase expression segregated concordantly with human cytoplasmic glutamic-oxaloacetic transaminase expression."
https://pharos.nih.gov/idg/targets/P19367,P19367,17080299,"The role of the HK1 interdomain alpha-helix at the interdomain signal transduction was studied."
https://pharos.nih.gov/idg/targets/P19367,P19367,16385451,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P19367,P19367,16166083,"Glucose 6-phosphate binds to human brain hexokinase in mitochondria"
https://pharos.nih.gov/idg/targets/P19367,P19367,12432216,"REVIEW: Gene expression and biological significance of HK1 and HKR isoforms of hexokinase in erythroid cells."
https://pharos.nih.gov/idg/targets/P78356,P78356,27132569,"PIP4K2B couples the cellular GTP concentration to the levels of the stress-regulated phosphoinositide PtdIns5P, to impact on tumor cell growth."
https://pharos.nih.gov/idg/targets/P78356,P78356,25728392,"Suppression of PIP4K expression selectively prevents tumor cell growth in vitro and prevents tumor development in mice that have lost the tumor suppressor p53. (Review)"
https://pharos.nih.gov/idg/targets/P78356,P78356,24209622,"Knocking down PI5P4Kalpha and beta in a breast cancer cell line bearing an amplification of the gene encoding PI5P4K beta and deficient for p53 impaired growth on plastic and in xenografts."
https://pharos.nih.gov/idg/targets/P78356,P78356,24127122,"Association between low PIP4K2B expression and poor patient survival.Analysis of gene expression datasets confirmed the association between low PIP4K2B and low CDH1expression."
https://pharos.nih.gov/idg/targets/P78356,P78356,21514270,"These results indicate that PIPKIIbeta-mediated PI(4,5)P(2) signaling is important for E-cadherin upregulation and inhibition of cellular motility induced by VDR activation."
https://pharos.nih.gov/idg/targets/P78356,P78356,17303380,"PIPkin IIbeta is expressed as a tagged protein, is active as revealed by immunoprecipitation and enzyme assay, and that cellular fractionation reveals that it is indeed nuclear."
https://pharos.nih.gov/idg/targets/P42338,P42338,29203244,"Taken together, our findings suggested that miR-126 alleviates ox-LDL-induced HUVECs injury through restoring autophagy flux via repressing PI3K/Akt/mTOR pathway, and further implicate the potential therapeutic targets to reverse atherosclerosis."
https://pharos.nih.gov/idg/targets/P42338,P42338,29046393,"data suggest that Rac1 can potentiate the activation of PI3Kbeta by GPCRs through an indirect mechanism, by driving the formation of macropinosomes that serve as signaling platforms for Gbetagamma coupling to PI3Kbeta."
https://pharos.nih.gov/idg/targets/P42338,P42338,28783168,"We further demonstrate that loss of one allele of PTEN is sufficient to shift isoform dependency from p110alpha to p110beta in vivo. These results provide insight into the molecular mechanism by which ErbB2-positive breast cancer escapes p110alpha inhibition."
https://pharos.nih.gov/idg/targets/P42338,P42338,28733463,"TLR4 and C5aR crosstalk in dendritic cells induces a core regulatory network of RSK2, PI3Kbeta, SGK1, and FOXO transcription factors."
https://pharos.nih.gov/idg/targets/P42338,P42338,28712871,"Taken together, these results suggested that the PI3K/Akt/FoxO pathway negatively regulates the BITC-induced antiproliferation in human colorectal cancer cells."
https://pharos.nih.gov/idg/targets/P42338,P42338,28578353,"these data highlight a key role of the P2Y1/PI3Kbeta axis in endothelial cell proliferation downstream of ecto-F1-ATPase activation by apoA-I. Pharmacological targeting of this pathway could represent a promising approach to enhance vascular endothelial protection."
https://pharos.nih.gov/idg/targets/P42338,P42338,28442344,"Likewise, inhibiting the PI3K-AKT-mTOR pathway with the ATP-competitive mTOR inhibitor PP242 reduced CD44 protein in SNU-423 and SNU-449 cells without altering CD44 mRNA levels."
https://pharos.nih.gov/idg/targets/P42338,P42338,28339079,"A combination of CAL-101, a p110delta-specific inhibitor, with bortezomib treatment of HT/EBV cells synergistically suppressed proliferation, reduced levels of drug resistance-related proteins, activated caspase cleavage and recovered expression of p110a/p110b."
https://pharos.nih.gov/idg/targets/P42338,P42338,28302479,"CONCLUSION: MiR-126 down-regulated S1PR2 and then prevented the activation of PI3K/AKT signaling pathway, which ultimately could damage intestinal mucosal barrier function."
https://pharos.nih.gov/idg/targets/P42338,P42338,28122716,"We demonstrated trophoblast cytoprotection by intervention with supraphysiological concentrations of relaxin, a process in part mediated through the PI3-kinase-Akt/PKB cell survival pathway. These results provide further rationale for clinical investigation of relaxin as a potential therapeutic in preeclampsia."
https://pharos.nih.gov/idg/targets/P42338,P42338,27806189,"People with allelic variation in four genes related to cardiovascular diseases and metabolism were more likely to die: apolipoprotein (APO)C1 GG and AG carriers, APOE varepsilon4 carriers, insulin-degrading enzyme (IDE) TC carriers, and phosphatidylinositol 3-kinase (PI3KCB) GG carriers."
https://pharos.nih.gov/idg/targets/P42338,P42338,27481935,"These findings highlight the importance of the hVps34-SGK3 pathway in counteracting inhibition of PI3K/Akt signalling."
https://pharos.nih.gov/idg/targets/P42338,P42338,27449010,"In acute schizophrenia patients, the mRNA expression levels of DRD2 and PI3KCB were significantly lower than those in the healthy controls, while the AKT1 mRNA levels were significantly higher than those in the healthy controls."
https://pharos.nih.gov/idg/targets/P42338,P42338,27422603,"In conclusion, our data suggest that SIRPalpha signaling through SHP-2-PI3K-Akt2 strongly influences osteoblast differentiation from bone marrow stromal cells."
https://pharos.nih.gov/idg/targets/P42338,P42338,27356299,"Cholesterol crystals activate specific cell signalling pathways which drive the production of inflammatory cytokines and degradative enzymes known to contribute to disease initiation and progression and are dependent on activation of Syk and PI3K"
https://pharos.nih.gov/idg/targets/P42338,P42338,27190335,"Single nucleotide polymorphism in the PIK3CB gene is associated with inflammation in chronic kidney disease."
https://pharos.nih.gov/idg/targets/P42338,P42338,27184134,"MYC gene copies, centromere status and PI3K activation may adversely impact trastuzumab treated metastatic breast cancer patient outcome and seem worthy validating in larger series."
https://pharos.nih.gov/idg/targets/P42338,P42338,27176780,"PI3K isoforms p110a, p110b and p110g were selectively inhibited and effects on proliferation and migration assessed. Inhibition increased transcription of cancer stem cell genes in both models, suggesting de-differentiation in response to blockade of the PI3K/AKT/mTOR signalling axis."
https://pharos.nih.gov/idg/targets/P42338,P42338,27169346,"The protein kinase activity of PI3K phosphorylates serine residue 70 on Src to enhance its activity and induce EGFR transactivation following betaAR stimulation."
https://pharos.nih.gov/idg/targets/P42338,P42338,27076174,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,27048245,"Our study demonstrates that the IGF1R/p110b/AKT/mTOR axis confers resistance to BYL719 in PIK3CA mutant breast cancers."
https://pharos.nih.gov/idg/targets/P42338,P42338,27013201,"High PIK3CB expression is associated with breast Tumor Metastasis."
https://pharos.nih.gov/idg/targets/P42338,P42338,26956052,"High expression level of PIK3CB is associated with recurrence in glioblastoma."
https://pharos.nih.gov/idg/targets/P42338,P42338,26884879,"Combined detection of p110alpha and p110beta is helpful to determine the neoplastic potential of colorectal villous adenoma and serrated adenoma."
https://pharos.nih.gov/idg/targets/P42338,P42338,26792722,"Our data suggested a potential role of Rab11-FIP2 in tumor progression and provided novel insights into the mechanism of how Rab11-FIP2 positively regulated cell migration and invasion in CRC cells."
https://pharos.nih.gov/idg/targets/P42338,P42338,26780727,"Mefloquine acts on gastric cancer cells via suppressing PI3K/Akt/mTOR pathway."
https://pharos.nih.gov/idg/targets/P42338,P42338,26775845,"Our results demonstrated the pro-inflammatory and angiogenic effects of PlGF on HIMECs in IBD through activation of PI3K/Akt signaling pathway. PlGF/PI3K/Akt signaling may serve as a potential therapeutic target for IBD."
https://pharos.nih.gov/idg/targets/P42338,P42338,26773499,"The data provide the first evidence that SJP protects SH-SY5Y cells against 6-OHDA toxicity possibly by inhibiting MAPK and NF-kappaB and activating PI3K/Akt signaling pathways."
https://pharos.nih.gov/idg/targets/P42338,P42338,26772887,"Our study demonstrates that CSE/H2S system is regulated by miR-216a, and regulates ABCA1-mediated cholesterol efflux and cholesterol levels through the PI3K/AKT pathway."
https://pharos.nih.gov/idg/targets/P42338,P42338,26759240,"PIK3CB D1067Y mutant behaved as an oncogene and transformed normal cells, an activity that was enhanced by PTEN depletion."
https://pharos.nih.gov/idg/targets/P42338,P42338,26747178,"PIK3CA and PIK3CB significantly increase multidrug resistance of CRC cells in vivo."
https://pharos.nih.gov/idg/targets/P42338,P42338,26729197,"upregulation of miR-31 targeting ITGA5 may suppress tumor cell invasion and metastasis by indirectly regulating PI3K/AKT signaling pathway in human SGC7901 GC cells"
https://pharos.nih.gov/idg/targets/P42338,P42338,26699864,"The results of this study demomstrated that PI3 kinase mutations as novel prognostic markers in gliomas."
https://pharos.nih.gov/idg/targets/P42338,P42338,26645485,"inhibition of Rac or PI3K impedes adhesion of breast cancer cells and melanoma cells to the brain endothelium."
https://pharos.nih.gov/idg/targets/P42338,P42338,26590370,"Cav-1 expression may be especially up-regulated in larger uveal melanomas. As it was correlated with PI3K expression and vasculogenic mimicry (VM) in this series of uveal melanoma, Cav-1 might induce the formation of VM via the PI3K-signalling cascade."
https://pharos.nih.gov/idg/targets/P42338,P42338,26549638,"our findings provide for the first time that PF-04691502 inhibits the constitutively activated PI3K/mTOR pathway in aggressive B-cell NHL cell lines associated with inhibition of cell cycle progression, cell proliferation and promotion of apoptosis."
https://pharos.nih.gov/idg/targets/P42338,P42338,26500061,"Results indicate that p110alpha primarily mediates PI3K/AKT signaling in HER2+ PTEN deficient breast tumors whereas p110beta conditionally mediates HER2/PI3K signaling in the absence of p110alpha."
https://pharos.nih.gov/idg/targets/P42338,P42338,26458524,"miR-130a plays a critical role in attenuation of cardiac dysfunction and remodeling after myocardial infarction. The mechanisms involve activation of PI3K/Akt signaling via suppression of PTEN expression."
https://pharos.nih.gov/idg/targets/P42338,P42338,26318878,"expression levels distinguish chronic lymphocytic leukemia B cells from normal B lymphocytes"
https://pharos.nih.gov/idg/targets/P42338,P42338,26270987,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,26206180,"Collectively, these results highlight the cleavage of shp-1 as a critical event in reprogramming LPS pathway to promote both neutrophil recruitment and survival and provide a novel mechanistic framework for the investigation of the post-traumatic MODS."
https://pharos.nih.gov/idg/targets/P42338,P42338,26122654,"TNFR1 Regulates Ovarian Cancer Cell Tumorigenicity Through PIK3CB-p110Beta"
https://pharos.nih.gov/idg/targets/P42338,P42338,26075907,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,25982275,"Our findings provide new insight into the genetic mechanisms underlying PI3K pathway activation in human tumors and indicate that PIK3Cb(D1067V) is a rational therapeutic target in certain cancers."
https://pharos.nih.gov/idg/targets/P42338,P42338,25605332,"Overexpression of P110BETA accelerated differentiation in C2C12 cells and primary human myoblasts through an Akt-dependent mechanism, while expression of kinase-inactive P110BETA had the opposite effect."
https://pharos.nih.gov/idg/targets/P42338,P42338,25550888,"The expression of both PIK3CA and PIK3CB is increased and related to the development and progress of colorectal carcinoma and multidrug resistance"
https://pharos.nih.gov/idg/targets/P42338,P42338,25473181,"PIK3CB is critically involved in response to preoperative radiotherapy and may serve as a novel target for therapeutic intervention."
https://pharos.nih.gov/idg/targets/P42338,P42338,25398937,"Platelet PI3Kbeta and GSK3 regulate thrombus stability at a high shear rate."
https://pharos.nih.gov/idg/targets/P42338,P42338,25348717,"PI3Kbeta regulates the nuclear envelope through upstream regulation of RCC1 and Ran"
https://pharos.nih.gov/idg/targets/P42338,P42338,25139353,"Phosphoinositide 3-kinase beta mediates microvascular endothelial repair of thrombotic microangiopathy."
https://pharos.nih.gov/idg/targets/P42338,P42338,25104021,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,24995579,"The score was higher in metastatic compared to primary lesions (P<0.001) and was significantly associated with potential measures of PI3K activation"
https://pharos.nih.gov/idg/targets/P42338,P42338,24958106,"Results show that cell stimulation promotes p110alpha and p110beta association, demonstrating oligomerization of PI3K catalytic subunits within cells."
https://pharos.nih.gov/idg/targets/P42338,P42338,24284056,"PI3Kbeta expression was elevated significantly in lung squamous cell carcinomas (SCC) compared with adenocarcinomas"
https://pharos.nih.gov/idg/targets/P42338,P42338,24223153,"HSP20 directly associates with PI3K subunits and suppresses its activity in hepatocellular carcinoma, resulting in the inhibition of the AKT pathway, and subsequently decreasing the growth of hepatocellular carcinoma."
https://pharos.nih.gov/idg/targets/P42338,P42338,24114431,"genetic association study in a population in Sweden: Data suggest that, among patients with growth hormone deficiency treated with hormone replacement therapy, homozygotes with SNP rs361072 in PIK3CB respond better than those with the major allele."
https://pharos.nih.gov/idg/targets/P42338,P42338,24073214,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,23734178,"Data sugget that the E633K mutant activates p110beta by enhancing its basal association with membranes."
https://pharos.nih.gov/idg/targets/P42338,P42338,23568272,"p110alpha acts as a negative regulator of beta cell exocytosis and insulin secretion, while p110beta is a positive regulator of insulin secretion through a mechanism separate from its catalytic activity"
https://pharos.nih.gov/idg/targets/P42338,P42338,23434372,"In mammalian cells, p110beta acts as a molecular sensor for growth factor availability and induces autophagy by activating a Rab5-mediated signaling cascade."
https://pharos.nih.gov/idg/targets/P42338,P42338,23318440,"Data indicate that phosphatidylinositol 3'-kinase (PI3K) alpha and beta p110 isoforms of PI3K are broadly expressed in myeloma."
https://pharos.nih.gov/idg/targets/P42338,P42338,23301033,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,23251686,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,23215766,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,23211529,"Disrupting the p110beta-Gbetagamma interaction by mutation or with a cell-permeable peptide inhibitor blocked the transforming capacity of PI3Kbeta in fibroblasts and reduced the proliferation, chemotaxis, and invasiveness"
https://pharos.nih.gov/idg/targets/P42338,P42338,23077641,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,23051731,"p110beta was activated near metaphase and controlled dynein/dynactin and Aurora B activities in kinetochores, chromosome segregation, and optimal function of the spindle checkpoint"
https://pharos.nih.gov/idg/targets/P42338,P42338,22984590,"Phosphoinositide 3-kinase C2beta regulates RhoA and the actin cytoskeleton through an interaction with Dbl"
https://pharos.nih.gov/idg/targets/P42338,P42338,22701645,"Combined blockade of P2Y12, P2Y1 and PI3-kinase p110beta fully prevents platelet and leukocyte activation during hypothermic extracorporeal circulation."
https://pharos.nih.gov/idg/targets/P42338,P42338,22528234,"results suggested that down-regulation of p110beta expression by siRNA obviously reduced cell number via accumulation in G(0)-G(1) phase of the cell cycle."
https://pharos.nih.gov/idg/targets/P42338,P42338,21765914,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,21487106,"Results define PI3Kbeta as a potential therapeutic target in inflammatory disease."
https://pharos.nih.gov/idg/targets/P42338,P42338,21383062,"study shows that p110beta nuclear localization signal and p85beta nuclear export sequence regulate p85beta/p110beta nuclear localization, supporting the idea that nuclear, but not cytoplasmic, p110beta controls cell survival"
https://pharos.nih.gov/idg/targets/P42338,P42338,21362552,"lipid kinase p110beta/p85beta elucidates an unusual SH2-domain-mediated inhibitory mechanism"
https://pharos.nih.gov/idg/targets/P42338,P42338,21321382,"Significance of this altered regulation in tumor models of PTEN deletion, as well as the potential implications of the unique p110beta regulation on GPCR-driven tumorigenesis."
https://pharos.nih.gov/idg/targets/P42338,P42338,21123564,"In hyperglycemic leptin-deficient Lep(ob/ob) transgenic mice, leptin acutely and potently improves glucose metabolism, before any change of body fat mass, via a mechanism involving the p110alpha and -beta isoforms of phosphatidylinositol-3-kinase."
https://pharos.nih.gov/idg/targets/P42338,P42338,21030680,"This study shows that the enhanced transforming potential of p110beta is the result of its decreased inhibition by p85, due to the disruption of an inhibitory C2-iSH2 domain interface."
https://pharos.nih.gov/idg/targets/P42338,P42338,21029719,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,20818790,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,20702582,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,20691427,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42338,P42338,20628086,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42338,P42338,20602615,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42338,P42338,20508983,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42338,P42338,20331378,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42338,P42338,20107106,"minor G allele of PIK3CB associates with decreased muscle subunit ratio and lower hepatic glucose production at high plasma insulin levels."
https://pharos.nih.gov/idg/targets/P42338,P42338,20107106,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42338,P42338,20103642,"Data show that similar responses were seen in cancer cells with wild-type or activated mutant PI3K genes treated with p110alpha/delta or p110alpha/beta/delta inhibitors in cell viability assays."
https://pharos.nih.gov/idg/targets/P42338,P42338,20058239,"Our results support the concept that p110beta appears to be the predominant functional class I PI 3-kinase isoform in prostate cancer cells."
https://pharos.nih.gov/idg/targets/P42338,P42338,20056178,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42338,P42338,20041213,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,20019835,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42338,P42338,19815551,"phosphoinositide 3-kinase isoforms alpha and beta have roles in glycoprotein VI-induced platelet signaling and thrombus formation"
https://pharos.nih.gov/idg/targets/P42338,P42338,19700402,"PI3Kbeta plays an essential role in GPVI-mediated platelet aggregation and Akt activation"
https://pharos.nih.gov/idg/targets/P42338,P42338,19380768,"PI3K p110beta positively controls lipopolysaccharide-induced interleukin-12 production through the c-jun kinase (JNK)-1-dependent pathway in human macrophages and dendritic cells."
https://pharos.nih.gov/idg/targets/P42338,P42338,19097921,"Rs361072 promoter variant of PIK3CB is associated with insulin resistance not with type 2 diabetes."
https://pharos.nih.gov/idg/targets/P42338,P42338,19097921,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42338,P42338,18996102,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42338,P42338,18854243,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,18755892,"Although p110alpha activation is required to sustain the proliferation of established PIK3CA-mutant tumors, PTEN-deficient tumors are dependent instead on p110beta signaling."
https://pharos.nih.gov/idg/targets/P42338,P42338,18558630,"required for sphingosine-1-phosphate -induced endothelial cell migration through activation of Rac1"
https://pharos.nih.gov/idg/targets/P42338,P42338,18453587,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,18398029,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42338,P42338,18372911,"p85alpha and p110beta are essential for androgen-stimulated AR transactivation, and their aberrant expression or activation might play an important role in prostate cancer progression"
https://pharos.nih.gov/idg/targets/P42338,P42338,18327411,"Phosphoinositide 3-kinase p110beta inhibitor TGX-221 inhibited shear-induced platelet activation and protected platelet function during extracorporeal circulation."
https://pharos.nih.gov/idg/targets/P42338,P42338,18285463,"PI3Kalpha and -beta present distinct activation requirements and kinetics in G(1) phase, with a selective action of PI3Kalpha at the G(0)/G(1) phase transition"
https://pharos.nih.gov/idg/targets/P42338,P42338,17986385,"Our data indicate that different signalling pathways are involved in retinoic acid-induced up-regulation of the secretases."
https://pharos.nih.gov/idg/targets/P42338,P42338,17977952,"C allele is a causal variant capable of attenuating insulin resistance in obese children."
https://pharos.nih.gov/idg/targets/P42338,P42338,17977952,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42338,P42338,17676480,"bFGF augments hypoxia induced VEGF release in breast cancer cells mainly through the PI3K pathway and partly depending on HIF-1 activity."
https://pharos.nih.gov/idg/targets/P42338,P42338,17632570,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,17522703,"Reduced activation of NF-kappaB via impaired PI3K/Akt activation under increased TNF-alpha levels could result in increased apoptosis of vitiliginous keratinocytes."
https://pharos.nih.gov/idg/targets/P42338,P42338,17157319,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,16524887,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,16432180,"p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase have roles in oncogenic transformation"
https://pharos.nih.gov/idg/targets/P42338,P42338,16380997,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42338,P42338,16339315,"although introduction of activating mutations from p110alpha at the corresponding sites in p110beta failed to render the enzyme oncogenic in human cells, the possibility remains that other mutations might activate the beta isoform"
https://pharos.nih.gov/idg/targets/P42338,P42338,16091017,"Introduction of a pH1 vector producing shRNA (short hairpin RNA) that targets p110beta abolished PIA [N6-(2-phenylisopropyl)adenosine]-induced Akt activation"
https://pharos.nih.gov/idg/targets/P42338,P42338,16081599,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,15689238,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,15582274,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42338,P42338,15468162,"Data highlight the differential signaling by p110alpha and -beta isoforms."
https://pharos.nih.gov/idg/targets/P42338,P42338,15242975,"determinination of the involvement of PI3K and MAPK pathways and the importance of cross-talk between these pathways, in glucose-potentiated vascular smooth muscle cell chemotaxis to serum factors"
https://pharos.nih.gov/idg/targets/P42338,P42338,14602571,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,12960231,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,12584329,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,12551992,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,12526811,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,12507995,"p110 has a role in activation of PI3K gamma along with G beta gamma"
https://pharos.nih.gov/idg/targets/P42338,P42338,12502677,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42338,P42338,12502677,"It is unlikely that the promoter polymorphisms -359T/C and -303A/G of the catalytic subunit p110beta gene of human PI 3-kinase have a major impact on insulin secretion, insulin sensitivity, or the risk of type 2 diabetes"
https://pharos.nih.gov/idg/targets/P42338,P42338,12077252,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,11994280,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,11916960,"A function for phosphoinositide 3-kinase beta lipid products in coupling beta gamma to Ras activation in response to lysophosphatidic acid."
https://pharos.nih.gov/idg/targets/P42338,P42338,11752399,"These results indicate that in addition to their roles in recruiting the catalytic subunit of PI3K to the insulin receptor substrate proteins, both p85alpha and p85beta play negative roles in insulin signaling"
https://pharos.nih.gov/idg/targets/P42338,P42338,11289809,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,11156964,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,11154208,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,10985305,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,10208934,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,9808187,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,9708406,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,9446795,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,9394803,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,9341793,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,9247029,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,8798481,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,8636073,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42338,P42338,2174051,"This paper reports the first purification of a phosphoinositide 3-kinase and shows that the protein is a heterodimer of an 85 kd regulatory subunit that mediates binding to phosphorylated proteins and a 110 kd catalytic subunit."
https://pharos.nih.gov/idg/targets/P42336,P42336,29133261,"Together, dual inhibition of BRD4 and PI3K by SF2523 suppresses human prostate cancer cell growth in vitro and in vivo."
https://pharos.nih.gov/idg/targets/P42336,P42336,29021135,"Overexpression of KAT6A or TRIM24 promoted PIK3CA expression, AKT phosphorylation, and cell proliferation."
https://pharos.nih.gov/idg/targets/P42336,P42336,28993455,"Ehrlichia chaffeensis infection activated the phosphatidylinositol 3-kinase (PI3K)-Akt-mTOR (mechanistic target of rapamycin) pathway, and activation was induced by three ehrlichial tandem repeat protein (TRP) effectors, with TRP120 inducing the strongest activation."
https://pharos.nih.gov/idg/targets/P42336,P42336,28947417,"Combined PI3Kalpha and CDK4/6 inhibition significantly improved disease control in human xenograft models compared with either monotherapy."
https://pharos.nih.gov/idg/targets/P42336,P42336,28867195,"These results indicated that dual targeting of PI3K and PERK pathways might improve clinical prognosis and enhance the treatment of ESCC patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,28867187,"These data indicate that increased irisin levels may have protective roles in liver cancer cells through partial activation of the PI3K/AKT pathway, which may facilitate liver cancer progression and decrease the sensitivity to chemotherapy."
https://pharos.nih.gov/idg/targets/P42336,P42336,28774796,"High PI3K expression is associated with melanoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,28755461,"Variation in organ-specific PIK3CA and KRAS mutant levels in normal human tissues correlates with mutation prevalence in corresponding carcinomas."
https://pharos.nih.gov/idg/targets/P42336,P42336,28692045,"Data suggest a critical role for KDM3A in the PI3K/AP-1 oncogenic axis and propose a novel strategy for inhibition of KDM3A against liver tumor development under PI3K pathway activation."
https://pharos.nih.gov/idg/targets/P42336,P42336,28676499,"Data suggest that Lys-776 (in the P-loop of PIK3CA) is critical for autophosphorylation in PIK3CA/PIK3R1 heterodimer; both His-936 and His-917 (in the activation and catalytic loops of PIK3CA) are important catalytically, but appear to have different functions; bisubstrate kinetic analysis of PIK3CA/PIK3R1 heterodimer indicates an ordered sequential mechanism."
https://pharos.nih.gov/idg/targets/P42336,P42336,28566443,"Mosaic mutations in PIK3CA or PIK3R2 which activate class 1A PI3K cause severe non-ketotic hypoglycaemia in a subset of patients, with the metabolic phenotype presumably related to the extent of mosaicism within the liver."
https://pharos.nih.gov/idg/targets/P42336,P42336,28550907,"This study revealed that (1) PIK3CA hotspot mutations occurred with low frequency in gastric cancer; (2) PIK3CA hotspot mutations were not directly associated with PI3K pathway activation; and (3) p-AKT (+) may be a biomarker for better outcomes for gastric cancer patients undergoing gastrectomy regardless of the PIK3CA mutation status."
https://pharos.nih.gov/idg/targets/P42336,P42336,28515318,"Data suggest HRas activates both p110alpha and p110delta isoforms; membrane-resident HRas, not soluble HRas, increases membrane recruitment of both p110alpha and p110delta. (HRas = v-Ha-ras Harvey rat sarcoma viral oncogene homolog; p110alpha = class IA phosphoinositide 3-kinases, subunit p110alpha; p110delta = class IA phosphoinositide 3-kinases, subunit p110delta)"
https://pharos.nih.gov/idg/targets/P42336,P42336,28442534,"Oncogenic beta-catenin and PI3K activities interact in the acquisition of multiple cancer-related phenotypes in organoids grown in Matrigel."
https://pharos.nih.gov/idg/targets/P42336,P42336,28384037,"PI3K protein was expressed in 81.3% (91/112) of all ESCC samples, whereas it was found in only 4.9% (5/56) of adjacent normal cells.PIK3CA gene mutations were highly correlated with age, tobacco use, and clinical stage (p<0.05), but not with gender, location, alcohol use, lymph node metastasis, or degree of differentiation. PI3K protein expression was not statistically correlated with PIK3CA gene mutations."
https://pharos.nih.gov/idg/targets/P42336,P42336,28381646,"Data, including data from hydrogen/deuterium exchange mass spectrometry studies using full-length constructs for both catalytic/p110alpha and regulatory/p85alpha subunits of phosphoinositide 3-kinase isoform, suggest that the catalytic subunit exhibits binding sites for four inhibitor compounds studied, including a low-affinity binding site for CAL-101."
https://pharos.nih.gov/idg/targets/P42336,P42336,28355296,"Tetraarsenic hexoxide (As4O6) induced G2/M arrest, apoptosis and autophagic cell death through PI3K/Akt and p38 MAPK pathways alteration in SW620 colon cancer cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,28339079,"A combination of CAL-101, a p110delta-specific inhibitor, with bortezomib treatment of HT/EBV cells synergistically suppressed proliferation, reduced levels of drug resistance-related proteins, activated caspase cleavage and recovered expression of p110a/p110b."
https://pharos.nih.gov/idg/targets/P42336,P42336,28328134,"Somatic PIK3CA mutations in seven patients with PIK3CA-related overgrowth spectrum have been reported."
https://pharos.nih.gov/idg/targets/P42336,P42336,28285689,"Out of 171 EGFR mutated tumor-patient cases, 20 were sequenced using at least a limited comprehensive genomic profiling platform. 50% harbored concurrent TP53 mutation, 10% PIK3CA mutation, 5% PTEN mutation, among others."
https://pharos.nih.gov/idg/targets/P42336,P42336,28263743,"Psgl-1 deficiency accelerates bleomycin-induced lung fibrosis and inflammation in mice through activating the PI3K/AKT axis."
https://pharos.nih.gov/idg/targets/P42336,P42336,28258248,"Data show that cancer-associated fibroblasts (CAFs)-derived hepatocyte growth factor (HGF) or recombinant HGF activated c-Met/phosphoinositide 3-kinase (PI3K)/Akt and glucose-regulated protein 78 (GRP78) signalling pathways in ovarian cancer cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,28233937,"This study provides insights as to how mutationally activated PIK3CA acts in concert with MEK1/2 signaling to cooperatively regulate mTORC1/2 to sustain PIK3CA-mutated melanoma proliferation."
https://pharos.nih.gov/idg/targets/P42336,P42336,28223411,"abundance is stimulated, in part, through AKT- and nuclear factor kappaB (NF-kappaB)-dependent pathways and that presence of PTX3 is necessary for PI3K-induced stem cell-like traits."
https://pharos.nih.gov/idg/targets/P42336,P42336,28209106,"Recurrent PIK3CA mutations associated with Epstein-Barr virus - infected Gastroesophageal junction tumor."
https://pharos.nih.gov/idg/targets/P42336,P42336,28206962,"Data indicate that PI3K pathway mutation predicts longer time to local progression after radioembolization of colorectal liver metastases."
https://pharos.nih.gov/idg/targets/P42336,P42336,28190247,"Compared to single-gene-targeted cells and parental controls, cells with both a PIK3CA mutation and TP53 alteration had increased cancerous phenotypes including cell proliferation, soft agar colony formation, aberrant morphology in acinar formation assays, and genomic heterogeneity."
https://pharos.nih.gov/idg/targets/P42336,P42336,28188750,"KRAS and PIK3CA genetic variants are associated with aggressive clinicopathological features in colorectal adenocarcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,28188683,"KRAS mutations and AKT activation are present in Wilms tumors (WT) and may represent novel therapeutic targets for this tumor."
https://pharos.nih.gov/idg/targets/P42336,P42336,28183140,"PIK3CA E545K/E542K mutations are associated with everolimus resistance in breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,28178653,"Derlin-1 is overexpressed in bladder cancer and promotes malignant phenotype through ERK/MMP-2/9 and PI3K/AKT signaling pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,28167203,"We identified a de novo phosphatidylinositol-4,5- bisphosphate 3-kinase catalytic subunit alpha gene (PIK3CA) mutation as a potential drug resistance mechanism."
https://pharos.nih.gov/idg/targets/P42336,P42336,28132399,"MicroRNA miR-155-5p promoted proliferation, invasion and migration, but inhibited apoptosis in hepatocellular carcinoma (HCC) by directly targeting the 3'-UTR of PTEN through the PI3K/Akt pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,28098897,"Upregulation of PI3K is associated with ovarian cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,28098872,"Upregulation of PI3K is associated with thyroid cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,28095868,"PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression."
https://pharos.nih.gov/idg/targets/P42336,P42336,28087713,"The expression of ribosomal and proteasomal components was significantly up-regulated in primary human colorectal tumors harboring PI3K pathway activation"
https://pharos.nih.gov/idg/targets/P42336,P42336,28068934,"PIK3CA mutations are associated with esophageal squamous cell carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,28029147,"Somatic PIK3CA variants in breast cancers associate with rs252913 and rs331499 SNPs in the locus 5q11.2 locus."
https://pharos.nih.gov/idg/targets/P42336,P42336,28025078,"Report KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer may depend on tumor histology."
https://pharos.nih.gov/idg/targets/P42336,P42336,27974663,"PIK3CA mutations have a role in breast tumor response to targeting mTOR-mediated MCL-1 translation"
https://pharos.nih.gov/idg/targets/P42336,P42336,27959444,"High PI3K expression is associated with liver cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,27933776,"Findings show that calmodulin (CaM) stimulates phosphoinositide-3-kinase (PI3K) lipid kinase activity by binding MARCKS and displacing it from phosphatidylinositol 4,5-bisphosphate (PIP2) headgroups, thereby releasing free PIP2 that recruits active PI3K to the membrane and serves as the substrate for the generation of phosphatidylinositol 3,4,5-trisphosphate (PIP3)."
https://pharos.nih.gov/idg/targets/P42336,P42336,27919038,"FBS. Following stimulation of RTKs (receptor tyrosine kinases), microinjected PI3Kalpha was recruited to the PM, but oncogenic forms of PI3Kalpha were not recruited to the PM to a greater extent and did not reside at the PM longer than the wild-type PI3Kalpha. Instead, the E545K mutant specifically bound activated Cdc42"
https://pharos.nih.gov/idg/targets/P42336,P42336,27918554,"Data show that acid sensing ion channel 1a (ASIC1a) mediated calcium influx, which resulted in the activation of PI3K/AKT signaling and increased drug resistance, suggesting that ASIC1a/Ca(2+)/PI3K/AKT signaling represents a pathway that regulates drug resistance, thus offering a potential target for chemotherapy of hepatocellular carcinoma (HCC)."
https://pharos.nih.gov/idg/targets/P42336,P42336,27913435,"Functional studies demonstrated that IDH2 and PIK3CA hotspot mutations are likely drivers of solid papillary carcinoma with reverse polarity"
https://pharos.nih.gov/idg/targets/P42336,P42336,27901576,"Study shows that PIK3CA mutation occurs approximately in 45% of breast cancer patients, and are frequent in exon 20 in comparison with exon 9 of the gene. Also, PIK3CA mutations were found significantly associated with low-grade tumors."
https://pharos.nih.gov/idg/targets/P42336,P42336,27864574,"PI3K catalytic-alpha(PIK3CA) mutations assessed from circulating tumor DNA represent the first potentially viable serum biomarker for the selection of ET combinations, and new data demonstrate the feasibility of this minimally invasive technique as an alternative to traditional tissue analysis"
https://pharos.nih.gov/idg/targets/P42336,P42336,27800646,"Our study did not demonstrate a significant survival advantage from aspirin use in stage 2 PIK3CA mutated colon cancer (CC). The 'real-world' nature of our cohort and the subsequent uncontrolled differences in age and fitness in aspirin users are likely to have contributed to this result. In the PIK3CA mutated group, there was a trend towards improved recurrence-free survival of CC."
https://pharos.nih.gov/idg/targets/P42336,P42336,27792260,"Mutations in PIK3CA gene is associated with breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,27750372,"Gains of PIK3CA is associated with hypopharyngeal squamous cell carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,27742746,"PIK3CA and AKT1 are frequently mutated in Hidradenoma papilliferum (HP) tumours (29% and 14%, respectively). PIK3CA/AKT1 pathway alterations in HP further support the hypothesis that HP is the vulvar (anogenital mammary-like gland) analogue of breast intraductal papilloma."
https://pharos.nih.gov/idg/targets/P42336,P42336,27737711,"No significant impact on prognosis was observed for mutated KRAS, NRAS, and PIK3CA genes or combined RAS mutations"
https://pharos.nih.gov/idg/targets/P42336,P42336,27686608,"High expression of PI3K is associated with glioma."
https://pharos.nih.gov/idg/targets/P42336,P42336,27672108,"Sixteen of 20 patients treated at the MTD had reduced (18)FDG-PET uptake; 7 (33%) had a reduction >25%. One patient achieved a complete response (CR; endometrial carcinoma exhibiting both PIK3CA and PTEN mutations and complete PTEN loss) and two had a partial response (PR; both metastatic breast cancer)."
https://pharos.nih.gov/idg/targets/P42336,P42336,27634934,"PI3K signaling enhanced SOX2 translation, which in turn induced the expression of genes regulating the stemness characteristics of cancer stem cells ."
https://pharos.nih.gov/idg/targets/P42336,P42336,27629725,"Data show that the incidence of phosphatidylinositol 3-kinase catalytic 110-KD alpha (PIK3CA) mutation is low in small cell lung cancer (SCLC) and the pseudogene-positive alteration of A1634C is prone to occur in exon 9 of PIK3CA mutations in cancers."
https://pharos.nih.gov/idg/targets/P42336,P42336,27621407,"Studies suggest to maximize therapeutic benefit, drug combinations and schedules for Inhibition of the PI3K/AKT/mTOR Pathway must be explored to identify those with the highest efficacy and lowest toxicity overlap."
https://pharos.nih.gov/idg/targets/P42336,P42336,27614430,"Bis(acetylacetonato)-oxidovanadium(IV) and sodium metavanadate induced the activation of both PI3K/AKT and MAPK/ERK signaling pathways dose- and time-dependently."
https://pharos.nih.gov/idg/targets/P42336,P42336,27573562,"The primary end point was progression-free survival (PFS) in the intention-to-treat (ITT) population and patients with PIK3CA-mutated tumours.In patients with PIK3CA-mutated tumours, the median PFS was 7.3 months for pictilisib (n = 32) versus 5.8 months with placebo (n = 30) (HR, 1.06; 95% CI 0.52-2.12; P = 0.88)"
https://pharos.nih.gov/idg/targets/P42336,P42336,27554588,"Study found that PIK3CA mutation occurred in approximately 2.8% of patients with lung adenocarci- noma in a cohort of Chinese patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,27525871,"PTEN and PIK3CA were shown to be upregulated by 89 and 76% (western blot), respectively, in the pemetrexed-resistant cell line compared with control cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,27520487,"In the very high-risk Bladder Cancer patients , several genes had a higher frequency of mutations than reported in the The Cancer Genome Atlas database, including PIK3CA . Mutation associations with receipt of neoadjuvant chemotherapy, nodal involvement, metastatic disease development, and survival were analyzed."
https://pharos.nih.gov/idg/targets/P42336,P42336,27502552,"Case Report: sildenafil could be an alternative treatment option for lymphatic malformations in patients with syndromes belonging to the PIK3CA-related overgrowth spectrum."
https://pharos.nih.gov/idg/targets/P42336,P42336,27491861,"the expression of 3 miRs and 9 mRNAs associate with the PIK3CA status. Expression of LRG1 is independent of luminal (A or B) subtype, decreased after neo-adjuvant aromatase inhibitor treatment."
https://pharos.nih.gov/idg/targets/P42336,P42336,27491860,"relevant genomic aberrations such as mutations in the hotspot regions of exon 9 and 20 of the PIK3CA gene can be detected in single circulating tumor cells and might provide insights into mechanisms of resistance to HER2-targeted therapies."
https://pharos.nih.gov/idg/targets/P42336,P42336,27465249,"Mutant PIK3CA is a potent oncogenic driver in many urothelial carcinoma cell lines"
https://pharos.nih.gov/idg/targets/P42336,P42336,27455559,"The FGFR3, PIK3CA, TERT mutations, along with aberrant DNA methylation patterns, can serve as reliable genetic markers for the diagnosis of urinary bladder cancer. (Review)"
https://pharos.nih.gov/idg/targets/P42336,P42336,27449034,"Data show that zinc finger protein 143 (ZNF143) promotes epithelial-mesenchymal transition (EMT) through regulating PI3K/AKT pathway in gastric cancer (GC) cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,27448972,"Combined treatment with gamma-irradiation (gammaIR) and a dual PI3K/mTOR inhibitor causes loss of stemness and of FoxO1/3 proteins in p53-proficient glioblastoma multiforme stem cells (GBM-SCs)."
https://pharos.nih.gov/idg/targets/P42336,P42336,27441415,"Our data indicate that, similar to other benign proliferative lesions occurring in the breast parenchyma, activating PIK3CA mutations are very common in nipple adenomas"
https://pharos.nih.gov/idg/targets/P42336,P42336,27436848,"Our findings suggest that PIK3CA mutation has the neutral prognostic effects on colorectal cancers (CRC) OS and progression-free survival. Evidence was accumulating for the establishment of CRC survival between PIK3CA mutations and patient-specific clinical or molecular profiles."
https://pharos.nih.gov/idg/targets/P42336,P42336,27426476,"CLOVES syndrome is an overgrowth syndrome caused by mosaic activating mutation in phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) gene."
https://pharos.nih.gov/idg/targets/P42336,P42336,27426307,"Combined inhibition of PI3K and PARP effectively synergized to block the growth of three wild-type PIK3CA ovarian cancer cell lines and explants of a primary ovarian tumor specimen."
https://pharos.nih.gov/idg/targets/P42336,P42336,27401370,"This is the first report on phosphorylation of p53 serine 46 as a modulator of p53-PIK3CA promoter interaction."
https://pharos.nih.gov/idg/targets/P42336,P42336,27388585,"PIK3CA, PTEN, and AKT1 mutations occurred more frequently in the presence of hormone receptor overexpression (androgen, progesterone, or estrogen receptor). PIK3CA mutations were also more common in the HER2-positive than in the HER2-negative group; the opposite pattern was seen for PTEN mutation or PTEN loss"
https://pharos.nih.gov/idg/targets/P42336,P42336,27388016,"Results showed that mutations in PIK3CA exons 9 and 20 were observed in 25 of the 208 (12 %) gastric cancer patients but found that no correlation with prognosis."
https://pharos.nih.gov/idg/targets/P42336,P42336,27387578,"Mutations in PIK3CA, AKT1, and PTEN also were less frequently found in cancers with mutations in the DNA guardian, TP53. This observation might seem counterintuitive because increased genome instability might facilitate development and selection of advantageous mutations."
https://pharos.nih.gov/idg/targets/P42336,P42336,27379604,"PIK3CA mutation is associated with salivary duct carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,27369359,"TP53 and PIK3CA mutations appear to have diverse effects on the outcome of early breast cancer patients, according to whether these genes are co-mutated or not, and for TP53 according to tumor-infiltrating lymphocyte density and ER/PgR-status"
https://pharos.nih.gov/idg/targets/P42336,P42336,27348297,"PIK3CA mutation is associated with endometrial carcinoma progression and abdominopelvic metastasis."
https://pharos.nih.gov/idg/targets/P42336,P42336,27339899,"NEDD4L negatively regulates PIK3CA protein levels via ubiquitination and is required for the maintenance of PI3K-AKT signaling pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,27336598,"This meta-analysis proved that detecting PIK3CA gene mutation by cfDNA has high diagnostic accuracy in breast cancer, especially for metastatic breast cancer. It may serve as a reliable non-invasive assay for detecting and monitoring PIK3CA mutation status in order to deliver personalized and precise treatment."
https://pharos.nih.gov/idg/targets/P42336,P42336,27329843,"AQP9 overexpression decreased the protein levels of phosphatidylinositol-3-kinase (PI3K), leading to reduced phosphorylation of Akt, and subsequently the protein levels of forkhead box protein O1 (FOXO1) were increased."
https://pharos.nih.gov/idg/targets/P42336,P42336,27317099,"Study shows that PIK3CA is required for the proliferation, migration, invasion and clone formation of gallbladder carcinoma (GBC) cells in vitro and that the E545K mutation of PIK3CA promotes GBC progression through its enhanced binding to EGFR."
https://pharos.nih.gov/idg/targets/P42336,P42336,27308891,"MARCH2 has a role in regulating autophagy by promoting CFTR ubiquitination and degradation and PIK3CA-AKT-MTOR signaling"
https://pharos.nih.gov/idg/targets/P42336,P42336,27307077,"Data indicated next-generation sequencing (NGS) for the identification of somatic variation in the phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA)-related overgrowth spectrum (PROS) among 14 patients submitted for clinical testing."
https://pharos.nih.gov/idg/targets/P42336,P42336,27301639,"We revealed that activation of the PI3K/Akt pathway was the main cause of impaired autophagy in ELK3 KD. Our results suggest that targeting ELK3 may be a potential approach to overcome doxorubicin resistance in breast cancer therapeutics."
https://pharos.nih.gov/idg/targets/P42336,P42336,27282497,"to our knowledge, this is the largest study to evaluate the PIK3CA mutation in Indian breast cancer patients. The frequency and distribution pattern of PIK3CA mutations is similar to global reports"
https://pharos.nih.gov/idg/targets/P42336,P42336,27268661,"Mutations in PIK3CA Sensitize Breast Cancer Cells to Physiologic Levels of Aspirin."
https://pharos.nih.gov/idg/targets/P42336,P42336,27255162,"Identify mutually exclusive activating hotspot mutations in FGFR1 and related PI-3K/RAS signaling genes in malignant phyllodes tumors which are implicated in tumor pathogenesis and/or progression."
https://pharos.nih.gov/idg/targets/P42336,P42336,27220763,"that the spindle cell type of Mmtaplastic breast carcinoma with myoepithelial features exhibits a higher frequency of PIK3CA mutation than other types of metaplastic or basal-like breast cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,27219019,"Study identified PIK3CA mutation as an independent prognostic factor in patients who underwent APR for ASCC recurrence."
https://pharos.nih.gov/idg/targets/P42336,P42336,27197157,"PIK3CA gene mutation is associated with breast Cancers."
https://pharos.nih.gov/idg/targets/P42336,P42336,27191687,"we report a fourth patient with asymmetric overgrowth due to a somatic PIK3CA mutation who had nephroblastomatosis or Wilms tumor. Similar to two of three reported patients with a somatic PIK3CA mutation and renal tumors, he shared a PIK3CA mutation affecting codon 1047, presented at birth with asymmetric overgrowth, and had fibroadipose overgrowth."
https://pharos.nih.gov/idg/targets/P42336,P42336,27189717,"Single TOR serine-threonine kinases (mTOR) and dual phosphatidylinositol 3-kinases (PI3K)/mTOR inhibitors promote Treg cells immunosuppressive activity."
https://pharos.nih.gov/idg/targets/P42336,P42336,27184479,"Like the mammary intraductal papillomas, activating mutations in PIK3CA or AKT1 are present in most hidradenoma papilliferums."
https://pharos.nih.gov/idg/targets/P42336,P42336,27177864,"Overall PIK3CA mutant/HER2+ tumours had significantly lower pCR rates compared with wild-type tumours, however mainly confined to the HR+/PIK3CA mutant population. No definite conclusions can be drawn regarding survival"
https://pharos.nih.gov/idg/targets/P42336,P42336,27176780,"PI3K isoforms p110a, p110b and p110g were selectively inhibited and effects on proliferation and migration assessed. Inhibition increased transcription of cancer stem cell genes in both models, suggesting de-differentiation in response to blockade of the PI3K/AKT/mTOR signalling axis."
https://pharos.nih.gov/idg/targets/P42336,P42336,27167344,"Results indicate that des-gamma-carboxy prothrombin (DCP) antagonizes the inhibitory effects of Sorafenib on hepatocellular carcinoma (HCC) through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways."
https://pharos.nih.gov/idg/targets/P42336,P42336,27167340,"Data show that long noncoding RNA RMEL3 is required for MAPK and PI3K signaling, and its knockdown decrease BRAFV600E melanoma cell survival and proliferation."
https://pharos.nih.gov/idg/targets/P42336,P42336,27127129,"PIK3CA gene mutations were sought in 145 tissue samples from central nervous system metastases of NSCLC using 3 PCR techniques.  One E542K and two H1047R substitutions were found in male patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,27120806,"Concomitant inhibition of PIM kinase and p110alpha activities inhibits glioma stem cell function and survival."
https://pharos.nih.gov/idg/targets/P42336,P42336,27108388,"The results suggest PIK3CA H1047R mutant cells have a selective advantage in breast, contribute to breast cancer susceptibility, and drive tumor progression during breast carcinogenesis, even when present as only a subpopulation of tumor cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,27101199,"Data indicate that EPHA3 is involved in regulating the multidrug resistance (MDR) of small cell lung cancer (SCLC) via PI3K/BMX/STAT3 signaling and may be a therapeutic target in SCLC."
https://pharos.nih.gov/idg/targets/P42336,P42336,27076174,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,27070496,"A recursively partitioned mixture model of all 3 somatic alteration burden measures resulted in classes of tumors whose epigenetic and genetic burden profile were associated with the PAM50 subtype and mutations in TP53, PIK3CA, and CDH1"
https://pharos.nih.gov/idg/targets/P42336,P42336,27059323,"Mutations of PIK3CA were found in our cohort in 21 cases (28 %), 10 (13 %) in exon 9 and 11(15 %) in exon 20. Mutation frequency of AKT1 and PTEN genes was 4 and 3 %, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,27048245,"Our study demonstrates that the IGF1R/p110b/AKT/mTOR axis confers resistance to BYL719 in PIK3CA mutant breast cancers"
https://pharos.nih.gov/idg/targets/P42336,P42336,27037860,"The authors present three clinically challenging cases with congenital mosaic tissue overgrowth caused by a heterozygous missense mutation in PIK3CA in the affected tissue."
https://pharos.nih.gov/idg/targets/P42336,P42336,27030595,"These data demonstrate a causal relationship between activating Pik3ca mutations and the genesis of vascular malformations."
https://pharos.nih.gov/idg/targets/P42336,P42336,27030594,"activating PIK3CA mutations gives rise to sporadic venous malformations in mice, which closely resemble the histology of the human disease."
https://pharos.nih.gov/idg/targets/P42336,P42336,27020460,"Data show that the elevated activities of PI3Ks, AKt and GSK-3beta were effectively suppressed by exogenous carbon monoxide (CO), leading to the improvement of platelet function."
https://pharos.nih.gov/idg/targets/P42336,P42336,27016421,"Data indicate that PIK3CA copy number gain was an independent poor prognostic factor for disease-free survival (DFS)."
https://pharos.nih.gov/idg/targets/P42336,P42336,27007084,"PIK3CA mutations are associated with metastatic lung adenocarcinomas."
https://pharos.nih.gov/idg/targets/P42336,P42336,27001433,"PIK3CA plays a key role in promoting the proliferation and motility of esophageal squamous carcinoma cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,26997442,"Low incidence of PIK3CA mutations in adenocarcinomas of the ampulla of Vater suggest no major role in tumorigenesis."
https://pharos.nih.gov/idg/targets/P42336,P42336,26995633,"PIK3CA mutations detected at high frequencies in breast cancer and mostly associated with better or insignificant outcomes in estrogen receptor-positive (ER+) early stage breast cancer and tend to be with worse prognosis in ER- disease."
https://pharos.nih.gov/idg/targets/P42336,P42336,26980034,"PIK3CA was overexpressed in Epstein Barr virus-associated gastric adenocarcinoma and was associated with a less aggressive phenotype and better prognosis."
https://pharos.nih.gov/idg/targets/P42336,P42336,26971883,"Data underscore the importance of phosphatidylinositol 3-kinase (PI3K) signalling in myeloid cells in the context of chronic inflammatory diseases."
https://pharos.nih.gov/idg/targets/P42336,P42336,26956874,"Pharmacophore model suggested the mechanism of the inhibition of PI3Kalpha and mTOR by the compounds were mostly the same, which was supported by the docking study showing similar docking modes. The analysis also suggested the importance of the flat plane shape of the ligands, the space surrounding the ligands in the binding pocket, and the slight difference in the shape of the binding sites between PI3Kalpha and mTOR."
https://pharos.nih.gov/idg/targets/P42336,P42336,26947513,"investigated mutations in exons 9 and 20 of the PI3K gene in gallbladder cancer (GBC) ; results show the PI3K gene to be mutated in approximately 17% of GBC"
https://pharos.nih.gov/idg/targets/P42336,P42336,26947331,"Fulvestrant plus palbociclib was associated with significant and consistent improvement in progression-free survival compared with fulvestrant plus placebo, irrespective of the degree of endocrine resistance, hormone-receptor expression level, and PIK3CA mutational status. The combination could be considered as a therapeutic option for patients with HER2-negative breast cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,26945423,"No relation was found between PIK3CA expression and clinical features of ovarian clear cell carcinoma. PIK3CA expression had no impact on survival."
https://pharos.nih.gov/idg/targets/P42336,P42336,26927447,"PI3KCA mutations were extremely rare in pancreatic cancer, suggesting that they play a limited role in PC development.[review]"
https://pharos.nih.gov/idg/targets/P42336,P42336,26921096,"PIK3CA gene mutations are associated with breast cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,26918351,"Data suggest that class I phosphatidylinositol 3-kinase (PI3K) inhibitor ZSTK474 induced autophagy might contribute to the antitumor activity."
https://pharos.nih.gov/idg/targets/P42336,P42336,26902608,"The siRNA-induced AKT3 and PI3KCA mRNA knockdown."
https://pharos.nih.gov/idg/targets/P42336,P42336,26889984,"PIK3CA gene plays a crucial role in carcinogenesis in general and head and neck squamous cell carcinoma in particular."
https://pharos.nih.gov/idg/targets/P42336,P42336,26884879,"Combined detection of p110alpha and p110beta is helpful to determine the neoplastic potential of colorectal villous adenoma and serrated adenoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,26876212,"our results offer significant insight into how PIK3CA overexpression drives squamous cell carcinoma (HNSCC) invasion and metastasis, providing a rationale for targeting PI3K/PDK1 and TGFb signaling in advanced HNSCC patients with PIK3CA amplification"
https://pharos.nih.gov/idg/targets/P42336,P42336,26853422,"Results suggest, a potential role for PIK3CA, VEGFR2, RET and FGFR2 as therapeutic targets in EGFR non-mutated NSCLC that requires further clinical validation."
https://pharos.nih.gov/idg/targets/P42336,P42336,26851524,"Here we report a Hungarian girl with macrodactyly and syndactyly. Genetic screening at hotspots in the PIK3CA gene identified a mosaic mutation (c.1624G > A, p.Glu542Lys) in the affected tissue, but not in the peripheral blood"
https://pharos.nih.gov/idg/targets/P42336,P42336,26848623,"Results indicate that eIF4B integrates the signals from Pim and PI3K/Akt/mTOR pathways in Abl-expressing leukemic cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,26832731,"PIK3CA and MET may play an important role in oncogenesis of certain specific subtypes of head and neck cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,26829882,"Activation of the NF-kappaB-JNK pathway is independent of the PIK3CA-Rac1-JNK pathway involved in the bFGF-regulated human fibroblast cell migration and wound healing."
https://pharos.nih.gov/idg/targets/P42336,P42336,26827608,"Though Wortmannin was found to nullify the effect of H1047R over the PIK3CA, further studies are required for designing a better compound."
https://pharos.nih.gov/idg/targets/P42336,P42336,26826201,"This work identifies PI3K signaling as an important target for precision medicine trials in meningioma patients"
https://pharos.nih.gov/idg/targets/P42336,P42336,26823876,"PIK3CA rs17849071 and rs17849079 polymorphisms may increase the risk of hepatocellular carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,26823766,"Suggest that copy number loss of Variation_91720 in PIK3CA predicts risk of esophageal squamous cell carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,26820797,"KRAS and PIK3CA mutations can influence the response of DLD1 colorectal cancer cell lines to MEK and PI3K inhibitors, but that the effect is dependent on the experimental model used to assess drug sensitivity."
https://pharos.nih.gov/idg/targets/P42336,P42336,26797279,"Based on the collective findings, we suggest that vIRF2 acts as an activator in PI3K/Akt pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,26797271,"Therefore, we identified a tumorigenic role of Id-1 in OS and suggested a potential therapeutic target for OS patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,26796526,"we reported the rare occurrence of PIK3CA mutations in imatinib-naive gastrointestinal stromal tumors"
https://pharos.nih.gov/idg/targets/P42336,P42336,26792725,"effects. Further studies indicated that PRKCI knockdown-mediated autophagy was associated with the inactivation of phosphatidylinositol 3-kinase alpha/AKT-mammalian target of rapamycin (PIK3CA/AKT-MTOR) signaling."
https://pharos.nih.gov/idg/targets/P42336,P42336,26747178,"PIK3CA and PIK3CB significantly increase multidrug resistance of CRC cells in vivo."
https://pharos.nih.gov/idg/targets/P42336,P42336,26733612,"Continuous and metronomic PI3K inhibition elicits robust anticancer effects in ER(+), PIK3CA-mutant breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,26730736,"Data show that 14-3-3beta protein augmented the expression of matrix metalloproteinasea MMP2 and MMP9 through PI3 kinase/Akt protein/NF-kappaappa B pathway, thereby enhancing the invasiveness of hepatocellular carcinoma (HCC) cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,26722541,"none of the nine tested SNPs of PIK3CA was associated with susceptibility to oral squamous cell carcinoma in the studied population."
https://pharos.nih.gov/idg/targets/P42336,P42336,26718898,"It was suggested that somatic point mutations in BRAF, CDKN2A and PI3KCA do not participate in the oncogenesis of Medullary thyroid carcinoma"
https://pharos.nih.gov/idg/targets/P42336,P42336,26712086,"PIK3CA Mutation is associated with Colorectal Cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,26701847,"Patients with PIK3CA amplifications were more likely to have diffuse-type and poorly differentiated gastric cancers and were more likely to experience peritoneal recurrence compared with those without PIK3CA amplifications."
https://pharos.nih.gov/idg/targets/P42336,P42336,26691448,"These results revealed differences in the genetic profiles of KRAS, NRAS, PIK3CA and BRAF at mutation hotspots between Chinese CRC patients and those of Western countries."
https://pharos.nih.gov/idg/targets/P42336,P42336,26687646,"High PI3K expression is associated with prostate cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,26680641,"Study shows that high EGFR protein expression and exon 9 PIK3CA activating mutations are independent prognostic factors in triple negative breast cancers."
https://pharos.nih.gov/idg/targets/P42336,P42336,26670666,"Findings of frequent mutations in CDKN2A, NOTCH1, PIK3CA, and EGFR (all in excess of 20%) point to potential therapeutic avenues. Trials of targeted therapies directed toward these mutations should be explored."
https://pharos.nih.gov/idg/targets/P42336,P42336,26650777,"As depicted in Figure 3, APC (25%) followed by KRAS (20%), TP53 (14%), and PIK3CA (11%) were the most frequently mutated genes."
https://pharos.nih.gov/idg/targets/P42336,P42336,26643470,"These results indicate an association between PIK3CA gene polymorphism on the rs7621329(C/T) site and the risk of schizophrenia."
https://pharos.nih.gov/idg/targets/P42336,P42336,26640141,"Inducible expression of mutant PIK3CA resulted in a robust activation of phosphatidylinositol-3-kinase (PI3K)/AKT signaling but attenuation of Her2/Her3 signaling, and this can be reversed by deinduction of PIK3CAH1047R expression."
https://pharos.nih.gov/idg/targets/P42336,P42336,26637981,"Somatic activating PIK3CA mutations cause venous malformation."
https://pharos.nih.gov/idg/targets/P42336,P42336,26617776,"miR-203 represses NF-kappaB signaling via targeting TAK1 and PI3KCA and miR-203 overexpression may contribute to the COPD initiation."
https://pharos.nih.gov/idg/targets/P42336,P42336,26600545,"PIK3CA mutations were observed in 32% (8) of the 25 breast cancer tissues examined, Sequencing of exon 2 of KRAS suggested that 20% (5) of the 25 samples harbored a mutation and 16% (4) of BRAF harbored a mutation."
https://pharos.nih.gov/idg/targets/P42336,P42336,26581613,"Increased Expression of Phosphatidylinositol 3-Kinase p110alpha and Gene Amplification of PIK3CA is associated with Nasopharyngeal Carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,26568302,"Findings indicate that Epstein-Barr virus(EBV)-encoded latent membrane protein 1 (LMP1), PI3K/AKT, miR-21 and PTEN constitute a positive feedback loop and have a key role in LMP1-induced cancer stem cells (CSCs) in nasopharyngeal carcinoma (NPC)."
https://pharos.nih.gov/idg/targets/P42336,P42336,26559013,"miR-490-5p functions as a tumour suppressor in renal carcinoma by targeting PIK3CA"
https://pharos.nih.gov/idg/targets/P42336,P42336,26549032,"Cytokines IL-2/7/9 stimulation activates PI3K/Akt pathways downstream of Ras in RasGRP1 T-cell acute lymphoblastic leukemia (T-ALL)."
https://pharos.nih.gov/idg/targets/P42336,P42336,26543351,"High PI3K p110alpha expression contributes to MET inhibitor resistance in gastric carcinoma xenografts."
https://pharos.nih.gov/idg/targets/P42336,P42336,26540293,"PIK3CA mutations and PI3K/AKT pathway activation are common events in TNBC."
https://pharos.nih.gov/idg/targets/P42336,P42336,26528858,"Mutations in PIK3CA gene are associated with esophageal squamous cell carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,26515594,"Data indicate the role of tropomyosin-related kinase-B (TrkB) in activation of the interleukin-6/Janus kinase 2/STAT3 transcription factor and PI3 kinase/c-AKT proto-oncogene protein pathway in breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,26506516,"Data show that the combination of a phosphatidylinositol 3-Kinase (PI3K)/mTOR protein inhibitor with an androgen receptor {AR) inhibitor results in a synergistic anti-tumor response in non-castration-resistant prostate cancer (CRPC) and CRPC models."
https://pharos.nih.gov/idg/targets/P42336,P42336,26503204,"PIK3CA mutation is associated with response to therapy in Breast Cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,26500061,"Results indicate that p110alpha primarily mediates PI3K/AKT signaling in HER2+ PTEN deficient breast tumors whereas p110beta conditionally mediates HER2/PI3K signaling in the absence of p110alpha."
https://pharos.nih.gov/idg/targets/P42336,P42336,26499886,"Data suggest that the overexpression of microRNA miR16 inhibits the proliferation, invasion and metastasis of hepatocellular carcinoma cells associated with the"
https://pharos.nih.gov/idg/targets/P42336,P42336,26499488,"Data show that puquitinib mesylate (XC-302) induced autophagy in nasopharyngeal cancer cells CNE-2 by promoting cell autophagy and inhibits the phosphatidylinositol 3-Kinase (PI3K)/AKT protein/TOR serine-threonine kinases (mTOR) signaling pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,26498688,"Data show that low-level phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) mutations were detectable in the serum indicating the utility of cell free DNA (cfDNA) as a DNA source to detect mutations in metastatic biliary cancers."
https://pharos.nih.gov/idg/targets/P42336,P42336,26497122,"Somatic mutations affecting PI3K pathway genes were found to be highly prevalent in infiltrating epitheliosis, suggesting that these lesions may be neoplastic rather than hyperplastic."
https://pharos.nih.gov/idg/targets/P42336,P42336,26482612,"Data show that microRNA miR-221 targets PTEN protein, leading to activation of the PI3K/Akt pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,26462835,"Data show that synergistic apoptotic effect of the combination treatment is correlated with the block of the PI3K/Akt signal pathway in breast cancer cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,26460589,"Results indicate that resveratrol could increase the anti-proliferative activity of bestatin through downregulating P-gp expression via suppressing the PI3K/Akt/mTOR signaling pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,26459773,"Data show that RNA silencing of CCN family member 1 protein (CCN1) inhibits umbilical vein endothelial cell (HUVEC) proliferation under hypoxic conditions by inhibiting phosphoinositide 3-kinase (PI3K)/AKT protein signaling."
https://pharos.nih.gov/idg/targets/P42336,P42336,26453385,"We have observed a 4% oncogenic mutation frequency of the PIK3CA gene, which plays a minor role in the development of OSCC in an Indian population."
https://pharos.nih.gov/idg/targets/P42336,P42336,26452060,"no prognostic significance of specific PIK3CA mutations in breast cancer treated with adjuvant chemotherapy"
https://pharos.nih.gov/idg/targets/P42336,P42336,26447856,"Data show that apoptotic cell death by esculetin was associated with inhibition of the EGFR/PI3K/Akt signaling pathway and the decreased expression of nucleophosmin (NPM)."
https://pharos.nih.gov/idg/targets/P42336,P42336,26393468,"29b lowers postoperative IOP and sustains the function of filtering bleb. It inhibits the proliferation of fibroblasts and reduces collagen deposition by repressing the PI3K/Akt/Sp1 pathway in rabbits subjected to GFS."
https://pharos.nih.gov/idg/targets/P42336,P42336,26390889,"Down-regulation of PIK3 is associated with osteoporosis."
https://pharos.nih.gov/idg/targets/P42336,P42336,26390688,"Overexpression of PI3K-p110alpha is associated with progression of uterine cervical neoplasia, and the expression of pAkt and DJ-1 is positively correlated with PI3K-p110alpha expression in this process."
https://pharos.nih.gov/idg/targets/P42336,P42336,26358014,"patients with mutant PIK3CA had distinct characteristics in age, menopausal status, and histological subtype and have better treatment outcome and less distant metastasis after surgery-based multimodal therapy."
https://pharos.nih.gov/idg/targets/P42336,P42336,26356562,"Data show that rapamycin-insensitive companion of mTOR protein (RICTOR) plays a central role in phosphatidylinositol 3-kinase (PI3K)/proto-oncogene protein c-akt (AKT) pathway in melanocytes and its deregulation could be involved in melanoma development."
https://pharos.nih.gov/idg/targets/P42336,P42336,26353837,"the presence of PIK3CA major mutations of cell-free DNA could be a discriminatory predictor of survival in early-stage triple negative breast cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,26351730,"We describe the case of a patient in whom we were able to confirm a causative PIK3CA mutation."
https://pharos.nih.gov/idg/targets/P42336,P42336,26340871,"Somatic mutations in PIK3CA have roles in PIK3CA-related somatic overgrowth spectrum"
https://pharos.nih.gov/idg/targets/P42336,P42336,26339434,"Case Report: undifferentiated pleomorphic sarcoma with two missense mutations - KRAS mutation (35G > A, G12D) and PIK3CA mutation (1636C > A, Q546K."
https://pharos.nih.gov/idg/targets/P42336,P42336,26334752,"A concurrent PIK3CA mutation is a poor prognostic factor in patients with advanced EGFR-mutant or KRAS-mutant lung adenocarcinomas."
https://pharos.nih.gov/idg/targets/P42336,P42336,26334097,"analysis of ARID1A, CDH1, cMET and PIK3CA expression and target-related microRNA expression in gastric cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,26333383,"Data show that dual epidermal growth factor receptor 2 HER2/phosphatidylinositol 3-kinase PIK3CA blockade may be a drug therapy for uterine serous carcinoma (USC) with HER2 gene amplification and mutated wild-type PIK3CA resistant to chemotherapy."
https://pharos.nih.gov/idg/targets/P42336,P42336,26325104,"Results show that oncogenic PIK3CA mutations in HER2/neu overexpressing uterine serous carcinoma cells are common and may constitute a major mechanism of resistance to trastuzumab."
https://pharos.nih.gov/idg/targets/P42336,P42336,26301495,"assessed the clinical impact of changes in the frequency and topology of PIK3CA mutation and HER2 (ERBB2) amplification within HER2-positive breast cancer during neoadjuvant the"
https://pharos.nih.gov/idg/targets/P42336,P42336,26296968,"Data show that leukemia inhibitory factor (LIF) signaling promote chemoresistance in cholangiocarcinoma by up-regulating myeloid cell factor-1 (Mcl-1) via phosphatidylinositol 3-kinase (PI3K)/c-akt protein (AKT)-dependent pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,26281684,"It plays a role in cell survival, cell differentiation and cell proliferation in neoplasms."
https://pharos.nih.gov/idg/targets/P42336,P42336,26276776,"Distinct beta-catenin and PIK3CA mutation are linked in endometriosis-associated ovarian endometrioid and clear cell carcinomas"
https://pharos.nih.gov/idg/targets/P42336,P42336,26271341,"PIK3CA Mutations are associated with Head and Neck Squamous Cell Carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,26270987,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,26267533,"Findings indicate inositol polyphosphate 5-phosphatase PIPP (INPP5J) as a suppressor of oncogenic phosphoinositide 3-kinase (PI3K)/AKT signaling in breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,26267517,"Studied the global phosphotyrosine proteome of isogenic knock-in cell lines containing two hotspot mutations in PIK3CA (E545K and H1047R); 824 unique phosphopeptides were identified."
https://pharos.nih.gov/idg/targets/P42336,P42336,26266985,"oncogenic Pik3ca(H1047R) activates a multipotent genetic program in normally lineage-restricted populations at the early stage of tumour initiation, setting the stage for future intratumoural heterogeneity"
https://pharos.nih.gov/idg/targets/P42336,P42336,26266975,"there is a key effect of PIK3CA(H1047R) on mammary cell fate in the pre-neoplastic mammary gland and the cell of origin of PIK3CA(H1047R) tumours dictates their malignancy, thus revealing a mechanism underlying tumour heterogeneity and aggressiveness"
https://pharos.nih.gov/idg/targets/P42336,P42336,26247526,"Found no association between PIK3CA mutational status and other clinical/biological parameters in breast cancer treated with adjuvant trastuzumab."
https://pharos.nih.gov/idg/targets/P42336,P42336,26213461,"the current study illustrated that downregulation of miR203 and overexpression of PIK3CA were novel potential prognosis predictors of gastric cancer patients"
https://pharos.nih.gov/idg/targets/P42336,P42336,26192087,"Studied how rapamycin affects CCN2 expression and migration of lung fibroblasts in vitro; PI3K and inhibitors were used to determine rapamycin's mechanism of action."
https://pharos.nih.gov/idg/targets/P42336,P42336,26191320,"Case Report: enlarging cystic lymphangioma of the mediastinum might harbor a neoplastic nature related to the recently discovered PIK3CA mutation."
https://pharos.nih.gov/idg/targets/P42336,P42336,26174078,"HSP60 overexpression increases the protein levels of the p110alpha subunit of phosphoinositide 3-kinase and c-Myc"
https://pharos.nih.gov/idg/targets/P42336,P42336,26173098,"we also observed frequent PIK3CA mutations in Tiawanese oral squamous cell carcinoma patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,26149216,"Data show that immunoglobulin-like transcript 4 (ILT4) increases the expression of the co-inhibitory molecule B7-H3 through PI3K/AKT/mTOR signalling."
https://pharos.nih.gov/idg/targets/P42336,P42336,26138515,"Genomic amplifications through copy gain of the PI3KCA have been frequently found in Follicular thyroid carcinoma (in 24% of tumors) and Anaplastic thyroid carcinoma (in 42% of tumors)."
https://pharos.nih.gov/idg/targets/P42336,P42336,26138514,"Mutations of PIK3CA occur in approximately 20% of urothelial carcinoma ,and often include gain-of-function mutations that involve the helical and kinase domain."
https://pharos.nih.gov/idg/targets/P42336,P42336,26124336,"It also inhibited extrinsic pathway protein caspase 8, growth-related protein PI3K and further activated PTEN in combination with cisplatin."
https://pharos.nih.gov/idg/targets/P42336,P42336,26122737,"Analysis of interdomain interactions of wild-type and mutants at the p110alpha-p85alpha interface with molecular dynamics simulations suggest that tumor-associated mutations weaken interactions between p110alpha and p85alpha by disrupting key stabilizing interactions."
https://pharos.nih.gov/idg/targets/P42336,P42336,26119563,"ata show that activation of EphB2 receptor kinase arrests tau protein hyperphosphorylation through phosphatidylinositol 3-kinase (PI3K)/Akt protein-mediated glycogen synthase kinase-3beta (GSK-3beta) inhibition."
https://pharos.nih.gov/idg/targets/P42336,P42336,26107192,"PIK3CA Mutation and Amplification is not associated with Clinicopathological Characteristics of Gastric Cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,26075907,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,26070568,"Loss of PIPKIgamma or its focal adhesion-targeting variant, PIPKIgammai2, impaired PI3K/Akt activation upon stimulation with growth factors or extracellular matrix proteins in different tumor cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,26067136,"observations during clinical tumor genotyping suggest that when other pro-oncogenic pathways are mutated along with PIK3CA, then, PIK3CA inhibition alone may not be effective and combination therapy may be warranted"
https://pharos.nih.gov/idg/targets/P42336,P42336,26058752,"we also explored the downstream molecules of miR-19a/PIK3CA signaling. We found that Notch signaling was induced by upregulation of miR-19a, and inactivation of Notch signaling attenuated the cell proliferation, migration and invasion promoted by miR-19a"
https://pharos.nih.gov/idg/targets/P42336,P42336,26054797,"This is the first study identifying the PIK3CA mutation specifically in sporadic cribriform-morular variant of papillary thyroid carcinoma"
https://pharos.nih.gov/idg/targets/P42336,P42336,26053643,"The aim of the present study was to obtain the first data for the phosphatidylinositol-4,5-bisphosphate 3-kinase (PIK3CA) mutation frequency among nonsmall-cell lung cancer (NSCLC) patients in Turkey."
https://pharos.nih.gov/idg/targets/P42336,P42336,26040420,"Data show that PI3 kinase is an attractive therapeutic target in malignancies induced by proto-oncogene protein c-Kit mutations."
https://pharos.nih.gov/idg/targets/P42336,P42336,26036761,"our results demonstrate that miR-375 functions as a growth-suppressive miRNA and plays an important role in inhibiting the tumorigenesis through targeting PIK3CA in osteosarcoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,26019684,"PIK3CA amplification may be an early and important event in colorectal carcinogenesis and may drive the development of left-side tubular adenomas independently with KRAS mutation."
https://pharos.nih.gov/idg/targets/P42336,P42336,25994739,"The prevalence of PIK3CA mutation status in colorectal cancer does not differ according to race/ethnicity, but may vary according to other relevant clinicopathologic and etiologic factors"
https://pharos.nih.gov/idg/targets/P42336,P42336,25962638,"treatment with butein significantly increased reactive oxygen species (ROS) generation and reduced the phosphorylation of PI3K, AKT and mTOR expression, which contributes to the inhibition of the tumor growth of cervical cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,25962440,"PI3KCA gene polymorphism is associated with poor drug response in metastatic renal cell carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,25953087,"Proteins induced by PIK3CA mutations correlated with EGFR signaling and reduced relapse-free survival in basal-like breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,25915427,"Data show that microRNA miR-451 target tuberous sclerosis 1 (TSC1) gene and activates the PI3-kinase/Akt protein/mTOR protein signaling in multiple myeloma (MM) Side population (SP) cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,25909227,"Data show that microRNA miR-21 plays an oncogenic role in diffuse large B-cell lymphoma (DLBCL) by modulating the PI3-Kinase/AKT protein/mTOR protein/forkhead box O1 protein (FOXO1) pathway at multiple levels resulting in strong prognostic implication."
https://pharos.nih.gov/idg/targets/P42336,P42336,25896413,"MiR-10b directly targets the 3'-UTRs of ZEB1 and PIK3CA."
https://pharos.nih.gov/idg/targets/P42336,P42336,25886136,"Among 264 patients, mutations in KRAS exon 2, KRAS exons 3 or 4, NRAS, BRAF and PIK3CA were detected in 34.1%, 3.8%, 4.2%, 5.4% and 6.4%, respectively. Thus, a total of 12.1% of patients without KRAS exon 2 mutations had other RAS mutations"
https://pharos.nih.gov/idg/targets/P42336,P42336,25858893,"Despite the rare prevalence of the 5 most common PIK3CA mutations in Langerhans cell histiocytosis, this report highlights that the PI3K-AKT pathway could be implied in the pathogenesis of Langerhans cell histiocytosis."
https://pharos.nih.gov/idg/targets/P42336,P42336,25855885,"The PIK3CA mutations within our engineered cell model did not lead to enhanced oncogene-dependent cell death when treated with direct inhibition of the PI3K enzyme yet did show increased sensitivity compared with control with dual PI3K/mTOR inhibition."
https://pharos.nih.gov/idg/targets/P42336,P42336,25852062,"Data indicate that high-grade serous ovarian carcinoma (HGSC) cell lines with high GRB2 associated binding protein 2 (GAB2) expression are more responsive to phosphatidylinositol 3-kinases (PI3K) inhibitor PF-04691502."
https://pharos.nih.gov/idg/targets/P42336,P42336,25851630,"PIK3CA mutations often affect a limited fraction of transformed metastatic colorectal cancer cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,25850957,"in a high number of HNSCC tumours, PI3K/Akt signalling is activated by different molecules or by the combination of these molecules."
https://pharos.nih.gov/idg/targets/P42336,P42336,25839328,"PIK3CA hotspot mutations (c.1624G>A [p.Glu542Lys] and c.1633G>A [p.Glu545Lys]) were enriched in APOBEC-signature esophageal squamous cell carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,25835181,"This result suggests polymorphic GT repeat of PIK3CA gene may be a potential predictive marker of colorectal cancer risk in Iranian population"
https://pharos.nih.gov/idg/targets/P42336,P42336,25834816,"These findings provide evidence that a miR-520a binding site polymorphism rs141178472 in the PIK3CA 3'-UTR may play a role in the etiology of colorectal cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,25826091,"Study demonstrates the oncogenic cooperation between PI3K and Yap pathways along liver carcinogenesis. The PIK3CA/Yap mouse represents an important preclinical liver tumor model."
https://pharos.nih.gov/idg/targets/P42336,P42336,25816324,"PIK3CA mutation is associated with breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,25815786,"The frequency of mutations in either KRAS or PIK3CA were significantly higher in patients without lymph node metastasis than those with."
https://pharos.nih.gov/idg/targets/P42336,P42336,25773678,"Somatic mutations and copy number amplification of PIK3CA were associated with response to CCRT in patients with cervical squamous cell carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,25771729,"PIK3CA and AKT2 mutations occurred at low frequency in gastric cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,25757539,"PI3K is activated after imatinib secondary resistance in gastrointestinal stromal tumors."
https://pharos.nih.gov/idg/targets/P42336,P42336,25753288,"Overexpression of STAT1 or of a constitutively active PI3Kalpha mutant failed to induce basal IDO production"
https://pharos.nih.gov/idg/targets/P42336,P42336,25742472,"Neither all RAS gene mutation status nor PIK3CA mutation status was prognostic for PFS or OS."
https://pharos.nih.gov/idg/targets/P42336,P42336,25736040,"Circulating tumor DNA containing PIK3CA mutations is highly predictive of shorter recurrence-free survival and overall survival in primary breast cancer patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,25724520,"Mutations in the PI3K pathway seem therefore to be an important parameter to predict absence of response to cetuximab."
https://pharos.nih.gov/idg/targets/P42336,P42336,25722288,"findings identify PI3K/AKT pathway mutations as an important cause of epileptogenic brain malformations and establish megalencephaly, hemimegalencephaly, and focal cortical dysplasia as part of a single pathogenic spectrum."
https://pharos.nih.gov/idg/targets/P42336,P42336,25710724,"Data show that licochalcone A (LicoA) suppresses solar UV-induced cyclooxygenase (COX-2) expression by acting as a potent inhibitor of enzymes PI3K, MEK1, and B-Raf."
https://pharos.nih.gov/idg/targets/P42336,P42336,25701704,"The PIK3CA hotspot mutations E542K, E545K, and H1047R were found to be significantly more prevalent in PIK3CA-mutant MSS (21/58, 36%) compared to PIK3CA-mutant MSI-H EECs (5/37, 13.5%; p=0.019)."
https://pharos.nih.gov/idg/targets/P42336,P42336,25701229,"Lastly, 17.5% of hepatocellular carcinoma paradoxically had diffuse loss of the oncoprotein p110alpha compared with strong expression in background cirrhotic liver"
https://pharos.nih.gov/idg/targets/P42336,P42336,25695693,"PIK3CA, SMAD4, and TP53 are most often involved in clonal divergence, providing potential targets that may help guide the clinical management of tumor progression or metastases."
https://pharos.nih.gov/idg/targets/P42336,P42336,25689095,"PIK3CA amplifications and mutations in Non-small cell lung cancer have been reported in 37% and 9%, respectively. Both are poor prognostic factors in Squamous Cell Carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,25681199,"Somatic PIK3CA mutations are the most common cause of isolated LMs and disorders in which LM is a component feature."
https://pharos.nih.gov/idg/targets/P42336,P42336,25679319,"The present study emphasizes that the treatment for breast cancer should include molecular analysis of relevant driver mutations with priority to PIK3CA gene while taking clinical decisions in breast cancer patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,25641861,"PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,25639555,"our results unveil a functional cross-talk between YB-1, DeltaNp63alpha and the PI3K/AKT pathway critically governing survival of squamous carcinoma cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,25627962,"suggests that PIK3CA mutations account for a small fraction of PI3K pathway activation and have a limited impact in interfering with the BRAF/NRAS-driven growth in melanoma"
https://pharos.nih.gov/idg/targets/P42336,P42336,25624177,"High tumor PI3K signaling was correlated with adverse survival outcome in patients with rectal cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,25601471,"we will summarize the current knowledge about the role of PAM ( PI3K/AKT/mTOR) signaling in medulloblastoma and discuss the strategies that are currently being evaluated with targeted agents against this pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,25569182,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,25550888,"The expression of both PIK3CA and PIK3CB is increased and related to the development and progress of colorectal carcinoma and multidrug resistance"
https://pharos.nih.gov/idg/targets/P42336,P42336,25542038,"Combined analysis of PIK3CA mutation and PTEN expression may serve as critical indicators to identify patients unlikely to respond to trastuzumab."
https://pharos.nih.gov/idg/targets/P42336,P42336,25539732,"The purpose of the study was to investigate the heterogeneity of PIK3CA mutational status within single circulating Tumor Cells isolated from individual metastatic breast cancer patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,25538040,"self-renewal versus differentiation of human ESCs (hESCs) in response to Wnt signaling is predominantly determined by a two-layer regulatory circuit involving beta-catenin, E-cadherin, PI3K/Akt, and Slug in a time-dependent manner."
https://pharos.nih.gov/idg/targets/P42336,P42336,25501831,"Drugs interfering with expression and activity of XIAP re-sensitize mutant PIK3CA colorectal cancer cells to TRAIL-induced cell death."
https://pharos.nih.gov/idg/targets/P42336,P42336,25501707,"AKT3, PI3KCA, and VEGFR2 silencing reduces the invasiveness of glioblastoma multiforme T98G cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,25498454,"Data indicate that ibrutinib significantly reduced PI3K-Akt activity in cardiac cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,25497009,"Data indicate that pretreatment of BEZ235 can confer the radiation-inducing phosphoinositide 3-kinase/mammalian target of rapamycin/AKT signaling pathway, and further inhibit the cell viability."
https://pharos.nih.gov/idg/targets/P42336,P42336,25491778,"While P7170 inhibits PI3K and mTOR in ER+/HER2- human breast cancer cells and tumors ex vivo, in vivo data indicate that the primary mechanism of P7170 anti-tumor action is inhibition of mTOR and cell proliferation"
https://pharos.nih.gov/idg/targets/P42336,P42336,25491172,"Study sequenced a large clinical series of patients with metastatic colorectal cancer (mCRC) for RAS and PIK3CA mutations. RAS alterations occurred in 48% of mCRC cases, with mutations within KRAS exon 2 in 43%, KRAS exons 3 and 4 in 3%, and NRAS in 2% of cases. PIK3CA mutations occurred in about 10% of mCRC and were significantly associated with concurrent RAS mutation."
https://pharos.nih.gov/idg/targets/P42336,P42336,25483727,"Combination therapy of PI3Kis with IGF1R inhibitors for treating IGF1R-positive human cancers."
https://pharos.nih.gov/idg/targets/P42336,P42336,25483439,"Tim-3 triggers growth factor type responses in acute myeloid leukaemia cells by activating a phosphatidylinositol-3 kinase (PI-3K)/mammalian target of rapamycin (mTOR) pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,25473901,"Data indicate that phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutations have no negative impact on survival after surgery or systemic therapy. However"
https://pharos.nih.gov/idg/targets/P42336,P42336,25471734,"Data show that the combination of PI3 kinase inhibitors with ErbB receptors HER2/HER3 targeting antibodies may constitute a promising therapeutic strategy for prostate cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,25467032,"Patients with HER2-amplified tumors were more likely to present PIK3CA mutations compared to patients with triple negative tumors."
https://pharos.nih.gov/idg/targets/P42336,P42336,25466966,"certain Akt/mTOR/4E-BP1 pathway signals could be novel therapeutic targets for Merkel cell carcinomas regardless of Merkel cell polyomavirus infection status"
https://pharos.nih.gov/idg/targets/P42336,P42336,25458846,"Breast cancers harboring oncogenic PIK3CA activate SGK3 signaling while suppressing Akt, indicative of oncogenic functions for both INPP4B and SGK3 in these tumors."
https://pharos.nih.gov/idg/targets/P42336,P42336,25431257,"MALAT1 might suppress the tumor growth and metastasis via PI3K/AKT signaling pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,25422220,"PIK3CA gene mutation is a good indication of breast cancer development in early diagnosis of cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,25398847,"PIK3CA hotspot mutations are present at a relatively high frequency in CTCs and their presence is associated with worse survival in patients with breast cancer with metastasis."
https://pharos.nih.gov/idg/targets/P42336,P42336,25387153,"Studies indicate that phosphatidylinositol 3-kinases (PI3Ks) and phosphatidylinositol 3-kinase-related protein kinases (PIKKs) are two related families of kinases and share very similar kinase domains."
https://pharos.nih.gov/idg/targets/P42336,P42336,25384882,"Classification by PIK3CA and SOX2 protein expression is useful for predicting the prognosis of Asian patients with lung SQCC with stage I."
https://pharos.nih.gov/idg/targets/P42336,P42336,25367220,"HER3 knock down decreases cell proliferation preferentially in PIK3CA kinase domain mutation (H1047R) cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,25340423,"Studied the structure and dynamics of the PIK3CA wild-type and H1047R oncogenic mutant."
https://pharos.nih.gov/idg/targets/P42336,P42336,25337237,"Report PIK3CA mutation status in colorectal neoplasms and neuroendocrine differentiation in primary/metastatic colorectal neoplasms."
https://pharos.nih.gov/idg/targets/P42336,P42336,25326806,"These results suggest that the combination of a selective MEK inhibitor and a PI3K/mTOR inhibitor was effective in CRC harboring with KRAS and PIK3CA mutations."
https://pharos.nih.gov/idg/targets/P42336,P42336,25318886,"Data indicate that quercetin induces apoptosis via phosphatidylinositol 3-kinase PI3k/Akt pathways, suggesting quercetin has potential to be used as an anti-tumor agent against human cervix cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,25310235,"The phosphoinositide 3-kinase/Akt signaling pathway was activated in cells overexpressing Sox2."
https://pharos.nih.gov/idg/targets/P42336,P42336,25280563,"High PI3K is associated with hepatocellular carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,25257839,"RI represents an important predictor of progression in patients with CRC and suppresses proliferation and metastasis in CRC cells through inhibiting PI3K/AkT pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,25257463,"Impaired EPCs proliferation could be reversed by BBR via the PI3K/AKT/eNOS signaling pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,25247763,"Aberrant activation of PI3K pathway leads to increased phosphorylation of a surprisingly wide variety of kinases and downstream signalling networks."
https://pharos.nih.gov/idg/targets/P42336,P42336,25220666,"Mutations in the TP53 gene and to lesser extent in the PIK3CA gene seem more frequent in cervical adenocarcinoma than in squamous cell carcinoma and CIN3"
https://pharos.nih.gov/idg/targets/P42336,P42336,25215588,"In this review we present a state of art review on various classes of small molecule inhibitors selectively involving PI3K/Akt/mTOR pathway and their clinical potential in this disease."
https://pharos.nih.gov/idg/targets/P42336,P42336,25199759,"HER2-positive breast carcinomas with a PIK3CA mutation are less likely to achieve a pCR after neoadjuvant anthracycline-taxane-based chemotherapy plus anti-HER2 treatment, even if a dual anti-HER2 treatment is given."
https://pharos.nih.gov/idg/targets/P42336,P42336,25197873,"KRAS (41%) and PIK3CA (8%) mutations in Colorectal cancer in patient-derived xenograft models closely paralleled patient tumors (35 to 51% KRAS, 12 to 21% PIK3CA)."
https://pharos.nih.gov/idg/targets/P42336,P42336,25194338,"Data indicarte that Helicobacter pylori infection promotes protein synthesis through phosphatidylinositol 3 kinase/mTOR serine-threonine kinases(PI3K/Mtor)."
https://pharos.nih.gov/idg/targets/P42336,P42336,25194337,"Data show that IL-27 on IFN-gamma mediated autophagy perpetuates by simultaneous induction of kinases mTOR via JAK/PI3 K/Akt cascade and increment in myeloid cell leukemia sequence 1 (Mcl-1) level through PI3 K pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,25192370,"PIK3CA mutations are associated with better outcomes in primary estrogen receptor positive disease and have been reported to be associated with resistance to human epidermal growth factor receptor 2 and endocrine therapies."
https://pharos.nih.gov/idg/targets/P42336,P42336,25186604,"Studies indicate that phosphatidylinositol 3-kinase (PI3K) pathway involved in glioblastoma (GBM) pathogenesis, and PI3K pathway inhibitors can help optimize GBM vaccine immunotherapy."
https://pharos.nih.gov/idg/targets/P42336,P42336,25176561,"PIK3CA mutations were significantly related to ER/PR expression."
https://pharos.nih.gov/idg/targets/P42336,P42336,25172557,"E2-induced Nrf2 activation was completely suppressed by the PI3K inhibitors."
https://pharos.nih.gov/idg/targets/P42336,P42336,25150293,"These results provide a rationale for targeting mutant RAS or PI3K/AKT/mTOR signaling in the subset of Erdheim Chester disease patients with NRAS or PIK3CA mutations."
https://pharos.nih.gov/idg/targets/P42336,P42336,25146530,"Studies indicate that the PI3K/PTEN/Akt/mTOR pathway is in the pathogenesis of malignancies and development of resistance to anticancer therapies, and inhibitors are a promising therapeutic option."
https://pharos.nih.gov/idg/targets/P42336,P42336,25122428,"The PI3K/AKT/mTOR pathway is distinguishable in SCLC genomic alterations. Therefore, a sequencing-based comprehensive analysis could stratify SCLC patients by potential therapeutic targets."
https://pharos.nih.gov/idg/targets/P42336,P42336,25120743,"other mutation was in exon 19 of the phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (PIK3CA) gene, resulting in a G-A substitution at position 1624 (E542K)"
https://pharos.nih.gov/idg/targets/P42336,P42336,25120209,"It is anticipated that through an improved understanding of the biology of the PI3K/Akt pathway in prostate cancer, relevant biomarkers and rationale combination therapies will optimize targeting of this pathway"
https://pharos.nih.gov/idg/targets/P42336,P42336,25108739,"Germline SNPs in the PI3 K-AKT-mTOR pathway were associated with breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,25104442,"PIK3CA mutation status are not associated with recurrence, metastatic disease or progression in endocrine-treated breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,25104021,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,25103565,"PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors."
https://pharos.nih.gov/idg/targets/P42336,P42336,25099740,"The presence of PIK3CA and RAS mutations and other alterations affecting the mTOR pathway activity in HNSCC could be exploited to predict the potential resistance to cetuximab"
https://pharos.nih.gov/idg/targets/P42336,P42336,25090459,"The presented data subclassified colorectal cancers (CRCs) based on their activated signaling pathways and identify a role for c-MET and IGF1R-driven PI3K signaling in CRCs, which is superior to KRAS mutational tests alone."
https://pharos.nih.gov/idg/targets/P42336,P42336,25078343,"A significant percentage of Uterine malignant mesodermal mixed tumors, Uterine clear cell carcinomas, and Uterine serous carcinomas have mutations in PIK3CA."
https://pharos.nih.gov/idg/targets/P42336,P42336,25073438,"KRAS, BRAF, and PIK3CA mutations were evaluated in 204 colorectal carcinoma samples; the frequency of KRAS, BRAF, and PIK3CA mutations was 23.5, 9.8, and 5.9 %, respectively."
https://pharos.nih.gov/idg/targets/P42336,P42336,25068972,"we have found that the PI3Ka/b isoforms and AKT are involved in the downstream mechanisms leading to actin polymerization, ATP secretion and aggregation of human platelets stimulated by 2-AG."
https://pharos.nih.gov/idg/targets/P42336,P42336,25056500,"PTEN was neither a significant prognostic nor predictive factor. PIK3CA mutations were an adverse prognostic factor for survival but not predictive for lapatinib benefit."
https://pharos.nih.gov/idg/targets/P42336,P42336,25054828,"PIK3CA mutations were not correlated with clinicopathological characteristics.  However in the esophageal squamous cell carcinoma patients with family cancer history, PIK3CA mutations were independently correlated with worse overall survival."
https://pharos.nih.gov/idg/targets/P42336,P42336,25051360,"Studies indicate the importance of the EGFR/PI3K/PTEN/Akt/mTORC1/GSK-3 pathway in breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,25044986,"We detected a mosaic disease-causing mutation in PIK3CA by sequencing of DNA extracted from cultured amniotic cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,25027743,"PIK3CA mutations are associated with good response to docetaxel plus epirubicin neoadjuvant chemotherapy in breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,25013125,"In tDNA, 50 mutations (36 EGFR, 5 ERBB2, 4 KRAS, 3 BRAF, and 2 PIK3CA) were identified, of which 26 were detected in cfDNA. These data demonstrate the feasibility and potential utility of mutation screening in the detection of a range of tumor biomarkers"
https://pharos.nih.gov/idg/targets/P42336,P42336,25009009,"Different targeted therapies may be necessary for Triple-negative breast cancer that involves activation of PIK3CA and AKT1 ."
https://pharos.nih.gov/idg/targets/P42336,P42336,25002028,"The combination of PI3K and CDK 4/6 inhibitors overcomes intrinsic and adaptive resistance leading to tumor regressions in PIK3CA mutant xenografts."
https://pharos.nih.gov/idg/targets/P42336,P42336,24981670,"PIK3CA mutations are associated with classical markers of good prognosis and signatures of PI3K pathway activity. The presence of a PIK3CA mutation does not preclude a response to neoadjuvant anastrozole treatment."
https://pharos.nih.gov/idg/targets/P42336,P42336,24980293,"High expression of PI3K is associated with sinonasal and laryngeal small-cell neuroendocrine carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,24967401,"Knockdown of AKT3 and/or PI3KCA genes in T98G cells led to a significant reduction in cell viability, the accumulation of subG1-phase cells and, a reduced fraction of cells in the S and G2/M phases."
https://pharos.nih.gov/idg/targets/P42336,P42336,24964744,"Data indicate that combination of epidermal growth factor (EGFR) inhibitors with either the phosphatidylinositol 3-kinases inhibitor ZSTK474 or the mTOR serine-threonine kinases inhibitor sirolimus showed increased activity."
https://pharos.nih.gov/idg/targets/P42336,P42336,24958106,"Results show that cell stimulation promotes p110alpha and p110beta association, demonstrating oligomerization of PI3K catalytic subunits within cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,24957098,"Data indicate that malic enzyme 2 knockdown impacts phosphatidylinositol 3-kinases/proto-oncogene protein akt (PI3K/AKT) signaling."
https://pharos.nih.gov/idg/targets/P42336,P42336,24952635,"Results show that thioridazine regulates endothelial cell function and subsequent angiogenesis by inhibiting VEGFR-2/PI3K/mTOR signal transduction."
https://pharos.nih.gov/idg/targets/P42336,P42336,24936148,"our results demonstrate that activation of the PI3K/Akt/mTOR/p70S6K signaling pathway is involved in S100A4-induced viability, migration, upregulation of VEGF and downregulation of E-cadherin in CRC cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,24930890,"the transcriptional activity of nuclear beta-Catenin depends on PI3K activity and both factors synergize for full WNT signaling activity and are associated with distant metastasis in colon cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,24920352,"Shorter GT dinucleotide repeat in the intron 1 of PIK3CA gene is associated with increased risk of breast cancer in Iranian women."
https://pharos.nih.gov/idg/targets/P42336,P42336,24918944,"sequencing analysis revealed missense mutations in PIK3CA, and TP53 genes in the breast cancer samples of various histologic types"
https://pharos.nih.gov/idg/targets/P42336,P42336,24910434,"Findings implicate APOBEC3B activity as a key driver of PIK3CA mutagenesis and HPV-induced transformation."
https://pharos.nih.gov/idg/targets/P42336,P42336,24909280,"Data indicate that combined PI3K inhibitor LY294002 and mitogen activated protein kinase kinase (MEK) inhibitor AZD6244 showed synergistic effect on inhibition of SKOV3/DDP cell growth by inducing apoptosis and blocking cell cycle."
https://pharos.nih.gov/idg/targets/P42336,P42336,24908601,"PIK3CA mutations were observed in 11 of 79 cases (13.92%), including a rare mutation, Q546 P, that had not previously been reported in OSCC."
https://pharos.nih.gov/idg/targets/P42336,P42336,24908061,"PIK3CA single nucleotide polymorphism rs17849071 GT+GG genotype was inversely associated with P53 protein accumulation in breast cancer samples."
https://pharos.nih.gov/idg/targets/P42336,P42336,24903382,"Data indicate that Src kinase participates in the regulation of apoptosis through Src/PI-3 K/Akt signaling pathway in Hep-2 cell line."
https://pharos.nih.gov/idg/targets/P42336,P42336,24903376,"Data indicate that upregulation of TRPM cation channel TRPM8 promoted epithelial-mesenchymal transition of breast cancer cells via activating c-akt protein/glycogen synthase kinase 3 beta (GSK-3beta) pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,24887566,"Further experiments demonstrated that phosphatidylinositide 3-kinases/protein kinase B/mammalian target of rapamycin/p70S6 kinase (PI3K/AKT/mTOR/p70S6K) and extracellular regulated protein kinases (ERK)."
https://pharos.nih.gov/idg/targets/P42336,P42336,24878609,"MCP-1 was shown to have a role in activation of the ER1 by phosphorylating Ser167 via the PI3K/Akt/mTORC1 signaling pathway"
https://pharos.nih.gov/idg/targets/P42336,P42336,24866151,"We identified differential therapeutic vulnerabilities that emerge upon the loss of both PTEN and p53, and observed that combined inhibition of PARP and PI3K provides increased efficacy in hormone-insensitive advanced prostate cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,24861917,"Chinese colorectal cancer patients with either KRAS or PIK3CA mutations are more susceptible to distant metastasis."
https://pharos.nih.gov/idg/targets/P42336,P42336,24838432,"The expression of PIK3CA and survivin had a significant correlation with pathological grade and lymph node metastasis in the primary adenosquamous lung carcinoma patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,24821574,"Dual MAPK and PI3K/Akt inhibition was detected."
https://pharos.nih.gov/idg/targets/P42336,P42336,24818793,"Our results indicate that, besides HIF-1alpha, several other pathways, including PI3K/Akt, may be involved in the response to hypoxia of immature and, more specifically, of mature DC to sustain their trafficking and functions within hypoxic microenvironments."
https://pharos.nih.gov/idg/targets/P42336,P42336,24806753,"FAM3A plays crucial roles in the regulation of glucose and lipid metabolism in the liver, where it activates the PI3K-Akt signaling pathway by way of a Ca(2+) /CaM-dependent mechanism"
https://pharos.nih.gov/idg/targets/P42336,P42336,24788832,"E4-ORF1 interacts with Dlg1 and PI3K to assemble a ternary complex where E4-ORF1 hijacks the Dlg1 oncogenic function to relocate cytoplasmic PI3K to the membrane for constitutive activation."
https://pharos.nih.gov/idg/targets/P42336,P42336,24784415,"These data indicate that HIV-1 might also promote PI3K signalling to balance processing of its transcripts by regulating phosphorylation of splicing regulatory proteins."
https://pharos.nih.gov/idg/targets/P42336,P42336,24782652,"We have identified no significant relationship between PIK3CA amplification, race (p= 0.630) and histological type (p=0. 731) in breast carcinoma, but correlation of PIK3CA amplification and age showed a significant relationship (p=0. 003) between them"
https://pharos.nih.gov/idg/targets/P42336,P42336,24774510,"This study indicated that mutations of KRAS, PIK3CA and NRAS were rare in advanced gastric cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,24770869,"Data demonstrate that the BRAF(V600E) cooperates with either PIK3CA(H1074R) or with silencing of the tumor-suppressor PTEN, to promote development of anaplastic thyroid carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,24769208,"TEIF is a downstream effector in EGF/PI3K/Akt signaling."
https://pharos.nih.gov/idg/targets/P42336,P42336,24766330,"PIK3CA isoform is of paramount importance for constitutive Akt activity in multiple myeloma , and - in contrast to inhibition of other class I isoforms - only the blockade of PIK3CA was sufficient to induce cell death in a sizeable subgroup of MM samples."
https://pharos.nih.gov/idg/targets/P42336,P42336,24762137,"PI3K-dependent binding of FOXO to the HBP1 promoter is part of a pathway that controls cell proliferation."
https://pharos.nih.gov/idg/targets/P42336,P42336,24736592,"Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease"
https://pharos.nih.gov/idg/targets/P42336,P42336,24735980,"Aberrant activation of the PI3K/Akt/mTOR axis acts in parallel to RCAN1 in phosphorylating tau, in DS and DS/AD."
https://pharos.nih.gov/idg/targets/P42336,P42336,24726064,"Protein expression of PI3K, Akt and survivin were significantly associated with the development, progression and metastasis of gastric cancer and may have value as diagnostic and prognostic markers in gastric cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,24718026,"Consistent expression of the PI3K catalytic isoform PI3K p110alpha was detected in a panel of glioblastoma patient samples. Inhibition of PI3K p110alpha activity impaired the anchorage-dependent growth of glioblastoma cells and induced tumor regression in vivo."
https://pharos.nih.gov/idg/targets/P42336,P42336,24713430,"Data indicate PI3K/Akt signaling as an essential pathway regulating the distribution of nucleolin."
https://pharos.nih.gov/idg/targets/P42336,P42336,24699302,"We examined the response of 80 samples of primary cells from acute myeloid leukemia patients to selective inhibitors of the phosphatidylinositol 3 kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) axis."
https://pharos.nih.gov/idg/targets/P42336,P42336,24691006,"the outcome of 68 patients with advanced colorectal cancer and RAS, BRAF and PI3KCA status according to ALK gene status, is reported."
https://pharos.nih.gov/idg/targets/P42336,P42336,24687028,"Increased PTGS2 expression or the presence of mutated PIK3CA did not predict benefit from aspirin in colon cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,24673525,"Among the 42 patients who were seropositive for hepatitis B, 17 (40.5%) had HBx mutations and 4 (9.52%) had mutations in PIK3CA."
https://pharos.nih.gov/idg/targets/P42336,P42336,24666267,"Mutations in PIK3CA predict resistance to anti-EGFR therapies."
https://pharos.nih.gov/idg/targets/P42336,P42336,24662006,"In this review, we discuss the emerging evidence for a functional relationship between the IGF-I/PI3K/AKT/mTOR pathway and ASDs, as well as a possible role of this signaling pathway in the diagnosis and treatment of ASDs. [review]"
https://pharos.nih.gov/idg/targets/P42336,P42336,24651445,"The present experiments demonstrated a critical role for the GPRC6A-ERK1/2 and PI3K/Akt signaling pathway in arginine-mediated fibroblast survival."
https://pharos.nih.gov/idg/targets/P42336,P42336,24642661,"PIK3CA gene was found to be mutated in 11 (22%) squamous cell anal carcinoma cases."
https://pharos.nih.gov/idg/targets/P42336,P42336,24641407,"PIK3CA mutations play a critical role in the genesis of rhabdomyosarcoma"
https://pharos.nih.gov/idg/targets/P42336,P42336,24630930,"Inhibition of PI3K (and mTOR) leads to an increase in catalase expression in MCF-7 breast cancer cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,24619078,"Our data indicate that activation of the PI3K/AKT pathway evidenced on the protein level might be a valuable prognostic marker to stratify patients for their risk of tumour recurrence."
https://pharos.nih.gov/idg/targets/P42336,P42336,24615084,"NGF regulates the expression of VEGF through the PI3K/mTOR signaling pathway in human HaCaT keratinocytes."
https://pharos.nih.gov/idg/targets/P42336,P42336,24603487,"Data suggest that the expression of ATP-binding cassette sub-family G member 2 (ABCG2) and the side population may be regulated by phosphatase and tensin homologue deleted on chromosome -10 (PTEN) through the PI3K/Akt pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,24599934,"PIK3CA mutations are more common in HPV(+) OPSCC and are associated with activation of mTOR, but not AKT. These data suggest that inhibitors for mTOR may have activity against HPV(+) PIK3CA mutant oropharyngeal cancers."
https://pharos.nih.gov/idg/targets/P42336,P42336,24595049,"These results reveal betaig-h3 enhances the metastasis potentials of human osteosarcoma cells via integrin alpha2beta1-mediated PI3K/AKT signal pathways."
https://pharos.nih.gov/idg/targets/P42336,P42336,24569712,"Data show the expression of N-myc downstream-regulated gene 2 (NDRG2) is frequently downregulated in adult T-cell leukaemia-lymphoma, resulting in enhanced phosphorylation of PTEN and activation of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,24533074,"PIK3CA mutations frequently coexist with EGFR/KRAS mutations and may have a role in survival and prognosis"
https://pharos.nih.gov/idg/targets/P42336,P42336,24518503,"Data indicate that oncogenic activation of the phosphoinositide 3-kinase (PI3K) pathway involving phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA) gene mutations can contribute to the progression of mucin-producing neoplasms"
https://pharos.nih.gov/idg/targets/P42336,P42336,24511546,"Studied the PIK3CA gene expression status and hotspot mutations in six cases of SDC by immunohistochemistry and genomic DNA sequencing."
https://pharos.nih.gov/idg/targets/P42336,P42336,24507683,"Studied the expression of phosphatidylinositol 3 kinase (PI3-K), protein kinase B (PKB) and glycogen synthase kinase 3 beta (GSK-3 beta) in skeletal muscle tissue of gestational diabetes mellitus patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,24505629,"frequent PIK3CA amplification and promoter methylation of RASSF1A and PAX6 genes in gastric cancers"
https://pharos.nih.gov/idg/targets/P42336,P42336,24486107,"miR-1 may play an important role in the pathogenesis of NSCLC by regulating PIK3CA through the PI3K/Akt pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,24471188,"PIK3CA mutation was found to be a frequent genetic change in all breast cancer subtypes but occurred with the highest rate in HR(+)/HER2(-) tumors"
https://pharos.nih.gov/idg/targets/P42336,P42336,24469048,"molecular or pharmacologic inhibition of the Lyn-PI3K/AKT pathway, markedly increased the sensitivity of the otherwise chemoresistant Cbl mutant-JMML cells to chemotherapeutic agents currently used in the treatment of JMML patients"
https://pharos.nih.gov/idg/targets/P42336,P42336,24468202,"mutations may confer resistance to epidermal growth factor receptor-tyrosine kinase inhibitors in lung adenocarcinoma patients with mutated EGFR"
https://pharos.nih.gov/idg/targets/P42336,P42336,24467828,"PIK3CA mutations do not have clinical validity to predict intrinsic resistance to adjuvant tamoxifen and may therefore be unsuitable as companion diagnostic for PI3K/AKT/mTOR inhibitors in ERalpha- positive, postmenopausal, early breast cancer patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,24453288,"this is the first reported case to our knowledge of a patient with both a possible germline EGFR T790M mutation and a somatic PIK3CA mutation."
https://pharos.nih.gov/idg/targets/P42336,P42336,24451154,"These results suggest that the combination of PI3K inhibition with dual HER2 blockade is necessary to circumvent the resistance to HER2 inhibitors conferred by PIK3CA mutation and also provides benefit to HER2+ tumors with wild-type PIK3CA tumors."
https://pharos.nih.gov/idg/targets/P42336,P42336,24450638,"Te structure and function of the p110alpha enzyme and two of its most common oncogenic mutations. [Review]"
https://pharos.nih.gov/idg/targets/P42336,P42336,24440976,"PIK3CA mutations showed a trend toward an association with an increased risk of death compared to absence of those mutations in African American colorectal cancer patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,24440701,"Data indicate that siRNA-mediated silencing of PIK3CA blocked the inhibitory effect of miR-375 on Colorectal cancer (CRC) cell growth."
https://pharos.nih.gov/idg/targets/P42336,P42336,24428908,"Data indicate that PI3K signaling pathway was critical for the anti-myeloma activity of BENC-511."
https://pharos.nih.gov/idg/targets/P42336,P42336,24425104,"AFP can promote the proliferation of hepatoma cells via activation of PI3K/Akt signaling pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,24374682,"Affected tissue from individuals with facial infiltrating lipomatosis contains PIK3CA mutations that have previously been reported in cancers and in affected tissue from other nonheritable, overgrowth disorders."
https://pharos.nih.gov/idg/targets/P42336,P42336,24370118,"PIK3CA mutations are associated with non--small-cell lung cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,24364210,"This paper presents an overview of PIK3CA mutations in the path PI3K/PTEN/Akt of the most common cancers."
https://pharos.nih.gov/idg/targets/P42336,P42336,24360885,"patients with PIK3CA-mutated tumors showed trend towards favorable overall survival (P = .085) but not disease-free survival (P = .238), suggesting that PIK3CA gene status may be favorable predictive marker in esophageal squamous cell carcinoma patients"
https://pharos.nih.gov/idg/targets/P42336,P42336,24347489,"blocking PI3K/Akt signaling pathway by LY294002 or Akt siRNA could remarkably inhibit the PAK1 activation and cell invasion has to"
https://pharos.nih.gov/idg/targets/P42336,P42336,24347284,"PIK3CA gene alteration in non-muscle invasive bladder tumors predicts reduced recurrence."
https://pharos.nih.gov/idg/targets/P42336,P42336,24341335,"PIK3CA mutations/amplification, HRAS mutation, or PTEN loss that likely lead to PI3K pathway activation were identified in 34 of 75 cases (45%) and did not correlate with disease specific survival."
https://pharos.nih.gov/idg/targets/P42336,P42336,24328409,"Low expression of miR-1 and high expression of PIK3CA are closely related to the invasion, progression and metastasis of non-small-cell lung cancer.There is a negative correlation between the expression of miR-1 and PIK3CA in non-small-cell lung cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,24323028,"Data indicate that seven genes showed statistical enrichment for mutation: TP53, RB1, PTEN, NFE2L2, KEAP1, MLL2, and PIK3CA."
https://pharos.nih.gov/idg/targets/P42336,P42336,24323026,"Data indicate that responses were noted in patients with HER2-amplified breast cancer resistant to trastuzumab, HER2-mutant non-small-cell lung cancer, and tumor types without identified mutations in the HER-PI3K-mTOR pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,24320611,"The Pik3ca(H1047R) mutation promotes the development of highly aggressive and invasive adenocarcinomas in intestine."
https://pharos.nih.gov/idg/targets/P42336,P42336,24314632,"Dengue virus 2 subgenomic RNA induces apoptosis through the Bcl-2-mediated PI3k/Akt signaling pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,24299208,"Our study demonstrates relatively low frequency of PIK3CA mutations and amplifications in ovarian clear cell carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,24276243,"Findings show that PPP1R1B-STARD3 fusion transcript has a key role in subsets of gastric cancers through the activation of PI3K/AKT signaling."
https://pharos.nih.gov/idg/targets/P42336,P42336,24263107,"Data iindicate that he combination therapy of mTOR inhibitor RAD001 and PI3K (phosphatidylinositol 3-kinase) inhibitor LY294002 decreased the cell growth in vitro and progression of liver metastasis in vivo."
https://pharos.nih.gov/idg/targets/P42336,P42336,24262879,"PIK3CA exon 9 or exon 20 missense mutations were more commonly observed in cases that were deficient for mismatch repair protein expression (p=0.0058) and showed loss of ARID1A expression"
https://pharos.nih.gov/idg/targets/P42336,P42336,24249715,"This allows the usage of p110alpha-specific PI3K inhibitors and thus may spare patients the toxicities of pan-PI3K inhibition to allow maximal dosage and efficacy."
https://pharos.nih.gov/idg/targets/P42336,P42336,24244431,"Knockdown of RPS7 resulted in increased expression of P85alpha, P110alpha, and AKT2."
https://pharos.nih.gov/idg/targets/P42336,P42336,24241346,"PIK3CA gene hypomethylation plays a key role in the tumorigenesis and development of esophageal cancer in Chinese patients, while the mutations of PIK3CA gene have little effect on the development of esophageal cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,24233241,"PI3KCA mutation was associated with the absence of Her2/neu amplification/overexpression and a low level of MIB1/Ki-67 labelling"
https://pharos.nih.gov/idg/targets/P42336,P42336,24231454,"Overall tumor PIK3CA mutation status is not associated with stage III colon cancer prognosis. PIK3CA mutation does not appear to serve as a predictive tumor molecular biomarker for response to irinotecan-based adjuvant chemotherapy."
https://pharos.nih.gov/idg/targets/P42336,P42336,24229379,"PIK3CA mutations and PIK3R1 underexpression show opposite effects on patient outcome and could become useful prognostic and predictive factors in breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,24218517,"In chemotherapy-refractory colorectal cancer, neither PIK3CA mutation status nor PTEN expression were prognostic, nor were they predictive of benefit from cetuximab"
https://pharos.nih.gov/idg/targets/P42336,P42336,24193002,"A screen of a cohort of radial scars for a large panel of activating point mutations, revealing PIK3CA mutations in over 60% of specimens."
https://pharos.nih.gov/idg/targets/P42336,P42336,24186142,"The frequently discordant genotypes of usual ductal hyperplasia/columnar cell change and concurrent carcinoma support a role for PIK3CA-activating point mutations in breast epithelial proliferation, perhaps more so than transformation."
https://pharos.nih.gov/idg/targets/P42336,P42336,24175786,"In a Chinese cohort, rs7646409 genotype distributions between the osteosarcoma and control groups was significantly different (P = 0.032). Taking genotype TT as a reference, the risk of osteosarcoma increased three fold in patients with genotype CC."
https://pharos.nih.gov/idg/targets/P42336,P42336,24175777,"Results show PI3KCA mutations present in 34% of human breast cancer patients and significantly higher PIK3CA expression in breast cancer tissues in comparison with control tissues."
https://pharos.nih.gov/idg/targets/P42336,P42336,24122611,"PIK3CA gene mutations were found in 13 (16%), of 28 patients with squamous cell anal cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,24122451,"Phosphoinositide 3-kinase (PI3K) is required for PSGL-1-induced beta1 integrin clustering which ultimately regulates beta1 integrin-mediated Jurkat cell adhesion to fibronectin."
https://pharos.nih.gov/idg/targets/P42336,P42336,24117074,"Its signal plays a crucial role in tumor genesis and tumor progression by promoting cell proliferation and inhibiting apoptosis."
https://pharos.nih.gov/idg/targets/P42336,P42336,24105357,"Induced apoptosis mainly via the PI3K/AKT pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,24099783,"Heavy metals in cigarette smoke induce PI3K expression in epithelial cells and tumor cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,24077110,"Some mutations in the gene encoding for the catalytic subunit of phosphatidyl-inositol-3-kinase, the PIK3CA gene, plays an important role, especially in the resistance to targeted therapies."
https://pharos.nih.gov/idg/targets/P42336,P42336,24073214,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,24069951,"suggesting that the changes in AKT/BCL2 signaling molecules might mediate growth and anti-apoptosis processes at least in part, thus increasing the survival potential of Congenital Giant Nevi melanocytes and maintaining their integrity"
https://pharos.nih.gov/idg/targets/P42336,P42336,24062397,"PIK3CA mutation does not predict benefit from rofecoxib therapy, but it does predict reduced colorectal carcinoma recurrence in regular users of low-dose aspirin after diagnosis."
https://pharos.nih.gov/idg/targets/P42336,P42336,24011934,"Data indicate that dual targeted inhibitors of PI3K/mTOR in combination with inhibitors of RAS/ERK signalling as a potentially effective approach to treating ovarian cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,24011769,"PIK3CA gene mutations have been shown to predict a better otcome in ER/HER2 negative breast cancer, treated with endocrine therapy."
https://pharos.nih.gov/idg/targets/P42336,P42336,24006859,"mutations in KRAS codon 61, KRAS codon 146, BRAF, NRAS, or PIK3CA detected in Asian patients were not predictive of clinical benefits from cetuximab treatment."
https://pharos.nih.gov/idg/targets/P42336,P42336,24001613,"Data indicate that PYK2 N-terminal domain interacting receptor 1 (Nir1) could induce epithelial-mesenchymal transition by stabilising Snail via the PI3K/Akt/GSK3beta/Snail signalling pathway through binding to CCL18."
https://pharos.nih.gov/idg/targets/P42336,P42336,23996432,"Multivariate analyses revealed that PTEN expression (HR, 0.48; p = 0.02) and absence of PI3K expression (HR, 0.2; p = 0.001) were independent prognostic factors for increased PFS"
https://pharos.nih.gov/idg/targets/P42336,P42336,23990352,"PI3K p85alpha-depletion results in activated expression of apoptosis-associated genes."
https://pharos.nih.gov/idg/targets/P42336,P42336,23982433,"PIK3CA mutations are significantly associated with lower grade and hormone receptor positivity in Arab breast cancer patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,23981382,"Data indicate that inflammatory cytokine-induced increases in chronic lymphocytic leukemia (CLL) cell adhesion to stromal cells are correlated with ZAP-70 expression and blocked by PI3K inhibitor."
https://pharos.nih.gov/idg/targets/P42336,P42336,23971979,"PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,23936502,"Oncogenic mutations of p110alpha isoform of PI 3-kinase upregulate its protein kinase activity."
https://pharos.nih.gov/idg/targets/P42336,P42336,23903756,"In PIK3CA-mutant cancer cell lines with persistent mTORC1 signaling, the addition of the allosteric mTORC1 inhibitor RAD001 to the cells along with BYL719 resulted in reversal of resistance in vitro and in vivo."
https://pharos.nih.gov/idg/targets/P42336,P42336,23891627,"Uterine serous carcinoma cell lines with oncogenic PIK3CA mutations were significantly more sensitive to GDC-0980 exposure."
https://pharos.nih.gov/idg/targets/P42336,P42336,23891538,"Results suggest that IFN-gamma-mediated IL-27 protein but not IL-27p28 gene expression is positively regulated by the C-Jun N-terminal kinases (JNK), mitogen-activated protein kinases (MAPKs) and the phosphoinositide 3-kinase (PI3K)."
https://pharos.nih.gov/idg/targets/P42336,P42336,23888070,"AKT1 E17K is a bona fide oncogene in a human luminal breast cancer context. Distinct PI3K pathway mutations confer differential sensitivity to drugs targeting the pathway at different points and by distinct mechanisms."
https://pharos.nih.gov/idg/targets/P42336,P42336,23887305,"our findings suggest that loss of CDKN2A and, to a lesser extent, KRAS and PIK3CA somatic mutations have a role in the progression of a benign to an atypical proliferative Brenner tumor"
https://pharos.nih.gov/idg/targets/P42336,P42336,23886157,"Increase in the expression of PI3K was associated with colorectal carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,23884447,"Among 30 breast tumors, 10(33%) had BCSCs with AKT1, HRAS, or PIK3CA mutations. 3 mutations were detected in PIK3CA.Tumors in which BCSCs have defects in PI3K/Akt signaling are significantly more likely to manifest nodal metastases."
https://pharos.nih.gov/idg/targets/P42336,P42336,23867821,"This study shows that PI3K inhibitors only transiently inhibit AKT which limits their antitumor activities."
https://pharos.nih.gov/idg/targets/P42336,P42336,23867512,"we discuss the preclinical and clinical experience with the rapalogues in RCC, potential mechanisms of resistance to the rapalogues, and the progress in the clinical development of novel agents directed against the phosphatidylinositol 3-kinase/Akt/mTOR"
https://pharos.nih.gov/idg/targets/P42336,P42336,23852799,"frequent PIK3CA mutations in patients with high-risk HNSCC confined predominantly to the oropharyngeal and sinonasal subsites; for the first time, mutation in AKT1 has been identified in HNSCC"
https://pharos.nih.gov/idg/targets/P42336,P42336,23851329,"PIK3CA mutations and/or PTEN loss were identified in the wide morphologic spectrum of salivary duct carcinomas."
https://pharos.nih.gov/idg/targets/P42336,P42336,23832540,"Data indicate that increased activation of PI3K/AKT signaling was observed in the cholangiocarcinoma (CCA) tissues, and suggest that inhibition of PI3K and mTOR activity by the inhibitor NVP-BEZ235 has anti-cancer activity against CCA."
https://pharos.nih.gov/idg/targets/P42336,P42336,23826284,"Single-nucleotide polymorphism in PIK3CA gene is associated with Insulin Resistance."
https://pharos.nih.gov/idg/targets/P42336,P42336,23826249,"Study developed a cancer stem cell model from a colorectal cancer patient-derived xenograft tumor and identified a PIK3CA (H1047R) mutation in the CSC population as a predictive biomarker to guide targeted therapy."
https://pharos.nih.gov/idg/targets/P42336,P42336,23821376,"This study investigated the impact of KRAS, NRAS, BRAF, PI3KCA and TP53 status on outcome of elderly metastatic colorectal cancer patients"
https://pharos.nih.gov/idg/targets/P42336,P42336,23813545,"PIK3CA mutation and copy number gain were detected in 3 (4.9%) and 8 (13.1%), respectively, of 61 gastric cancer samples while PTEN loss was detected in 24 (39%) of the tumours. Two tumours had both PTEN loss and PIK3CA copy number gain."
https://pharos.nih.gov/idg/targets/P42336,P42336,23812937,"Activation of the PI3K/Akt pathway with expression of survivin identified a subgroup of acute myeloid leukemia patients with an excellent outcome."
https://pharos.nih.gov/idg/targets/P42336,P42336,23800951,"These results suggest that the phosphatidylinositol 3-kinase/Akt signaling pathway plays an important role in beta1 integrin-mediated internalization of Staphylococcus aureus by alveolar epithelial cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,23787421,"4 of 41 HPV-negative tumors (10%) demonstrated PIK3CA hot spot mutations, 3 at codon 1047 and 1 at codon 542. Of 46 HPV-positive tumors, 13 (28%) demonstrated activating PIK3CA mutations, including 7 at codon 542, 5 at codon 545, and 1 at codon 1047."
https://pharos.nih.gov/idg/targets/P42336,P42336,23785428,"PIK3CA mutation also contributes to significantly decreased survival for patients with wild-type BRAF tumors."
https://pharos.nih.gov/idg/targets/P42336,P42336,23743572,"The PI3K/Akt inhibitor LY294002 can enhance chemosensitivity of human gastric cancer to VCR."
https://pharos.nih.gov/idg/targets/P42336,P42336,23739063,"PIK3CA mutations were associated with a better outcome, however this effect disappeared after 3 years. There were no statistically significant associations with trastuzumab benefit."
https://pharos.nih.gov/idg/targets/P42336,P42336,23734265,"Data indicate that the activation of MAPK and PI3K pathways resulted in TGF-beta1 signaling by down-regulating Nm23-H1 expression and up-regulating the expression of TbetaRI and TbetaRII, favoring further activation of multiple signaling pathways."
https://pharos.nih.gov/idg/targets/P42336,P42336,23728594,"PIK3CA-mutated colorectal cancer appears to have a distinct epidemiologic profile that is of clinical significance."
https://pharos.nih.gov/idg/targets/P42336,P42336,23728071,"We also examined 61 of our cases for the presence of PIK3CA, AKT1, PTEN and K-RAS mutations."
https://pharos.nih.gov/idg/targets/P42336,P42336,23725225,"A downregulation of FASN effectively inhibits the activity of \"HER2-PI3K/Akt axis\" and alters the malignant phenotype in colorectal cancer cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,23721513,"Data indicate that NVP-BKM120 inhibited pan-class I phosphatidyl-inositol-3-kinase and decreased cell proliferation and increased apoptotic cell death in diffuse large B-cell lymphoma (DLBCL)."
https://pharos.nih.gov/idg/targets/P42336,P42336,23709421,"no specific relationship between mutation in the exon of PIK3CA and clinical characteristics of the hepatocellular carcinoma in korean patients"
https://pharos.nih.gov/idg/targets/P42336,P42336,23708425,"Effectively inhibited the PI3K signaling pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,23702729,"Loss of ARID1A expression, PI3K-Akt pathway alterations, TP53 status and microsatellite instability are involved in endometrial cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,23695676,"Mitotic Plk1 activity is regulated not only by Plk1-Thr210 phosphorylation, but also by Plk1 binding to 14-3-3gamma following Plk1-Ser99 phosphorylation downstream of the PI3K-Akt signalling pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,23684925,"Report a synthetic lethal interaction between PI3K/mTOR and MEK inhibitors in rhabdomyosarcoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,23680019,"These results reveal a previously unknown, essential role of PI3K in the life cycle of human astrovirus type 1."
https://pharos.nih.gov/idg/targets/P42336,P42336,23660947,"Aberrations in PIK3CA and PTEN did not add significant prognostic information on colorectal carcinoma patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,23643389,"Disruption of the IRS1-p110alpha E545K interaction destabilizes the p110alpha protein, reduces AKT phosphorylation, and slows xenograft tumor growth of a cancer cell line expressing p110alpha E545K."
https://pharos.nih.gov/idg/targets/P42336,P42336,23640046,"our results suggest that CAPE suppresses phosphoinositide 3-kinase/AKT/XIAP pathway leading to apoptosis in melanoma tumor cells in vitro and in vivo"
https://pharos.nih.gov/idg/targets/P42336,P42336,23633456,"PIK3CA exon 20 and PTEN mutations associated with features of colon cancer tumorigenesis"
https://pharos.nih.gov/idg/targets/P42336,P42336,23626817,"the PI3K/AKT/mTOR signaling pathway, which was overactivated in APA and IHA compared with normal zona glomerulosa, may mediate aldosterone hypersecretion and participate in the development of PA."
https://pharos.nih.gov/idg/targets/P42336,P42336,23625205,"Results indicate that ADAM17 is upregulated by hypoxia and contributes to hypoxia-induced cisplatin resistance via EGFR/PI3K/Akt pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,23624506,"Data indicate that the PI3K/Akt pathway plays an important role in the regulation of telomerase reverse transcriptase (hTERT) activity in response to histone deacetylases (HDACs) inhibitor."
https://pharos.nih.gov/idg/targets/P42336,P42336,23615713,"Results show that stromal cell-derived factor-1 (SDF-1) enhanced ovarian cancer cell invasion through alphavbeta6 integrin-mediated urokinase-type plasminogen activator (uPA) expression via the p38 MAPK and PI3 K/Akt pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,23612454,"These results confirm that the outcome of HER2-positive patients treated with trastuzumab is significantly worse in patients with PIK3CA-mutated compared with wild-type tumours."
https://pharos.nih.gov/idg/targets/P42336,P42336,23597702,"the review provides a complete picture of the PIK3CA oncogene and its deregulation in oral cancer (Review)"
https://pharos.nih.gov/idg/targets/P42336,P42336,23592373,"PIK3CA mutation status was also not associated with treatment outcome after first-line tamoxifen"
https://pharos.nih.gov/idg/targets/P42336,P42336,23588386,"PI3K signaling contributed to tumor growth and vasculogenic mimicry of gallbladder carcinomas."
https://pharos.nih.gov/idg/targets/P42336,P42336,23583669,"mutational analysis of TP53 (exons 4-9) and CTNNB1 (exon 3) as well as PIK3CA (exon 9) genes in hepatocellular carcinoma from Southern Italy"
https://pharos.nih.gov/idg/targets/P42336,P42336,23580570,"Data show that somatic cell knockin of both KRAS G12V and oncogenic PIK3CA mutations in human breast epithelial cells results in cooperative activation of the phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) pathways."
https://pharos.nih.gov/idg/targets/P42336,P42336,23568272,"p110alpha acts as a negative regulator of beta cell exocytosis and insulin secretion, while p110beta is a positive regulator of insulin secretion through a mechanism separate from its catalytic activity"
https://pharos.nih.gov/idg/targets/P42336,P42336,23564819,"PIK3CA mutations are not associated with tyrosine kinase inhibitors treatment efficacy in non-small cell lung cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,23563091,"APG dramatically reduced Nrf2 expression at both the messenger RNA and protein levels through downregulation of PI3K/Akt pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,23549875,"Data indicate that concurrent BRAF and PI3K/mTOR blockade results in induction of apoptosis."
https://pharos.nih.gov/idg/targets/P42336,P42336,23548132,"About one fourth of mCRC cases wild-type for KRAS codons 12 and 13 present other mutations either in KRAS, BRAF, or PIK3CA, many of which may explain the lack of response to anti-EGFR therapy observed in a significant proportion of these patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,23546602,"Data suggest that 17 beta-estradiol enhances the the glucose uptake, activates PI3K/Akt signaling pathway, leading to translocation of glucose transporter 4 to the plasma membrane in an ERalpha-dependent manner."
https://pharos.nih.gov/idg/targets/P42336,P42336,23538402,"High phospho-stathmin(S38) is associated with PI3K pathway alterations: amplification of the 3q26 region and increased PIK3CA copy number."
https://pharos.nih.gov/idg/targets/P42336,P42336,23532889,"PIK3CA mutations in esophageal squamous cell carcinoma are associated with longer survival."
https://pharos.nih.gov/idg/targets/P42336,P42336,23523798,"PI3K is involved in CKII inhibition-mediated cellular senescence in HCT116 cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,23475955,"these data suggest the efficacy of agents that target the MAPK and PI3K pathways can be improved by combination with a Bcl-2 family inhibitor."
https://pharos.nih.gov/idg/targets/P42336,P42336,23453624,"cell-autonomous phosphoinositide 3-kinase and 3-phosphoinositide-dependent protein kinase 1 are key effectors of oncogenic Kras in the pancreas, mediating cell plasticity, acinar-to-ductal metaplasia, and pancreatic ductal adenocarcinoma formation"
https://pharos.nih.gov/idg/targets/P42336,P42336,23435830,"PIK3CA mutation is a promising predictive biomarker for poor survival in mCRC patients treated with anti-EGFR mAbs, particularly in KRAS wild-type patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,23429328,"The correlation between T stage of gastric cancer and the higher expression of CD40, VEGF, AKT, and PI3K, along with lower S100 expression in DC, may provide insights into future targets for more effective immunotherapy for cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,23418602,"Results indicate that the induction of MCP-2/CCL8 by mycobacteria is dependent on the activation of TLR2/PI3K/Akt signaling pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,23417417,"Studies suggest that adipokines, AMPK, PI3K and the PPAR signaling pathways could be targets of therapeutic strategies for the ovarian cancers and reproductive pathologies."
https://pharos.nih.gov/idg/targets/P42336,P42336,23409016,"down regulation of fibroblast growth factor receptor 3 (FGFR3) and PI3K/Akt signaling mechanisms leading to inhibition of cell proliferation and induction of molecular mechanisms of apopto"
https://pharos.nih.gov/idg/targets/P42336,P42336,23401445,"PIK3CA-mutant lung cancers are dependent on this driver oncogene, whereas in other patient cases, the mutation may modulate the effect of another oncogenic process."
https://pharos.nih.gov/idg/targets/P42336,P42336,23392229,"PIK3CA mutations are associated with lung cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,23386617,"14-3-3 negatively regulates the RGC downstream of the PI3-kinase/Akt signaling pathway"
https://pharos.nih.gov/idg/targets/P42336,P42336,23383294,"PI3K abrogation interferes with key T cell activation processes through both differential expression and alternative splicing, which together actively contribute to T cell suppression."
https://pharos.nih.gov/idg/targets/P42336,P42336,23374602,"only 5 tumours with exon 20 PIK3CA mutations were detected. Only PIK3CA mutations occasionally coexisted with other gene mutations in colorectal cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,23352210,"The rate of PIK3CA mutations in this series of micropapillary carcinomas is similar to invasive ductal carcinomas; however, there may be an enrichment of AKT1 mutations."
https://pharos.nih.gov/idg/targets/P42336,P42336,23345407,"Results indicate a key role of class I PI3K in IL-2R endocytosis that creates a link with IL-2 signalling."
https://pharos.nih.gov/idg/targets/P42336,P42336,23341541,"High PIK3CA/PIK3CD ratio identified a subset of primary mantle cell lymphomas resistant to GS-1101 and this ratio increased significantly with relapse."
https://pharos.nih.gov/idg/targets/P42336,P42336,23335533,"PIK3CA amplifications in large cell and squamous cell carcinomas were significantly higher compared with adenocarcinomas."
https://pharos.nih.gov/idg/targets/P42336,P42336,23318440,"Data indicate that phosphatidylinositol 3'-kinase (PI3K) alpha and beta p110 isoforms of PI3K are broadly expressed in myeloma."
https://pharos.nih.gov/idg/targets/P42336,P42336,23314198,"No correlation was observed between PIK3CA exon 9 and 20 mutations and age at breast cancer diagnosis, histological type, hormone receptor and HER2 status."
https://pharos.nih.gov/idg/targets/P42336,P42336,23301057,"PIK3CA has a role in response to everolimus and letrozole in estrogen receptor positive breast cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,23301033,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,23300780,"FGFR2, KRAS and PIK3CA are frequently mutated in primary and metastatic endometrial lesions."
https://pharos.nih.gov/idg/targets/P42336,P42336,23292187,"Data indicate protein secretion pathways activated by monosodium urate (MSU) in macrophages, and reveal a novel role for cathepsin B and Src, Pyk2, PI3 kinases in the activation of unconventional protein secretion."
https://pharos.nih.gov/idg/targets/P42336,P42336,23275335,"Selective inhibition of phosphoinositide 3-kinase p110alpha preserves lymphocyte function"
https://pharos.nih.gov/idg/targets/P42336,P42336,23271282,"Coincided with the activation of the PI3K/AKT pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,23266353,"In cervical cancer patients treated with CRT, tumor PIK3CA mutation status was associated with overall survival in FIGO stage IB/II cervix cancers."
https://pharos.nih.gov/idg/targets/P42336,P42336,23261389,"Linoleic acid induces opening of connexin26 hemichannels through a PI3K/Akt/Ca(2+)-dependent pathway"
https://pharos.nih.gov/idg/targets/P42336,P42336,23251686,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,23248156,"PIK3CA mutations in diverse cancers were not associated with clinical characteristics, but were correlated with MAPK mutations. PIK3CA mutations, especially, H1047R, were associated with attaining a PR/CR to PI3K/AKT/mTOR pathway inhibitors."
https://pharos.nih.gov/idg/targets/P42336,P42336,23246288,"8 of 91 (8.8%) unrelated CS individuals without germline PTEN mutations carried 10 germline PIK3CA mutations"
https://pharos.nih.gov/idg/targets/P42336,P42336,23243017,"Findings suggest that inhibiton of Bcl-2, Bcl-xL and PI3K, and release of Bim from Bcl-2/Bcl-xL and GSK3alpha/beta culminating in Bax/Bak activation and apoptosis."
https://pharos.nih.gov/idg/targets/P42336,P42336,23237847,"Findings indicate driver mutations in AKT1, and extend the number and type of mutations that activate the PI3-kinase pathway in human breast cancers."
https://pharos.nih.gov/idg/targets/P42336,P42336,23233531,"miR-148b controls malignancy by coordinating a novel pathway involving over 130 genes and, in particular, it directly targets players of the integrin signaling, such as ITGA5, ROCK1, PIK3CA/p110alpha, and NRAS, as well as CSF1"
https://pharos.nih.gov/idg/targets/P42336,P42336,23224067,"Mutations affecting BRAF, EGFR, PIK3CA, and KRAS are not associated with sporadic vestibular schwannomas."
https://pharos.nih.gov/idg/targets/P42336,P42336,23219661,"in primary endometrial carcinoma, mutations in PIK3CA, TP53, PTEN and FBXW7 correlate with high tumor grade, endometrial cancer type and lymph node status; PIK3CA H1047R mutations serve as prognostic markers for relapse-free survival in endometrial cancer patients"
https://pharos.nih.gov/idg/targets/P42336,P42336,23215766,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,23192871,"In conclusion, authors have found that the varicella-zoster virus ORF12 protein activates the PI3K/Akt pathway to regulate cell cycle progression."
https://pharos.nih.gov/idg/targets/P42336,P42336,23185308,"A dramatically lower prevalence of the heterozygous genotype G/T at rs17849071 of PIK3CA was found in patients with follicular thyroid cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,23184205,"Our finding that PIK3CA exon 20 mutations were associated with more aggressive breast cancer and poor outcomes, regardless of the treatment regimen, has important clinical implications."
https://pharos.nih.gov/idg/targets/P42336,P42336,23182717,"Data show that a photodynamic therapy (PDT) dose-dependent upregulation of CRP gene, as well as of PTX3 and ficolin 1 genes in lung tumor A549 cells, and indicate critical role played by PI3K/Akt/AP-1 pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,23172887,"Targeting the phosphoinositide 3-kinase p110-alpha isoform impairs cell proliferation, survival, and tumor growth in small cell lung cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,23136247,"Molecular characterization of single CTCs demonstrated considerable intra- and interpatient heterogeneity of EGFR expression and genetic alterations in EGFR, KRAS, and PIK3CA"
https://pharos.nih.gov/idg/targets/P42336,P42336,23136191,"PIK3CA amplification was detected in thirty-seven percent of lung squamous tumors and five percent of lung adenocarcinomas."
https://pharos.nih.gov/idg/targets/P42336,P42336,23125007,"One hundred and ten patients (51%) were identified who were potentially nonresponders to anti-EGFR therapy:  7/209 (3.3%) had mutations in PIK3CA exon 20."
https://pharos.nih.gov/idg/targets/P42336,P42336,23115297,"In the present study, the authors provide evidence that the West Nile virus capsid protein blocks apoptosis through a phosphatidylinositol (PI) 3-kinase-dependent pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,23110163,"Data indicate that cells grown in three-dimensional (3D) gels showed reduced proliferation and migration as well as reduced PI3K pathway activation when compared to cells grown in 2D."
https://pharos.nih.gov/idg/targets/P42336,P42336,23107319,"PI3K/AKT/mTOR signalling components appear to be differentially implicated in urothelial tumorigenesis and, with the exception of p85aPI3K, are unrelated to the PIK3CA or AKT1 mutational status."
https://pharos.nih.gov/idg/targets/P42336,P42336,23100325,"identified somatic gain-of-function mutations in PIK3CA in the affected nerve that caused macrodactylous overgrowth"
https://pharos.nih.gov/idg/targets/P42336,P42336,23094721,"Use of aspirin after diagnosis was associated with longer survival among patients with mutated-PIK3CA colorectal cancer. Suggests that the PIK3CA mutation in colorectal cancer may serve as a predictive molecular biomarker for adjuvant aspirin therapy."
https://pharos.nih.gov/idg/targets/P42336,P42336,23092874,"activation of the PI3K-AKT pathway through loss of PTEN or PIK3CA mutation was frequently observed in trastuzumab refractory breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,23085752,"either mutant PIK3CA expression or PTEN loss, but not mutant AKT1 E17K, cause disrupted epithelial architecture."
https://pharos.nih.gov/idg/targets/P42336,P42336,23082158,"PI3K/Akt signaling is utilized by alphaIIb-mediated outside-in signaling to activate platelets."
https://pharos.nih.gov/idg/targets/P42336,P42336,23077641,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,23071680,"Data indicate that resistance to UVB induced apoptosis in the alpha6 integrin(high+)/CD44(+) cells involved increased expression of TAp63 and was overcome by PI-3 kinase inhibition."
https://pharos.nih.gov/idg/targets/P42336,P42336,23066039,"PIK3CA H1047R mutation was the only independent factor predicting response to PI3K/AKT/mTOR inhibitors in patients with advanced cancers"
https://pharos.nih.gov/idg/targets/P42336,P42336,23066026,"Src family kinases, PI3 kinase and protein kinase C synergize to mediate Gq-dependent platelet activation"
https://pharos.nih.gov/idg/targets/P42336,P42336,23051731,"p110alpha was activated at mitosis entry and regulated early mitotic events, such as PIP(3) generation, prometaphase progression, and spindle orientation."
https://pharos.nih.gov/idg/targets/P42336,P42336,23028762,"PIK3CA mutations lead to a shift towards a highly glycolytic phenotype."
https://pharos.nih.gov/idg/targets/P42336,P42336,23021375,"EGFR and downstream genetic alterations in KRAS/BRAF and PI3K/AKT pathways have roles in colorectal cancer and treatment [review]"
https://pharos.nih.gov/idg/targets/P42336,P42336,23013731,"PIK3CA mutation is associated with early-stage low-grade endometrial cancers."
https://pharos.nih.gov/idg/targets/P42336,P42336,22998445,"PI3K is a mediator of stretch-induced COX-2 expression in urothelial cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,22997091,"Investigated PIK3CA mutations in ILBC with special reference to late stage tumor progression. PIK3CA mutations were detected in 32/88 (36%) specimens."
https://pharos.nih.gov/idg/targets/P42336,P42336,22994717,"LY294002 prevented phosphorylation of protein kinase B (PKB/Akt) by inhibition of PI3K phosphorylation activity."
https://pharos.nih.gov/idg/targets/P42336,P42336,22994622,"Data indicate that copy number amplification of the PIK3CA gene is associated with poor prognosis in head and neck squamous cell carcinoma (HNSCC) patients without lymph node metastasis."
https://pharos.nih.gov/idg/targets/P42336,P42336,22988297,"PI3K has a crucial role in regulating Brn-2 and Pax3 expression and neoplasm invasiveness, and it is a key determinant of melanoma subpopulation diversity."
https://pharos.nih.gov/idg/targets/P42336,P42336,22982396,"the Ras-PI3K signaling pathway targets specific epigenetic modifications in tumor cells"
https://pharos.nih.gov/idg/targets/P42336,P42336,22964641,"Results indicate that CIB1 is uniquely positioned to regulate PI3K/AKT and MEK/ERK signaling and that simultaneous disruption of these pathways synergistically induces a nuclear GAPDH-dependent cell death."
https://pharos.nih.gov/idg/targets/P42336,P42336,22955107,"The subgroup of ovarian clear cell carcinomas harboring activated PIK3CA seems to have better prognosis possibly due to more indolent biological property compared to tumors without PIK3CA activation."
https://pharos.nih.gov/idg/targets/P42336,P42336,22949682,"diverse PIK3CA mutations stimulate lipid kinase activity by facilitating allosteric motions required for catalysis on membranes"
https://pharos.nih.gov/idg/targets/P42336,P42336,22949056,"results suggest that PIK3CA gene mutations may play a key role in tumourigenesis and aggressiveness of bronchopulmonary neuroendocrine tumours"
https://pharos.nih.gov/idg/targets/P42336,P42336,22940133,"these results demonstrate that miR-124 functions as a growth-suppressive miRNA and plays an important role in inhibiting the tumorigenesis through targeting PIK3CA."
https://pharos.nih.gov/idg/targets/P42336,P42336,22938585,"Data indicate that KRAS, BRAF, PIK3CA, and AKT1 mutations can be rapidly and accurately detected for cancer diagnosis."
https://pharos.nih.gov/idg/targets/P42336,P42336,22936809,"Data indicate that resveratrol suppressed IL-1beta-induced activation of NF-kappaB and PI3K in a dose- and time-dependent manner."
https://pharos.nih.gov/idg/targets/P42336,P42336,22931052,"heterogeneity in frequencies of KRAS/PIK3CA somatic mutations is consistent with already-reported discrepancies in distribution of germline mutations for other malignancies within Sardinian population."
https://pharos.nih.gov/idg/targets/P42336,P42336,22928013,"Class IA phosphatidylinositol 3-kinase p110alpha is required for vacuole maturation"
https://pharos.nih.gov/idg/targets/P42336,P42336,22923510,"Molecular genetic aberrations involving the p53, cyclin E-FBXW7, and PI3K pathways represent major mechanisms in the development of uterine serous carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,22912864,"Data indicate that mutation frequency in malanoma patients was found witih BRAF(V600) in 51%, NRAS in 19%, PI3K pathway in 41% and PTEN in 22%."
https://pharos.nih.gov/idg/targets/P42336,P42336,22905202,"Grape proanthocyanidin inhibit pancreatic cancer cell growth in vitro and in vivo through induction of apoptosis and by targeting the PI3K/Akt pathway"
https://pharos.nih.gov/idg/targets/P42336,P42336,22897902,"These results demonstrated that hepatitis B virus X protein could upregulate LASP-1 through PI3-K pathway to promote the proliferation and migration of hepatoma cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,22897848,"Deregulated c-MYC and PI3K activity cooperate in Burkitt lymphoma pathogenesis."
https://pharos.nih.gov/idg/targets/P42336,P42336,22880054,"The Epstein-Barr virus protein LMP1, which lacks the canonical ITAM required for Syk activation, can nevertheless activate Syk, and the Src kinase Fyn, resulting in downstream c-Cbl and PI3K/Akt activation."
https://pharos.nih.gov/idg/targets/P42336,P42336,22875023,"Data suggest that targeting Hedgehog (Hh) pathway alone or in combination with PI3K/AKT pathway could be a novel therapeutic option in treating endocrine-resistant breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,22870241,"High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations."
https://pharos.nih.gov/idg/targets/P42336,P42336,22863784,"LOX-1 up-regulation induced by AGE-BSA was a receptor mediated through RAGE and is via the PI3K/PDK1/mTORC2 pathway"
https://pharos.nih.gov/idg/targets/P42336,P42336,22851869,"PI3K expression and PIK3CA mutations are related to colorectal cancer metastases"
https://pharos.nih.gov/idg/targets/P42336,P42336,22842715,"Electroacupuncture profoundly activated PI3K/Akt signaling in ischemic cerebral tissues."
https://pharos.nih.gov/idg/targets/P42336,P42336,22840496,"Data provide information for developing new therapeutics targeting PI3K/Akt/mTOR signaling pathway in autoimmune diseases like psoriasis and rheumatoid arthritis."
https://pharos.nih.gov/idg/targets/P42336,P42336,22807617,"PIK3CA-targeted short hairpin RNAs can block the phosphoinositide 3-kinase-Akt signaling pathway and inhibit cell growth, increase apoptosis, and induce cell cycle arrest in PIK3CA-mutant colon cancer SW948 cells"
https://pharos.nih.gov/idg/targets/P42336,P42336,22798500,"In CRC patients treated with cetuximab, activating mutation signatures for PIK3CA (49 genes) were developed."
https://pharos.nih.gov/idg/targets/P42336,P42336,22782554,"This study demonstrates the presence of somatic mutations and amplifications of the PIK3CA gene in a second series of pituitary adenomas, corroborating the previously described involvement of the PI3K/Akt signaling pathway in this tumorigenic process."
https://pharos.nih.gov/idg/targets/P42336,P42336,22779686,"study demonstrated that the somatic mutations of PIK3CA and JAK2 occurred in a small fraction of sarcomas and that these mutations may not play a principal role in the development of sarcomas"
https://pharos.nih.gov/idg/targets/P42336,P42336,22768179,"These data support a strong biological-link between NFkB and the PI3-kinase/AKT pathway in the modulation of anti-apoptotic effects in primary effusion lymphoma cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,22768164,"Epithelial CEACAMs associate in cis with other membrane receptor(s) via their extracellular domains to trigger bacterial uptake in a PI3K-dependent manner."
https://pharos.nih.gov/idg/targets/P42336,P42336,22744290,"this study evaluated whether activating mutations of PI3KCA or complete loss of PTEN is associated with response to anti-human Her2 treatment in breast cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,22737248,"analysis of multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitor"
https://pharos.nih.gov/idg/targets/P42336,P42336,22736407,"A high copy number of MET or PIK3CA was found to be associated with poorer prognostic features and triple receptor-negative disease"
https://pharos.nih.gov/idg/targets/P42336,P42336,22729224,"identified mutations in AKT3, PIK3R2 and PIK3CA in 11 unrelated families with megalencephaly-capillary malformation and megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndromes"
https://pharos.nih.gov/idg/targets/P42336,P42336,22729223,"Exome sequencing and mass spectrometry analysis in paired brain-blood samples from individuals with hemimegalencephaly (20 cases) identified de novo somatic mutations in 30% of affected individuals in the PIK3CA, AKT3 and MTOR genes."
https://pharos.nih.gov/idg/targets/P42336,P42336,22729222,"Sequencing of PIK3CA in ten individuals with fibroadipose hyperplasia syndromes identified either the p.His1047Leu alteration or a second cancer-associated alteration, p.His1047Arg, in nine cases."
https://pharos.nih.gov/idg/targets/P42336,P42336,22723903,"Using high throughput mutation screening platform, we identified that PIK3CA mutations were the most frequently observed target for gastric adenocarcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,22705004,"Mucinous breast carcinomas lack PIK3CA mutations."
https://pharos.nih.gov/idg/targets/P42336,P42336,22705003,"PIK3CA mutations were significantly associated with a favorable overall survival of patients with ovarian clear cell carcinoma"
https://pharos.nih.gov/idg/targets/P42336,P42336,22704443,"Cyclic hydrodynamic pressure stimulating the roliferation of human bladder smooth muscle cells cultured in scaffolds. The signal transduction mechanism for this process is involved with the PI3K/SGK1 and not the PI3K/AKT signaling pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,22689060,"PIK3CA H1074R mutation and PTEN loss differentially regulate LIM-kinase1 and slingshot-1L."
https://pharos.nih.gov/idg/targets/P42336,P42336,22683270,"several Rho family small GTPases activate PI3K by an indirect cooperative positive feedback that required a combination of Rac, CDC42, and RhoG small GTPase activities"
https://pharos.nih.gov/idg/targets/P42336,P42336,22675553,"The interaction between HGF and c-Met increases OPN expression in human osteoblasts via the PI3K, Akt, c-Src, c-Jun, and AP-1 signaling pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,22675430,"KRAS and PIK3CA mutations frequently coexist in patients with colorectal cancer, and are associated with clinical characteristics and outcome."
https://pharos.nih.gov/idg/targets/P42336,P42336,22662165,"Our data highlights a new functional synergism between oncogenic EGFR and PIK3CA with WNT/beta-catenin conferring high tolerance to oxidative stress generated by nutrient deprivation."
https://pharos.nih.gov/idg/targets/P42336,P42336,22658544,"CLOVES syndrome is caused by postzygotic activating mutations in PIK3CA"
https://pharos.nih.gov/idg/targets/P42336,P42336,22649008,"In conclusion, SPRY2 is an important tumour suppressor in prostate cancer since its loss drives the PI3K/AKT pathway via functional interaction with the ErbB system."
https://pharos.nih.gov/idg/targets/P42336,P42336,22648906,"Angiosarcoma (AS) is characterized by a complex pattern of alterations of the TP53 and PIK3CA/AKT/mTOR pathways that does not depend on MYC amplification status."
https://pharos.nih.gov/idg/targets/P42336,P42336,22640628,"Breast cancer patients with tumors harboring a PIK3CA mutation have a better clinical outcome than those with a wild-type PIK3CA gene."
https://pharos.nih.gov/idg/targets/P42336,P42336,22635024,"Single nucleotide polymorphism in PIK3CA is associated with synchronous endometrial and ovarian cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,22623730,"Our findings implicate amplifications of 3q26 focused on PIK3CA and 8q24 focused on MYC in chronic lymphocytic leukemia."
https://pharos.nih.gov/idg/targets/P42336,P42336,22619175,"Data suggest that phosphoinositide-3-kinase/Akt and mammalian target of rapamycin (mTOR) pathway signaling differentially regulate phospho-Mst1-Thr-120/Thr-183."
https://pharos.nih.gov/idg/targets/P42336,P42336,22586484,"In the present study, we did not find any significant correlations between KRAS, BRAF and PIK3CA mutations and the loss of PTEN expression and various clinicopathological features in Chinese patients with colorectal cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,22579930,"KRAS, BRAF, and PIK3CA mutations in colorectal cancer have sustained prevalence rate in the Taiwanese population."
https://pharos.nih.gov/idg/targets/P42336,P42336,22575839,"We further identify the activation of the PI3K/AKT signal pathway by T3 as an underlying mechanism for the enhanced conversion to cell pluripotency in this model."
https://pharos.nih.gov/idg/targets/P42336,P42336,22556379,"Although there is an association of PI3 kinase signaling and chemoresistance in advanced ovarian cancer, there is no clear evidence that this is driven specifically by PIK3CA mutations."
https://pharos.nih.gov/idg/targets/P42336,P42336,22556157,"In human airway smooth muscle cells, regulation of CD38 expression occurs by specific class I PI3K isoforms."
https://pharos.nih.gov/idg/targets/P42336,P42336,22552288,"findings describe a PI3K-driven, NF-kappaB-dependent transcriptional profile that may play a critical role in promoting a microenvironment amenable to tumor progression"
https://pharos.nih.gov/idg/targets/P42336,P42336,22522847,"Aberrant DLC1 methylation and PIK3CA mutat-ions may have important roles in extra-mammary Paget's disease pathogenesis."
https://pharos.nih.gov/idg/targets/P42336,P42336,22522453,"In summary, the PI3K/PKCiota regulates the alternative splicing of Bcl-x pre-mRNA with implications in the cell survival of NSCLC cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,22498935,"A PIK3CA mutation was observed in 16 (17%) specimens in patients with endometrial cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,22495819,"Both osteopontin-c and osteopontin-b splic-ing isoforms promote distinct aspects of PCa progression by inducing PI3K signaling."
https://pharos.nih.gov/idg/targets/P42336,P42336,22488590,"The PI3K/AKT pathway can be an important signaling pathway for the survival of BRCA1-defective breast cancer cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,22471665,"This review outlines the interaction of the PI3K pathway with other signaling cascades, highlights mechanisms involved in hyperactivation, discusses current therapeutics in cancer-related clinical trials that target this pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,22463491,"Data indicate a functional link between the Notch1 and PI3K/Akt pathways in clear cell renal cell carcinoma (CCRCC)."
https://pharos.nih.gov/idg/targets/P42336,P42336,22460814,"PIK3CA mutations were identified in 13/24 columnar cell lesions (54%) and 3/8 invasive carcinomas (37%)."
https://pharos.nih.gov/idg/targets/P42336,P42336,22430209,"Our findings indicate that the effects of mutant PIK3CA are both cell type- and mutation-specific."
https://pharos.nih.gov/idg/targets/P42336,P42336,22430133,"The PIK3CA mutation rate was lower in adenocarcinomas compared to other forms of lung cancers"
https://pharos.nih.gov/idg/targets/P42336,P42336,22417847,"we have analyzed the prevalence of somatic mutations in the FGFR3, PIK3CA, AKT1, KRAS, HRAS, and BRAF genes in bladder cancers"
https://pharos.nih.gov/idg/targets/P42336,P42336,22383975,"analysis of FGFR2 point mutations in 466 endometrioid endometrial tumors and their relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations"
https://pharos.nih.gov/idg/targets/P42336,P42336,22363598,"Merkel cell carcinoma samples were analyzed for activating PIK3CA and AKT1 mutations."
https://pharos.nih.gov/idg/targets/P42336,P42336,22363436,"The relationship between expression and genetic alterations of the components of the PI3K/AKT pathway in non-small cell lung cancer, was investigated."
https://pharos.nih.gov/idg/targets/P42336,P42336,22357840,"coexistence of PIK3CA (the PI3K p110alpha subunit) exon 9 and 20 mutations, but not PIK3CA mutation in either exon 9 or 20 alone, is associated with poor prognosis of colorectal cancer patients"
https://pharos.nih.gov/idg/targets/P42336,P42336,22355357,"High p110alpha is associated with non-small cell lung cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,22351695,"Data indicate that the mechanisms of action of ON 01910.Na invloved PI3K/AKT inhibition and induction of oxidative stress response."
https://pharos.nih.gov/idg/targets/P42336,P42336,22340730,"Studies suggest that the effects of PHLPP1 deletion on prostate carcinogenesis may be explained by the strong dependence of prostate cancer on phosphoinositide 3-kinase (PI3K)/Akt signalling."
https://pharos.nih.gov/idg/targets/P42336,P42336,22336586,"PI3K/mTOR inhibitors can enhance 5-FU cytotoxicity in vitro and in vivo, especially in PIK3CA mutant tumor cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,22336203,"PIK3CA mutations at exon 9 or 20 may have different impact on the prognosis in endometrial carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,22330809,"PIK3CA mutation was associated with significantly longer metastasis-free survival in breast cancer patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,22325221,"PIK3CA mutations may play an important role in the carcinogenesis and development of breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,22315990,"PIK3CA mutations confer constitutive activation of PI3K, which initiates intracellular kinase signaling cascades that promote cell proliferation and survival."
https://pharos.nih.gov/idg/targets/P42336,P42336,22302350,"These findings strengthen the evidence for involvement of the Notch, Hedgehog, NF-KB, and PIK3CA pathways in breast cancer development, and point to novel processes that likely are involved."
https://pharos.nih.gov/idg/targets/P42336,P42336,22301279,"data suggest that lamin A/C proteins are positively involved in malignant behavior of PC cells through the PI3K/AKT/PTEN pathway. Lamin A/C may represent a new oncogenic factor and a novel therapeutic target for PC"
https://pharos.nih.gov/idg/targets/P42336,P42336,22287190,"PIK3CA mutation is associated with colorectal serrated adenocarcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,22285928,"UCA1 regulated cell cycle through CREB via PI3K-AKT dependent pathway in bladder cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,22285706,"loss of PTEN expression (by immunohistochemistry) and PIK3CA mutation is likely to be predictive of a lack of benefit to anti-EGFR therapy in metastatic colorectal cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,22271473,"Patients with PIK3CA mutations treated with PI3K/AKT/mTOR inhibitors demonstrated a higher response rate than patients without mutations."
https://pharos.nih.gov/idg/targets/P42336,P42336,22258409,"Mutational activation of both BRAF and PIK3CA genes does contribute to hepatocellular tumorigenesis at somatic level in Southern Italian population."
https://pharos.nih.gov/idg/targets/P42336,P42336,22227580,"Results describe how phosphatidylinositol 3-kinase and protein kinase D1 cooperate to regulate the insulin-like growth factor signaling pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,22214007,"Although PIK3CA mutation has been found in 10-18% of colorectal cancer patients, the results are still inconclusve if it affects the efficacy of cetuximab or panitumumab.[review]"
https://pharos.nih.gov/idg/targets/P42336,P42336,22212451,"conclude that exocrine pancreatic expression of phosphatidylinositol 3-kinase p85alpha subunit is attenuated by aging"
https://pharos.nih.gov/idg/targets/P42336,P42336,22209294,"PIK3CA mutation status was analyzed by sequencing in 94 tumors. phosphatidylinositol 3'-kinase pathway alteration might have a favorable prognostic impact on endometrial cancers in Chinese women."
https://pharos.nih.gov/idg/targets/P42336,P42336,22208359,"Results show a novel anti-inflammatory role for the PI3K/Akt signaling pathway in microglia, and show that Ad-IRF3 suppressed proinflammatory genes and enhanced anti-inflammatory genes."
https://pharos.nih.gov/idg/targets/P42336,P42336,22190283,"Gene mutations of PIK3CA are not associated with the postoperative prognosis of patients with hepatocellular carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,22188813,"Data indicate that NVP-BKM120 inhibits all four class I PI3K isoforms in biochemical assays."
https://pharos.nih.gov/idg/targets/P42336,P42336,22188534,"Mutations in ras PIK3CA are present in benign lichenoid keratosis."
https://pharos.nih.gov/idg/targets/P42336,P42336,22185283,"Data suggest that wild-type PTEN gene transfection might increase drug sensitivity or reverse drug resistance via inhibiting the PI3K/Akt pathway and regulating downstream molecules of the cell signaling transduction pathway in K562/ADM cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,22172323,"Breast cnacer patients with PIK3CA mutations or increased PI3K pathway activity had a significantly poorer survival despite adequate treatment with adjuvant chemotherapy and trastuzumab."
https://pharos.nih.gov/idg/targets/P42336,P42336,22157930,"Loss of ARID1A protein expression occurs as a very early event in ovarian clear-cell carcinoma development and frequently coexists (not mutually exclusive) with PIK3CA mutations."
https://pharos.nih.gov/idg/targets/P42336,P42336,22146979,"PIK3CA rs6443624 and rs9838411 variants either somewhat or significantly decreased risk of endometrial cancer in a dominant model."
https://pharos.nih.gov/idg/targets/P42336,P42336,22146375,"BDNF promotes EGF-induced proliferation and migration of neural stem/progenitor cells through the PI3K/Akt pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,22135231,"Data indicate that PIK3CA mutations occur in lung adenocarcinomas, usually concurrently with EGFR, KRAS, and anaplastic lymphoma kinase (ALK)."
https://pharos.nih.gov/idg/targets/P42336,P42336,22120431,"PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,22107784,"The prognostic impact of Akt (Akt1) phosphorylated at threonine308 and serine473, Akt2, Akt3, PI3K and PTEN, alone and in coexpression with ER and PgR in non-gastrointestinal stromal tumor soft tissue sarcomas."
https://pharos.nih.gov/idg/targets/P42336,P42336,22105580,"proliferation of human IVD cells is regulated by exogenous and autocrine growth factors mainly via the MEK/ERK and PI-3K/Akt pathways."
https://pharos.nih.gov/idg/targets/P42336,P42336,22095222,"combination of low CEN7 copy number, PTEN loss, and PI3KCA gain may be useful for identifying NSCLC patients unlikely to benefit from treatment with EGFR (TKIs), specifically in wild-type EGFR cases"
https://pharos.nih.gov/idg/targets/P42336,P42336,22072736,"In endometriotic stromal cells, overactivation of the phosphatidylinositol 3-kinase/AKT signaling pathway contributes to the reduced expression of the decidua-specific gene, IGFBP1, potentially through reduced levels of nuclear FOXO1."
https://pharos.nih.gov/idg/targets/P42336,P42336,22064833,"PIK3R1, like PIK3CA, is a potential therapeutic target in Glioblastoma multiforme and that it also influences tumor cell growth and motility"
https://pharos.nih.gov/idg/targets/P42336,P42336,22045127,"Addition of short (6 to 16 amino acids) peptide sequences to the N-terminus of p110alpha induces a gain of function includeds signaling, oncogenic transformation and stimulation of cell growth."
https://pharos.nih.gov/idg/targets/P42336,P42336,22039088,"PIK3CA exon 20 mutations may be a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer. [Review and meta-analysis]"
https://pharos.nih.gov/idg/targets/P42336,P42336,22037177,"the activation of PI3K and MEK pathways is not the only mechanism of EGFR-resistance"
https://pharos.nih.gov/idg/targets/P42336,P42336,22033276,"Common germline variation in PIK3CA does not have a strong influence on the risk of breast cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,22026810,"The overall prevalence of PIK3CA mutations was 23% (7/31) for both tumor types (22% in glioblastoma multiform, and 25% in anaplastic astrocytoma)."
https://pharos.nih.gov/idg/targets/P42336,P42336,22020193,"activating mutation of PIK3CA, loss of PTEN, or IGF1R expression have a role in round cell transformation"
https://pharos.nih.gov/idg/targets/P42336,P42336,22006429,"multiple mutations were identified in phosphoinositide-3-kinase (PI3K), catalytic, alpha polypeptide (PIK3CA) (H1047R, E-->lysine at codon 545 [E545K], and H-->proline at codon 701 [H701P]) that were not observed previously in osteosarcoma"
https://pharos.nih.gov/idg/targets/P42336,P42336,21997360,"A frequent PIK3CA mutation appears in a series of rosette-forming glioneuronal tumors."
https://pharos.nih.gov/idg/targets/P42336,P42336,21994334,"Findings suggest that large HBsAg (LHBs) promotes tumorigenesis of hepatoma cells by triggering a PKCalpha/Raf1 to Src/PI3K/Akt signaling pathway, revealing novel insights into the underlying mechanisms of HBV-associated hepatocarcinogenesis."
https://pharos.nih.gov/idg/targets/P42336,P42336,21991326,"Survival, proliferation, leptin production, OB-R isoforms (OB-Ra and OB-Rb), phosphoinositide 3-kinase (PI3k) and BCL-2 expression have been tested after 24h, 48h and 72h of treatment with alpha-linolenic acid."
https://pharos.nih.gov/idg/targets/P42336,P42336,21990951,"Data show that siRNA mediated targeting of PIK3CA may specifically knockdown the expression of PIK3CA in gastric cancer cells, providing a potential implication for therapy of gastric cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,21970855,"FASN inhibition not only abrogates lipogenesis, which is indispensable for cancer growth, but also downregulates oncogenic PI3K signaling."
https://pharos.nih.gov/idg/targets/P42336,P42336,21949775,"These findings, representing the first genomewide search for variants influencing human protein phosphorylation, provide useful information about the PI3K/AKT/mTOR pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,21945955,"Mutations in PIK3CA were found in 3 of 11 Intraductal tubulopapillary pancreatic neoplasms but not in intraductal papillary pancreatic mucinous neoplasms"
https://pharos.nih.gov/idg/targets/P42336,P42336,21937609,"PI3 kinase-alpha/gamma-mediated signaling downstream of VEGFR2 activation regulated Akt-dependent survival signals, but it was not required to activate endothelial nitric oxide synthase or to elicit NO production in glomerular endothelial cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,21932420,"PIK3CA mutations were uncommonly, but exclusively, seen in tubulovillous adenomas (4/124, 3.2%) and 1/4 (25.0%) tubulovillous adenomas with a focus of cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,21906875,"Results demonstrate a PIK3CA mutation simultaneously occuring with a 15-up deletion in KIT exon 11 in gastrointestinal stromal tumors."
https://pharos.nih.gov/idg/targets/P42336,P42336,21899695,"Accumulation of viral RNA in cells infected with influenza A or B viruses results in PI3K activation."
https://pharos.nih.gov/idg/targets/P42336,P42336,21893189,"The OHCI induces mitochondrial oxidative stress, leading to DNA double-strand breaks and elicitation of a phosphoinositol 3-kinase-mediated cellular response in peripheral blood lymphocytes."
https://pharos.nih.gov/idg/targets/P42336,P42336,21887250,"FGF2 and EGF affect the motor neuron fate decision in human fetal neural stem cells differently through a fine tuning of the PI3K/AKT/GSK3beta pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,21872252,"CREG plays a critical role in protecting the vascular endothelium from apoptosis, and the protective effort of CREG against ECs apoptosis is through the activation of the VEGF/PI3K/AKT signaling pathway"
https://pharos.nih.gov/idg/targets/P42336,P42336,21861134,"Down-regulation of JAK1 by RNA interference inhibits growth of the lung cancer cell line A549 and interferes with the PI3K/mTOR pathway"
https://pharos.nih.gov/idg/targets/P42336,P42336,21830111,"PIK3CA mutation in exon 20 is a negative prognostic factor in stage III colon cancer patients. Moreover, this negative effect is not present in stage I and II patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,21829508,"PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers."
https://pharos.nih.gov/idg/targets/P42336,P42336,21824802,"data confirm that PIK3CA is important to oral squamous cell carcinoma (OSCC) tumorigenesis and can contribute to oncogene activation of the PIK3CA/AKT pathway in OSCC"
https://pharos.nih.gov/idg/targets/P42336,P42336,21822287,"Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms."
https://pharos.nih.gov/idg/targets/P42336,P42336,21789382,"results show that hotspot mutations in the PI3K, JAK2, FLT3 and NPM1 genes are not common in myelodysplastic syndrome patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,21788516,"Cells transformed by the p110alpha-H1047R mutant of PI3K show increased tyrosine phosphorylation of Stat3."
https://pharos.nih.gov/idg/targets/P42336,P42336,21769475,"These findings indicate that the expression of IL-15 up-regulated by IL-6 is associated with MAPKs-ERK1/2 and PI3K-AKT signaling pathways in HaCaT cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,21768115,"Glycosaminoglycans and glucose prevent apoptosis in 4-methylumbelliferone-treated human aortic smooth muscle cells in a process mediated by Toll-like receptor 4, CD44, and PI3K but not by ERK1/2"
https://pharos.nih.gov/idg/targets/P42336,P42336,21765914,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,21735444,"These findings provide evidence that mutations of the PIK3CA gene occur in the putative precursor lesions of ovarian clear cell adenocarcinoma"
https://pharos.nih.gov/idg/targets/P42336,P42336,21725367,"Results indicate that stimulation of the early metastatic steps of motility and invasion by ErbB3 requires activation of the PI3-kinase pathway by the ErbB3 receptor."
https://pharos.nih.gov/idg/targets/P42336,P42336,21713404,"TGF-beta1 undergo a switch into mesenchymal cells and PI3K/Akt and MAPK/Erk1/2 signaling pathways serve to regulate TGF-beta1-induced epithelial-to-mesenchymal transition of A549 cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,21711108,"Beclin1/PI3K-mediated autophagy prevents hypoxia-induced apoptosis in EAhy926 cell line"
https://pharos.nih.gov/idg/targets/P42336,P42336,21708979,"PI3K signaling via p110alpha regulates invadopodia-mediated invasion of breast cancer cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,21682666,"Data suggest that PI3K and PKC are along the same pathway that branches into two separate ones involving each either p38MAP kinase or MEK/ERK."
https://pharos.nih.gov/idg/targets/P42336,P42336,21676217,"PIK3CA mutations occur more often in elderly HER2-positive breast cancer patients. Most mutations were at H1947R & E542K. PI3K pathway activation resulting from PIK3CA mutations may lead to drug resistance to lapatinib & trastuzumab."
https://pharos.nih.gov/idg/targets/P42336,P42336,21673026,"Studies indicate that PI3K can phosphorylate and convert phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol 3,4,5-trisphosphate (PIP3) that leads to activation of AKT."
https://pharos.nih.gov/idg/targets/P42336,P42336,21667306,"Investigated PIK3CA mutation in Chinese hepatocellular carcinoma patients.Exons 9 and 20 mutations of PIK3CA gene were detected.Two point mutations in exon 9 were found in only one patient (1/90; 1.11%), no mutation was found in exon 20 in any cases."
https://pharos.nih.gov/idg/targets/P42336,P42336,21663621,"The present data indicate that activation of the PI3-kinase/PKB/AKT pathway through PIK3CA regulates various transformed phenotypes as well as growth and differentiation of HPV-immortalized cells"
https://pharos.nih.gov/idg/targets/P42336,P42336,21660567,"patients with Non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue that are positive for both PIK3CA and FOXP1 had a worse overall and progression-free survival"
https://pharos.nih.gov/idg/targets/P42336,P42336,21646525,"Results identify unique sites of PTEN and Akt regulation by means of S-nitrosylation, resulting in an \"on-off\" pattern of control of Akt/PI3K signaling."
https://pharos.nih.gov/idg/targets/P42336,P42336,21622527,"Tannerella forsythia epithelial cell entry is dependent on host PI3K signalling, purified BspA protein causes activation of this lipid kinase, and also requires the cooperation of host Rac1 GTPase."
https://pharos.nih.gov/idg/targets/P42336,P42336,21620963,"Retinal pigment epithelial disruption induced by high glucose plus IL-1beta is prevented by erythropoietin through the downstream signaling of JAK2 and PI3K/AKT pathways."
https://pharos.nih.gov/idg/targets/P42336,P42336,21620836,"Data show that PI3K dependent phosphorylation of Fbw7 stimulates its ability to ubiquitinate and degrade its substrates."
https://pharos.nih.gov/idg/targets/P42336,P42336,21617917,"Demonstrate the presence of PIK3CA and AKT1(E17K) mutations from pre-invasive to invasive to metastatic breast cancer tissue."
https://pharos.nih.gov/idg/targets/P42336,P42336,21595858,"These studies validate the Kit L575P-activated model of melanoma and establish the PI3K pathway as a dominant signaling pathway downstream of Kit in melanoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,21594665,"PIK3CA activating mutations and and PTEN loss is associated with less efficacy of trastuzumab therapy in metastatic breast cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,21558396,"Prediction of CH5132799 response on the basis of PIK3CA mutations could enable patient stratification in clinical settings."
https://pharos.nih.gov/idg/targets/P42336,P42336,21557211,"Findings show that the oncogenic PI3K/Akt signalling pathway participates in maintaining cells in a type II phenotype by excluding CD95 from lipid rafts."
https://pharos.nih.gov/idg/targets/P42336,P42336,21538027,"Inhibition of PI3K reduced rhTRAIL sensitivity independently of the cell line preference for either DR4- or DR5-mediated apoptosis signaling."
https://pharos.nih.gov/idg/targets/P42336,P42336,21531001,"PIK3CA somatic mutations occurred in 39 (19.9%) of 196 endometrial carcinomas.  No PIK3CA mutations were found in endometrial hyperplasias. PIK3CA amplification was observed in 24 (12.2%) carcinomas and in 2 (10%) hyperplasias."
https://pharos.nih.gov/idg/targets/P42336,P42336,21507233,"PIK3CA amplification was frequently found in NSCLC"
https://pharos.nih.gov/idg/targets/P42336,P42336,21501368,"Moreover, sustained PI3K/Akt signalling in Aspergillus fumigatus infected cells is an important determinant to resist apoptosis."
https://pharos.nih.gov/idg/targets/P42336,P42336,21499215,"Data show that hepatocyte growth factor inhibits anoikis of pancreatic carcinoma cells through phosphatidylinositol 3-kinase pathway in which activation of Akt may be involved."
https://pharos.nih.gov/idg/targets/P42336,P42336,21490305,"PIK3CA mutations were detected in 19 (40%) of primary tumors and 21 (42%) of metastases"
https://pharos.nih.gov/idg/targets/P42336,P42336,21482677,"The PIK3CA H1047R oncogene targets a multipotent progenitor cell and, furthermore, show that this model recapitulates features of human breast tumors with PIK3CA H1047R."
https://pharos.nih.gov/idg/targets/P42336,P42336,21482133,"A detachment-induced and PI3K/Akt-mediated resistance to apoptotic effects of TRAIL, is demonstrated."
https://pharos.nih.gov/idg/targets/P42336,P42336,21480388,"Data show that the Ras/PI3K/Akt pathway can account for Fyn over-expression in cancers."
https://pharos.nih.gov/idg/targets/P42336,P42336,21474066,"Based on a comparative molecular analysis, we show that activated PIK3CA/AKT is a weaker inducer of cell senescence than is activated RAS."
https://pharos.nih.gov/idg/targets/P42336,P42336,21469098,"controls inflammatory cytokine production in human neutrophils"
https://pharos.nih.gov/idg/targets/P42336,P42336,21468554,"These results suggest that ERalpha induces the down-regulation of PTEN through PI3K activation in breast cancer cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,21454528,"CCL5 signaling induces GLI2 through a PI3K-AKT-IkappaBalpha-p65 pathway and requires GLI2 transcriptional activity to modulate IL-6 expression and Ig secretion in vitro and in vivo"
https://pharos.nih.gov/idg/targets/P42336,P42336,21442372,"Data suggest that the PI3K/Akt signal transduction pathway is involved in the regulation and release of pro-inflammatory cytokines such as TNF-alpha and plays an important role in the development and progression of ulcerative colitis."
https://pharos.nih.gov/idg/targets/P42336,P42336,21440011,"Studies indicate that FoxOs have emerged as an important effector arm of PI3K/Akt signaling by driving multiple apoptotic gene expression."
https://pharos.nih.gov/idg/targets/P42336,P42336,21424126,"data indicated that colorectal cancers with KRAS and PIK3CA bi-mutations are more likely to develop into liver metastasis"
https://pharos.nih.gov/idg/targets/P42336,P42336,21419810,"Data suggest that glioma cell survival occurs through a PI(3)-kinase/PDK1/PKC-iota/BAD mediated pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,21412012,"Single nucleotide polymorphisms in PI3K gene is not associated with colorectal cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,21408138,"Allele-specific qPCR assays for the most frequent activating mutations in EGFR, KRAS, BRAF and PIK3CA in tumor-positive fine needle cytological aspirates were compared against histological material of primary tumors."
https://pharos.nih.gov/idg/targets/P42336,P42336,21407159,"Overexpression of PIK3CA was confirmed in biopsy washout specimens and in postoperative tissues of papillary thyroid carcinoma, in comparison to macroscopically unchanged thyroid tissue"
https://pharos.nih.gov/idg/targets/P42336,P42336,21406404,"Results show the mechanism by which EZH2 regulates BRCA1 expression and genomic stability mediated by the PI3K/Akt-1 pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,21377268,"Our data demonstrate that PIK3CA is a mediator of collagen I-induced down-regulation of E-cadherin."
https://pharos.nih.gov/idg/targets/P42336,P42336,21372221,"Studies suggest that dual PI3K and mTOR inhibition using NVP-BEZ235 may be an effective novel therapeutic approach in patients with ovarian cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,21367892,"Thus, sendai virus infection-mediated apoptosis is temporally regulated by the prevention of XIAP degradation by PI3K."
https://pharos.nih.gov/idg/targets/P42336,P42336,21358673,"demonstrate here that breast cancer cells harbouring PIK3CA mutations are selectively sensitive to mTOR allosteric and kinase inhibitors. However, cells with PTEN loss of function are not sensitive to these drugs"
https://pharos.nih.gov/idg/targets/P42336,P42336,21357506,"Phosphatidylinositol 3'-kinase signaling pathway is essential for Rac1-induced hypoxia-inducible factor-1(alpha) and vascular endothelial growth factor expression in hypoxia."
https://pharos.nih.gov/idg/targets/P42336,P42336,21355052,"PI3K-activating hormones inhibit ROMK by enhancing its endocytosis via a mechanism that involves phosphorylation of WNK1 by Akt1 and SGK1."
https://pharos.nih.gov/idg/targets/P42336,P42336,21345071,"Report novel hotspot PIK3CA mutation in Iranian breast cancer patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,21332555,"PIK3CA mutations were rare in colorectal laterally-spreading tumors."
https://pharos.nih.gov/idg/targets/P42336,P42336,21310649,"The importance of PIK3K/PAK in neoplasm transformation and progression, their disregulation detected in oral squamous cell carcer may provide early diagnosis and aid in the design of new therapies."
https://pharos.nih.gov/idg/targets/P42336,P42336,21303542,"The presence of activating mutations in PIK3CA specifically in gallbladder cancer has clinical implications in both the diagnosis of this cancer type, as well as the potential utility of targeted therapies such as PI3 kinase inhibitors."
https://pharos.nih.gov/idg/targets/P42336,P42336,21300060,"Data suggest that the PI3K/Akt pathway is involved in apoptotic function in PKHD1-silenced cells, and PI3K/Akt inhibition correlates with upregulation of NF-kappaB activity."
https://pharos.nih.gov/idg/targets/P42336,P42336,21290341,"PI3K/AKT/mTOR signalling pathway activation is a common event in high-risk neuroblastoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,21266528,"analysis of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas"
https://pharos.nih.gov/idg/targets/P42336,P42336,21258250,"PIK3CA mutations are associated with drug resistance in non-small cell lung cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,21255011,"Data show that the effects of PI3K-Akt signalling on IL-10 responses were mediated at least in part by GSK3."
https://pharos.nih.gov/idg/targets/P42336,P42336,21252315,"study identified one PIK3CA missense mutation in pancreatic neuroendocrine tumors"
https://pharos.nih.gov/idg/targets/P42336,P42336,21228233,"Here, the authors show that VP11/12 is required for virus-induced activation of PI3K-Akt signaling in herpes simplex virus 1-infected Jurkat T cells and primary fibroblasts."
https://pharos.nih.gov/idg/targets/P42336,P42336,21225506,"EGFR, PI3Kp110 and PTEN expression is a common feature of neuroblastoma"
https://pharos.nih.gov/idg/targets/P42336,P42336,21209903,"PIK3CA mutation and the Wnt pathway have roles in ERalpha-positive breast cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,21209852,"the PI3K/PAK1/ERK signaling pathway has a role in LPA-stimulated breast cancer cell migration"
https://pharos.nih.gov/idg/targets/P42336,P42336,21191416,"Expression of matrix metalloproteinase-13 is controlled by IL-13 via PI3K/Akt3 and PKC-delta in normal human dermal fibroblasts."
https://pharos.nih.gov/idg/targets/P42336,P42336,21185392,"Results suggest that low magnitude stretch can induce cPLA(2) phosphorylation through the MEK/ERK and PI3K-Akt pathways, independently."
https://pharos.nih.gov/idg/targets/P42336,P42336,21179398,"Data support the idea that PI3Kalpha plays an important role in the metastatic process and suggest a more informed strategy for selecting drugs worthy of further development for clinical application."
https://pharos.nih.gov/idg/targets/P42336,P42336,21169263,"PIL3Ca mutations may not only be a prognostic factor, but may also be predictive of preoperative radiation benefit."
https://pharos.nih.gov/idg/targets/P42336,P42336,21168197,"Mutations in PIK3CA, KRAS and NRAS were exclusive to tumors of uterine origin and age-adjusted Cox proportional hazards modeling associated advanced age, stage and TP53 mutations with decreased survival in the uterine subset."
https://pharos.nih.gov/idg/targets/P42336,P42336,21127054,"down-regulation of PI3K-C2alpha may be a feature of type 2 diabetes."
https://pharos.nih.gov/idg/targets/P42336,P42336,21123564,"In hyperglycemic leptin-deficient Lep(ob/ob) transgenic mice, leptin acutely and potently improves glucose metabolism, before any change of body fat mass, via a mechanism involving the p110alpha and -beta isoforms of phosphatidylinositol-3-kinase (PI3K)."
https://pharos.nih.gov/idg/targets/P42336,P42336,21113787,"Activation of the PI3K/AKT in addition to MAPK/ERK signaling pathways may underlie biological aggressiveness in pilocytic astrocytoma (PA). Specifically, it may mediate the increased proliferative activity observed in histologically anaplastic PA."
https://pharos.nih.gov/idg/targets/P42336,P42336,21113138,"PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors."
https://pharos.nih.gov/idg/targets/P42336,P42336,21103049,"Data show that among 181 CRC patients, stratified by microsatellite instability status, DNA sequence changes were identified in KRAS (32%), BRAF (16%), PIK3CA (4%), PTEN (14%) and TP53 (51%)."
https://pharos.nih.gov/idg/targets/P42336,P42336,21093899,"Common genetic variation in PTEN, PIK3CA, AKT1, MLH1, or MSH2 was not statistically significantly associated with endometrial cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,21092549,"Expressions of Akt1, Akt2 and PI3K were decreased in ovarian epithelial cancer cells transduced with PTEN."
https://pharos.nih.gov/idg/targets/P42336,P42336,21072204,"Data show that of primary tumors 64% were mutant for FGFR3, 11% for RAS, 24% for PIK3CA, and 26% for p53."
https://pharos.nih.gov/idg/targets/P42336,P42336,21072204,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,21071597,"Although the mechanism of load-induced mTORC1 activation remains to be determined, it is clear that it does not require classical growth factor signaling."
https://pharos.nih.gov/idg/targets/P42336,P42336,21062993,"Combined inhibition of PI3K and mTOR, which activates autophagy without activating Akt, cooperated with inhibition of autophagy to cause glioma cells to undergo apoptosis."
https://pharos.nih.gov/idg/targets/P42336,P42336,21051183,"findings indicate that somatic mutations in KRAS and PIK3CA but not BRAF oncogenes are closely associated with the development of cholangiocarcinoma in Chinese population"
https://pharos.nih.gov/idg/targets/P42336,P42336,21051183,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,21048031,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,21042767,"the PI3K/AKT signaling pathway is aberrantly active and plays a critical role for the cell cycle progression in human pleural mesothelioma cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,21035469,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,21029719,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,20959404,"cIAP2 upregulated by E6 via EGFR/PI3K/AKT cascades may contribute to cisplatin resistance, revealing that the EGFR or PI3K inhibitor combined with cisplatin may improve the chemotherapeutic efficacy in HPV-infected lung cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,20954287,"Up-regulation of PIK3CA may promote the metastasis of gastric cancer through aberrant activation of PI3K/Akt."
https://pharos.nih.gov/idg/targets/P42336,P42336,20953381,"the p110alpha and beta isoforms of class IA PI3K are both required for the proinflammatory response to flagellin via TLR5"
https://pharos.nih.gov/idg/targets/P42336,P42336,20940279,"PIK3CA mutants overall showed a significantly longer time to first recurrence than wild type cases"
https://pharos.nih.gov/idg/targets/P42336,P42336,20940279,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20937558,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20881644,"Mutations in PIK3CA is associated with squamous cell carcinomas of the lung."
https://pharos.nih.gov/idg/targets/P42336,P42336,20881644,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20860430,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20857497,"Findings suggest that there is p70S6K-mediated, cross-inhibitory regulation between the MEK/ERK and PI3K/mTOR pathways, in which each contribute to the maintenance of the self-renewal and tumorigenic capacity of glioblastoma glioblastoma stem-like cells"
https://pharos.nih.gov/idg/targets/P42336,P42336,20827662,"STC1 induction by thyroid hormone depends on both TRbeta and PI3K activation."
https://pharos.nih.gov/idg/targets/P42336,P42336,20826237,"The levels of total Akt and phosphorylated Akt (active Akt) are increased in E6-AP overexpressing prostate gland and LNCaP cells suggesting that E6-AP regulates the PI3K-Akt signaling pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,20824703,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20818790,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,20813970,"PIK3CA mutation is associated with poor trastuzumab response in HER2-positive metastatic breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,20813970,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20813562,"study supports that mutations in the PIK3CA gene make at least a minor contribution to OSCC tumorigenesis"
https://pharos.nih.gov/idg/targets/P42336,P42336,20813562,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20736745,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20718712,"Sodium butyrate increased PTEN expression, promoted the expression of MUC2 and induced the differentiation of gastric cancer cells through the PTEN/PI3K signalling pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,20713702,"Data show that the mutations weaken an inhibitory interaction between p85alpha and p110alpha."
https://pharos.nih.gov/idg/targets/P42336,P42336,20703095,"Data show that DLBS1425 significantly reduced phosphoinositide-3 (PI3)-kinase/protein kinase B (AKT) signalling by reducing PI3K transcript level and subsequent reduction in AKT phosphorylation."
https://pharos.nih.gov/idg/targets/P42336,P42336,20702582,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,20699365,"Genetic ablation of the mutant PIK3CA allele in MEK inhibitor-resistant cells restores MEK pathway sensitivity, re-expression of mutant PIK3CA reinstates resistance, highlighting the importance of this mutation in resistance to therapy in cancers."
https://pharos.nih.gov/idg/targets/P42336,P42336,20691427,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20652941,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20629539,"Hyaluronic acid and thrombin increase protein synthesis of MT1-MMP and activate mitogen-activated protein kinase, phosphatidylinositol 3-kinase, and Rac-1 signaling pathways in homing of hematopoietic stem/progenitor cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,20629536,"mediates activation of TGF-beta2 promoter response elements leading to high cytokine expression in cancer cells"
https://pharos.nih.gov/idg/targets/P42336,P42336,20628086,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20622004,"PIK3CA rs7651265 GG genotype was associated strongly with colon and rectal cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,20622004,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20619739,"if KRAS is not mutated, assessing BRAF, NRAS, and PIK3CA exon 20 mutations (in that order) gives additional information about the efficacy of cetuximab plus chemotherapy in metastatic colorectal cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,20616362,"PIK3CA HRMA assay was evaluated by performing repeatability, sensitivity, and comparison with DNA sequencing studies and was further validated in 129 formalin-fixed paraffin-embedded breast tissue samples: 99 tumors, 20 noncancerous, and 10 fibroadenomas"
https://pharos.nih.gov/idg/targets/P42336,P42336,20602615,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20593314,"Oncogenic mutations of PI3Kalpha result in a constitutively activated enzyme that triggers downstream pathways that increase tumor aggressiveness and survival (Review)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20571907,"PIK3CA mutations may have a role in KRAS and BRAF wild type colorectal cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,20571907,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20569675,"reports the low frequency of PIK3CA and B-RAF mutations in astrocytomas, despite the presence of activated ERK and AKT proteins."
https://pharos.nih.gov/idg/targets/P42336,P42336,20569675,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20557351,"Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations."
https://pharos.nih.gov/idg/targets/P42336,P42336,20551053,"Results suggest that mutation of PIK3CA is an early event in breast cancer that is more likely to play a role in breast tumor initiation than in invasive progression. A role for exon 9 mutations in the progression of a subset of DCIS cannot be excluded."
https://pharos.nih.gov/idg/targets/P42336,P42336,20551053,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20535651,"the relevance of PIK3CA mutations to a wide range of common human tumor types (Review)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20526288,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20514448,"Decreased expression of PTEN together with overexpression of PI3K and AKT contribute to gastric cancer progression."
https://pharos.nih.gov/idg/targets/P42336,P42336,20508983,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20495538,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20493625,"Direct sequencing analysis of endometrial DNA analysis did not reveal any activating somatic mutations in either PI3KCA or AKT1 gene, indicating that these mutations are rarely associated with endometriosis in South Indian women."
https://pharos.nih.gov/idg/targets/P42336,P42336,20493625,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20491626,"Studies indicate that the high-frequency somatic mutations of PIK3CA observed in different human cancers further strengthen the notion that PI3Ks are optimal targets for therapeutic intervention."
https://pharos.nih.gov/idg/targets/P42336,P42336,20479250,"Although the PIK3CA gene signature was not associated with prognosis in ER- and HER2+ breast cancer, it could identify better clinical outcomes in ER+/HER2- disease."
https://pharos.nih.gov/idg/targets/P42336,P42336,20479250,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20453000,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20447721,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20416519,"No hotspot mutations were detected in any of the samples. PIK3CA hotspot mutations are unlikely to play a major role in the pathogenesis of OSCC in the Greek population."
https://pharos.nih.gov/idg/targets/P42336,P42336,20416077,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20413299,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20407443,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20398348,"PIK3CA mutations in gastric carcinoma may be a signature of cancer type"
https://pharos.nih.gov/idg/targets/P42336,P42336,20398348,"Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20379197,"Mutant PIK3CA interferes with apoptosis downstream of death receptor-signal complex, allowing caspase-8 activation without apoptosis. Cleavage of ROCK-1 by caspase-8 triggers amoeboid shape and invasiveness of HCT116 cells in response to TRAIL and CD95L."
https://pharos.nih.gov/idg/targets/P42336,P42336,20331378,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20308428,"The p110alpha selectively mediates activation of the Tyr kinase Pyk2 to regulate barrier function."
https://pharos.nih.gov/idg/targets/P42336,P42336,20308328,"Data show that PTPN11 mutations causing Leopard syndrome (LS) facilitate EGF-induced PI3K/AKT/GSK-3beta stimulation through impaired GAB1 dephosphorylation, resulting in deregulation of a novel signaling pathway that could be involved in LS pathology."
https://pharos.nih.gov/idg/targets/P42336,P42336,20237496,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20186503,"We evaluated the presence of mutations in PIK3CA, AKT1, AKT2, AKT3, PTEN, and PDPK1 genes in 83 papillary thyroid carcinomas"
https://pharos.nih.gov/idg/targets/P42336,P42336,20186503,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20177704,"PIK3CA alterations specifically correlate with clinicopathological characteristics of Bulgarian patients with breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,20177704,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20167866,"TLR2 cooperates with MyD88, PI3K, and Rac1 in lipoteichoic acid-induced cPLA2/COX-2-dependent airway inflammatory responses"
https://pharos.nih.gov/idg/targets/P42336,P42336,20130133,"The results showed that inhibition of PI3K and Akt-2 was associated with reduced SREBP-1 activation by genotype 3a hepatitis c virus core protein."
https://pharos.nih.gov/idg/targets/P42336,P42336,20107891,"PIK3CA mutations were detected in 13/46 (28%) plasma-derived and 10/46 (21%) serum-derived cfDNA samples from metastatic breast cancer patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,20107891,"Observational study of genetic testing. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20103642,"Data show that similar responses were seen in cancer cells with wild-type or activated mutant PI3K genes treated with p110alpha/delta or p110alpha/beta/delta inhibitors in cell viability assays."
https://pharos.nih.gov/idg/targets/P42336,P42336,20101210,"mutations in critical genes within the PI3-kinase (PI3K) pathway are not functionally equivalent, and that other cooperative genetic events may be necessary to achieve oncogenic PI3K pathway activation in cancers that contain the AKT1 E17K mutation."
https://pharos.nih.gov/idg/targets/P42336,P42336,20098682,"Observational study of genetic testing. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20056178,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,20041213,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,20034918,"Expression of PIK3CA was higher in the hepatocellular carcinoma tissue than in the corresponding adjacent tissue."
https://pharos.nih.gov/idg/targets/P42336,P42336,20030946,"PI3-kinase regulates the thrombin-induced actin cytoskeleton reconstitution in platelets by the RhoA-mDia1 pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,20028853,"These findings demonstrate the importance of cross-talk between the PI3K/Akt and beta-catenin pathways in medulloblastoma"
https://pharos.nih.gov/idg/targets/P42336,P42336,20022634,"PI3K/AKT mutations may not play a major role in multiple myeloma."
https://pharos.nih.gov/idg/targets/P42336,P42336,20019835,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,20008098,"Leptin plays an important role in papillary thyroid carcinoma pathogenesis through PI3K/AKT pathway via Ob-R and is a potential prognostic marker associated with an aggressive phenotype and poor disease-free survival."
https://pharos.nih.gov/idg/targets/P42336,P42336,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19903845,"Tumors expressing the p110alpha helical domain mutant showed a increase in tumor cell intravasation into the blood and tumor cell extravasation into the lung compared with tumors expressing wild-type p110alpha or the kinase domain mutant."
https://pharos.nih.gov/idg/targets/P42336,P42336,19903786,"PIK3CA mutations may have a role in recurrence of rectal cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,19903786,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19898424,"approximately two-thirds of papillomas are driven by mutations in the PI3CA/AKT pathway"
https://pharos.nih.gov/idg/targets/P42336,P42336,19891769,"Aurora-A, via activating Akt, stimulated nuclear factor-kappaB signaling pathway to promote cancer cell survival."
https://pharos.nih.gov/idg/targets/P42336,P42336,19874421,"PI3K physically interacts with the glucocorticoid receptor (GR)through two putative PI3K recruitment consensus YxxM binding motifs in the GR suggesting that some functions regulated by this receptor might occur through kinase interaction."
https://pharos.nih.gov/idg/targets/P42336,P42336,19861897,"In hereditary breast cancer, PIK3CA mutations were found only in the BRCA2 group."
https://pharos.nih.gov/idg/targets/P42336,P42336,19861897,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19853286,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19845664,"Three of five stucco keratosis samples revealed a PIK3CA mutation(E542K, E545K), but no FGFR3 mutation was found. In contrast, both dermatosis papulosa nigra samples harboured an FGFR3 mutation (R248C, S249C) but no PIK3CA mutation."
https://pharos.nih.gov/idg/targets/P42336,P42336,19844788,"PIK3CA KD mutation was a favorable prognostic factor for relapse-free survival in response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,19844788,"Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19844234,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19839777,"Rare mutations in the PIK3CA gene contributing to aggressive endometrial cancer - has been shown."
https://pharos.nih.gov/idg/targets/P42336,P42336,19839777,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19826477,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19822807,"Age-associated changes in transgenic murine heart lead to suppression of the p110 alpha isoform of phosphoinositide 3-kinase activity that modifies cardiac aging."
https://pharos.nih.gov/idg/targets/P42336,P42336,19818761,"PIK3CA mutations mostly began to develop at the stage from the DIN1B to the carcinoma in situ (DCIS), which is a late event of breast oncogenesis."
https://pharos.nih.gov/idg/targets/P42336,P42336,19818761,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19815551,"phosphoinositide 3-kinase isoforms alpha and beta have roles in glycoprotein VI-induced platelet signaling and thrombus formation"
https://pharos.nih.gov/idg/targets/P42336,P42336,19805105,"The structural and biochemical data suggest a previously undescribed mechanism for mutational activation of PIK3CA that involves perturbation of its interaction with the cellular membrane."
https://pharos.nih.gov/idg/targets/P42336,P42336,19789368,"VDR overexpression in colorectal cancer is independently associated with PIK3CA and KRAS mutations."
https://pharos.nih.gov/idg/targets/P42336,P42336,19789314,"PI3K pathway alterations are common in bladder cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,19735264,"association of PIK3CA gene amplification with worse prognosis in nasopharyngeal carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,19735264,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19706770,"Mutation analysis showed activation mutations in the PIK3CA gene in tumors that also had DNA copy number increases in the PIK3CA locus, suggesting an additive effect of coexisting activating amino acid substitution and dosage increase from amplification."
https://pharos.nih.gov/idg/targets/P42336,P42336,19704056,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19701705,"Associations between PIK3CA expression and clinicopathological variables, molecular classes, and patients' outcome were investigated. PIK3CA is an oncogenic biomarker associated with poor prognosis in breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,19686742,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19685490,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19679877,"a link between PI3K(p110alpha) and atrial fibrillation"
https://pharos.nih.gov/idg/targets/P42336,P42336,19671852,"Positive prognostic significance of PIK3CA mutations in breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,19671852,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19654299,"Nicotine increases PPARbeta/delta gene expression through alpha7 nAChR-mediated activation of PI3K/mTOR signals that inhibit AP-2alpha protein expression and DNA binding activity to the PPARbeta/delta gene promoter."
https://pharos.nih.gov/idg/targets/P42336,P42336,19638206,"Investigated PI3K/AKT genetic alterations such as PIK3CA amplification, PIK3CA mutation, PTEN protein loss.  PIK3CA amplification was seen in 54 of 152 epithelial ovarian cancer (EOC) cases analyzed."
https://pharos.nih.gov/idg/targets/P42336,P42336,19633047,"PIK3CA mutations are associated with resistance to HER2-targeted agents."
https://pharos.nih.gov/idg/targets/P42336,P42336,19622295,"SHIP gene can inhibit K562 cell proliferation and promote cell apoptosis via inactivating PI3K/Akt pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,19608668,"Data show that no mutations were detected in PIK3CA and CTNNB1/beta-catenin hotspot sequences."
https://pharos.nih.gov/idg/targets/P42336,P42336,19603024,"PIK3CA (P=0.01) mutations predicted reduced progress free survival in response to cetuximab salvage therapy in patients with metastatic colorectal cancer ."
https://pharos.nih.gov/idg/targets/P42336,P42336,19603024,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19584164,"Findings show that PI3K inhibition diminished hepatoblastoma cell growth being accompanied by reduced AKT and GSK-3beta phosphorylation."
https://pharos.nih.gov/idg/targets/P42336,P42336,19573809,"Phosphatidylinositol 3-kinase (PI3K) signaling pathway occurs frequently in human cancer; PTEN tumor suppressor or PIK3CA oncogene mutations both direct PI3K-dependent tumorigenesis in breast cancers"
https://pharos.nih.gov/idg/targets/P42336,P42336,19549383,"PI3-K accelerates the short course of GPIb centralisation for two PAR signal pathways during the course of thrombin receptor activation in platelets."
https://pharos.nih.gov/idg/targets/P42336,P42336,19487299,"Absence of PIK3CA/AKT1 mutations in one specimen may not reflect the status at other sites because these mutations arise during progression."
https://pharos.nih.gov/idg/targets/P42336,P42336,19487299,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19443396,"results suggest that genetic alterations in the PI3K pathway are common in prostate cancer, and occur mainly through PIK3CA amplification and PTEN hemizygous or homozygous deletion"
https://pharos.nih.gov/idg/targets/P42336,P42336,19440799,"oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors"
https://pharos.nih.gov/idg/targets/P42336,P42336,19440000,"RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of ovarian cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,19420344,"Mutation E17K/AKT1 was not detected in the 24 samples of retinoblastoma analyzed. K-RAS mutations were identified in two samples. There were no mutations in any of the other genes analyzed."
https://pharos.nih.gov/idg/targets/P42336,P42336,19420344,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19418217,"complete concordance of PIK3CA and AKT1 mutations in matched samples of invasive and in situ tumor indicates that these mutations occur early in breast cancer development"
https://pharos.nih.gov/idg/targets/P42336,P42336,19418217,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19394761,"This study for the first time uncovered PIK3CA alterations in small cell lung cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,19383818,"PIK3 kinase expression is higher in metastatic melanoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,19380724,"GILZ1 and SGK1 provide a physical and functional link between the PI3K- and Raf-1-dependent signaling modules"
https://pharos.nih.gov/idg/targets/P42336,P42336,19366826,"PIK3CA mutations are not a major determinant of resistance to the epidermal growth factor receptor inhibitor cetuximab in metastatic colorectal cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,19366826,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19351817,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19349352,"Frequent activating mutations of PIK3CA is associated with ovarian clear cell carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,19330652,"low frequency of PIK3CA mutations in CLL suggests that such mutations are unlikely to cause any major transforming activity in CLL in general."
https://pharos.nih.gov/idg/targets/P42336,P42336,19276248,"There was an association of PIK3CA mutation (kinase domain) with increased androgen receptor levels in breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,19272638,"In the current study of primary uterine serous carcinoma (USC) tumors, oncogenic mutations of the PIK3CA gene were seen in 15% of USC cases"
https://pharos.nih.gov/idg/targets/P42336,P42336,19261849,"Amplifications of 3q26.32 harboring the oncogene PIK3CA were associated with poor prognosis and segregated with the aggressive transcriptional cluster."
https://pharos.nih.gov/idg/targets/P42336,P42336,19240718,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19237633,"Compared with patients with PIK3CA wild-type tumors, those with PIK3CA-mutated tumors experienced an increase in colon cancer-specific mortality according to univariate analysis."
https://pharos.nih.gov/idg/targets/P42336,P42336,19237633,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19234438,"PIK3CA mutations are frequent events in endometrial carcinomas of any histological type"
https://pharos.nih.gov/idg/targets/P42336,P42336,19234438,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19233141,"In this study they investigated the effect that the two major classes of PIK3CA mutation have on the biochemical properties of p110alpha."
https://pharos.nih.gov/idg/targets/P42336,P42336,19223544,"PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies."
https://pharos.nih.gov/idg/targets/P42336,P42336,19196980,"findings suggest GSK3beta is an important effector of mutant PIK3CA, and that lithium, an FDA-approved therapy for bipolar disorders, has selective antineoplastic properties against cancers that harbor these mutation"
https://pharos.nih.gov/idg/targets/P42336,P42336,19172191,"activation of PIK3CA may be an important molecular event contributing to the maintenance of OSE transformation initiated by oncogenes such as K-ras"
https://pharos.nih.gov/idg/targets/P42336,P42336,19164214,"genetic variations in PIK3CA may be associated with survival in esophageal cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,19164214,"Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19148475,"Missense mutations of PIK3CA are identified in 81% of cervical cancer cell lines, with mutation rate higher in older women."
https://pharos.nih.gov/idg/targets/P42336,P42336,19148475,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19143676,"a selective downregulation of the p110alpha catalytic isoform in pregnancy"
https://pharos.nih.gov/idg/targets/P42336,P42336,19076977,"results suggest that FGFR3 and PIK3CA mutations are involved in the pathogenesis of solar lentigo and occurrence of these mutations in both SL and SK suggests a common genetic basis."
https://pharos.nih.gov/idg/targets/P42336,P42336,19069650,"Zinc sulfate stimulation could activate the EGFR and the PI3K/Akt signaling pathway, further leading to upregulation of ICAM-1 expression in human airway epithelial cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,19064572,"Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19029981,"inhibitors of the PI3K-mTOR pathway may be active in cancers with PIK3CA mutations and, when combined with MEK inhibitors, may effectively treat KRAS mutated lung cancers"
https://pharos.nih.gov/idg/targets/P42336,P42336,19029838,"PIK3CA amplification and single nucleotide polymorphism may be a marker predicting ovarian cancer response and resistance to chemotherapy."
https://pharos.nih.gov/idg/targets/P42336,P42336,19029838,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19027487,"data showed a higher incidence of PIK3CA mutations in Malaysian breast cancers compared to colorectal & nasopharyngeal tumor tissue; findings also indicate PIK3CA mutations play a pivotal role in activation of the PI3 K signaling pathway in breast cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,19027487,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19012001,"The result showed that the mutation rate of PIK3CA in nasopharyngeal carcinomas (n = 73) was 9.6%, whereas both BRAF (n = 65) and RAS (n = 45) were wild type in every specimen with adequate DNA for analysis."
https://pharos.nih.gov/idg/targets/P42336,P42336,19012001,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,19003996,"JAK2, EGFR and PI3KCA hot spot mutations are uncommon in endocrine tumors"
https://pharos.nih.gov/idg/targets/P42336,P42336,18996102,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,18990689,"ARF1 regulates epidermal growth factor-dependent breast cancer cell growth and invasion during cancer progression by controlling the activation of the phosphatidylinositol 3-kinase pathway"
https://pharos.nih.gov/idg/targets/P42336,P42336,18980969,"our data reveal a novel function of p110alpha in medulloblastoma growth and survival."
https://pharos.nih.gov/idg/targets/P42336,P42336,18951408,"Mutant-specific differences in the catalytic cleft and activation loop behavior suggest that structure-based mutant-specific inhibitors can be designed for PIK3CA-positive breast cancers."
https://pharos.nih.gov/idg/targets/P42336,P42336,18854243,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,18852163,"strong genetic evidence supporting a role of the PI3K/AKT signaling pathway in the tumorigenesis of pituitary tumors, particularly the invasive types"
https://pharos.nih.gov/idg/targets/P42336,P42336,18835245,"These data establish a new function for the NBS1 protein as a regulator of PI3K activity via SFK members."
https://pharos.nih.gov/idg/targets/P42336,P42336,18829572,"In tumors with co-occurring mutations in multiple components of the PI3K pathway, selective inhibition of the alpha isoform of p110 is an attractive therapeutic strategy, especially for late-stage tumors."
https://pharos.nih.gov/idg/targets/P42336,P42336,18798071,"Higher BRCA1 mRNA expression is significantly correlated with advanced disease and ERBB2 overexpression in breast cancers."
https://pharos.nih.gov/idg/targets/P42336,P42336,18798071,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,18794883,"Inhibitors that target exclusively the cancer-specific mutants of p110 alpha constitute an important goal and challenge for current drug development."
https://pharos.nih.gov/idg/targets/P42336,P42336,18794094,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,18782444,"BRAF, KRAS and PIK3CA mutations occur prior to malignant transformation demonstrating that these oncogenic alterations are primary genetic events in colorectal carcinogenesis"
https://pharos.nih.gov/idg/targets/P42336,P42336,18782444,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,18769113,"TGFbeta activates PI3K to downregulate PTEN for enhancement of cell proliferation that is independent of SMAD proteins"
https://pharos.nih.gov/idg/targets/P42336,P42336,18757405,"RNA interference-mediated knockdown of PIK3CA inhibited colony formation of cell lines with PIK3CA mutations or gains but was not effective in PIK3CA wild-type cells. PIK3CA mutations or gains are present in a subset of lung cancers"
https://pharos.nih.gov/idg/targets/P42336,P42336,18691552,"study identified a potential hotspot for resistance mutations (I800), a drug-sensitizing mutation (L814C), and a surprising lack of resistance mutations at the \"gatekeeper\" residue"
https://pharos.nih.gov/idg/targets/P42336,P42336,18679714,"Exon 20 PIK3CA mutations are relatively frequent in Her-2+ breast tumors and shorten survival, whereas neither exons 9 and 20 mutations seem related with \"triple negative\" breast carcinomas"
https://pharos.nih.gov/idg/targets/P42336,P42336,18679714,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,18676830,"PIK3CA mutations, in comparison with PTEN loss and AKT1 mutations, were associated with significantly less and inconsistent activation of AKT and of downstream PI3K/AKT signaling in tumors and cell lines"
https://pharos.nih.gov/idg/targets/P42336,P42336,18669866,"KRAS mutations and PI3KCA/PTEN deregulation significantly correlate with resistance to cetuximab."
https://pharos.nih.gov/idg/targets/P42336,P42336,18669866,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,18660489,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,18641990,"Overexpression of PI3K and Akt is associated with malignant rhabdoid tumor"
https://pharos.nih.gov/idg/targets/P42336,P42336,18621636,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,18516290,"PIK3CA mutation is significantly associated with key molecular events in colorectal cancer, and MGMT loss likely contributes to the development of PIK3CA G>A mutation"
https://pharos.nih.gov/idg/targets/P42336,P42336,18516290,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,18503601,"FGFR3 and PIK3CA germline mutations can be excluded as an underlying genetic basis, therefore alternative mechanisms have to contribute to familial Seborrheic Keratoses."
https://pharos.nih.gov/idg/targets/P42336,P42336,18453587,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,18449193,"results provide the first in vivo evidence for p110-isoform selectivity in endothelial PI3K signalling during angiogenesis"
https://pharos.nih.gov/idg/targets/P42336,P42336,18418043,"structure of the complex between the catalytic subunit of PI3Kalpha, p110alpha, & a portion of its regulatory subunit, p85alpha reveals the majority of the oncogenic mutations occur at the interfaces between p110 domains & between p110 & p85 domains"
https://pharos.nih.gov/idg/targets/P42336,P42336,18382359,"PIK3CA is rarely mutated in diffuse large B-cell lymphoma"
https://pharos.nih.gov/idg/targets/P42336,P42336,18371219,"PIK3CA mutation was associated with a decreased rate of node-positive disease, particularly among ER-positive tumors."
https://pharos.nih.gov/idg/targets/P42336,P42336,18371219,"Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,18355852,"high frequency of mutations in the PIK3CA, HRAS and KRAS genes leads us to believe that dysregulation of the phosphatidylinositol 3-kinase or Ras pathway is significant for the development and progression of penile carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,18343945,"Our data provide evidence that PIK3CA and BRAF contribute to the tumorigenesis of IPMN/IPMC, but at a lower frequency than KRAS."
https://pharos.nih.gov/idg/targets/P42336,P42336,18335034,"identified and characterized the PIK3CA 5' upstream transcriptional regulatory region and confirmed that PIK3CA is transcriptionally regulated through NF-kappaB pathway"
https://pharos.nih.gov/idg/targets/P42336,P42336,18317450,"point mutations in the p110alpha subunit of class IA PI3K confer factor independence to hematopoietic cells in vitro and leukemogenic potential in vivo, but have lower transforming activity than a deregulated class III receptor tyrosine kinase."
https://pharos.nih.gov/idg/targets/P42336,P42336,18285463,"PI3Kalpha and -beta present distinct activation requirements and kinetics in G(1) phase, with a selective action of PI3Kalpha at the G(0)/G(1) phase transition"
https://pharos.nih.gov/idg/targets/P42336,P42336,18270270,"The demonstration that p53 binds directly to the PIK3CA promoter and inhibits its activity identifies a novel mechanism whereby these two mediators regulate cellular functions."
https://pharos.nih.gov/idg/targets/P42336,P42336,18262558,"In exon 9, a somatic mutation was found in two patients (2.2%) and in two cell lines; mutations included three E545K (G1633A) mutations and one E545Q (G1633C) mutation, in exon 20, no mutation was observed in our esophageal cancer patients"
https://pharos.nih.gov/idg/targets/P42336,P42336,18224685,"Mutations in the PIK3CA is associated with colon cancers"
https://pharos.nih.gov/idg/targets/P42336,P42336,18224685,"Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,18221484,"genetic alterations of KRAS and PIK3CA may play equivalent roles in endometrial carcinogenesis"
https://pharos.nih.gov/idg/targets/P42336,P42336,18216097,"Poliovirus simultaneously activates the phosphatidylinositol 3-kinase (PI3K)/Akt survival signaling pathway in these cells, limiting the extent of JNK activation and thereby cell death."
https://pharos.nih.gov/idg/targets/P42336,P42336,18193083,"analysis of PIK3CA mutations in Saudi Arabian colorectal cancer patience"
https://pharos.nih.gov/idg/targets/P42336,P42336,18183466,"PIK3CA mutations are common in invasive ductal carcinomas of the breast and PIK3CA exon 20 mutation is an independent risk factor for poor prognosis in breast cancer patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,18183466,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,18181165,"somatic PIK3CA mutations contribute to the frequent activation of the PI3K/AKT pathway in carcinomas of the biliary tract and liver"
https://pharos.nih.gov/idg/targets/P42336,P42336,18180098,"In this study, we were unable to find a clear association between PIK3CA mutations and gene amplifications, nor with tumor histological subtypes or staging"
https://pharos.nih.gov/idg/targets/P42336,P42336,18097548,"PIK3CA mutations in HNSCC are likely to be oncogenic and may significantly contribute to HNSCC carcinogenesis and pave attractive target for therapeutic prevention."
https://pharos.nih.gov/idg/targets/P42336,P42336,18084252,"PIK3CA mutations are associated with myometrial invasion and tumors with PIK3CA mutations in exon 20 are frequently high-grade, invasive endometrial carcinomas."
https://pharos.nih.gov/idg/targets/P42336,P42336,18079394,"study reports a 3.0 angstrom resolution structure of a complex between p110alpha and a polypeptide containing the p110alpha-binding domains of p85alpha; results suggest specific mechanisms for the effect of oncogenic mutations in p110alpha and p85alpha"
https://pharos.nih.gov/idg/targets/P42336,P42336,18074223,"different PIK3CA mutations differentially contribute to breast cancer transformation"
https://pharos.nih.gov/idg/targets/P42336,P42336,18070887,"Phosphatidylinositol 3-kinase-dependent membrane recruitment of Rac-1 and p47phox is critical for alpha-platelet-derived growth factor receptor-induced production of reactive oxygen species."
https://pharos.nih.gov/idg/targets/P42336,P42336,18064631,"These data provide the first evidence that IL-18 and FN stimulate each other's expression"
https://pharos.nih.gov/idg/targets/P42336,P42336,18022911,"Sexual dimorphisms and tissue specific factors might directly or indirectly influence the occurrence of PI3KCA cancer alleles."
https://pharos.nih.gov/idg/targets/P42336,P42336,18000091,"A higher incidence of PIK3CA alterations and the possible synergistic effect of these alterations and BRAF mutations suggest their major role in Middle Eastern papillary thyroid neoplasms."
https://pharos.nih.gov/idg/targets/P42336,P42336,18000091,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,17990317,"Using both direct genomic DNA sequencing and novel mutant-enriched sequencing methods developed specifically for the 3 hot-spot mutations (H1047R, E545K and E452K) of PIK3CA, we detected 5 mutations of PIK3CA in the 24 pharyngeal cancers (20.8%)."
https://pharos.nih.gov/idg/targets/P42336,P42336,17986027,"An impaired control of glycogen synthase kinase-3beta activity by insulin receptor-mediated signalling plays a role in the pathogenesis of AD, facilitating tau protein phosphorylation and neurofibrillary tangle formation."
https://pharos.nih.gov/idg/targets/P42336,P42336,17982280,"The results presented here indicate that actin reorganization through FAK/PI3-K/Rac-1 activation operates in various human cancer cell systems supporting a functional role for FAK/PI-3K/Rac1/actin signaling in controlling cell motility."
https://pharos.nih.gov/idg/targets/P42336,P42336,17971428,"The C allele of rs361072 attenuates insulin resistance in superobese European children."
https://pharos.nih.gov/idg/targets/P42336,P42336,17947469,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,17947469,"exon 9 PIK3CA mutations are typical of infiltrating lobular carcinomas"
https://pharos.nih.gov/idg/targets/P42336,P42336,17942548,"rotavirus-induced PI3K activation causes regulation of integrin expression in intestinal cells, leading to prolonged adherence of infected cells to collagen and increased virus production."
https://pharos.nih.gov/idg/targets/P42336,P42336,17936563,"Observational study of gene-disease association, gene-gene interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,17936563,"In trastuzumab-treated breast cancer patients combined analysis of PTEN and PIK3CA identified twice as many patients at increased risk for progression compared to PTEN alone."
https://pharos.nih.gov/idg/targets/P42336,P42336,17924977,"High levels of p-AKT expression occurred independently of the presence of PTEN or PIK3CA mutations in endometrial cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,17923698,"Engagement of NKG2D by itself is sufficient to stimulate the formation of the natural killer cells immunological synapse (NKIS), with recruitment of NKG2D to the center synapse."
https://pharos.nih.gov/idg/targets/P42336,P42336,17877460,"The three most common tumour-derived alleles of p110alpha were shown to potently activate phosphoinositide 3-kinase signalling in human epithelial cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,17875942,"Data suggest that PI3K-C2beta and AKT are epistatic to intersectin, and show that ITSN, independent of its role in endocytosis, regulates a critical cellular signaling pathway necessary for cell survival."
https://pharos.nih.gov/idg/targets/P42336,P42336,17855350,"plexin-B1 promotes endothelial cell motility through RhoA and ROK by regulating the integrin-dependent signaling networks that result in the activation of PI3K and Akt"
https://pharos.nih.gov/idg/targets/P42336,P42336,17827385,"IGF-1 plays a role in potentiating platelet aggregation by complementing G(i)- but not G(q)-signaling pathways via PI3-K p110alpha."
https://pharos.nih.gov/idg/targets/P42336,P42336,17803655,"PIK3CA has an important role in human lung carcinogenesis, possibly by promoting malignant transformation."
https://pharos.nih.gov/idg/targets/P42336,P42336,17681398,"There was significant difference in survival between the lung cancer patients with PIK3CA normal copy number and the patients with PIK3CA amplification"
https://pharos.nih.gov/idg/targets/P42336,P42336,17673550,"oncogenic PIK3CA mutations contribute to the pathogenesis of skin tumors lacking malignant potential"
https://pharos.nih.gov/idg/targets/P42336,P42336,17669465,"Coexistent mutations/epigenetic inactivations in PI3K/AKT pathway may be responsible for the unusually aggressive course of ACC."
https://pharos.nih.gov/idg/targets/P42336,P42336,17657213,"PIK3CA mutations are mutually exclusive with PTEN loss in diffuse large B-cell lymphoma"
https://pharos.nih.gov/idg/targets/P42336,P42336,17635910,"Phosphoinositide 3-kinase-independent non-genomic signals transit from the androgen receptor to Akt1 in membrane raft microdomains"
https://pharos.nih.gov/idg/targets/P42336,P42336,17632570,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,17590872,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,17590872,"PIK3CA mutation was significantly associated with shorter relapse-free survival in stage II/III patients, and shorter disease-specific survival in all patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,17586693,"Whereas PI3K is downstream of MUC1 activation and negatively regulates TLR5 signaling, it is not responsible for MUC1-induced suppression of TLR5 signaling."
https://pharos.nih.gov/idg/targets/P42336,P42336,17575221,"PIK3CA mutations and PTEN loss were not mutually exclusive events and associated with similar prognostic factors"
https://pharos.nih.gov/idg/targets/P42336,P42336,17549376,"PIK3CA copy number gain and amplification is associated with head and neck squamous cell carcinoma"
https://pharos.nih.gov/idg/targets/P42336,P42336,17546593,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,17546593,"Data suggest that PIK3CA mutations contribute to the invasion step from intramucosal carcinoma to invasive carcinoma in colorectal carcinogenesis."
https://pharos.nih.gov/idg/targets/P42336,P42336,17507466,"Data suggest that lipid rafts play critical roles in KSHV infection and gene expression, probably due to their roles in modulating KSHV-induced PI3-K, RhoA-GTPase, and Dia-2 molecules essential for postbinding and entry stages of infection."
https://pharos.nih.gov/idg/targets/P42336,P42336,17487277,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,17471559,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,17468516,"PI3K/ILK/Akt/NF-kappaB axis is a promising target for therapeutic intervention in renal cell carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,17449641,"TLR3, PI3K, and IRF3 are involved in the poly IC-induced galectin-9 expression in HUVECs"
https://pharos.nih.gov/idg/targets/P42336,P42336,17426084,"data from a Chinese cohort provide further genetic evidence suggesting that dysregulated PI3K/Akt pathway plays a significant role in the pathogenesis of thyroid tumors"
https://pharos.nih.gov/idg/targets/P42336,P42336,17377809,"PIK3CA amplification and Ki-67 index were strong predictors for an early tumor-associated death in ovarian cancer patients."
https://pharos.nih.gov/idg/targets/P42336,P42336,17376864,"PIK3CA mutations may have a role in cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,17369495,"p110alpha PI-3K appears to uniquely regulate important monocyte functions, where other PI-3K isoforms are uninvolved or unable to fully compensate."
https://pharos.nih.gov/idg/targets/P42336,P42336,17363507,"studies show that mutant PIK3CA increases the capacity for proliferation and survival under environmental stresses, such as growth factor deprivation stress while also imparting greater dependency on the PI3K pathway for proliferation and survival"
https://pharos.nih.gov/idg/targets/P42336,P42336,17341442,"These data demonstrate that IGF-I induces COX-2 expression in human ovarian cancer cells, which is mediated by three parallel signaling cascades--PI3K, MAPK, and PKC pathways that differentially regulate COX-2 expression."
https://pharos.nih.gov/idg/targets/P42336,P42336,17317825,"The data suggest that aberrant activation of PI3K/Akt pathway plays an extensive role in thyroid tumorigenesis, particularly in FTC and ATC, and promotes progression of BTA to FTC and to ATC as the genetic alterations of this pathway accumulate."
https://pharos.nih.gov/idg/targets/P42336,P42336,17314276,"These results suggest that there is a fine distinction between the signaling activators and downstream effectors of the oncogenic PI3K and RAS pathways in breast epithelium and those in other tissues."
https://pharos.nih.gov/idg/targets/P42336,P42336,17307335,"These results demonstrate that hypoxic condition-and high cell density-induced expression of Redd1 is mediated by coactivation of Sp1 and HIF-1alpha downstream of the PI3K/Akt signaling pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,17237249,"Thus EPO promotes survival of endothelial cells through PI3K-dependent Bcl-x(L)-induction and BIM regulation, as well as through a separate mechanism involving the ERK pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,17235514,"PIK3CA alterations in primary (de novo) and secondary glioblastomas."
https://pharos.nih.gov/idg/targets/P42336,P42336,17222361,"PIK3CA exon 9 and exon 20 rarely mutate in nasopharyngeal carcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,17219054,"Results indicate that stimulation of heme oxygenase-1 expression by hypericin-PDT is a cytoprotective mechanism governed by the p38(MAPK) and PI3K pathways."
https://pharos.nih.gov/idg/targets/P42336,P42336,17202311,"PIK3CA mutations might exert their effects through activation of the phosphatidylinositol 3-kinase/AKT/ER-alpha pathway"
https://pharos.nih.gov/idg/targets/P42336,P42336,17157319,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,17141917,"Results show that coculture with ECs enhances VSMC adhesion and spreading by up-regulating beta(1)-integrin expression and activating the PI3K/Akt pathway. Interaction between ECs and VSMCs serves a role in vascular homeostasis and remodeling."
https://pharos.nih.gov/idg/targets/P42336,P42336,17062663,"PIK3CA may serve as a marker of invasion in endometrial cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,17060456,"Activation of PI3K signaling by mutations in PTEN or PIK3CA can lead to activation of p53-mediated growth suppression."
https://pharos.nih.gov/idg/targets/P42336,P42336,17052259,"Mutations of the PIK3CA gene is associated with the development of oral squamous cell carcinoma"
https://pharos.nih.gov/idg/targets/P42336,P42336,17050665,"This is the first study showing PIK3CA mutations in pediatric glioblastomas, thus providing a molecular target in this important pediatric malignancy."
https://pharos.nih.gov/idg/targets/P42336,P42336,17006756,"It has recently been shown that Akt activation is associated with a worse outcome among endocrine treated breast cancer patients and that it also inhibits the progesterone receptor (PR) expression via the PI3K/Akt pathway in breast cancer cells."
https://pharos.nih.gov/idg/targets/P42336,P42336,16968743,"PI3K is an important intracellular regulator of epidermal homeostasis and repair."
https://pharos.nih.gov/idg/targets/P42336,P42336,16949921,"results confirm that PIK3CA mutations are frequent in endometrial carcinoma and support the hypothesis that PIK3CA mutations may have an additive effect to PTEN monoallelic inactivation in endometrial carcinoma"
https://pharos.nih.gov/idg/targets/P42336,P42336,16930767,"PIK3CA mutation incidence was significantly lower in lung adenocarcinoma than in lung squamous cell carcinoma; among eight patients with a PIK3CA mutation, three patients also harbored an EGFR somatic mutation."
https://pharos.nih.gov/idg/targets/P42336,P42336,16885334,"PIK3CA mutations were strongly associated with FGFR3 mutations in superficial papillary bladder tumors."
https://pharos.nih.gov/idg/targets/P42336,P42336,16840732,"Outside-in signaling via P2Y12 and both PI3Kbeta and PI3Kgamma isoforms is required for maintenance of a platelet aggregate."
https://pharos.nih.gov/idg/targets/P42336,P42336,16839745,"The expression of p110alpha siRNA significantly decreased cell migration, invasion and proliferation."
https://pharos.nih.gov/idg/targets/P42336,P42336,16837650,"These studies demonstrate that induction of fibulin 5 gene expression in lung fibroblasts is mediated via canonical TGF-beta/Smad signaling and requires the PI3-kinase/Akt pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,16822308,"Pik3ca, Ras family, and Braf activating mutations occur rarely in human neuroblastomas or in a murine model driven by neural-restricted MYCN overexpression."
https://pharos.nih.gov/idg/targets/P42336,P42336,16820791,"TGF-beta1 regulates COX-2 expression in human mesangial cells through the activation of ERK1/2, p38 MAPK, and PI3K."
https://pharos.nih.gov/idg/targets/P42336,P42336,16815198,"PIK3CA amplification is uncommon and appears to be late event in the development of ethmoid sinus adenocarcinoma."
https://pharos.nih.gov/idg/targets/P42336,P42336,16790501,"Acidic pH exposure protects HEMEC through induction of Hsps and activation of MAPK and PI3 kinase pathway."
https://pharos.nih.gov/idg/targets/P42336,P42336,16788758,"Increased expression for PIK3CA mrna is associated with regional lymph node metastasis in esophageal squamous cell carcinoma"
https://pharos.nih.gov/idg/targets/P42336,P42336,16778113,"First report of PIK3CA mutation in pancreatic cancer, providing evidence of its oncogenic properties."
https://pharos.nih.gov/idg/targets/P42336,P42336,16775835,"p110alpha play an important role in tumor growth by inducing angiogenesis and by increasing HIF-1alpha and VEGF expression. This work provides a better understanding of the molecular mechanism of human cancer induced by the activation of PI3K signaling."
https://pharos.nih.gov/idg/targets/P42336,P42336,16764926,"Various mutations in a variety of cancers, including a pseudogene and polymorphisms."
https://pharos.nih.gov/idg/targets/P42336,P42336,16728507,"PI3K-IA activity is necessary for both high NaCl- and ionizing radiation-induced activation of ATM and (ii) high NaCl activates PI3K-IA, which, in turn, contributes to full activation of TonEBP/OREBP via ATM."
https://pharos.nih.gov/idg/targets/P42336,P42336,16682946,"inhibition of PI 3-kinase activity reduced hypoxic HIF-1alpha protein levels to a similar extent as serum deprivation"
https://pharos.nih.gov/idg/targets/P42336,P42336,16627990,"Somatic mutations of PIK3CA, encoding p110alpha catalytic subunit of Class IA PI3Ks, have been found in various cancers."
https://pharos.nih.gov/idg/targets/P42336,P42336,16618717,"Observational study of gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,16582596,"Mutation of PIK3CA is associated with breast cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,16569657,"Although a key factor in TRAF6-dependent activation of PI 3-kinase, ectopic expression of Src was insufficient for NF-kappaB activation and, in contrast to NF-kappaB, was not inhibited by IRAK2."
https://pharos.nih.gov/idg/targets/P42336,P42336,16533766,"PIK3CA mutations are associated with head and neck squamous cell carcinoma"
https://pharos.nih.gov/idg/targets/P42336,P42336,16524887,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,16522324,"AT(1) receptor-mediated activation of PI 3-K/Akt cascades occurs at least partially via the transactivation of EGF receptor, which is under a negative control by AT(2) receptor in hypertrophic scar fibroblasts."
https://pharos.nih.gov/idg/targets/P42336,P42336,16406609,"These results indicate that PI3K plays different roles in the activation of Ras/ERK1/2 signaling by insulin and EGF, and that insulin-stimulated, but not EGF-stimulated, ERK1/2 and Akt signalings diverge at PI3K."
https://pharos.nih.gov/idg/targets/P42336,P42336,16397024,"Observational study of genotype prevalence. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,16380997,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,16380997,"study extends previous observations in other tumor types by demonstrating presence of somatic PIK3CA mutations in both SCC and adenocarcinoma of the esophagus, thus implicating the PI3K pathway in the initiation and/or progression of esophageal cancers"
https://pharos.nih.gov/idg/targets/P42336,P42336,16376301,"A mutation status profile of the PIK3Ca gene in the National Cancer Institute (NCI)-60 panel of human cancer cell lines provides insights into the role of mutant PIK3Ca in oncogenic signaling"
https://pharos.nih.gov/idg/targets/P42336,P42336,16353168,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,16341083,"cancer-specific mutations in PIK3CA have made p110alpha an ideal drug target [Review]"
https://pharos.nih.gov/idg/targets/P42336,P42336,16339315,"although introduction of activating mutations from p110alpha at the corresponding sites in p110beta failed to render the enzyme oncogenic in human cells, the possibility remains that other mutations might activate the beta isoform"
https://pharos.nih.gov/idg/targets/P42336,P42336,16339173,"Data show that alpha6 and alpha3 integrin subunits interact with laminin 5 to increase expression of E-cadherin, and suggest that phosphoinositide 3-kinase (PI 3-kinase) activation plays a key role in this cross-talk."
https://pharos.nih.gov/idg/targets/P42336,P42336,16317585,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,16317585,"PIK3CA mutations are associated with breast cancer"
https://pharos.nih.gov/idg/targets/P42336,P42336,16288007,"Mutant PIK3CA is likely to function as an oncogene in anaplastic thyroid cancer and less frequently well-differentiated thyroid carcinomas."
https://pharos.nih.gov/idg/targets/P42336,P42336,16287065,"increased activation state of AKT kinase appears to be present in cervical carcinogenesis, and may be accounted for by PIK3CA amplification, whereas PTEN mutation seems to be of little importance"
https://pharos.nih.gov/idg/targets/P42336,P42336,16203798,"analysis of PIK3CA mutations in ovarian cancer [letter]"
https://pharos.nih.gov/idg/targets/P42336,P42336,16168105,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,16168105,"The frequent and clustered mutations within PIK3CA make it an attractive molecular marker for early detection and a promising therapeutic target in breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,16150444,"this study has shown that the mutations detected in the helical and kinase domains of PIK3CA do not seem to affect the PI3-K pathway characteristics of the eight cell lines studied"
https://pharos.nih.gov/idg/targets/P42336,P42336,16150119,"an important role of PIK3CA gene aberrations in the molecular pathogenesis of primary glioblastomas"
https://pharos.nih.gov/idg/targets/P42336,P42336,16114017,"copy number gains, instead of mutation, may be a common mechanism for activation of PIK3CA in tumorigenesis of primary nasopharyngeal carcinoma"
https://pharos.nih.gov/idg/targets/P42336,P42336,16081599,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,16034135,"PI-3 kinase p110alpha subunit expression and recombinant heparin-binding epidermal growth factor-like growth factor (HB-EGF) synergistically decrease inducible nitric oxide synthase expression and nitric oxide production in intestinal epithelial cells"
https://pharos.nih.gov/idg/targets/P42336,P42336,15994075,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,15950905,"Amino acid substitutions in PIK3CA from human colorectal cancer cell lines constitutively activate the AKT pathway, and consequently, promote tumor cell growth and invasion."
https://pharos.nih.gov/idg/targets/P42336,P42336,15930273,"Colon cancer-associated PIK3CA mutations are functionally active so that they are likely to be involved in carcinogenesis."
https://pharos.nih.gov/idg/targets/P42336,P42336,15928251,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42336,P42336,15928251,"mutation of the PIK3CA gene is not common, but its amplification is relatively common and may be a novel mechanism in activating the PI3K/Akt pathway in some thyroid tumors"
https://pharos.nih.gov/idg/targets/P42336,P42336,15837735,"Data indicate that mutations of PIK3CA play an oncogenic role in substantial fractions of ovarian and breast carcinomas."
https://pharos.nih.gov/idg/targets/P42336,P42336,15805248,"Mutation of PIK3CA is frequent, occurs early in carcinoma development, and has prognostic and therapeutic implications for breast cancer."
https://pharos.nih.gov/idg/targets/P42336,P42336,15784156,"Activation of the PI3K signalling pathway in gastric cancer may be achieved through up-regulation or mutation of PIK3CA, in which the latter may be a consequence of mismatch repair deficiency."
https://pharos.nih.gov/idg/targets/P42336,P42336,15712344,"PIK3CA mutations in exons 9 & 20 were directly sequenced. A novel silent mutation was found. PIK3CA mutation may be an early event in ovarian carcinogenesis."
https://pharos.nih.gov/idg/targets/P42336,P42336,15689238,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,15647370,"determined the growth-regulatory and signaling properties of the three most frequently observed PIK3CA mutations: E542K, E545K, and H1047R"
https://pharos.nih.gov/idg/targets/P42336,P42336,15632060,"Data show that glucose is a crucial regulator of V-ATPase in renal epithelial cells and that the effect of glucose is mediated by phosphatidylinositol 3-kinase (PI3K)."
https://pharos.nih.gov/idg/targets/P42336,P42336,15605984,"Genetic alterations of class IA PI3K subunit genes can occasionally play a role in human glioblastoma by activating the PI3K-AKT signaling pathway independently of PTEN mutation."
https://pharos.nih.gov/idg/targets/P42336,P42336,15467468,"oncogenic mutations in human cancers"
https://pharos.nih.gov/idg/targets/P42336,P42336,15289301,"Mutations of PIK3CA is associated with anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas"
https://pharos.nih.gov/idg/targets/P42336,P42336,15254419,"Missense Mutation in PIK3CA is associated with breast cancers"
https://pharos.nih.gov/idg/targets/P42336,P42336,15016963,"data suggest that mutant PIK3CA is likely to function as an oncogene in human cancers; PIK3CA may prove useful for diagnostic and therapeutic purposes"
https://pharos.nih.gov/idg/targets/P42336,P42336,14602571,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,12960231,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,12704201,"agonist binding to Gq-coupled receptors blocks Akt activation via the release of active Galphaq subunits that inhibit PI3K via an inhibitory interaction between Galphaq and p110alpha PI3K."
https://pharos.nih.gov/idg/targets/P42336,P42336,12584329,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,12551992,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,12526811,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,12077252,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,11994280,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,11959846,"In squamous cell carcinomas the negative effect of p53 induction on cell survival involves transcriptional inhibition of PIK3CA that is independent of PTEN activity, as PTEN is not expressed in the primary tumors"
https://pharos.nih.gov/idg/targets/P42336,P42336,11289809,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,11156964,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,11154208,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,10985305,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,10208934,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,9808187,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,9708406,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,9446795,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,9394803,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,9341793,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,9247029,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,8798481,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,8636073,"HIV-1 Nef interacts with AKT1 and PI3K via its C and N terminal extremity, respectively"
https://pharos.nih.gov/idg/targets/P42336,P42336,2174051,"This paper reports the first purification of a phosphoinositide 3-kinase and shows that the protein is a heterodimer of an 85 kd regulatory subunit that mediates binding to phosphorylated proteins and a 110 kd catalytic subunit."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,28779020,"this study shows that PIKfyve coordinates the neutrophil immune response through the activation of the Rac GTPase"
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,27623384,"Here we identify the lipid kinase PIKfyve as a regulator of an alternative pathway that distributes engulfed contents in support of intracellular macromolecular synthesis during macropinocytosis, entosis, and phagocytosis. We find that PIKfyve regulates vacuole size in part through its downstream effector, the cationic transporter TRPML1"
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,27438886,"in PC-3 cells inhibition of PIKfyve by apilimod or depletion by siRNA increased the secretion of the exosomal fraction."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,26934981,"A cell-permeable tool for analysing APP intracellular domain function and manipulation of PIKfyve activity."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,26405034,"data identify a novel role of the ArPIKfyve-Sac3 complex in the mechanisms controlling aggregate formation of Sph1 and suggest that Sac3 protein deficiency or overproduction may facilitate aggregation of aggregation-prone proteins"
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,26396486,"A novel heterozygous frameshift mutation (c.3151dupA) and a copy number variations in PIKFYVE gene have been found in two unrelated Fleck corneal dystrophy patients."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,26216398,"The PIKfyve complex is required for APP trafficking, suggesting a feedback loop in which APP, by binding to and stimulating phosphatidylinositol-3,5-bisphosphate vesicle formation may control its own trafficking."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,26125944,"APP functionally cooperates with PIKfyve in vivo. This regulation is required for maintaining endosomal and neuronal function."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,24840251,"Data suggest PIKFYVE, MTMR3 (myotubularin related protein 3) and their product phosphatidylinositol 5-phosphate are involved in activation of RAC1 (rho family small GTP binding protein); this process regulates migration/invasion of carcinoma/sarcoma."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,24600036,"Data indicate that pharmacological or genetic inactivation of PIKfyve rapidly induces expression of the transcription repressor ATF3, which is necessary and sufficient for suppression of type I IFN expression."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,23757022,"Data indicate that AKT promotes EGFR recycling by phosphorylating and activating PIKfyve."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,23297396,"PIP5Kalpha promotes TLR4-associated microglial inflammation by mediating PIP(2)-dependent recruitment of TIRAP to the plasma membrane"
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,23188060,"the present observations show that PKB in conjunction with PIKfyve activates Kir2.1 channels."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,23178941,"Overexpression of phosphatidylinositol 4 phosphate 5-kinase (PIP5K) suppresses HIV-1 Tat-mediated inhibition of growth hormone secretion from cells"
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,23154468,"Production of phosphatidylinositol 5-phosphate via PIKfyve and MTMR3 regulates cell migration."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,22621786,"The results provide the first experimental evidence that the principal pathway for PtdIns5P intracellular production is through PIKfyve."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,22065932,"A novel c.3060-3063 delCCTT (p.P968Vfs23) mutation in the PIKFYVE gene has been described in a five generation Greek family, which segregated with the fleck corneal dystrophy."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,20945365,"The recent advances in Arf6/PIP5K signaling and its linkage to cellular functions, are reviewed."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,20041238,"Data conclude that PIKfyve participates in the regulation of TRPV6."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,19910676,"Coexpression of PIKfyve is followed by a marked increase of glutamate induced currents in EAAT2 expressing oocytes."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,19852935,"these results demonstrate that PIKfyve regulates CFTR activity, and suggest a novel mechanism of CFTR regulation."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,19841139,"PIKfyve-dependent channel degradation is essential to prevent Ca2+-induced toxicity in neurons."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,19840946,"PIKfyve-ArPIKfyve-Sac3 core complex: contact sites and their consequence for Sac3 phosphatase activity and endocytic membrane homeostasis"
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,19582903,"Results suggest that PIKfyve inhibition may render the late endosome/lysosome compartment refractory to fusion with both autophagosomes and with EGFR-containing multivesicular bodies."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,19232516,"PIKfyve is a potent stimulator of ClC-2-activity and contributes to SGK1-dependent regulation of ClC-2."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,19056739,"Kinesin adapter JLP links PIKfyve to microtubule-based endosome-to-trans-Golgi network traffic of furin."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,18950639,"The authors data indicate that the PAS complex is organized to provide optimal PIKfyve functionality and is maintained via ArPIKfyve homomeric and heteromeric interactions."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,18774718,"A phylogenetic study revealing co-evolution of phosphoinositides kinases and phosphatases ; PIKFYVE is absent from several organisms and co-evolved with VAC14 and FIG4"
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,18501703,"These data suggest for the first time a role of PtdIns5P and PIKfyve in oncogenesis, potentially linking intracellular trafficking to cancer."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,18429927,"REVIEW : PIKFYVE and other phosphoinositides regulatory proteins are implicated in human genetic diseases"
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,17570343,"The observations disclose that PIKfyve participates in the SGK1-dependent regulation of SLC5A1."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,17146146,"results suggest that the local production of PtdIns(3)P implicates the fusion of macropinosomes via EEA1 as well as conventional early endosomes"
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,16954148,"PIKfyve regulates endosome-to-TGN retrograde transport."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,16801682,"The first multicellular model for PIKFYVE loss, pointing to a role in lysosome maturation"
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,16448788,"PIKfyve is distributed in microdomains that are distinct from those occupied by EEA1 and Hrs"
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,15902656,"Linkage analysis localized CFD to a 24-cM (18-Mb) interval of chromosome 2q35 flanked by D2S2289 and D2S126 and containing PIP5K3."
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,15542851,"the PIKfyve-associated hVac14 protein has a major role in activating PIKfyve and thereby regulating PtdIns(3,5)P(2) synthesis and endomembrane homeostasis in mammalian cells"
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,14551253,"PIKfyve selectively regulates the sorting and traffic of peripheral endosomes containing lysosomaly directed fluid phase cargo through controlling the morphogenesis and function of multivesicular bodies"
https://pharos.nih.gov/idg/targets/Q9Y2I7,Q9Y2I7,14530284,"p40 interaction with PIKfyve p40 os demonstrated; PIKfyve interaction and the subsequent PIKfyve-catalyzed p40 phosphorylation anchor p40 to discrete membranes facilitating late endosome-to-TGN transport."
https://pharos.nih.gov/idg/targets/P42356,P42356,28566381,"hCKalpha functions as an indispensable regulator that bridges PI4KIIIalpha and hepatitis C virus NS5A and potentiates NS5A-stimulated PI4KIIIalpha activity, which then facilitates the targeting of the ternary complex to the endoplasmic reticulum for viral replication."
https://pharos.nih.gov/idg/targets/P42356,P42356,27870828,"Blockade of IQGAP1 interaction with PIPKIalpha or PI(3)K inhibited PtdIns(3,4,5)P3 generation and signalling, and selectively diminished cancer cell survival."
https://pharos.nih.gov/idg/targets/P42356,P42356,27093462,"The results showed that, in contrast to the enteroviruses and the cardioviruses, foot-and-mouth disease virus replication does not require PI4KIII (PI4KIIIalpha and PI4KIIIbeta), and phosphatidylinositol 4-phosphate levels do not increase in foot-and-mouth disease virus-infected cells and phosphatidylinositol 4-phosphate is not seen at replication organelles."
https://pharos.nih.gov/idg/targets/P42356,P42356,25886792,"PI4K III alpha plays a role in biosynthetic trafficking of two different classes of proteins from the ER to the Golgi complex."
https://pharos.nih.gov/idg/targets/P42356,P42356,25855803,"Missense mutations in PI4KA are associated with perisylvian polymicrogyria, cerebellar hypoplasia and arthrogryposis."
https://pharos.nih.gov/idg/targets/P42356,P42356,25608530,"Our results suggest a plasticity of the molecular interactions that control PI4KIIIalpha localization and functions at the plasma membrane."
https://pharos.nih.gov/idg/targets/P42356,P42356,25209194,"PI4KA and GRM3 polymorphisms have potential to jointly modulate antipsychotic response"
https://pharos.nih.gov/idg/targets/P42356,P42356,25168678,"our results suggest a mechanism of PI4K IIalpha recruitment, regulation, and function at the membrane."
https://pharos.nih.gov/idg/targets/P42356,P42356,24920820,"The N-terminal 1,152 amino acids were dispensable for hepatitis C virus replication, phosphatidylinositol 4-phosphate induction, and enzymatic function, thereby defining the minimal PI4KIIIalpha core enzyme at a size of ca. 108 kDa."
https://pharos.nih.gov/idg/targets/P42356,P42356,24671493,"These results suggest that type II PtdIns 4-kinases are part of piperine-mediated anti-inflammatory signaling mechanisms"
https://pharos.nih.gov/idg/targets/P42356,P42356,24415756,"PI4KA is essential for the maintenance of plasma membrane phosphatidylinositol 4,5-bisphosphate pools but only during strong stimulation of receptors coupled to phospholipase C activation."
https://pharos.nih.gov/idg/targets/P42356,P42356,24393405,"PI4KA mRNA could be used as a new molecular marker to improve established prognostic models for hepatocellular carcinoma."
https://pharos.nih.gov/idg/targets/P42356,P42356,24077433,"Descriptive Statement The genetic interactions associated with ILVatrophy rate in this study may be mapping variants inSYNJ2andPI4KAthat interact to decrease synthesisof PIP."
https://pharos.nih.gov/idg/targets/P42356,P42356,23675303,"we demonstrate that PI4KIIIalpha activity affects the NS5A phosphorylation status."
https://pharos.nih.gov/idg/targets/P42356,P42356,22896614,"Cell culture studies with Phosphatidylinositol-4-kinase IIIalpha inhibitors demonstrated that the kinase activity was essential for hepatitis C virus RNA replication."
https://pharos.nih.gov/idg/targets/P42356,P42356,22535966,"Phosphatidylinositol 4-kinase IIalpha is palmitoylated by Golgi-localized palmitoyltransferases in cholesterol-dependent manner"
https://pharos.nih.gov/idg/targets/P42356,P42356,22022594,"PI4KA is necessary for the local enrichment of PI 4-phosphate at the hepatitis c virus membranous web."
https://pharos.nih.gov/idg/targets/P42356,P42356,21697487,"These results suggest that hepatitis C virus NS5A modulation of PI4KA-dependent phosphatidylinositol 4-phosphate production influences replication complex formation."
https://pharos.nih.gov/idg/targets/P42356,P42356,21601653,"confirmed the high copy number of PI4KIIIalpha transcript in K562 cells along with several genes located in the same region in Chr22, including two pseudogenes that cover most exons coding for isoform 1, consistent with chromosome amplification"
https://pharos.nih.gov/idg/targets/P42356,P42356,21330372,"Study identify the molecular chaperone Hsp90 as a binding partner of PI4KIIbeta, but not of PI4KIIalpha."
https://pharos.nih.gov/idg/targets/P42356,P42356,21297162,"PI4KIIIalpha is an essential host factor that supports HCV proliferation and therefore PI4KIIIalpha may be a legitimate target for anti-HCV therapy."
https://pharos.nih.gov/idg/targets/P42356,P42356,21238945,"This analysis suggests that the direct activation of a lipid kinase PI4KA by hepatitis C virus NS5A contributes critically to the integrity of the membranous viral replication complex."
https://pharos.nih.gov/idg/targets/P42356,P42356,20628086,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42356,P42356,20530568,"Data suggest that Rab1 contributes to the specificity and timing of GBF1 recruitment by activating PI4KIIIalpha, and that the PtdIns(4)P produced then allows GBF1 to bind to Golgi membranes and activate Arf1."
https://pharos.nih.gov/idg/targets/P42356,P42356,20052689,"No strong association between PIK4CA and psychosis in people with 22q11.2 deletion syndrome"
https://pharos.nih.gov/idg/targets/P42356,P42356,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42356,P42356,19608626,"our library screening completed data on the clathrin-mediated endocytosis-dependant entry route of HCV and identified 2 kinases, PI4KIIIalpha and beta, as relevant potential therapeutic targets."
https://pharos.nih.gov/idg/targets/P42356,P42356,19605471,"genetic or pharmacological modulation of PI4KA and PI4KB inhibits multiple genotypes of HCV"
https://pharos.nih.gov/idg/targets/P42356,P42356,19304308,"the PI4KA gene was shown to be essential for the replication of all HCV genotypes tested"
https://pharos.nih.gov/idg/targets/P42356,P42356,18646052,"Association of the PIK4CA schizophrenia-susceptibility gene in adults with the 22q11.2 deletion syndrome is reported."
https://pharos.nih.gov/idg/targets/P42356,P42356,18646052,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42356,P42356,18615484,"Failure to confirm the association between the PIK4CA gene and schizophrenia in a Japanese population is reported."
https://pharos.nih.gov/idg/targets/P42356,P42356,18585705,"The putative bipartite nuclear localization signal(NLS) itself is a nucleolar targeting signal, and for nuclear import PI4K230 requires a larger sequence around it or, alternatively, the monopartite NLS."
https://pharos.nih.gov/idg/targets/P42356,P42356,18521859,"The present study suggests that the PIK4CA gene does not play a significant role in the vulnerability to METH use disorder in the Japanese population."
https://pharos.nih.gov/idg/targets/P42356,P42356,18521859,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42356,P42356,18077555,"These results indicate that a small fraction of the cellular PI4K activity is sufficient to maintain plasma membrane phosphoinositide pools."
https://pharos.nih.gov/idg/targets/P42356,P42356,17893707,"The PIK4CA gene is located in the chromosome 22q11 deletion syndrome region, which is of particular interest because it has been implicated in schizophrenia."
https://pharos.nih.gov/idg/targets/P42356,P42356,17893707,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42356,P42356,17555516,"PI4KIIalpha or PI4KIIbeta knockdown, but not type III PI4Kbeta knockdown, inhibits Listeria internalization."
https://pharos.nih.gov/idg/targets/P42356,P42356,17131383,"These experiments suggest the participation of PI4K230 in a DNase and RNase sensitive complex with a unique localization and function in the nucleolus."
https://pharos.nih.gov/idg/targets/P42356,P42356,16606619,"nuclear phosphatidylinositol 4-phosphate, and consequently, synthesis of polyphosphoinositides are required for a correct nuclear function"
https://pharos.nih.gov/idg/targets/P42356,P42356,15634669,"PI4KIIIbeta (PIK4CB) and PI4KIIalpha (PIK4CA) localize to discrete subcompartments of the Golgi complex in Madin-Darby canine kidney (MDCK) cells."
https://pharos.nih.gov/idg/targets/P42356,P42356,12497619,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/P42356,P42356,11907035,"parallel activation by extracellular calcium-sensing receptor"
https://pharos.nih.gov/idg/targets/O00750,O00750,29088297,"this study suggests that PIK3C2B might only have a minor role in SQCC oncogenesis"
https://pharos.nih.gov/idg/targets/O00750,O00750,25622909,"PI3KC2B-silencing inhibits early stages of neuroblastoa tumorigenic growth."
https://pharos.nih.gov/idg/targets/O00750,O00750,24073214,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,23320105,"Class II enzyme PI3K-C2beta and the class IB isozyme p110gamma mainly regulate the S1P- and high density lipoprotein (HDL)-dependent endothelial cell (EC) migration and PI3K-C2alpha primarily controls EC survival"
https://pharos.nih.gov/idg/targets/O00750,O00750,23301033,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,23251686,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,23215766,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,23028960,"Data suggest a novel role for nucleotide-free Ras in cell signaling in which PI3KC2beta stabilizes nucleotide-free Ras and that interaction of Ras and PI3KC2beta mutually inhibit one another."
https://pharos.nih.gov/idg/targets/O00750,O00750,22825724,"The results of this study showed that strong association between PIK3C2B gene alternation and high-grade oligodendroglial tumors."
https://pharos.nih.gov/idg/targets/O00750,O00750,22128329,"These findings provide a unique mechanism for regulating class II PI3Ks, and identify TRIM27 as a previously undescribed negative regulator of CD4 T cells."
https://pharos.nih.gov/idg/targets/O00750,O00750,21986133,"Overexpression of PIK3C2B is associated with esophageal squamous cell carcinoma."
https://pharos.nih.gov/idg/targets/O00750,O00750,21029719,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,20818790,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,20628086,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00750,O00750,20602615,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00750,O00750,20379614,"Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00750,O00750,20378550,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,20197460,"Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00750,O00750,20019835,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,19913121,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00750,O00750,19587117,"Data show that the class II phosphatidylinositol 3 kinase C2beta (PI3K-C2beta) is activated by the T-cell receptor (TCR) and functions upstream of NDPK-B to activate KCa3.1 channel activity."
https://pharos.nih.gov/idg/targets/O00750,O00750,19536175,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00750,O00750,19496756,"Epidermal growth factor stimulates the appearance of PI3K-C2beta in nuclei."
https://pharos.nih.gov/idg/targets/O00750,O00750,18996102,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O00750,O00750,18854243,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,18453587,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,17632570,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,17157319,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,16775008,"These findings suggest that PI3KC2beta regulates the migration and survival of human tumor cells by distinct molecular mechanisms."
https://pharos.nih.gov/idg/targets/O00750,O00750,16524887,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,16314532,"Class II phosphoinositide 3-kinase C2beta isnot essential for epidermal differentiation"
https://pharos.nih.gov/idg/targets/O00750,O00750,16271833,"identified the 185-kDa protein altered by nitrotyrosylation in platelets from patients with systemic sclerosis as phosphoinositide kinase C2beta (PI 3-K); the activity of PI 3-K increases in nitrotyrosylated platelet lystaes from patients with SSc"
https://pharos.nih.gov/idg/targets/O00750,O00750,16113997,"plays a regulatory role in cell motility"
https://pharos.nih.gov/idg/targets/O00750,O00750,16081599,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,15689238,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,14602571,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,12960231,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,12584329,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,12551992,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,12526811,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,12372612,"activity of nuclear phosphoinositide 3-kinase C2beta investigated in HL-60 cells induced to differentiate along granulocytic or monocytic lineages"
https://pharos.nih.gov/idg/targets/O00750,O00750,12356726,"different human small cell lung carcinoma cell lines overexpress distinct subsets of PI3Ks, resulting in differences in signalling cascades activated by stem cell factor; insights into specificity and functional significance of PI3K signalling in cancer"
https://pharos.nih.gov/idg/targets/O00750,O00750,12077252,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,11994280,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,11289809,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,11156964,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,11154208,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,10985305,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,10208934,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,9808187,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,9708406,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,9446795,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,9394803,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,9341793,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,9247029,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,8798481,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O00750,O00750,8636073,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,24983663,"Data indicate substituents of benzensulfonamide and pyrazine as phosphoinositide 3-kinase-C2gamma (PI3K-C2GAMMA) inhibitors."
https://pharos.nih.gov/idg/targets/O75747,O75747,24073214,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,23301033,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,23251686,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,23215766,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,21029719,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,20818790,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,20602615,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O75747,O75747,20019835,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,18996102,"Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O75747,O75747,18854243,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,18453587,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,17991425,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O75747,O75747,17991425,"The associations of five SNPs (SNPs1-5: A-5468G, A-3333G, C-1794T, C437T and T9148C) of the class II phosphoinositide 3-kinase gamma-subunit (PIK3C2G) gene with type 2 diabetes were examined."
https://pharos.nih.gov/idg/targets/O75747,O75747,17893707,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/O75747,O75747,17632570,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,17157319,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,16524887,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,16081599,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,15689238,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,14602571,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,12960231,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,12584329,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,12551992,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,12526811,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,12077252,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,11994280,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,11289809,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,11156964,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,11154208,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,10985305,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,10208934,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,9808187,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,9708406,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,9446795,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,9394803,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,9341793,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,9247029,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,8798481,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/O75747,O75747,8636073,"HIV-1 Tat induces phosphorylation of PI3K, AKT, PTEN, and GSK-3beta activating PI3K and AKT and inactivating PTEN and GSK-3beta in vIL-6 expressing cells"
https://pharos.nih.gov/idg/targets/Q8TBX8,Q8TBX8,20439292,"Observational study of gene-disease association, gene-gene interaction, and gene-environment interaction. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8TBX8,Q8TBX8,19644859,"Observational study of gene-disease association. (HuGE Navigator)"
https://pharos.nih.gov/idg/targets/Q8TBX8,Q8TBX8,18794853,"Meta-analysis and genome-wide association study of gene-disease association. (HuGE Navigator)"
